Category: Medical Info

FDA approves new cholesterol-lowering drug : NPR

The Food and Drug Administration has approved a powerful new kind of cholesterol-lowering drug.

Transcript

LEILA FADEL, HOST:

The Food and Drug Administration has approved a new kind of drug to cut cholesterol. So we’ve called up NPR health correspondent Rob Stein to learn what it can do. Good morning, Rob.

ROB STEIN, BYLINE: Good morning.

FADEL: So what is this new drug?

STEIN: It’s called Lipfendra, and it offers an important new way for people to protect their hearts by cutting the amount of LDL cholesterol in their blood. LDL, you know, is known as the bad cholesterol because it can clog up arteries and blood vessels, and that increases the risk for heart attacks and strokes, which remain the No. 1 killer. I talked about this development with Dr. Christopher Cannon. He’s a cardiologist at the Brigham and Women’s Hospital in Boston.

CHRISTOPHER CANNON: The new cholesterol drug is a wonderful advance for the field that will help tens of millions of people potentially in lowering cholesterol and ultimately helping prevent heart attacks and strokes. It comes at a perfect time.

STEIN: And that’s because the American Heart Association and the American College of Cardiology just issued new guidelines that recommend people get their cholesterol levels lower than ever before.

FADEL: And how does the drug work?

STEIN: So it works by inhibiting a protein known as PCSK9. That helps the liver get rid of bad cholesterol. And the FDA says two studies involving thousands of patients found Lipfendra could cut LDL levels big-time, by more than half, and it looks very safe. This type of drug had already been available as an injection, but, you know, a shot’s a big turnoff for a lot of people. This is the first pill form, which is obviously a lot easier to take.

I should mention that the studies didn’t actually show the drug reduces heart attacks and strokes, but experts think that’s – there’s no reason to think it wouldn’t.

FADEL: Now, aren’t there plenty of other really cheap drugs already available to lower cholesterol? Why would we need this one?

STEIN: So some people can control their cholesterol by eating well and exercising, but that just doesn’t work for millions of people. For them, there are plenty of safe drugs that do the trick, like pills called statins. That said, there are still millions of people who can’t control their cholesterol, get them down to safe levels. Here’s Dr. Puja Banka from Merck, which make Lipfendra.

PUJA BANKA: Seventy percent of patients that are already on treatment are not at their guideline-recommended LDL goals. And so we really think that this new advance has the potential to change how doctors help manage their patients and get them to their recommended goals.

STEIN: By prescribing Lipfendra in addition to drugs like statins for those who need it. You know, Leila, as kind of a side, I should mention that researchers are also developing other ways to target the same PCSK9 protein that Lipfendra targets. There’s even an experimental one-time gene editing therapy that’s showing promise for lowering bad cholesterol for life.

FADEL: OK. So when will this new pill be available, and how much will it cost?

STEIN: Merck says doctors should be able to start prescribing Lipfendra within the next few weeks. The company says the list price will be $315 for a 30-day supply, but it’ll cost a lot less for people with insurance, and Merck says it’ll help people who don’t have insurance.

FADEL: That’s NPR health correspondent Rob Stein. Thank you, Rob.

STEIN: You bet.

Copyright © 2026 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

Accuracy and availability of NPR transcripts may vary. Transcript text may be revised to correct errors or match updates to audio. Audio on npr.org may be edited after its original broadcast or publication. The authoritative record of NPR’s programming is the audio record.

FDA says do not eat shredded lettuce from Taco Bell in 5 states : NPR

Shredded lettuce served at Taco Bell in Michigan, Ohio, Kentucky, West Virginia and Indiana is linked to cyclospora outbreak. Investigation continues

Transcript

AILSA CHANG, HOST:

Lettuce from Mexico is linked to a multistate outbreak of cyclospora, and the Food and Drug Administration is now warning people not to eat shredded iceberg lettuce served at Taco Bell locations in the affected states. NPR’s Allison Aubrey joins us now with more details. Hi, Allison.

ALLISON AUBREY, BYLINE: Hi, Ailsa. Great to be here.

CHANG: Great to have you. OK, so what started out as this small outbreak seemed to grow really quickly, and now it sounds like we have the source of this outbreak. It’s been identified.

AUBREY: Well, yes, a likely source. The Centers for Disease Control and Prevention says more than 1,600 people infected with cyclospora reported eating Taco Bell in five states. These are Indiana, Kentucky, Michigan, Ohio and West Virginia. And in Michigan, where investigators interviewed nearly 200 people who’d gotten sick after eating at Taco Bell, 90% said they’d eaten iceberg lettuce as part of their meal.

CHANG: Ninety percent – OK, so…

AUBREY: Yeah.

CHANG: Is the contaminated lettuce being removed from the supply chain?

AUBREY: Well, that is certainly the goal. A statement from Taco Bell says it has taken immediate action to voluntarily remove potentially affected lettuce. The FDA’s trace back investigation has identified a single supplier of iceberg lettuce from Mexico. Earlier this afternoon, Taylor Farms confirmed it is removing all iceberg lettuce sourced from Central Mexico. The company says no Taylor Farms branded salads or kits – those are the ones, you know, that you can buy in the grocery store are associated with this outbreak. But as part of the investigation, the FDA says it’s working with states to collect sample products for testing and analysis. And the agency says it’s also increasing screening at the border, Ailsa, aiming to identify lettuce that may be implicated in this outbreak.

CHANG: OK. Well, you’ve named five states here – Indiana, Kentucky, Michigan, Ohio and West Virginia. But…

AUBREY: Yep.

CHANG: Allison, what about cases in other states?

AUBREY: Yeah. So the outbreak in the Midwest is big – thousands of cases there – but cyclospora cases have been reported in a total of 34 states. It’s possible that more states will be added to this advisory.

So here’s the rub, Ailsa. The link to shredded lettuce served at Taco Bell may not explain all of the cases. The FDA says, this investigation is ongoing, and contaminated lettuce may have been shipped to other retailers. It’s also possible that there’s another source that has led to some of these cyclospora cases.

CHANG: Oh, dear. OK, well, then, short of not eating any iceberg lettuce, how can people otherwise protect themselves right now?

AUBREY: Yeah. Well, cyclospora is a parasite that gets onto produce from contaminated water, typically when the crops are being irrigated, and then the parasite causes the GI issues, clearly. Now, I don’t know too many people who want to eat cooked lettuce, Ailsa.

CHANG: Oh.

AUBREY: But heat does kill the parasite. So food cooked to 158 degrees will get rid of the pathogen. More practically, the CDC recommends rinsing produce. Here’s Dr. Gwen Biggerstaff of the CDC.

GWEN BIGGERSTAFF: Wash your hands and any fresh produce thoroughly under running water before eating, cutting or cooking. This will reduce the risk of infection.

AUBREY: It may not get rid of all of the parasite, but it helps.

CHANG: OK. Wash, wash, wash.

AUBREY: That’s right.

CHANG: What should people do, though, if they think they might be infected?

AUBREY: Yeah.

CHANG: Oh, God.

AUBREY: Good question. This is a nasty infection with symptoms that can last weeks. So if you’ve had diarrhea with waves of fatigue or nausea, officials say you should ask to be tested. I mean, there is no routine testing for cyclospora, but with this big outbreak, it is now on the radar of healthcare providers. And the good news, Ailsa, is that it’s treatable with antibiotics.

CHANG: You can get rid of it.

AUBREY: That’s right.

CHANG: That is NPR’s Allison Aubrey. Thank you, Allison.

AUBREY: Thank you.

Copyright © 2026 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

Accuracy and availability of NPR transcripts may vary. Transcript text may be revised to correct errors or match updates to audio. Audio on npr.org may be edited after its original broadcast or publication. The authoritative record of NPR’s programming is the audio record.

How to make the complex world of skincare easy : NPR

NPR’s Life Kit breaks down what you really need to know about skincare.

Transcript

ADRIAN MA, HOST:

Before you step into the summer sun, you probably know to put on a little SPF. But say you want to go beyond that. What else do you need to know to protect your skin? Online, there are thousands of products and endless advice videos which can make skin care seem really complicated. The good news, though, is that it doesn’t have to be. From NPR’s Life Kit podcast, journalist Kelle Walsh explains the science of healthy skin.

KELLE WALSH: According to dermatologists, taking care of your skin isn’t difficult.

MICHELLE HENRY: You know, the fundamentals of skin care are very simple. Good quality products. You don’t need 20 of them. You need – consistency is more than having 25 products. Find a regimen that works with your skin type. Stick to it, right?

WALSH: That’s Michelle Henry, a dermatologist and surgeon who teaches at Weill Cornell Medical College in New York. She points to skin’s primary function as a barrier that protects us from external harm. It’s also essential for things like temperature regulation and vitamin D production. Maintaining skin health really is about keeping that barrier intact, and it’s pretty straightforward.

SARANYA WYLES: From a skin health standpoint, it’s really two key ingredients we’re talking about. This – you just have to keep your skin moisturized, and you have to keep your skin protected from UV with sunscreen.

WALSH: That’s Mayo Clinic dermatologist and researcher Saranya Wyles. Sun protection also includes clothing, hats and avoiding the strongest UV rays during the day. Also useful, say experts, a gentle cleanser, something that won’t strip skin’s natural oils. Besides those three core products, experts say there are a few ingredients that while not essential are considered nice-to-haves, like antioxidants.

KELLY DOBOS: Antioxidants go hand in hand with sunscreen.

WALSH: That’s cosmetic chemist Kelly Dobos, who teaches at the University of Cincinnati. She explains that UV damage, along with pollution, can cause skin to generate free radicals – unstable molecules that can damage DNA, proteins and the natural oils that help protect that skin barrier.

DOBOS: A topical antioxidant is going to help neutralize those free radicals.

WALSH: She says to look for ingredients like vitamin C and E, green tea and niacinamide in moisturizers and standalone serums. Exfoliants are another helpful ingredient, experts say. Alpha hydroxy acids like glycolic or lactic acid can help skin shed old cells more evenly, bringing new ones to the surface. This is a process that happens naturally, but slows down as we age, says Dr. Wyles, making skin drier and more vulnerable.

WYLES: So when you’re younger, your skin just has an innate reparative, regenerative capacity that’s just functioning at a very high level.

WALSH: Experts say that as these products and ingredients support the health of your skin, they can also make it look brighter, more even and possibly with fewer visible lines. But they aren’t going to turn back the hands of time, says Dr. Henry.

HENRY: So there’s just a limit to what skin care can do.

WALSH: If your goal is to reduce deep wrinkles, loose skin or lots of hyperpigmentation, Henry says, there are cosmetic medical treatments that can help. Things like prescription retinoids or lasers are common. You can see a dermatologist for these treatments.

As for what’s possible at home, helping your skin be healthy and look that way is definitely in the realm of over-the-counter skin care. Beyond that, manage your expectations. All those products with sciencey-sounding (ph) or just bizarre ingredients and the multi-step routines…

HENRY: In many ways, it’s a marketing tool for this, like, aesthetic ideal that is just basically made up. Just because you don’t have wrinkle-free, rosy skin does not mean it’s not healthy. Healthy skin is comfortable, functional skin, frankly, right? And the good thing is that, for the most part, healthy skin does look beautiful.

WALSH: For NPR News, I’m Kelle Walsh.

MA: Want more skin care tips from Life Kit? Sign up for their one-week newsletter series at npr.org/skincare.

(SOUNDBITE OF MUSIC)

Copyright © 2026 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

Accuracy and availability of NPR transcripts may vary. Transcript text may be revised to correct errors or match updates to audio. Audio on npr.org may be edited after its original broadcast or publication. The authoritative record of NPR’s programming is the audio record.

Patient-on-patient violence in dementia care can be fatal, records show : NPR

Attilio Cecchetto (right), pictured here with his son Gino. Attilio was born on a farm in Italy and lived in California since the 1960s, working as a tile journeyman and contractor for decades.

Marco Cecchetto

hide caption

toggle caption

Marco Cecchetto

Sam Ato Timaloa, a paroled sex offender who also served time for attempted murder, had dementia and an acute intolerance of noise — especially from roommates at Sunrise Post Acute, a nursing home in Banning, California. Over four months in 2025, a state investigative report found, Sunrise switched Timaloa’s room eight times, the last into one occupied by Attilio Cecchetto, 92, a retired tile installer whose dementia led him to frequently moan, mumble, and yell.

Overnight, a nurse aide walked into their room and saw blood splattered on the floor, walls, and ceiling, according to a grand jury transcript. Cecchetto’s face “looked twisted and smashed,” the aide testified. A Banning city police officer testified that Timaloa, 77, told him that he had punched Cecchetto twice.

“He just kept saying that Attilio was being too loud: ‘He talks too much,'” the officer said.

Cecchetto died two days later from blunt force facial trauma.

“You get placed in a facility like this to be taken care of, not to be murdered,” one of his sons, Gino Cecchetto, said in an interview. “This was completely preventable at many different points.”

Timaloa pleaded not guilty to assault. The charges were later upgraded to murder, and a judge ordered a mental health evaluation. The judge will rule as early as August on whether Timaloa is competent to stand trial.

PACS Group, the nursing home chain that owns Sunrise, denied negligence. “We strive to provide quality care to everyone we serve, and our hearts continue to go out to the Cecchetto family for their loss,” PACS spokesman Brooks Stevenson said in an email.

In nursing homes primarily occupied by impoverished people as well as posh assisted living facilities that cost upward of $10,000 a month, agitated residents have shoved, punched, bit, and kicked others. They have wielded canes, walkers, pens, a plate, a mop stick, a shoe, a belt buckle, and even the footrests of wheelchairs as weapons, federal inspection reports show.

How often these altercations take place nationwide is unknown, but an in-depth study of 14 assisted living facilities in New York state led by Cornell University researchers estimated 1 in 7 residents experienced aggression within a month, including verbal, physical, or sexual acts. Their separate study of 10 New York state nursing homes estimated 1 in 5 residents experienced an altercation in a month. Researchers have found that these assailants are disproportionately likely to have dementia.

The diseases that cause dementia can impair brain circuits involved in impulse control and threat perception, raising the risk of aggressive behavior. Residents with Alzheimer’s disease and other dementias constitute more than 900,000 of the 2.2 million people living in these settings, many of which include specialized memory care units.

Often, altercations involving a resident with dementia erupt after danger signals are missed or ineffectively addressed, according to a KFF Health News examination of court records, police reports, and state and federal inspection reports.

Since the start of 2024, the federal Centers for Medicare & Medicaid Services has faulted nursing homes at least 700 times for failing to protect residents from physical, sexual, or verbal abuse by other residents, CMS inspection reports show. The federal records do not include assisted living facilities, which are regulated by states.

In the first three months of this year, CMS cited nursing homes more often for resident-to-resident abuse than for any other type of abuse, neglect, or exploitation, including abuse by employees, the reports show.

The long-term care industry says not every clash can be averted. Presbyterian Homes & Services, a nonprofit Christian chain of senior living facilities, said in a statement: “Caring for individuals living with advanced dementia is complex, and behaviors can change in ways that are difficult to fully predict or prevent, even with clinical interventions in place.”

Eilon Caspi, a dementia consultant and researcher who studies resident-on-resident altercations, said that usually there is a specific unmet need that precedes an altercation. “In the vast majority of incidents,” he said, “there are warning signs in the months, weeks, days, hours, and sometimes minutes and seconds prior.”

Breeding grounds

One psychological theory about Alzheimer’s, the most common dementia disease, holds that as the brain’s networks deteriorate, the balance shifts between the prefrontal cortex, which helps govern judgment and self-control, and limbic regions including the amygdala, which helps process fear and threat responses.

As cognition clouds, people lose the ability to understand what is happening around them and to put distress into words, researchers say. Pain, infection, medication side effects, and other physical and emotional distresses may be expressed through shouting, intimidating gestures, kicking, pushing, or punching. Long-term care facilities can be triggering environments, with intimate care often delivered by a changing stream of aides whom residents can’t recognize. Amid noise, close quarters, and rigid routines, interactions become flash points.

“You don’t feel safe, because you don’t know these strangers who are coming in and taking off your clothes,” said Al Power, a geriatrician and an advocate for alternative models of care for people with cognitive issues. “These things will be distressing to anybody.”

The Cornell researchers found verbal altercations were the most common type of aggressive interaction but estimated 4% of assisted living residents and 5% of nursing home residents in their studies experienced physical assaults in a month.

Another Cornell study found that Connecticut police were called to nursing homes for resident-to-resident clashes more often than allegations of staff abuse, theft, and residents wandering away without supervision combined. A national analysis of survey data from the Centers for Disease Control and Prevention calculated nearly 8% of residents in assisted living facilities engaged in physical aggression or abuse toward other residents or staff members.

Many of the physical aggressions KFF Health News identified in CMS inspection reports were perpetrated by residents with diagnoses of dementia, schizophrenia, or other cognitive disorders. In some physical altercations, both residents were aggressors, while other fights were one-sided. Sometimes the residents were roommates.

Laura Mosqueda, a geriatrician at the University of Southern California’s Keck Medicine in Los Angeles and a senior adviser to the National Center on Elder Abuse, said: “What worries me is that we just end up blaming two people who have either cognitive impairment or severe, uncontrolled mental health issues, when they’re supposed to be in an environment where people are safe.”

“Only a matter of time”

Rebecca Norton warned officials at her mother’s memory care facility that another resident was harassing her mother, Gladys Lynch. Lynch was later shoved down by the resident and died five days later, a Minnesota report said.

Liam James Doyle for KFF Health News

hide caption

toggle caption

Liam James Doyle for KFF Health News

Gladys Lynch, a retired department store accountant, transferred into the memory care unit at Harbor Crossing in White Bear Lake, Minnesota, in September 2025. Her monthly cost was more than $10,000, according to an invoice provided by the family.

One of Lynch’s daughters, Rebecca Norton, installed web cameras in her room and often saw another resident inside. “Every day I looked at it, this woman would be walking into my mom’s room, harassing her, digging through her things, using her bathroom, yelling at her,” Norton said in an interview. She informed Harbor Crossing’s administration, and the facility said it would start locking her mother’s door.

Norton emailed a Harbor Crossing administrator a list of issues with her mother’s care. “My biggest concern,” she wrote, was that her mother’s door was not consistently locked and the webcam showed the woman had again entered, rummaged through the bathroom, and taken a couple of adult diapers.

Unknown to Norton, Harbor aides had raised concerns about the other resident, who like Lynch was new to Harbor Crossing’s memory unit, according to a Minnesota Department of Health report. Diagnosed with Alzheimer’s, severe dementia with agitation, depression, and anxiety, the woman was confused, had difficulty communicating her needs, and hit aides.

Aides repeatedly reported that the woman had “ongoing aggression, entered other residents’ apartments, invaded others’ personal space, and was difficult to redirect,” the health report said. They said medications had been ineffective and pressed for new ones. The report said one nurse told the woman’s doctor it was “only a matter of time before” she “hurts another resident.”

Captured on camera

On the last day of September, she entered Lynch’s room and resisted leaving, the state report said. The next morning, she reappeared. Video of the incident was described in the police and state reports and reviewed by KFF Health News. It shows Lynch guided the woman out and appeared to attempt to lock the door, but the woman opened it and returned once more.

The woman declared it was her house, went into Lynch’s bathroom, used the toilet, and then returned to the room Lynch was in. Lynch can be seen repeatedly pressing the alert pendant around her neck to signal nurses for help.

The video shows the woman was almost out of her apartment door when she attempted to touch an object near the door. Lynch put her hands up to block her. The woman slapped at her hands and said, “I’m going to kill you if you don’t quit it.” She pushed Lynch, who fell, her head hitting the floor and blood seeping out.

Aides arrived 13 minutes after she had initially pressed her pendant, the state report said. Lynch suffered a brain hemorrhage and fractures to her eye socket and ribs, according to the state report. She died in the hospital five days later at age 96; the medical examiner’s office declared it a homicide.

Gladys Lynch was a department store accountant and raised three daughters before developing dementia. Here is a collection of Lynch’s personal letters and photographs at her daughter Rebecca Norton’s home in Hugo, Minnesota.

Liam James Doyle for KFF Health News

hide caption

toggle caption

Liam James Doyle for KFF Health News

Norton said her mother was kind and pleasant and never combative. “My mom deserved better than what they gave her,” she said.

Prosecutors declined to bring charges, according to the police report. The state investigation concluded Harbor Crossing was responsible for neglect because it was aware the woman “exhibited violent and aggressive behaviors” and, yet, had failed to put in place effective interventions. Harbor Crossing has requested the state reconsider its findings.

Before Gladys Lynch’s death, employees at the memory care unit at Harbor Crossing in White Bear Lake, Minnesota, struggled to keep the resident who fatally assaulted her from behaving aggressively and wandering into other residents’ rooms, a state report found. Harbor Crossing has asked the state to reconsider its findings of negligence.

Liam James Doyle for KFF Health News

hide caption

toggle caption

Liam James Doyle for KFF Health News

In June, Suzanne Scheller, the attorney for Lynch’s family, filed a wrongful death lawsuit against Presbyterian Homes, which owns Harbor Crossing.

Presbyterian said in a statement: “We are deeply saddened by the loss of Ms. Lynch, and our thoughts remain with her family and all those impacted.” It declined to comment further on the incident or the lawsuit.

Preventive tactics

Geriatricians, researchers, and resident advocates say long-term care homes should employ strategies to reduce the risk of altercations, including closer supervision of residents at high risk, relocating them closer to nursing stations, separating residents with repeated conflicts, and adjusting roommate assignments or seating in shared spaces.

Each resident should have a care plan, and homes should train staff to be alert to a resident’s triggers and intervene quickly, dementia specialists say. Organized activities are essential to keep residents occupied and engaged. Antipsychotics and other psychotropic medications are often prescribed, but they can increase the risk of falls, strokes, and even death.

An aide can be assigned to watch a particularly challenging resident one-on-one, but many places lack enough staff for protracted, dedicated supervision. Some assisted living facilities will tell a resident’s family they must hire a personal aide, who can cost thousands of dollars extra each month. In extreme situations, facilities might send a resident to an emergency room for evaluation or to a psychiatric hospital, or evict or discharge them.

Camille Russell, who served as Kansas’ long-term care ombudsman until 2024, said she observed nurses and aides were often “woefully undertrained” in basic elements of dementia care.

“We’ve gotten too far away from making decisions that are caring decisions,” Russell said. “There has to be a balance, and the balance has gotten too far to the profit side.”

A debilitating kick

Many physical altercations between residents result in a scratch or a bruise, but nonfatal scraps can leave permanent damage on deeply frail residents.

Linda Twiddy’s first weeks in a Chesapeake, Virginia, memory care unit in August 2024 were happy, her daughter, Barbara Howerin, said in a May interview. Twiddy, a former church secretary with vascular dementia, sang along with a visiting church choir, decorated pumpkins, and visited a cat cafe. The facility, The Vero at Chesapeake, charged Twiddy a one-time $6,825 move-in fee and monthly charges of $7,475, according to the lease.

Seven weeks after Twiddy started living there, a nurse called Howerin. She told her that her mother had been kicked in an altercation with another resident and was being sent to the hospital.

When Howerin arrived at the hospital, she was shocked by the extent of the injury. “It was like 10 inches long by 6 inches wide, the whole front of her shin,” she said. “The calf was just like dangling down.”

According to an internal facility incident report the family obtained, an aide heard Twiddy scream for help and raced over to see a male resident with dementia trying to hit Twiddy as she sat on the floor in “a pool of blood.” The report said, “Linda was screaming get him away from me, he pushed and kicked me.”

The man had prior episodes of aggression, according to documents Twiddy’s family obtained in a lawsuit they brought against The Vero in Chesapeake Circuit Court. At his previous facility, a progress note from 2023 stated, he was “becoming very aggressive in tone and actions to residents and staff.” He “grabbed another resident by the wrists and pushed her,” according to the note. He was sent to an emergency room for evaluation of agitation, according to a hospital report. It did not make clear whether he was discharged back to the facility or elsewhere.

Agitation tied to pain

The male resident’s medical records at The Vero said he was diagnosed with late-onset Alzheimer’s disease, agitation, and anxiety, according to his doctor’s deposition. He had chronic pain in his back and trouble sleeping. He could answer simple yes-or-no questions but had trouble providing more extensive answers and couldn’t communicate that he was in pain, she testified. His behavioral changes usually occurred when he had a urinary tract infection, the doctor said.

When he was agitated, aides could sometimes calm him by turning on the television so he could watch his beloved New England Patriots, one aide testified in a deposition. A former aide said she tried to avoid dealing with him altogether. “If you go up to him and he was agitated, he’d reach out to try to grab you,” she testified. “If he had that cane, he would swing that cane or he would punch at you.”

In a court filing, The Vero denied allegations by Twiddy’s family that it should have protected residents from him. The filing said The Vero complied with all standards of care and that any injuries Twiddy sustained “were caused by her own negligence” or acts of others.

In their investigation of the incident, Virginia regulators alleged The Vero had failed to assume responsibility for the health, safety, and well-being of its residents. The inspection report said The Vero pledged to appropriately staff the memory care unit based on the number of residents and to ensure someone completed rounds at least every two hours during sleeping hours.

Twiddy underwent three surgeries at the hospital for her leg, including a skin graft, then spent a month in rehabilitation. “She was never able to walk again,” her son, Doug Twiddy, said in a May interview.

The family moved Linda Twiddy to a different memory care facility where the nursing station had a clear view of all the rooms. She lived there until her death earlier this year.

The lawsuit was settled on confidential terms in early June. Carlton Bennett, the family’s attorney, declined to comment. In an email, Lauren Rogers, a spokesperson for Sinceri Senior Living, which operates The Vero, said the company was pleased the legal case had been resolved but could not comment further, citing confidentiality and patient privacy.

“The Vero at Chesapeake is committed to providing a caring, supportive environment where resident health, safety, and well-being remain our highest priorities,” she said.

A history of violence

After Attilio Cecchetto was fatally bludgeoned at Sunrise Post Acute, his adult children and their attorney, Jody Moore, discovered disturbing details about Sam Ato Timaloa. He had been imprisoned in 1999 after being convicted of raping an underage girl and sentenced in 2008 to 24 years in prison for attempted murder involving domestic violence, according to Riverside County court records. His public defender declined to comment.

Cecchetto’s sons, Moore, and her colleagues at Moore Hutchins Moore also learned more about the home’s owner, PACS Group, a publicly-traded company with more than 300 long-term care facilities. Last year, PACS earned $191 million on revenue of $5.3 billion, according to its annual securities filing.

In the lawsuit the Cecchettos and their father’s widow filed against PACS, they accused the company’s founders, Jason Murray and Mark Hancock, of draining resources from their nursing homes to pay for the chain’s expansion and swell their personal wealth.

The two had earned more than $650 million through stock sales since taking the company public and bought two private luxury jets, according to the lawsuit and securities filings. PACS has also purchased corporate sponsorships for Utah sports teams even though it owns no nursing homes in the state, the lawsuit said.

California regulators fined Sunrise $120,000 for failing to protect Cecchetto and for not taking Timaloa’s articulated dislike of noise into account when assigning rooms. Medicare issued its own $62,810 fine.

In legal papers responding to the Cecchettos’ lawsuit, PACS denied negligence for his death and alleged he “failed to exercise ordinary care on his own behalf for his own safety.” It has sued to overturn the $120,000 state fine, saying it was issued too late and that Sunrise “did what might reasonably be expected of a long-term health care facility licensee acting under similar circumstances” to comply with state rules.

Police photographed Attilio Cecchetto’s bed after he was taken to a hospital. He died two days later.

Banning Police Department

hide caption

toggle caption

Banning Police Department

The Cecchettos’ lawsuit asks for a judge to impose robust procedures PACS homes must follow for admissions, staff training, room changes, and the reporting of altercations between residents. The suit asks for a court-appointed monitor to oversee compliance. In its written statement to KFF Health News, PACS said “important context” would come out during the process and declined further comment.

In an interview, Cecchetto’s three sons, Dino, Gino, and Marco, described their father’s life. He spent his childhood on a farm in Italy, growing up under Benito Mussolini. After World War II he moved to Canada, where he learned to tile and lay marble and terrazzo, a decorative flooring material made of chips of stone, glass, or other materials embedded in cement or resin. He relocated to California in the early 1960s, became naturalized, and worked as a tile journeyman and a contractor for decades.

“We don’t want this to happen to somebody again,” Gino Cecchetto said. “With the life he led, he deserved a quiet, dignified death. Instead, he ended his life in pain and fear.”

DATA METHODOLOGY

KFF Health News’ analysis of federal nursing home inspection reports focused on citations for violations of Medicare and Medicaid regulations stating that each resident has the right to be free of abuse, neglect, and exploitation.

The analysis looked at the most serious levels of citations, those in which inspectors determined that one or more residents had been harmed, or that the facility’s actions caused — or were likely to place residents in immediate jeopardy of — serious injury, harm, impairment, or death. We reviewed the reports since January 2024 and tallied those that explicitly described resident-to-resident altercations.

We conducted a more granular analysis of a subset of the inspection reports from January through March 2026 involving harm or immediate jeopardy. Each report was reviewed and categorized by the type of abuse, neglect, or exploitation.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

President Trump threatens Canada with tariffs due to wildfire smoke : NPR

Smoke from massive wildfires in Canada and Minnesota engulf the Washington, D.C. skyline on July 17, 2026, reducing visibility and casting a colored haze over the Lincoln Memorial.

Finn Gomez/Getty Images

hide caption

toggle caption

Finn Gomez/Getty Images

WASHINGTON — Poor air quality persisted in the Northeast, Mid-Atlantic and Midwestern states on Saturday, as smoke from hundreds of wildfires burning in Minnesota and Canada continued to spread and envelop skylines. The National Weather Service (NWS) said heavy rain and storms could help clear the air in the northeast and mid-Atlantic this weekend, while dangerous levels of air pollution will still hang over the Midwest.

“As we start clearing out here in the east, they’re going to get the next batch of smoke later this afternoon into tonight across areas from upper Michigan, eastern Wisconsin, into Illinois and Indiana, including Chicago,” NWS Forecaster Brian Hurley told NPR. “That will continue through [Sunday], unfortunately.”

Major League Baseball postponed Friday’s game between the Pittsburgh Pirates and the Cleveland Guardians due to poor air quality in Cleveland until Saturday.

Hurley said conditions in the National Capital Region are improving, following the eerie appearance of Washington, D.C. landmarks in a thick, smoky haze. Air pollution will still be elevated.

“But not nearly to the level that we’ve been seeing. We’re only talking about maybe a fourth or a third of the concentration of particulates,” he explained, adding the haze will have mostly faded away by Sunday.

Clearer air conditions are also expected in areas north of D.C. along the east coast, including New York City and northern New Jersey, where Sunday’s World Cup final between Argentina and Spain will be played at MetLife Stadium, an open-air venue.

More than 900 active wildfires are burning in Canada, including in the Manitoba and Ontario provinces bordering the northern U.S.

President Trump threatened to impose new tariffs on Ottawa in a post on Truth Social on Friday. He accused Canada of failing to maintain its forests and said the U.S. is being “invaded by filthy, polluted, and unhealthy air.” Trump said he planned to call Prime Minister Mark Carney:

“This is Willful Negligence, and becoming a yearly occurrence, costing the United States Billions of Dollars, which cost of this pollution must of necessity be added to the TARIFFS Canada is currently paying,” Trump’s post read in part.

Canadian officials have said in recent days both countries share responsibility in fighting climate change. Human-caused climate change has increased the risk of wildfires and intensified them.

Concerns about toxic smoke particles

Health experts are concerned about the effects on public health.

Peter DeCarlo, a professor in the Department of Environmental Health and Engineering at Johns Hopkins University, recommended using an air clearing device such as an air purifier to eliminate toxic air particles spread by the smoke.

“That’s going to minimize the amount of particles that you would be breathing in that space,” DeCarlo said.

He added: “The age of the home and how tight the building is adjusts how much of that particulate matter from outside smoke comes in. A rough estimate is on the order of 50% for a lot of the houses in the continental U.S.”

DeCarlo also warned that children, pregnant women, older adults and people with pre-existing conditions face a particular risk of experiencing harmful impacts from poor air quality.

“N-95 masks are protective, not only from COVID particles, but also for pollution,” said DeCarlo. “You can put on an N-95 and actually protect yourself pretty significantly with that if you want to go walk around the block and get some time outdoors.”

The National Weather Service issued air quality alerts across New England on Saturday.

“A lot of these advisories or alerts are going to be through midnight. I think most areas are going to start to see improvement before that,” said Hurley.

However, state and federal officials in Minnesota are warning fire conditions there remain volatile. MPR News reports more than 600 fire fighters are battling wildfires in northeast Minnesota in extremely hot and dry conditions. The flames have burned through more than 70,000 acres, and are approaching residential and resort areas that were under evacuation orders on Saturday. Air quality levels in Minnesota have broken records in recent days, according to officials.

Thunderstorms, flooding and a possible risk of tornadoes are forecasted in the mid-Atlantic, most of Pennsylvania and other areas of the northeast this weekend.

ICE shared Medicaid data it shouldn’t have with Palantir : NPR

ICE agents stand guard outside a immigrant detention center in Newark, New Jersey in May 2026. Medicaid officials improperly shared data about millions of people with ICE, who then shared that data with the data analytics firm Palantir, according to new court filings.

Adam Gray/Getty Images

hide caption

toggle caption

Adam Gray/Getty Images

After Medicaid officials improperly shared data about millions of people in January with immigration officials, ICE then shared that data with the data analytics firm Palantir, according to new court filings. Palantir operates an app called ELITE that is used by ICE agents to show the addresses of noncitizens who may be subject to deportation.

That revelation was made public in a motion filed Thursday by more than 20 Democratic attorneys general who sued the Trump administration last year over its data-sharing agreement between the Centers for Medicare and Medicaid Services and ICE.

U.S. District Judge Vince Chhabria in California ruled in December that health officials could share with ICE certain details from Medicaid data about immigrants without lawful status from the states that had sued, such as home addresses, dates of birth and immigration status.

Chhabria, who was appointed by former President Obama, then temporarily paused data sharing between CMS and ICE for immigration enforcement purposes in late May after federal officials admitted CMS had shared data with ICE in January that went beyond what the court order allowed. One dataset of refugees in Minnesota included U.S. citizens, and another that was transferred on Jan. 7 contained data of millions of people, including those in the country legally.

ICE was supposed to delete the improperly shared data. Chhabria set a hearing for August to further clarify his order and clear up ambiguity regarding which categories of noncitizens’ data could be lawfully shared with ICE.

But in recent days, federal officials have admitted to additional instances of improper data sharing.

In a court filing last week, the Justice Department said that CMS again inadvertently reshared with ICE the dataset with millions of names that CMS had first improperly shared with ICE in January. The government said the error occurred during an effort to share data from states not involved in the lawsuit.

Alberto Briseno, a section chief for ICE’s Homeland Security Investigations, wrote in a declaration that ICE personnel deleted the file after it was discovered and it was not used for law enforcement purposes.

Then Briseno revealed that a day later, the agency had done a broader search and discovered that half a dozen users still had a copy of the Jan. 7 dataset.

In that most recent declaration, Briseno said he was not aware of any additional copies of the dataset, but said the recent searches have “highlighted technological difficulties of making a representation that every possible variation of the file has been searched for and located.” He added, “ICE will continue to make good faith efforts to delete any copies that may be found in the future.”

Meanwhile, the Department of Justice is asking the judge to expand his order to allow ICE to receive data on a broader category of noncitizens – to potentially include all immigrants who are not legal permanent residents, citizens or have another form of permanent status.

“ICE’s inability to identify Medicaid records in its possession undercuts any claim that the agency should be entitled to more access to that data,” the Democratic attorneys generals wrote in their motion filed late Thursday.

Their motion continued, “Each successive revelation of a violation of the Order makes it more difficult for Plaintiff States to have confidence in Defendants’ ability to maintain and secure this data in compliance with the Order, and more difficult for Plaintiff States to communicate assurances to Medicaid providers, enrollees (and their counsel), and the public at large about the privacy and confidentiality of their healthcare data.”

Palantir did not immediately return a request for comment about whether the company had deleted the Jan. 7 dataset that ICE had shared after improperly receiving it from CMS. DHS also didn’t immediately return a request for comment about its transfer of data to Palantir.

According to a declaration filed by California deputy attorney general Anna Rich, when plaintiffs asked what federal officials did to ensure Palantir and other contractors had purged the data, defendants responded that the data had been shared over a Microsoft Teams chat and the shared data was deleted from the chat. Rich shared in her declaration a document turned over in discovery from federal officials that shows a redacted transcript of what appears to be ICE personnel asking Palantir to delete the file.

In an April 30 hearing, Chhabria had warned the federal government would not be able to continue using Medicaid data for deportation efforts if it continued improperly sharing the data of citizens and legal immigrants.

“If the federal government cannot be sufficiently careful then it can’t use the information, ok?” Chhabria had said.

Iceberg lettuce at Taco Bell linked to cyclospora outbreak : NPR

Taco Bell announced it is removing all iceberg lettuce from its supply chain and replacing it after federal health officials linked an outbreak of cyclosporiasis to a single supplier.

Mario Tama/Getty Images

hide caption

toggle caption

Mario Tama/Getty Images

The Centers for Disease Control and Prevention and the Food and Drug Administration advise consumers to avoid eating shredded iceberg lettuce at Taco Bell locations in Indiana, Kentucky, Michigan, Ohio and West Virginia.

Health officials analyzed 190 cases of cyclospora in Michigan where a person who fell ill reported eating at Taco Bell. Officials found that 90% of those people said they ate iceberg lettuce.

More than 1,644 sick people in this multi-state cyclospora outbreak reported eating at Taco Bell in those states starting May 13, according to the agencies. There have been 94 hospitalizations and no deaths reported.

The FDA traced this subset of cases identified nationwide to a single supplier of contaminated iceberg lettuce from Mexico, but did not name the supplier.

FDA says it’s working with the supplier to identify other locations where the contaminated lettuce has been distributed. The agency notes this is one large cluster that is epidemiologically related. There are other clusters across the country that may or may not be associated. Cases have been identified in 34 states.

Want the latest stories on the science of healthy living? Subscribe to NPR’s Health newsletter.

Taco Bell issued a statement July 16 that it took “immediate action to voluntarily remove potentially impacted lettuce from a supplier in select states.” The statement also said the lettuce would be removed from the supply chain nationwide and replaced within 24 hours.

A wide reach for salad suppliers

The Associated Press, citing an unnamed federal official, has reported that Taylor Farms was the supplier of the lettuce. NPR has not independently confirmed that, and Taylor Farms has not responded to a request for comment.

A handful of big players with integrated supply chains and advanced processing infrastructure, including Taylor Farms, dominate the bagged lettuce and salad industry in the U.S.

With such a big reach, a single supplier can provide lettuce products to a number of retailers, so it’s possible that additional clusters of cyclospora around the country could be linked to lettuce from the same supplier. It’s also possible that there are multiple sources and suppliers linked to other cases around the country.

The FDA and CDC say the investigation is continuing.

How to protect yourself

The symptoms of the illness include watery diarrhea, loss of appetite and fatigue, and people contract it by eating or drinking contaminated food or water.

To protect yourself from the parasite, the CDC advises people to follow standard food safety handling protocols. “Wash your hands and any fresh produce thoroughly under running water before eating, cutting or cooking. This will reduce the risk of infection. Cooking kills the parasite, so heating food to 158 F or 70 C or higher is effective,” said Dr. Gwen Biggerstaff with the CDC’s Division of Foodborne, Waterborne, and Environmental Diseases.

If people do develop symptoms, health officials advise people to contact their healthcare providers to be tested specifically for cyclospora. Routine stool tests often don’t include that test.

“People with symptoms should stay well-hydrated and avoid preparing food for others while acutely ill, out of general caution, even though person-to-person spread is very unlikely,” Biggerstaff said.

Is smoke in your home? Here’s how to make an air purifier using a box fan : NPR

Smoke from massive wildfires in Canada and Minnesota engulf the Washington, D.C. skyline on Friday morning, reducing visibility and casting a haze over the Washington Monument and Lincoln Memorial.

Finn Gomez/Getty Images

hide caption

toggle caption

Finn Gomez/Getty Images

A version of this story was originally published on Jan. 10, 2025. It has been updated to reflect the wildfires currently bringing smoke to the U.S.

Interest in air filters and purifiers is spiking as wildfire smoke spreads, including questions about how to build a homemade air purifier.

On Friday, the air in a large section of the U.S. — from Minnesota to Virginia — was listed as “very unhealthy” due to particulate matter from large wildfires, according to the federal AirNow air quality monitor.

The smoke is coming from wildfires in Ontario, Canada, and northern Minnesota — where Duluth and other cities are enduring hazardous air at record levels, as Minnesota Public Radio reports.

On AirNow’s map, a purple zone signals “very unhealthy” air quality index values from 201 to 300. That level triggers public health alerts, because “everyone may experience more serious health effects,” the Environmental Protection Agency says. Of particular concern are children, older adults, and people with heart of lung disease.

Within the warning area, many communities are currently in an even more dire “hazardous” category, reflecting an AQI of at least 301 — a level the EPA considers “extremely rare.”

A big worry, experts say, is fine inhalable particulate matter known as PM 2.5 (for 2.5 microns) that can lodge deep into our lungs.

And as researchers at the University of Washington note, “Smaller ultrafine particles (PM 0.1) can pass into the bloodstream and organs, including the brain.”

Here’s a quick guide to getting cleaner air:

Search filters by their MERV rating

Filters are key, whether you’re using them to upgrade your home’s HVAC system or put them in an air purifier or a DIY air cleaner. A filter’s ability to pull particulates and other matter out of the air are rated by Minimum Efficiency Reporting Values, or MERV. Filters with higher values can catch smaller contaminants like smoke, bacteria and viruses.

A MERV rating of 13 means the filter is efficient at catching items from 0.3 to 1 micron in size: “Bacteria, droplet nuclei (sneeze), most tobacco smoke, insecticide dust,” according to the California Air Resources Board, or CARB.

“Upgrading to a filter rated MERV 13 or higher can be especially important during smoky periods to effectively remove fine particle pollution from smoke in the indoor air,” the EPA says. It adds that most HVAC systems work fine using MERV 13 filters, as long as the filter is replaced frequently — but if you’re in doubt, ask an HVAC technician to be sure.

One thing to remember: If you’re using your HVAC system to clean your home’s air, it only does so when the unit is running. You can learn more about filter rating systems at member station LAist.

An air quality map shows a large part of the U.S. with “very unhealthy” air on Friday morning, due to large wildfires in Minnesota and Canada.

Air Now/EPA

hide caption

toggle caption

Air Now/EPA

Build an air cleaner at home

All you need is a box fan, good air filters and some duct tape, and you’re in business.

NPR has previously posted a design and guide to building an air purifying cube known as a Corsi-Rosenthal Box, using four 20-inch MERV 13 filters, a 20-inch box fan and two 20-inch panels of cardboard.

A smaller and more affordable approach is to attach one MERV filter to the back of a box fan, an idea laid out in a website from the Montana group Climate Smart Missoula. The group notes that people using that option should use newer box fans, and be sure the motor is clean to reduce the risk of overheating.

The Centers for Disease Control and Prevention says these DIY purifiers can be effective for a temporary solution, especially if you don’t have any other alternatives.

A satellite image from 8 a.m. ET shows a plume of dark smoke extending from Minnesota to Virginia and out into the Atlantic Ocean.

NOAA/NESDIS/STAR GOES-19

hide caption

toggle caption

NOAA/NESDIS/STAR GOES-19

Use HEPA air purifiers and other methods

HEPA (for high-efficiency particulate air) filters are used in many air purifier machines. HEPA is roughly equivalent to a MERV 17 filter, the California Air Resources Board says.

“A well-sealed HEPA filter is more than 99.9% efficient for all sizes of particles,” according to the American Society of Heating, Refrigerating, and Air-Conditioning Engineers, or ASHRAE.

If you plan to buy a portable air cleaner or purifier, the EPA says you should make sure it has a HEPA filter. To help your search, the EPA has a guide on matching your room size with the appropriate unit. And California has a table of state-certified air cleaners that lists more than 1,000 products by brand, model number, and type.

Whichever strategy you choose, experts say you should also make sure doors, windows and air ducts are well sealed, to keep out smoke and pollution. You should also drink plenty of water to help ease irritation — and wear a mask if you go outside, as NPR has reported.

Wildfire smoke is like smoking ‘half a pack a day.’ Here’s how to protect yourself : NPR

People wear masks in Chicago on Thursday to protect themselves from smoke from Canadian wildfires. City officials are encouraging people to remain inside as data shows Chicago having some of the worst air quality of any large city in the world.

Scott Olson/Getty Images

hide caption

toggle caption

Scott Olson/Getty Images

A version of this story was originally published on Jan. 8, 2025. It has been updated to reflect the wildfires currently bringing smoke to the U.S.

Smoke from wildfires in Canada and Minnesota prompted more air quality alerts Friday in the Northeast and Mid-Atlantic U.S., as well as in the Upper Midwest.

Michigan saw a statewide air quality advisory on Wednesday, and Minnesota’s air quality reached the hazardous “purple” alert level. The wildfire smoke is setting records in Wisconsin and turning skies orange in Vermont. And after a brief respite Friday morning, New York City will see more smoke.

Exposure to wildfire smoke is a growing health problem across the country, as human-caused climate change increases the risk and intensity of wildfires and the smoke that can drift thousands of miles downwind from them.

Here’s what you need to know about the health risks — and how to protect yourself.

The health risks of breathing wildfire smoke

May-Lin Wilgus, a pulmonologist and professor at UCLA, compares breathing wildfire smoke to smoking cigarettes — a lot of cigarettes.

Scientists track air quality with the air quality index, or AQI, which incorporates different pollution sources like ozone and fine particulates. Many scientists don’t think there’s a “safe” AQI level because the measurement doesn’t capture many harmful pollutants, but under 50 is often considered acceptable. Higher numbers indicate more health-damaging pollution in the air.

On Friday morning, the AQI in Detroit was 435 — the worst for any major city in the world. On a smoky day, when AQI levels reach 100 to 200, “the exposure to the fine particulate matter, the air pollution, is similar to smoking a quarter to half a pack a day,” Wilgus says.

That exposure takes a toll on a healthy person. But it is particularly harmful for those with preexisting health issues, Wilgus adds. Emergency room visits for respiratory issues like asthma and COPD increase dramatically during wildfire smoke events, as much as doubling in some cases. During the Canadian wildfires in 2023, when smoke wafted across much of the U.S., emergency room visits for asthma increased by nearly 20%.

Smoke exposure can also worsen other medical conditions. Emergency departments see more cardiovascular related visits after smoky days. And a growing body of research suggests smoke exposure is linked to long-term impacts such as a higher risk of developing dementia.

Overall, air quality has improved in the U.S. over the past 20 years, says Tarik Benmarhnia, a climate and health scientist at the Scripps Institution of Oceanography at the University of California, San Diego. But wildfire smoke is erasing many of those gains.

“Just maybe like 10 years ago, wildfire was an exceptional issue. It was something that happens once in a lifetime for most people,” he says.

But climate change has increased the chance of wildfires across many parts of the country and the intensity of many of the burns themselves and the smoke they produce.

“This is unfortunately not the first one and not the last one the people in Los Angeles are going to be experiencing,” Benmarhnia says.

Wondering what AQI is safe and what activities are safe at different AQIs? Life Kit explains.

The dangers of breathing wildfire smoke 

Wildfires burn at extremely high temperatures, which makes their ash more toxic than other pollution, such as car exhaust. But in many cases, including during these ongoing fires, it’s not just trees and organic matter that burn. Homes, cars and other materials go up in flames, too, adding potentially harmful particles to the pollution load.

“It’s just a toxic soup,” says Lisa Miller, a wildfire smoke expert at the University of California, Davis. “Think of all the synthetic fibers that are present in your living room — in your couch, in your carpet, in your clothes. All those things can be particularly toxic” if they go up in smoke, she says.

Higher risks for some people

Wildfire smoke is hazardous for everyone, but it’s especially dangerous for some people, including children and older adults, pregnant people and anyone with preexisting health problems.

First responders and firefighters are exposed to the worst of the smoke. A 2019 study found that heavy, repeated smoke exposure among wildland firefighters is linked with higher risks of lung cancer and cardiovascular disease.

Children can be especially vulnerable, doctors say, because they breathe in more air — and therefore more smoke — relative to their body size.

Pregnant people should also take care, says Miller. There’s growing evidence that wildfire smoke exposure is linked with higher chances of preterm birth and lower birth weights, an outcome sometimes linked with health issues later in life.

Older people and those with preexisting health problems like heart issues are also at higher risk.

The Shots Blog breaks down advice for how to protect people who are more at risk from wildfire smoke.

How to protect yourself from wildfire smoke 

“If you can smell smoke, those are times to limit your exposure as much as possible,” says Wilgus. She says the best way to protect yourself is to leave the area and get outside the range of the wildfire smoke, if possible.

If that’s not an option, she suggests staying indoors with the windows tightly shut. Limit your physical activity. Run an air filter if you have one.

If you have to go outside, consider wearing an N95 mask, which effectively blocks most tiny particles from getting into your lungs if worn correctly.

No level of exposure to wildfire smoke is completely safe, says Miller. But toxicologists have a saying, she says: “The dose makes the poison. It’s about how much, and how long, you’re exposed.”

That means everything you can do to limit the dose, she says, helps protect you.

For more tips, check out Life Kit’s guide.

‘No children’ died from USAID cuts. Consider these cases : NPR

These three children died in the wake of the cutoff of funding from the U.S. Agency for International Development. Their parents say that the loss of medical services supported by these funds played a role. From left: Abdullahi Ibrahim of Nigeria, age 10, suffered a fatal asthma attack. Purity Wamboi of Kenya, 16, contracted tuberculosis. Ibrahim Garba of Nigeria, 8, succumbed to typhoid.

From left: David Augustine, Lameck Nyagudi and Kazeem Olawale Nasiru for NPR

hide caption

toggle caption

From left: David Augustine, Lameck Nyagudi and Kazeem Olawale Nasiru for NPR

Abdullahi Ibrahim developed asthma when he was 5. Over time, it became increasingly serious.

“Sometimes he would wake up suddenly, gasping for air,” recounts his father, Ibrahim Musa, through an interpreter. “I feel very, very scared. We usually rush him to the hospital.”

They would take the motorcycle Musa uses as a taxi driver, Abdullahi sandwiched between his parents.

Those visits, plus the drugs and inhalers, were usually free, says Esther Agbo, a nurse at Mucciya Primary Health Care who often interacted with the family living in the north of Nigeria, in Sabon Gari. She says that the costs had been offset by USAID — the United States Agency for International Development.

“Because of that support,” says Musa, “people like us who don’t have much could still get treatment.”

Last year, when he was 10, Abdullahi had an especially severe asthma attack. “He told me, ‘Daddy, I can’t breathe well,'” says Musa. “He was just lying there, helpless. We rushed to the clinic.”

He says the clinic told them the drugs were no longer free of charge. “USAID stopped supplying the treatment [for] free,” says Agbo, who was not on duty there at the time. “The cost of the medication was too much for the parents,” she says.

Fatima Ibrahim sits alongside a portrait of her son, Abdullahi, in the family’s one-room home in Sabon Gari, Nigeria.

David Augustine for NPR

hide caption

toggle caption

David Augustine for NPR

Abdullahi died from that final asthma attack, says his father. “If there was still help coming from USAID,” says Musa, “I’m very sure my child would still be alive today.”

Naming names

In May of last year, Secretary of State Marco Rubio testified before Congress about the termination of USAID. He said, “No children are dying on my watch.”

As recently as June 28 and 29 of this year, Elon Musk wrote on X that deaths in Africa went down after funding to USAID was cut and that those who indicate otherwise “cannot cite a single name of someone who died out of the ‘millions’ they falsely claim have died. Not a single name!” Last year, as head of President Trump’s Department of Government Efficiency, Musk presided over the shutdown of the agency, noting that he was “feeding USAID into the wood chipper.”

Abdullahi Ibrahim is one name. And there are others. NPR worked with photojournalists who are part of a global consortium called The Everyday Projects to identify the names of children whose deaths over the past year and a half had a strong connection to the cutback in services provided by USAID funding.

In this story, we are looking at the deaths of Abdullahi and two other children.

In each instance, we interviewed a parent of the child and a health worker familiar with the case.

NPR reached out to the U.S. State Department to ask for comments on the cases of these three children in Nigeria and Kenya. The department didn’t address the specifics of their deaths.

In its response, the department pointed to the Trump administration’s signing of 32 bilateral global health memorandums of understanding, including with the Kenyan and Nigerian governments, as proof of a different type of foreign assistance commitment.

It is difficult to say for sure what would have happened had USAID remained, says Brooke Nichols, an infectious disease modeler and health economist at Boston University, but the agency had been in Africa enabling a range of treatments.

Nichols created the Impact Counter to tally the number of projected deaths likely associated with reductions in U.S. foreign aid starting in March 2025. “Over the course of one year,” she says, “we estimate more than 700,000 people have died from the abrupt stopping of USAID, including more than half a million children.”

These deaths occurred largely in low- and middle-income countries, with the vast majority in sub-Saharan Africa — including the three deaths described here.

Purity’s mother: “I could see her shivering”

Last August, in central Nairobi, Kenya, 16-year-old Purity Wamboi was home on a school holiday. She loved to read and was happy to help wash clothes and do other chores around the house.

Her mother, Rachael Wanjiru, noticed something was off in her girl.

Rachael Wanjiru, 43, holds a photo of her 16-year-old daughter, Purity Wamboi, who died from tuberculosis-related complications after missing her medication.

Lameck Nyagudi for NPR

hide caption

toggle caption

Lameck Nyagudi for NPR

“She wasn’t feeling too well,” Wanjiru says through an interpreter. “She used to cough severely. She had chest pains. Sometimes I could see her shivering. And therefore I asked her to take a break.”

Purity tried to keep the discomfort to herself. “I would ask her what was it that she was hiding,” recalls Wanjiru. “She understood that I didn’t have money, and she didn’t want to stress me.” (Wanjiru had developed a goiter, so she wasn’t working at the time.)

She got Purity some painkillers, which helped.

Her younger brother, 14-year-old James Gitau Mwai, remembers thinking, “I thought Purity was going to get well and be able to be like she was before.”

Pages from Purity’s journal.

Lameck Nyagudi for NPR

hide caption

toggle caption

Lameck Nyagudi for NPR

But after she returned to school, the chest pain came back even stronger.

Over the next three weeks, things deteriorated quickly. Purity’s family raced to figure out what was wrong — amid a lapse in USAID funding that they say undermined their urgent search.

When Wanjiru brought Purity in for a checkup at the Tumutumu Community Medical Centre in Nairobi, the medical staff explained that she had pneumonia. But she didn’t respond to the treatment.

A couple of weeks passed before Tabitha Mugweru bumped into Wanjiru and Purity on the road. She’s a close family friend and a community health promoter — a role that involves visiting households, making medical referrals and supporting the health needs of underserved communities.

“They were coming from a private hospital,” says Mugweru. “I saw Purity was very weak. Purity was not doing well at all.”

So Mugweru referred the family to Mwiki Health Centre, a governmental facility, which sent Purity to a different hospital for a chest X-ray. The scans revealed that Purity didn’t have pneumonia at all. She was suffering from tuberculosis.

Purity received new medications, but “the TB was diagnosed very, very late,” says Mugweru. This meant that the bacterial infection had already consumed a portion of her lungs.

Mugweru says there had been a more extensive team of community health promoters who once fanned out across Kenya, visiting families in their homes, where they may have caught something like Purity’s tuberculosis sooner. These workers were paid with funds that came from USAID, according to Mugweru.

So when the Trump administration shuttered the agency last year, Mugweru says, that money dried up.

“Most of them stopped working when USAID withdrew their support,” she explains. “They could have reached Purity earlier during [a] home visit.”

The TB treatment wound up coming too late for Purity — who at that point didn’t even want to take all the pills because she felt they were causing unpleasant side effects. Then came the day when she asked to sit in the sunshine and have a cup of porridge.

Purity’s mother, Rachael Wanjiru, and her 14-year-old brother, James Gitau Mwai, sit outside their home in Nairobi, Kenya.

Lameck Nyagudi for NPR

hide caption

toggle caption

Lameck Nyagudi for NPR

It was later, after Purity went back inside, that things got bad. “She started shaking,” says Mugweru, who was there. “And then her eyes were wide open. And they turned white.”

The family called an Uber to take her to the hospital. But she didn’t survive the trip.

“Purity died when I was holding her,” says Mugweru. “We didn’t think that Purity was going to die, no. We thought everything was going to be good. Then all of a sudden, boom, Purity was no more.”

Her younger brother says he has felt lonely without having Purity as a playmate.

Ibrahim’s father: “He would just look at me and tell me, ‘Baba, I am tired'”

In early 2025, in central Nigeria, a cheerful 8-year-old named Ibrahim Garba contracted typhoid fever. It’s a dangerous bacterial infection that his father, Yakubu Garba, says he likely picked up from the drinking water.

“It started like a normal sickness,” says Garba. “He had fever, weakness and was not eating well.”

Ibrahim Garba’s portrait hangs inside his family’s home. The boy had written, “God is with us” on the wall.

Kazeem Olawale Nasiru for NPR

hide caption

toggle caption

Kazeem Olawale Nasiru for NPR

Ibrahim’s condition worsened. The family visited the local clinic and received an antibiotic and rehydration regimen for free. They say the staff told them that USAID was picking up the tab, a fact that Grace Samuel, a nurse at the nearby Zokotu Primary Health Centre, confirmed to NPR.

Soon, Ibrahim was feeling better, so much so that he didn’t complete his course of antibiotics. “Once the fever goes down, we may forget some of the dose,” explains Garba. “Sometimes, too much stress at home will make us not to remember to give the child the medicines to take.” If Ibrahim had finished the antibiotics, perhaps the drugs would have cured him of the illness.

Instead, his typhoid rebounded and knocked him flat. “He would just look at me and tell me, ‘Baba, I am tired,'” says Garba. “That broke me.”

When he and his family returned to the clinic, the meds were no longer free — another apparent casualty of the dismantling of USAID. “It’s something that happened everywhere,” says Samuel, who observed the same situation unfold at her own health facility. Ibrahim’s family couldn’t afford the new round of drugs. They took him home, tried an herbal remedy … and prayed.

“We delayed, hoping we could find money or that he would get better,” says Garba. “But he did not. That delay we keep thinking about till now.”

Swapping USAID for MOUs

In the comments that the State Department sent to NPR for this story, it championed the use of memorandums of understanding — MOUs — as a new way of providing assistance.

The State Department stated: “This co-investment model ensures greater country ownership and accountability, while building a strong long-term foundation for surveillance and outbreak response, laboratory systems, health commodities, frontline healthcare workers, and data systems, and reducing dependency on U.S. taxpayers.”

In Kenya, the five-year MOU amounts to a total of $2.5 billion from both countries combined to support tuberculosis programs in part. And in Nigeria, across the same time horizon, the MOU consists of nearly $2.1 billion in health assistance from the U.S. alongside another roughly $3 billion from the Nigerian government. These amounts represent a 23% and 22% decrease in U.S. government contributions to health funding for Kenya and Nigeria, respectively, compared with earlier USAID levels, says Dr. K.J. Seung of the Health Security Policy Academy at Brigham and Women’s Hospital.

“In theory, setting up these systems is great,” observes Boston University’s Nichols. “This amount of investment by the U.S. government and by the countries themselves will actually generate a lot of good health.”

“But,” she continues, “that doesn’t answer the question as to whether or not deaths occurred because of how this all happened in the first place — the cutting overnight of aid.” Nichols argues that this abrupt termination led to a breakdown of trust and supply chains, which are challenging to reinstate.

“It’s one thing to turn something off,” she says. “It is something entirely different to turn something back on again. This funding could have done much more good if there was a transition from the before-times into the current MOU because we wouldn’t have had that disruption of services.”

A set of final chapters

These bilateral agreements came too late to help the family from Kenya and the two Nigerian families.

Musa and his wife, who have four kids including their oldest, Abdullahi, who died of the asthma attack, are left with their memories.

“His heart is just kind,” says Musa. “If someone was sad, he would go and sit with them.”

Four days after Ibrahim’s family was told they’d have to pay for the typhoid antibiotics, he passed away. “The day we lost him,” says his father, Yakubu Garba, “it felt like everything stopped working.” Samuel, the nurse who knows the family, remembers seeing Garba afterward. “He just looked broken,” she says.

Asibi Garba and her husband, Yakubu Garba, sit outside their home holding a portrait of their son, Ibrahim, who died from typhoid.

Kazeem Olawale Nasiru for NPR

hide caption

toggle caption

Kazeem Olawale Nasiru for NPR

For Rachael Wanjiru, Purity’s mother, she says that since her daughter’s death, “I have felt like a part of me has been taken away.”

“Sometimes I feel like I could just take my two sons and just go with them far, far away,” she says. “A place that I do not have to come back.”

Purity’s death, she says, “has really put a dent of pain in my heart.”

Relatives and friends place flowers on Purity Wamboi’s gravesite in Kenya.

Family photo

hide caption

toggle caption

Family photo

Mugweru, who held Purity during her final moments in the Uber, is left wondering what might have happened had her fellow health promoters continued to receive their pay. Maybe they could have kept on doing their work in the community.

And that leads her to the hardest hypothetical of all: “If [USAID] did not withdraw their support,” she says, “maybe Purity could be alive today.”

David Augustine, Kazeem Olawale Nasiru and Lameck Nyagudi are part of The Everyday Projects, a global community of photographers using images to challenge harmful stereotypes.

TrumpRx only offers some brand-name drugs for sale to consumers : NPR

A centerpiece of President Trump’s push to make prescription medicines more affordable is a government website for drug discounts that carries his own name. TrumpRx, launched in February, now boasts 92 deals on brand-name prescription drugs made by pharmaceutical companies that announced highly publicized agreements with the Trump administration.

But nearly six months since the website’s launch, those deals on TrumpRx represent fewer than 12% of the more than 800 brand-name drugs made by the participating pharmaceutical companies.

A wide range of medicines — including treatments for inflammatory conditions, HIV and cancer — aren’t offered by TrumpRx, according to an NPR analysis of a database of drugs on the market maintained by the Food and Drug Administration.

Stay up to date with our Up First newsletter, sent every weekday morning.

“The key takeaway is that most of these companies are doing this for a small number of products and in a limited setting,” says Dr. Ben Rome, a health policy researcher and physician at Brigham and Women’s Hospital in Boston. “They’re not engaging to do this on a large scale.”

TrumpRx touted as a marketplace for better drug prices

TrumpRx’s origins go back to the Trump Administration’s May 2025 executive order aimed at bringing American drug prices in line with or below what other wealthy countries pay. Last summer, the administration sent letters to 17 drug companies with a list of demands.

The demands included selling drugs directly to consumers at lower prices, which is something some drug companies, such as Eli Lilly and Novo Nordisk, had already started doing.

Drugmakers had 60 days to meet the administration’s demands voluntarily, or, the letters stated, “if you refuse to step up, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices.”

Then came the closed-door negotiations, which included the threat of tariffs stemming from an investigation into whether pharmaceutical imports posed a threat to national security.

Although the text of the agreements hasn’t been made public, the administration began announcing the pacts in the fall, starting with Pfizer. That’s also when the administration announced it would create TrumpRx, a government website for direct-to-consumer discounts.

TrumpRx launched on February 5, with 43 drugs made by five of those companies.

“It’s the biggest thing to happen in healthcare, I think, in many, many decades,” President Trump said during the launch event at the Eisenhower Executive Office Building next to the White House. All 17 companies that received letters have announced agreements with the Trump administration, concluding with Regeneron in April.

A sparse menu of brand-name drugs 

As of mid-July, there are 92 brand-name drugs on TrumpRx from 15 of the 17 companies that announced deals with the Trump administration. But those companies make more than 800 brand-name drugs that are on the market today, according to NPR’s analysis of a Food and Drug Administration database of marketed drugs.

Pfizer has 30 drugs listed on TrumpRx, by far the most drugs on the site. But those drugs represent a fraction of the company’s portfolio of at least 178 brand-name drugs on the market.

In addition, some of the drugs that generate the most revenue for Pfizer are not offered at a TrumpRx discount, according to financial filings. Those include Eliquis, Pfizer’s blood thinner marketed with Bristol Myers Squibb, and Ibrance, a drug for advanced and metastatic breast cancer. Pfizer’s COVID treatment drug Paxlovid is also nowhere to be found on TrumpRx.

Pfizer does offer its blockbuster pill Xeljanz for inflammatory diseases like rheumatoid arthritis for $1,518 on TrumpRx, as much as a 53% discount off the brand-name price. But Xeljanz is now also available as a generic, called tofacitinib, which can be purchased for about $30 for a bottle of 60 tablets for patients paying out-of-pocket on Mark Cuban’s Costplusdrugs.com website.

Pfizer said in a statement that it was offering savings as high as 85% off its sticker prices on more than 30 medicines, spanning various treatment areas. “We will continue to make regular assessments and adjustments as the program evolves,” Pfizer spokesperson Kat Romaniuk wrote in an email to NPR.

Gilead and Regeneron both announced deals with the Trump Administration that included TrumpRx discounts and still have no drugs on the site. The companies tell NPR they will add one drug each: Gilead’s Epclusa for hepatitis C and Regeneron’s Praluent for bad cholesterol. But when those drugs will appear at a discount on TrumpRx has not been determined, the companies said.

Generic alternatives beat some of the presidential deals

In May, TrumpRx added hundreds of generic drugs available at partners like Cost Plus Drugs and Amazon Pharmacy. The site then was effectively divided in two. There is a tab for “presidential deals” on brand-name drugs that have the lowest prices available on the site. A second tab is for drugs with “standard prices,” which include generics and some brand-name drugs that cost more than generic options.

NPR found that at least some of the 79 presidential deal drugs on TrumpRx also have generic competition. For example Januvia and Janumet, two of the three Merck drugs listed as TrumpRx presidential deals, are available as generics.

At $84.57, Janumet on TrumpRx is a better deal than the generic version sold on CostPlusDrugs, where it costs $142.31 for the same strength and number of tablets. Pristiq, a Pfizer drug for major depressive disorder, is a presidential deal listed on TrumpRx for $200.10, but its generic costs less elsewhere: $20 to $30 with a GoodRx coupon, depending on which pharmacy the patient wants to use.

But Merck’s biggest drug, Keytruda, a treatment for various cancers, is not available for a discount on TrumpRx and isn’t available yet as a generic. The oral cancer medications Lynparza and Lenvima aren’t available either. Merck didn’t respond to requests for comment in time for publication.

Boston University health economist Rena Conti says it’s telling that companies haven’t added some of their most popular and crucial medicines.

“The companies are offering deals on the products that they choose, not the universe of products that they offer,” she says. “And that consequently sounds good and may help a small share of people who are purchasing these products at a cash price but are not helping all the consumers of their products.”

TrumpRx could boost sales a little, she says, and offering discounts to consumers paying cash won’t hurt the drugmakers much. The insured market is where they make the majority of their money. 

She adds that many consumers with health insurance would be better off simply using their coverage to pay for drugs whether those drugs appear on TrumpRx or not. Insurance copays will be cheaper than the discounts, she says.

TrumpRx can fill insurance gaps 

Still, TrumpRx can be useful, particularly for patients whose drugs are not covered by their insurance plans, such as people undergoing fertility treatments and people seeking obesity medications, says Rome of Brigham and Women’s Hospital.

“But that is not the majority of prescription drugs,” he says. “It’s not the majority of patients who need prescription drugs.”

The top of the TrumpRx website says it has saved more than $400 million dollars for Americans. But that statistic hasn’t been updated in more than a month and it’s difficult to verify.

NPR didn’t receive a response from the White House about how many patients have used the site and the specific drugs people were purchasing most frequently on TrumpRx.

Some pharmacists have had patients come in seeking TrumpRx prices, says Ronna Hauser, the senior vice president of policy and pharmacy affairs for the National Community Pharmacists Association. “I wouldn’t say that it’s extremely common.”

Most patients who mention TrumpRx are seeking discounts on GLP-1s, she says.

GoodRx, which is a website that helps patients find discounts on prescription drugs, has been a key partner for TrumpRx, providing the coupon infrastructure that works in the existing healthcare system. When someone uses a TrumpRx coupon for a brand-name drug at the pharmacy counter, GoodRx processes the claim on the back end.

The company told investors in May that it was “seeing encouraging traction” from the site, adding that “early data shows strong demand concentrated in GLP-1 therapies. … expanding access to new patients rather than shifting existing demand.”

Federal funding changes have slowed cancer disparities research : NPR

Cancer disparities cost lives and researchers push to understand what is behind these gaps. Federal funding for such work has slowed since last year.

Andrew Brookes/Image Source/Getty Images

hide caption

toggle caption

Andrew Brookes/Image Source/Getty Images

Why are some people more likely to get cancer, and to die from it than others? Rural Americans, for instance, are 18% more likely to die from cancer overall, and Black women are 35% more likely to die from breast cancer than white women. That’s according to a recent report from the American Association for Cancer Research, or AACR.

Cancer disparity researchers study these gaps and how to close them. Their work has contributed to reductions in many disparities.

But the AACR report found that federal policy changes have affected about 93% of surveyed researchers in this field.

“Many medical trials were stopped in the middle — meaning those patients suddenly didn’t receive the treatments they were getting, because the funding stopped,” says Mariana Stern, professor of preventive medicine and urology at the Keck School of Medicine of USC and chair of the report committee.

The report draws on a survey of 122 researchers including professors, scientists and students. Seventy-eight percent said they’ve been unable to apply for funding, and 59% said ongoing research projects were disrupted. And 59% of respondents said the funding that was lost came from the National Institutes of Health, or the NIH.

The report also points to data published in JAMA Oncology in November showing that in roughly the first half of 2025, the Trump administration canceled 181 grants from the National Cancer Institute, or NCI, a division of the NIH. The grants totaled more than $317 million and many studied disparities.

All told, thousands of grants across NIH were terminated in 2025, according to a non-profit called Grant Witness which tracks terminations and other changes to grant funding for scientific agencies. These funding cuts followed an executive order in January 2025 calling to end “radical” and “wasteful” DEI research.

Heather Pierce, senior director for science policy at the Association of American Medical Colleges, AAMC, described the funding disruption as a mass termination “for simply not moving forward priorities of a new administration.” She says that under prior administrations “termination was reserved as a very extreme remedy,” and that the scale was unprecedented.

While many cancelled NIH grants were restored after several court cases fighting the change, there have been other terminations since, reported by the Department of Health and Human Services, the agency overseeing the NIH. And, fewer new grants from the Cancer Institute and the National Institute of Minority Health and Health Disparities have been awarded this year than they have at this time in previous years.

There have been other disruptions with grant funding. Pierce says that there has been a “continued slowdown this year” in grant making and renewals.

Some researchers in the field are alarmed about the funding slowdown — and are worried that as it hinders their ability to do their work, it will translate to poorer patient outcomes.

“If we take our foot off the pedal of disparities research, there will be more Americans — in rural communities and others not near [centers of excellence] — who will not do well,” says Dr. Robert Winn, the cancer center director at the Fox Chase Cancer Center in Pennsylvania who was not an author of the 2026 report but whose work was discussed in it.

In response to questions about cuts to cancer disparities funding, the NIH said in a statement: “NCI identifies cancer disparity research as a priority and recognizes that advancements in the field generate knowledge benefiting all patients across the cancer continuum, from prevention and early detection to treatment and survivorship.”

“Completely unprecedented”

Scarlett Lin Gomez, a professor of epidemiology and biostatistics at University of California, San Francisco, says the Greater Bay Area Cancer Registry, which she leads, has gotten NCI funding for the last 53 years.

“We received a cut that was completely unprecedented in the years my registry has been funded through the NCI. We’ve not had a cut of this magnitude at all — by far,” Gomez says.

Gomez runs a lab of approximately 50 people. Gomez says she had to let go of about seven full-time employees last year and expects she’ll have to let go five or six more this year.

“It literally keeps me up at night — the impacts on individuals in my lab,” Gomez says. “I’m hearing from colleagues over the past several months [that] everybody’s looking at doing the same thing … It’s scary to even think about what that’s going to look like and what the impact is going to be.”

Winn concurs: “It’s been disruptive. It’s forced folks to be creative to keep things going.”

Stern, who researches cancer epidemiology, personally had to reframe some of her work to stay compliant and keep funding. In some cases, she simply reworded funding requests. In other cases, she had to change the focus of the project.

Stern had previously gotten federal grant funding for training and career development for students from racial and ethnic minorities to help them get into medical school or go into research. This is important, she says, to “overcome structural reasons minorities are underrepresented” in medicine.

“The data show that patients do better when they’re treated by people who look like them, speak their language, and understand their culture — and research moves faster when teams are diverse and include members of the communities they’re trying to understand,” Stern says.

But, she says, the researchers had to change focus under Trump’s executive orders: “We are no longer allowed to have programs that target exclusively racial and ethnic minorities.”

“When you look at what percent of Ph.D. or medical graduates belong to racial and ethnic minority communities, you see underrepresentation,” she says. “We still have a way to go — but with the current political climate, right now, it’s impossible to do that.”

Tackling gaps

The AACR report stresses that progress has been made on cancer disparities and that today’s gaps are narrower than they were a generation ago.

For example, Stern says “the Black community historically has had much higher cancer death rates and incidence compared to the white population.” That gap has narrowed from about 34% higher in the 1990s to 9% higher today.

Cancer disparities research contributed to this progress, according to the report.

“If we don’t continue to support the research and the clinical care, all the progress we’ve made over the last 30-plus years — and all the progress to come — is literally at risk,” Winn says. “That keeps me up at night.”

Many disparities remain. The report finds veterans face 72% higher odds of skin cancer and rural Americans are 18% more likely to die from cancer overall — including a 36% greater likelihood for lung cancer.

The report calls such disparities “among the most profound forms of inequity and injustice.”

“It’s an injustice,” Gomez says, “and we understand that a lot of these disparities can be avoidable.”

And medical disparities cost American society about $451 billion a year, says Stern, citing a 2023 study published in JAMA, which estimated the medical costs and the value of productive life-years lost, calculated at $100,000 a year.

Cancer disparities research, Gomez says, informs not only the gaps in outcomes and care among everyone in the U.S. but also the effect of individual and biological differences — providing a clue for scientists to better diagnose and treat cancer.

“Without both of those lines of evidence … we simply have no way of intervening,” Gomez says.

Winn led a program studying cancer disparities when he was director of the Virginia Commonwealth University Massey Comprehensive Cancer Center. The program partnered with the Chickahominy Tribe, assessing the cancer burden in rural Virginia, identifying possible environmental factors, and deploying culturally tailored cancer care.

“We did water testing, we had interesting findings,” Winn says. But more importantly, he says, “we were building trust, because we were creating access to care.”

Winn says that everyone should care about cancer disparities research because it could mean life or death for a disease that can happen to anyone.

“Cancer doesn’t care whether you’re rich or poor, whether you’re from the south side of Chicago or the east end of Richmond,” he says. “It doesn’t care.”

Researchers also worry about the impact funding cuts will have on the next generation of physicians and scientists.

“The studies we do don’t only contribute data — they contribute to training and workforce development, so all that stops when the funding stops,” Stern says.

Stern says more and more of her students are now hesitant to go into academia.

Gomez agrees. “We’re definitely seeing an academic brain drain, and this current environment is certainly going to further hasten that,” she says.

“Please do not stop the research,” Chickahominy Tribe citizen and cancer survivor Melanie Stewart says. “Everyone deserves health care.”

Keep cool in extreme summer heat without air conditioning : NPR

It’s a summer of extreme heat around much of the world.

I know what that feels like. In Uttar Pradesh, India, where I grew up, temperatures easily soar upward of 120 degrees in May and June. But few people have access to an air conditioner. With a per capita income of around $1,000 a year, many people in this part of the country can’t afford to buy an AC unit or pay the power bills that come with using one.

So how do people keep cool?

People in India and other countries across the Global South have long figured out ways to deal with horrible heat. I’d like to share a few tips I’ve learned from my elders back home in India. Some of the advice is just what you’d think — drinking lots of liquids and staying out of the sun. Other strategies might surprise you.

I know that each of these tips on its own may seem trivial. But as a heat wave researcher, I can tell you that done together, they can really help the body cool down. The key is to be mindful of the power of heat — and be prepared to prevent its adverse effects.

And remember, upon seeing any signs of heatstroke — like fever, headache, nausea, confusion or weakness — call an ambulance ASAP and get medical help. Use ice packs while waiting to be treated at the hospital. Seriously, folks, don’t delay. Heatstroke can be fatal.

(Also: We want to hear from you! Scroll to the end of this story to find out how to share tips from your culture on how to cope with heat.)

Drink lots of liquids — it doesn’t have to be water!

One of the childhood lessons seared into my head was to always be aware of your hydration status. And drink water, even in small sips, as soon as you do any physical activity. Carrying a water bottle when going out is not just common sense but is lifesaving.

Some of the drinks that are popular in India can help replenish the electrolytes lost in sweat, as well as keep your body hydrated.

We quench our thirst with fruity drinks like sugarcane juice, coconut water and a tangy and raw mango juice called aam ka pana. Made from boiled and blended tart raw mangoes, aam ka pana replenishes electrolytes lost in sweat. Premade mix is available from online vendors and in ethnic grocery stores. Just add chilled water and enjoy!

In India, we also like cooling, milk-based drinks like lassi, a yogurt beverage popular in the summertime, and buttermilk.

And eat something!

Another lesson was to never go out on an empty stomach — always eat something. A cucumber (which contains dissolved electrolytes) or a pineapple snack will do the trick. In India, we’ll sprinkle black salt on a cuke, adding to its restorative powers.

Shower power

If you feel hot, take a cold shower or at least periodically splash water on your face and hands and douse your head in water — that’ll bring down body temperature.

You can also play with water. When I was a kid in India, I’d have water balloon fights with neighborhood kids. Or we’d fill a tub with water and splash it on each other in the backyard.

Find a cool spot to chill out

Seek out the coolest parts of the building where you live and make that the place where you sleep or hang out. Because heat rises, lower floors in a multistory house are cooler. Verandas are shady and airy. During the day, block out the sunlight with heavy curtains. Turn on any fans you have. And don’t be afraid to move furniture around in your quest for coolness. Back in Uttar Pradesh, we used to scoot our beds closer to the windows so we could catch a breeze while we slept.

If it becomes impossibly stuffy indoors, move outdoors and lie in a hammock. Air created from swinging helps cool the body down. As a kid, I remember that mango orchards were the best for hanging out. The dense foliage provided maximum shade coverage. The shade is your friend!

Take inspiration from architecture

Among many architectural innovations is a building design called jaali (meaning simply a net in Hindi and Urdu). Think of the Taj Mahal. It’s basically a way of turning a stone wall into a latticed screen by carving geometric patterns with a series of small openings rather than a solid wall. This stone screen blocks direct sunlight and also causes air to speed up as it passes through the holes.

Now, it’s true there’s no way you can rebuild your house in the style of the Taj Mahal.

But you can take inspiration from another architectural ploy. Some buildings have a small body of water outside — like the Hawa Mahal (the Wind Palace) in Jaipur. Wind enters the palace through the jaali holes in the thousand windows and picks up moisture from the courtyard water body. The humid wind then moves toward the palace’s thousand windows and cools down the inside air.

A nifty trick to bring in cool, humid air is to hang a curtain woven from grass on the door. Sprayed with water, it converts the hot air into a cool breeze. A special fragrant grass called khus is used for this purpose in India. I’ve also seen curtains made of fine bamboo — offering protection from direct sunlight — with a fine wet cloth added on the inside for cooling. Or a heavy, dampened cloth curtain will do the job.

The swamp cooler effect

The ubiquitous swamp cooler works best in low-humidity settings. Also known as an evaporative cooler, this electrical device passes a room’s air over water-saturated pads, which cools down the air, then blows that air back into the room. These devices are cheaper than air conditioners and use less energy. You can even make one yourself.

Wear airy and light-colored clothing

Rabari people (a nomadic tribe in western India) and many other tribal communities use small mirrors on their clothes to reflect sunlight.

Besides the use of cotton and linen fabrics for their clothing — both materials are cooling because they have big pores in their woven threads that allow for air circulation — their choice of color in their clothes is ingenious. They cleverly make use of the fact that black not only takes in heat faster than white but that it also gives off heat much faster than white. Due to the nature of their work, women frequently go in and out of their tents while men grazing livestock stay out for longer durations. Therefore, to stay cool, it makes sense for women to wear darker colors (these hues cool down fast as soon as women go indoors) and men to wear lighter colors (which heat up more slowly than darker colors during prolonged outdoor stays).

Cover your head or neck

In the summers, covering one’s head is an age-old practice. Whether it was the nobles wearing a pagdee (a turban) or the commonfolk using a wet rectangular piece of traditional cotton cloth called gamcha for men and dupatta for women. A variation of a white wet towel, it is almost universal in the countryside and even seen in cities.

Or take a light towel, called a gamchha in Hindi, dampen it and wear it around your neck or on your head like a scarf. This wet garb is omnipresent among men in the hinterlands and small towns.

Even our erstwhile British colonial masters fended off the sun with pith helmets — made of an extremely lightweight, dried, milky-white, spongy plant material that could be pressed into various shapes.

Avoid the noonday sun

During the hottest parts of the day, try not to burn energy or exhaust yourself by going out, exercising or standing outside, because the scorching sunlight and hot air will make you hotter. Instead, do what I did in Uttar Pradesh: chill at home or take an afternoon siesta. If you have to work and have a flexible schedule, try to perform your duties in the cooler hours of the day. Farmers in my state, for example, toil in the early mornings and late evenings. And markets close in the hot afternoons but remain open until late in the night.

Embrace the shade

Whether you are working outdoors or walking down the street, stay in the shade provided by trees. The actual air temperature is the same as in the sun, but your skin won’t absorb the sun’s rays and cause your body to heat up. Thanks to our forefathers for planting trees for us! And we return the favor by planting trees now, even when we know we aren’t going to enjoy that shade in our lifetime. Our kids will. And that’s what makes us a civilization.

Your turn: Share tips on how to cope with the heat

Did you grow up without an air conditioner in a hot place? How did you deal with the heat? Email us at globalhealth@npr.org with the subject line “Heat hacks,” and we may feature your story on NPR.org. Please include your name and location. Submissions close on Monday, July 20. 

Dr. Gulrez Shah Azhar is a Seattle-based Aspen New Voices fellow who researches the health impacts of heat. Previously, he was a postdoctoral fellow at the University of Washington, a policy researcher at the RAND Corp. and an assistant professor at the Indian Institute of Public Health.

CDC director nominee Erica Schwartz faces Senate for confirmation hearing : NPR

Dr. Erica Schwartz faces a Senate confirmation hearing for the role of CDC director.

U.S. Department of Health and Human Services

hide caption

toggle caption

U.S. Department of Health and Human Services

Dr. Erica Schwartz, Trump’s latest nominee to lead the Centers for Disease Control and Prevention, is scheduled to appear before a Senate committee Wednesday morning, to answer questions about her vision and qualifications for the role.

The confirmation hearing, with the Senate Health, Education, Labor and Pensions committee, will be Schwartz’s first public appearance since Trump nominated her for the role in mid-April. Schwartz is Trump’s third nominee to lead the nation’s beleaguered public health agency, which has not had a permanent director for most of Trump’s second term in office.

If confirmed, Schwartz will work under Robert F. Kennedy, Jr., secretary of the Department of Health and Human Services, which oversees the CDC.

Schwartz is a retired Rear Admiral in the U.S. Public Health Service Commissioned Corps, with degrees in medicine, law and public health. She previously served as chief medical officer of the U.S. Coast Guard, and as deputy surgeon general in the first Trump administration.

Earlier this year, on Instagram, Schwartz voiced her support for vaccines as tools to prevent illness and prevent readiness in the military. (Her Instagram page was removed soon after she was nominated for the CDC director role).

Public health veterans say she has the credentials and experience for the job. “People are very optimistic about her candidacy and are supportive of her potentially being in the role,” says Dr. Marcus Plescia, district health director for Fulton County, which includes Atlanta where the CDC is headquartered.

“What we really need right now is a CDC director who can step in and be a spokesperson on some of the emerging issues we’re facing,” says Plescia, “We need somebody in that position who can get in and establish themselves and be there to stay.”

Schwartz is generally expected to clear the Senate confirmation process. However, the role comes with major challenges and pitfalls.

Health Secretary Kennedy came into office with an agenda to change vaccine policy. In recent months, his changes have largely been blocked by a federal judge, but the intention remains, Dr. Georges Benjamin, head of the American Public Health Association, told NPR. “The political agenda is still there,” he says.

Still, the political winds have shifted a bit. “The president said he was going to let the secretary go wild, and he did. He’s now had to pull him back because it is creating political damage.” Benjamin says it may give the next CDC leader some space to follow the evidence with less political interference.

Roadblocks for an early director

Trump’s first pick for CDC head was Dr. Dave Weldon; his nomination was withdrawn shortly before his confirmation hearing because he did not have the votes to pass.

Trump’s second pick, Susan Monarez, received Senate confirmation but served in the role for less than a month last summer, before she was fired by Kennedy.

The next director would be tasked with turning around a CDC that’s been through an exceptionally tough period, including facing pressure to bend to political directives and cuts to staffing and capacity while needing to respond to pressing outbreaks on several fronts.

A recent trove of internal CDC emails, released by Senator Bernie Sanders of Vermont, shed insights into Monarez’s brief, rocky tenure and the chaotic months preceding it.

They show select, high-level exchanges between top CDC officials during a tumultuous period from January through August 2025, as the CDC lost thousands of staffers to cuts and attrition, faced public criticism from Secretary Kennedy, upended typical procedures and adjusted to new levels of political oversight.

The last director lacked autonomy in making policy and hiring decisions. For instance, on August 19, 2025, Matt Buckham, then chief-of-staff to Secretary Kennedy, sent an email to Susan Monarez, the recently confirmed CDC director. “I wanted to elevate the absolute need for political review of major policy decisions at CDC,” by the immediate office of the Secretary and political leadership at CDC, he wrote. “Please err on the side of caution,” he wrote, before signing off with “Make America Great!”

Other exchanges chronicled confusion from HHS over who was leading the CDC, the pervasive disorganization around reductions in force, and how Secretary Kennedy’s delegates worked to direct vaccine policy outcomes against the legal and scientific advice of CDC scientists and general counsel.

In an internal CDC all-hands meeting last month, new leadership at the agency addressed the impacts of all that’s happened on remaining employees.

“I’ve heard a lot … from people about what the morale is like here, how we’ve gotten to a point where it’s not as happy as it used to be, the stress level’s extremely high,” said Sean Slovenski, a former Walmart executive and now the CDC’s deputy director and chief operating officer, in a recording of the meeting reviewed by NPR.

NPR obtained this recording from a current CDC employee who asked to remain anonymous for fear of professional repercussions.

“If any organization went through one of the things you’ve had to endure in the last year and a half, it would be traumatic to that organization, institution, for years to come. You’ve had multiple ones,” he said.

Slovenski pledged to proceed with an upcoming reorganization with care. “I’m not promising that everyone will be happy. What I’m promising is that everyone will be clear,” he said. “Everyone will know what’s coming and they’ll know it was done in the most thoughtful manner.”

Also up for confirmation: head of preparedness and response

Wednesday’s session also includes a confirmation hearing for Sean Kaufman, nominated by the White House to serve as the Assistant Secretary for Strategic Preparedness and Response at HHS.

Kaufman is a senior adviser for global affairs at CDC, and has previously responded to infectious disease outbreaks including anthrax and West Nile Virus. He has also served as an expert witness in multiple cases defending people who faced professional consequences for refusing COVID vaccines, according to his Linkedin profile. Kaufman has questioned the safety and need for universal COVID and hepatitis B vaccines. The head of ASPR oversees the development of vaccines and countermeasures against pandemics and emerging threats.

What to know about the food-borne illness cyclosporiasis : NPR

The Centers for Disease Control and Prevention offices in Atlanta are seen in 2022. The agency is investigating a rise in cyclosporiasis cases.

Ron Harris/AP

hide caption

toggle caption

Ron Harris/AP

A large number of cases of intestinal illness that causes diarrhea, nausea and fatigue have been detected in 34 states, according to federal health authorities, but the source is still under investigation.

As of Tuesday, the Centers for Disease Control and Prevention said it had received reports of 1,645 confirmed cases of cyclosporiasis, the gastrointestinal affliction caused by the parasite Cyclospora.

But the true number of infections is likely much higher, because that figure only represents cases reported by states directly to the CDC. There is also a lag between symptom onset and reporting, and many people recover from the illness without medical treatment. Michigan alone reported 3,309 cyclosporiasis cases as of Tuesday.

According to the CDC, as of Thursday, there have been 141 hospitalizations nationwide and no deaths.

Health officials are also investigating several clusters of cases that may be epidemiologically linked, including a multistate outbreak that includes at least four states: Michigan, Ohio, West Virginia, and Kentucky

People can contract the illness by eating food or drinking water contaminated with the parasite. Previous outbreaks have been linked to fresh produce. In 2018, McDonald’s removed salads from restaurants in 14 states after federal health officials linked them to dozens of cases of cyclosporiasis, and tainted lettuce imported from Mexico was suspected to have sickened 400 people in the U.S. in 2013.

The illness does not spread from person to person, noted Gwen Biggerstaff, deputy director of CDC’s Division of Foodborne, Waterborne, and Environmental Diseases at a press conference Tuesday: “The source of this outbreak is what we eat or drink — not casual contact with someone who’s sick. “

It’s typical for cyclosporiasis infections to rise in the spring and summer, but the CDC said Friday that multiple states had reported a larger jump in cases over the previous two weeks than they had during the same period last year. Only 249 cases had been reported nationally at this time last year.

For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.

Where are cyclosporiasis infections occurring?

Health officials from California to Texas to Florida have reported cases of cyclosporiasis since the start of May.

Some of the hardest-hit areas appear to be in the Midwest and Northeast, including Michigan and New York.

The Ohio Department of Health reported 177 cyclosporiasis cases as of July 2, most of which occurred in June. Dr. Bruce Vanderhoff, director of the Ohio Department of Health, said cyclosporiasis is a “serious illness that can cause dehydration and require people to seek emergency medical care, and it should be taken seriously.”

According to the CDC, those sickened with the disease have ranged in age from 5 to 88 years old.

The total number of nationwide cases is expected to grow, due to the estimated six-week gap between when illnesses begin and when they are reported to federal health authorities.

What’s causing the outbreak?

That is still unclear. The CDC says it is continuing to try to identify the source or sources of the recent surge of cyclosporiasis infections.

Investigators do that in part by interviewing those who’ve become sick to find out what they’ve eaten. But since symptoms can appear anywhere between two days and two weeks or more after a person was infected, they may not remember everything they ate during that period.

Previous U.S. outbreaks of cyclosporiasis have been associated with raspberries, basil, cilantro, snow peas and lettuce, according to the Food and Drug Administration.

Federal health officials are urging doctors to test for the condition and to specifically request laboratory testing on stool samples.

How to prevent cyclosporiasis

Cooking produce is an effective way to avoid an infection, as heating food to 158 degrees Fahrenheit or higher kills Cyclospora.

Public health officials advise thoroughly rinsing all fresh produce under running water, even items that say they are prewashed. Do this before eating (if eaten raw) or cooking.

It is also important for home cooks to observe standard food safety rules, and that includes washing your hands with soap and water before and after handling fresh produce.

Public health officials don’t yet know what foods may be the sources of the recent cases and stress the importance of washing any fresh produce you intend to eat.

What to do if you have symptoms

The CDC encourages people to seek medical attention if they have symptoms of cyclosporiasis, especially if you develop prolonged watery diarrhea along with fatigue or loss of appetite.

Dr. Kawsar Talaat, a physician at Johns Hopkins Hospital board certified in pediatrics, internal medicine and infectious diseases, says that cyclosporiasis can present in different ways. “If your diarrhea persists for more than a couple days, go see your doctor,” Talaat says.

Some patients might experience a waxing and waning pattern. “If the diarrhea goes away and comes back, that’s another sign of a potential cyclospora infection,” she says. “And again, go see your doctor.”

Talaat says there is also an epidemiological importance to reporting. She says getting tested could help officials understand where the outbreak is coming from and how it’s being transmitted.

Talaat also explains that standard tests for diarrhea can’t diagnose cyclosporiasis. She echoes the CDC recommendation that clinicians need to request a test specifically for cyclosporiasis if suspected. It’s a stool test, Talaat explains, but it can miss cyclospora if the sample is small or taken at the wrong moment in the life cycle of the organism. You may have to send in more than one stool sample to confirm you have the parasite she says.

For those with cyclosporiasis, Talaat says there is an effective treatment: The antibiotic trimethoprim/sulfamethoxazole, brand name Bactrim or Septra, taken for seven to ten days. While cyclospora is a parasite, not a bacteria, the antibiotic is effective against it.

Talaat says many won’t even realize they had cyclosporiasis. “For most healthy adults, it’s often a self-limited infection, it will go away by itself,” she says.

But for those who are older, younger or immunocompromised, Talaat says to be proactive in getting tested and treated earlier to avoid risk of hospitalization.

Carmel Wroth contributed to this report.

Ebola deaths pass 700 as spread continues in eastern Congo : NPR

A health worker stands at the Evangelical Medical Center, in Bunia, eastern Congo, Friday, July 3, 2026, where Ebola clinical trials are scheduled to take place.

Dirole Lotsima Dieudonne/AP

hide caption

toggle caption

Dirole Lotsima Dieudonne/AP

Eighty percent of new Ebola cases in eastern Congo are emerging from unknown chains of transmission, the World Health Organization said Tuesday, a sign the outbreak is spreading faster than health officials can track despite an expanding response.

Congo has been battling an outbreak of a rare type of Ebola since May, with no approved treatment or vaccine. The Africa Centres for Disease Control says it is the fastest-growing Ebola outbreak on the continent.

“Perhaps the most alarming finding is that many of the newly reported deaths are people who died in their communities without ever reaching a health facility and without receiving care,” Chikwe Ihekweazu said after returning from Bunia, in Ituri province, one of the worst-hit cities. “And as of today, 80% of new cases are outside our contact lists and so are coming to us from unknown chains of transmission.”

People who die outside the health system cannot be isolated, treated or have their contacts traced promptly, increasing the risk of further transmission.

The outbreak, Ihekweazu said, “continues to outpace the response efforts.”

As of Monday, at least 1,926 people have been infected, of whom 702 have died, in three provinces in Congo from the rare Bundibugyo virus, Congolese authorities said. Cases have also been confirmed in neighboring Uganda.

Ihekweazu told reporters in Geneva that his visit to Bunia had been “quite encouraging on many fronts, but also deeply concerning.”

Treatment capacity in Bunia is now close to 800 beds, with capacity increasing every week, and lab capacity has grown from 1 to 14 labs, an effort the emergency chief lauded.

However, Ihekweazu said that despite “our best efforts … we have not caught up in the race.”

A funding gap, attacks on health centers, an ongoing conflict in eastern Congo, and mistrust among local communities have hampered the response.

Dozens of healthcare workers at an Ebola virus treatment center in northeast Congo went on strike over unpaid salaries and bonuses on Monday. On Tuesday, they agreed to resume work under the condition that the government pays them within 72 hours.

“Just one day of strike action has already caused damage. Patients were unable to access the center,” the striking health workers said in a statement. “We hold the government solely responsible for any loss of life if the site closes after this ultimatum.”

The Congolese authorities declared a fresh Ebola outbreak on May 15 after the disease had been transmitting for weeks without official detection, according to the WHO. Clinical trials for treatment began last week after researchers launched a highly anticipated study in the hope of fighting the virus.

The U.S. Centers for Disease Control and Prevention said on July 11 that a U.S. citizen working for a humanitarian organization in Congo has tested positive for the Ebola virus, without providing further details.

Trump’s HHS backs off most radical effort to stop healthcare for trans youth : NPR

Protestors rally for healthcare for transgender people at a march in June 2025 in Manhattan. NPR has learned the Trump administration shelved a plan to cut off all Medicare and Medicaid funding to any hospital that provided gender-affirming care to minors.

Erik McGregor/LightRocket via Getty Images

hide caption

toggle caption

Erik McGregor/LightRocket via Getty Images

For new discoveries, everyday mysteries, and the science behind the headlines, follow NPR’s Short Wave podcast .

The Trump administration is abandoning its most aggressive attempt to end gender-affirming care for youth nationally, according to an official document obtained by NPR.

The document shows that the Department of Health and Human Services will not be finalizing a proposed rule that would have blocked all Medicaid and Medicare funding for hospitals that provide pediatric gender-affirming care. The Centers for Medicare and Medicaid Services and the Department of Health and Human Services did not immediately respond to a request for comment.

Not a “retreat” from anti-trans efforts

The fact that the Trump administration is backing off from this action is “a victory for people who are defending the rights and interests of trans people,” says Sam Bagenstos, a professor at Michigan Law who served as general counsel at HHS under the Biden administration. “But I don’t think it indicates a more general retreat from the aggressive posture of the Trump administration.”

Bagenstos notes that this type of leverage — a “conditions of participation” rule for the Medicare and Medicaid program — has historically been used by HHS to compel states and hospitals to meet basic health and safety standards. Things like “making sure that you have stockpiles of certain kinds of equipment, making sure that you have certain kinds of emergency protocols, making sure that you have certain staffing ratios,” he explains.

The proposed rule was unprecedented, Bagenstos says, because it instead would have prohibited certain kinds of treatments for a certain population. He says it seemed unlawful in a variety of ways. For one, “it violates the Medicare Act, which says that Medicare and Medicaid can’t be used to control the practice of medicine within the state — states get to regulate the practice of medicine,” Bagenstos says.

Medical groups opposed the change

Normally, HHS would propose a rule, accept public comment for 60 days, and then finalize the rule so that it could take effect. In this case, after proposing the rule in December and receiving more than 30,000 comments, the administration is abandoning the rule. At least in the next year, it will not be finalized and will not take effect.

The American Medical Association and the Children’s Hospital Association both submitted comments urging the agency to rescind or withdraw the proposed rule. Major U.S. medical groups say that puberty blockers and sex hormones are safe and can be effective for transgender young people.

Even so, gender-affirming care for youth is banned in 27 states after a flurry of laws passed over the last several years. In the remaining 23 states, many hospital clinics that offer gender-affirming care have continued to operate, while others have shuttered in the past year citing pressure from the Trump administration.

That pressure has come in the form of this proposed rule, another rule that would bar federal Medicaid reimbursement for transgender pediatric patients, and a declaration from Health Secretary Robert F. Kennedy Jr. that aimed to redefine the standard of care. (Interestingly, the press release issued when those actions were unveiled in December is now missing from the HHS website, as is the Kennedy declaration document.)

The Medicaid rule is currently in the final stage of review and appears to be on track to take effect in the coming weeks. A coalition of Democratic-led states sued over the so-called Kennedy declaration and succeeded in blocking it in federal court in Oregon. The Trump administration has not appealed that decision so far.

Protesters who are against gender-affirming care for young people gathered outside Boston Children’s Hospital in Sept. 2022.

Carlin Stiehl for The Boston Globe/Getty Images

hide caption

toggle caption

Carlin Stiehl for The Boston Globe/Getty Images

At the same time, the Department of Justice has issued administrative and criminal subpoenas to hospitals seeking full personal medical files for transgender youth and employment files for their medical providers, although many of those attempts have been blocked in court so far. The Trump administration has also reached settlements with hospitals in Texas and Ohio that involved establishing “detransition” clinics.

And last month, when the Supreme Court allowed states to bar young transgender girls from sports, the White House issued a press release saying that the decision “Bolsters President Trump’s Push to Eliminate Transgender Insanity.” The release listed actions targeting transgender people across the federal government, from passport markers to military service to research funding.

Will hospitals that ended care for trans youth restart it?

While the Trump administration does not appear to be backing down from anti-transgender actions broadly, its decision not to finalize its most aggressive healthcare rule is significant, says Katie Keith, director of the Health Policy and the Law Initiative at Georgetown University who also worked in the Biden administration. Those other efforts are not nearly as durable as a finalized rule that takes effect, she notes.

The decision of the Trump administration not to finalize this rule “should give hospitals more confidence to either resume or continue offering the care,” she says. Because the rule was never in effect, “I would argue that they should have been doing this all along anyway.”

Kellan Baker agrees. He’s a senior adviser for health policy at the Movement Advancement Project think tank, which focuses on LGBTQ issues. “This administration may have checked itself in one of the most extreme expressions of its agenda and I think people should take solace in that,” he says. “But at the same time, this administration is continuing to show that its ultimate goal is eliminating health care for trans people and that it is apparently prepared to use almost any means necessary to do so.”

The Medicare and Medicaid rule could theoretically be revived at some point, since it has not been formally withdrawn. An entry in the Trump administration’s recent unified agenda sets a final action date for the proposed rule as December 2028, just before President Trump leaves office.

Pythons’ extreme biology may hold clues for treating human disease : NPR

Pythons have several unusual traits that scientists are studying for potential clues for treating human disease.

Ari Daniel for NPR

hide caption

toggle caption

Ari Daniel for NPR

For new discoveries, everyday mysteries, and the science behind the headlines, follow NPR’s Short Wave podcast.

When Skip Maas first adopted Agrapina, a mottled ball python, she hadn’t eaten in 14 months.

But as he soon observed, she was still a taut coil of spring-loaded muscle. Presented with a rat, she struck quickly, constricted it and then gorged on her meal.

And then her body performed another feat pythons are known for: It accelerated its metabolism dramatically to deal with the sudden influx of protein and fats, says Maas, “to help break down that meal and extract all of its nutrients.”

Most people prefer to keep their distance from pythons — and for good reason. A quick strike followed by relentless constriction can be lethal. But Maas, a molecular biologist at the University of Colorado Boulder, and his colleagues argue that these snakes may hold secrets that could help people live longer and better.

In addition to being able to fast for weeks or months and still maintain muscle tone, they’re able to grow and shrink their heart and other organs during feast and famine with seemingly no issue.

Molecular biologist Skip Maas holds his pet ball python Agrapina alongside fellow python researchers Jack Gugel (left), Tommy Martin (right) and Yuxiao Tan (far right), in Boulder, Colo.

Ari Daniel for NPR

hide caption

toggle caption

Ari Daniel for NPR

“It makes a lot of sense that pythons, because they live in such extreme environments, would have secrets that would apply to humans,” says Leslie Leinwand, a geneticist who, two decades ago, first came up with this idea of translating the unique biology of pythons into medical treatments.

She’s currently the executive science officer of CU Boulder’s BioFrontiers Institute. And her lab runs an ongoing research project studying the reptiles, regularly publishing findings they hope could lead to medical breakthroughs.

Pythons “are so adapted to their lifestyle,” says Maas, who recently completed his Ph.D. in Leinwand’s lab. “I think it’s a really great avenue to look at something that evolution has already figured out to take inspiration.”

A python’s dramatic internal renovation

One particularly extreme feature of the python is its metabolism — the rate at which it can transform food into usable energy.

“Pythons ramp up their metabolism from 10 to 40 times following a feeding, depending on the size of the meal,” says Tommy Martin, an assistant professor at the University of Nebraska Medical Center and a former researcher in Leinwand’s lab.

Leslie Leinwand is a a geneticist who, two decades ago, first came up with the idea of translating the unique biology of pythons into medical treatments.

Ari Daniel for NPR

hide caption

toggle caption

Ari Daniel for NPR

That’s “the equivalent of a Kentucky Derby racehorse at rest, compared to when they’re sprinting around the track,” says Jack Gugel, a molecular biologist at CU Boulder and former student of Leinwand. But pythons, he notes, can maintain “that high metabolic state for days as they digest the meal.”

To handle such super-high metabolism, the python’s body undergoes a dramatic renovation. “Their organs will actually grow,” says Gugel. That includes the snake’s heart — to be able to pump more blood and oxygen to digest the meal.

Human hearts can increase in size too, over years. When that growth is due to high blood pressure or a heart attack, the heart stays enlarged and it stiffens — with potentially fatal consequences.

“Some people, no matter what they do, even if they have the perfect diet and they’re exercising every day, they’re still going to have heart disease,” adds Gugel.

In pythons, however, a month or so after consuming a meal, their heart returns to its previous size.

“And we were really interested in figuring out — OK, what are the signals that tell this heart to get bigger?,” says Gugel. “And then also, what are the signals that tell the heart to go back down to a normal size?”

Answering such questions might offer insights into how to stop or even reverse problematic heart growth in people.

Yuxiao Tan, a molecular biologist at CU Boulder is researching python cardiac cellls. Here he poses with a toy python in the lab.

Ari Daniel for NPR

hide caption

toggle caption

Ari Daniel for NPR

Yuxiao Tan, a molecular biologist at CU Boulder who was supervised by Leinwand, has revealed another important insight in a soon-to-be published study. “Their heart can not only become bigger,” he says, “but their cardiac muscle cells also increase in numbers after they eat.”

It’s different in humans. “When people suffer a heart attack,” explains Tan, “they end up getting a scar over their heart because our heart muscle cells aren’t able to proliferate and repair the scar.”

The research in Leinwand’s lab is still underway, but it’s possible that pythons may carry the clues for how we might remodel human hearts to improve our own cardiac health at different stages of life.

Of muscles and molecules

Another line of investigation that these researchers are pursuing is related to the python’s apparent ability to resist muscle atrophy.

Take Agrapina, Maas’ pet python. Even after months of not eating and barely moving, when she caught site of the rat he offered her, “she was strong enough to then constrict it completely. She was fully capable,” he says. “She had lost very little muscle tone despite all that time fasting.”

“I know of no other creature that can do this kind of fasting without losing muscle function,” says Leinwand. She believes this ability could one day lead to treatments for people dealing with muscle atrophy as they age.

And Leinwand says the snake’s digestive processes have something to teach us as well, pointing to the countless small molecules produced as the animal breaks down a meal. “I think that this could be what we call a gold mine.”

Indeed, Leinwand coauthored a paper, published this spring in the journal Nature Metabolism, with collaborators from a variety of institutions, describing a molecule coursing through the blood of both Burmese and ball pythons that surged a thousand times after feeding.

“If I were a betting person,” says Leinwand, “I’d bet that something that changes a thousand-fold is probably doing something important.”

The study confirmed her suspicion. Gugel says the molecule, which is called pTOS, appears to act as an appetite suppressant by targeting the hypothalamus in the brain.

Jack Gugel stands with a pet python around his neck in front of the Flatirons, the iconic slabs of sandstone that help make Boulder a climber’s paradise. Gugel has been researching how pythons are able to rapidly increase the size of their hearts.

Ari Daniel for NPR

hide caption

toggle caption

Ari Daniel for NPR

“When we give this molecule to obese mice, they eat less and they lose weight,” he says.

Jasmin Camacho, an evolutionary biologist at the Stowers Institute for Medical Research, applauds the python work as another way of looking in unexpected places for potential drugs and cures. “By going to this extreme animal, that molecule was expressed at a higher level in a way that it just stood out,” she says.

Camacho, who wasn’t involved in the python research, studies bats that she thinks might hold secrets for fighting diabetes since they can consume large amounts of nectar without any apparent health problems.

“Evolution’s been running natural experiments for hundreds of millions of years,” she says. “So by studying these adaptations, we start to think of other ways that our bodies can work.”

Animal-inspired renaissance

GLP-1 weight loss drugs, like Ozempic, came out of research on the venomous gila monster lizard. Gugel hopes for a similar trajectory for the new molecule that the python studies uncovered.

“I think that there’s big potential in the market for a drug that specifically can inhibit appetite in the brain to help people with weight loss,” he says.

To that end, Gugel, Leinwand, Martin, and Jonathan Long of Stanford University have formed a company called Arkana Therapeutics to develop this and other discoveries into new drugs and treatments. They hope to look beyond pythons to other overlooked species, Martin says.

Ashley Zehnder is the CEO of Fauna Bio, a company that searches for disease resistance therapies among mammals equipped with unique adaptations. She says the approach that Leinwand’s team at CU Boulder is taking could expand the drug discovery palette.

“You can find these really potent bioactive molecules in these extreme species,” she says, “because they were evolutionarily perfected, and we can use that for medicines.”

There are challenges to this approach, naturally, says Zehnder, including learning how to care for the animals in the lab and having to figure out their complex inner workings from scratch.

But the payoff, Zehnder argues, could be potential cures for our afflictions drawn from the great tree of life. “I think there’s a lot that we can learn by putting ourselves back in that evolutionary tree and saying, ‘what can we learn from these other animals?,'” she says.

“And I think what it will do at the end of the day is make us really greatly appreciate the value of that diversity.”

This doctor says eat your ice cream for a long, healthy life : NPR

Oncologist and bioethicist Zeke Emanuel takes a back-to-basics approach to maintain good health in his new book, including tips like allowing yourself to enjoy ice cream.

WeBond Creations/Getty Images

hide caption

toggle caption

WeBond Creations/Getty Images

If you’re hankering for a cool treat on a hot day, nothing screams summer like ice cream.

And a physician renowned for shaping U.S. healthcare policy has a message: Go ahead and enjoy it.

Zeke Emanuel is an oncologist and bioethicist who served as an advisor to the Obama administration, helping shape the Affordable Care Act. He believes in a system that invests in prevention, one that aims to keep people healthy. So when he released his book, literally titled Eat Your Ice Cream: Six Simple Rules For A Long And Healthy Life, I asked him what motivated him.

“Mostly anger at the wellness industrial complex,” Emanuel told me. He says the wellness industry is selling people all kinds of things that are expensive and clinically unproven, pointing to the latest peptide trend, whole body scans and “all sorts of supplements” marketed as anti-aging elixirs.

Emanuel takes a back-to-basics approach, based on evidence, to maintain good health in his book.

And though the title is a bit tongue-in-cheek, he points to evidence that people who are in the habit of eating ice cream have a lower risk of metabolic disease, despite the fact that it has lots of sugar and fat. Researchers have dubbed this the “ice cream paradox.” There’s data from 2015 that suggests “that ice cream is actually pretty good at preventing development of type two diabetes, and dairy in general is good at preventing type two diabetes,” Emanuel says.

Want the latest stories on the science of healthy living? Subscribe to NPR’s Health newsletter.

Dairy contains whey protein that may benefit glucose regulation which may partially explain the association, though the research doesn’t nail down cause and effect. Emanuel is also big on consuming more fiber and fermented foods, pointing to the need to feed the bacteria in our guts.

“Evolution would have gotten rid of them if they weren’t there for a reason,” Emanuel says. “And so treating them well, through eating more fermented foods, whether it’s yogurt or cottage cheese or hard cheeses like gruyere or kimchi or sauerkraut, good things for us.”

Prioritize sleep and stay active

Emanuel’s other recommendations for increasing your chances of a long, healthy life track with a huge body of evidence on the importance of daily habits, including exercise, social connections and sufficient sleep. A new study published this month in the Annals of Internal Medicine finds people who skimp on sleep for just six weeks start to gain weight, in part because lack of sleep throws off hunger hormones.

“We know that biologically sleep is important. We know that it’s important to clear out the brain’s, to basically empty the garbage, as it were. We know it’s important to consolidate long-term memories. We know it’s important for DNA to repair. So there’s a lot of very important elements,” Emanuel says.

Bottom line: Sleep, he says, should not be shortchanged.

Emanuel’s most controversial advice: Do not retire. He points out that work provides a structure and a schedule, “so you get up and you go. It also provides a mental challenge and a social environment,” Emanuel says. So, you’ve got to think through how you’ll find structure, purpose and a social circle if you plan to leave a job that provides these elements.

He says that unless you consciously recreate this sense of purpose, you could increase your risk of cognitive decline. There are endless hobbies and volunteer opportunities to take up instead. Research from UC Davis shows people who report a higher sense of purpose in life are 28% less likely to develop cognitive impairment.

“There are lots of organizations that need help, and you have skills, and you can get to know people,” Emanuel says, pointing to everything from volunteering at a school or food bank to signing up for a class or joining a club — all good ways to meet people.

People who may want to meet up, he suggests, could also get ice cream.

“I enjoy it, that’s for sure,” Emanuel says. Chocolate hazelnut is his flavor of the summer. But of course, everything should be taken in moderation.

Here’s a take on his six simple rules:

1. Don’t be a schmuck! Avoid self-destructive risks. “Smoking is obviously not good for you. Vaping is also not good for you,” he says. Emanuel recommends limiting alcohol to 3 or 4 drinks a week, avoiding distracted driving, and he says it’s probably a “schmuck move” to climb Mt. Everest, pointing to high risk of harm or death.

2. Talk to people. Strike up conversations. “My standard when I get into an Uber is to ask the person, where are you from?” Emanuel says. If you initiate a conversation, people will likely respond. “People actually like to interact. We’re social beings. We’re programmed to interact. And so you just need to take the initiative.” Casual interactions are meaningful and can promote positive feelings.

3. Expand your mind. Emanuel says he realizes most people eventually retire, but take steps to maintain lifelong learning and stay curious. Finding ways to stay engaged and having a strong sense of purpose can reduce the risk of cognitive decline.

4. Eat your ice cream. A balanced diet matters, and people should eat to nourish and enjoy. Making simple shifts such as limiting soda and sugary drinks and snacks while focusing on healthy meals and having a treat at the end of the day. Everything in moderation.

5. Move it! Regular movement is important, including aerobic exercise that gets your heart rate up, as well as strength training. Walking after a meal is a great way to stabilize blood sugar and can help offset the harms of sitting.

6. Sleep like a baby. Sleep is fundamental to good health, and people who give short-shrifts to sleep are more likely to gain weight and be more sedentary. Sleep aides don’t work well, so practice good sleep hygiene, including setting a regular bedtime and optimizing your bedroom for sleep.

What to know about the U.S. outbreak of cyclosporiasis : NPR

The Centers for Disease Control and Prevention offices in Atlanta are seen in 2022. The agency is investigating a rise in cyclosporiasis cases.

Ron Harris/AP

hide caption

toggle caption

Ron Harris/AP

An outbreak of an intestinal illness that causes diarrhea, nausea and fatigue has been detected in 31 states, according to federal health authorities, but the source is still under investigation.

As of Thursday, the Centers for Disease Control and Prevention said it had received reports of 843 cases of cyclosporiasis, the gastrointestinal affliction caused by the parasite Cyclospora.

But the true number of infections is likely much higher, because that figure only represents cases reported by states directly to the CDC. There is also a lag between symptom onset and reporting, and many people recover from the illness without medical treatment. Michigan alone reported 1,562 cyclosporiasis cases as of Friday.

According to the CDC, as of Thursday, there had been been 86 hospitalizations nationwide and no deaths.

People can contract the illness by eating food or drinking water contaminated with the parasite. Previous outbreaks have been linked to fresh produce. In 2018, McDonald’s removed salads from restaurants in 14 states after federal health officials linked them to dozens of cases of cyclosporiasis, and tainted lettuce imported from Mexico was suspected to have sickened 400 people in the U.S. in 2013.

It’s typical for cyclosporiasis infections to rise in the spring and summer, but the CDC said Friday that multiple states had reported a larger jump in cases over the previous two weeks than they had during the same period last year.

Where are cyclosporiasis infections occurring?

Health officials from California to Texas to Florida have reported cases of cyclosporiasis since the start of May.

Some of the hardest-hit areas appear to be in the Midwest and Northeast, including Michigan and New York.

The Ohio Department of Health reported 177 cyclosporiasis cases as of July 2, most of which occurred in June. Dr. Bruce Vanderhoff, director of the Ohio Department of Health, said cyclosporiasis is a “serious illness that can cause dehydration and require people to seek emergency medical care, and it should be taken seriously.”

According to the CDC, those sickened with the disease have ranged in age from 5 to 88 years old.

The total number of nationwide cases is expected to grow, due to the estimated six-week gap between when illnesses begin and when they are reported to federal health authorities.

What’s causing the outbreak?

That is still unclear. The CDC says it is continuing to try to identify the source or sources of the recent surge of cyclosporiasis infections.

Investigators do that in part by interviewing those who’ve become sick to find out what they’ve eaten. But since symptoms can appear anywhere between two days and two weeks or more after a person was infected, they may not remember everything they ate during that period.

Previous U.S. outbreaks of cyclosporiasis have been associated with raspberries, basil, cilantro, snow peas and lettuce, according to the Food and Drug Administration.

How to prevent cyclosporiasis

Cooking produce is an effective way to avoid an infection, as heating food to 158 degrees Fahrenheit or higher kills Cyclospora.

Public health officials also suggest that people thoroughly wash all of their fresh produce, including herbs, though the parasites are not easy to rinse off.

It is also important for home cooks to observe standard food safety rules, such as washing their hands with soap and water before and after handling fresh produce.

Anyone who suspects they’ve been sickened with cyclosporiasis and is experiencing dehydration or severe diarrhea is encouraged to see a doctor. Cyclosporiasis infections are typically treated with antibiotics.

NPR’s Allison Aubrey contributed reporting.

A promising tale from Senegal of fish, rice and snails : NPR

Researchers net tilapia, which they’ll transport to the paddies of a rice farm in the Senegal River Valley.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

Momy Seck Ndao has been planning for this day for months.

The environmental engineer is standing beside two swimming-pool sized ponds, each lined with a black tarp and full of hundreds of tilapia. Two of her colleagues trudge through the pond in waders, trying to corral the fish with a net.

“For this project, we need a lot of tilapia, about 1,900,” says Ndao, as she eyes the horizon. They’re in a race against the rising sun.

It’s still relatively low but will soon heat this part of the Senegal River valley to about 100 F, hot enough to bake the fish on the way to their final destination — a rice field.

There, these tilapia — and a handful of other fish — are the key ingredients in an ambitious experiment. Ndao and her colleagues are trying to see if adding fish to rice farms can help solve three problems plaguing rice farmers, and Senegal more broadly — food insecurity, poverty and a debilitating disease.

To Ndao, it’s a particularly Senegalese solution.

The national dish, thieboudienne, is a delectable combo of rice and fish. “We eat it every day. So if you grow rice and fish in the same area, you just need to add vegetables,” Ndao says with an easy laugh, “and you will have your daily dish.”

Fishing expedition

But first, Ndao and her team have to catch those tilapia and schlep them to the farm.

Once enough fish are concentrated by the net into a writhing mass, other colleagues swoop in with smaller buckets to scoop them up. Quickly, but careful not to spill, they shuttle the buckets to a big green tank on the bed of a pickup.

The team is on a mission to scoop up nearly 2,000 tilapia at a fish farm in Dagana, Senegal.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

It takes about an hour to load up the fish. Kayla Kauffmann, a Stanford disease ecologist on the project, rushed over to the truck just after the tank was sealed. “I wanted to look in before they closed it,” she says. “It’s quite the operation.”

Today’s operation began before dawn and is far from over.

On the outskirts of the coastal town of Saint Louis, the team — over a dozen scientists, aquaculture technicians and interns — set off in the dark. Before reaching the tilapia farm in Dagana, about 80 miles northeast across the vast expanse of the Sahel, some of the caravan peeled off to catch a few larger fish of a different species, which will be the main disease-fighters.

Momy Seck Ndao, an environmental engineer who is part of the fish-rice project, wrangles an African bonytongue fish, also called heterotis, that escaped its bucket. The fish will soon be introduced to a rice farm, where researchers hope it’ll eat snails that spread a debilitating disease called schistosomiasis.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

The next and final stop, about 20 minutes away, is Keur Mbaye, where the fish will be introduced to a rice field. There, all those fish will live and poop, fertilizing the crop.

It’s one of 60 fields across the region where the team, in conjunction with local farmers, will be trying out this potential win-win-win solution. To Ndao, the stakes are high.

“The potential is here,” she says. “Everything will depend on what they will see in this experiment, what they will learn.”

Dangerous worms, protective fish

Rice production is booming along the winding Senegal river, which forms the border with Mauritania to the north. The immense Sahara is just a hundred-some miles away. Historically, the semi-arid climate meant that farming could only happen during the rainy season. But dam construction starting in the 1980s helped supply a steadier stream of water for crops.

Knee-deep in a Keur Mbaye rice field, Kauffman holds out in her gloved hand a tiny example of what else the dams allowed to flourish — freshwater snails that can carry the disabling disease known as schistosomiasis.

Small snails like this one can carry the worms that spread schistosomiasis.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

“The link between dam construction and schistosomiasis is really strong,” she says. “After a dam is built, way more people end up with schisto.”

The disease, which afflicts more than 200 million people a year, is caused by a parasitic worm that spends part of its life cycle in freshwater snails. There, the worm replicates itself, producing thousands of parasites that slink back into the water.

“They then try to find a person that’s wading in the water, like a rice farmer, and burrow into that person’s skin,” says Kauffmann. Ultimately, they lay eggs in the intestines or urinary tract, causing a slew of problems from stomach pain to bladder cancer.

Before dam construction, freshwater snail numbers were kept in check by migratory prawns that eat snails. But the dam “cut off their migration route,” says Kauffman. Fewer prawns meant more snails, and more schistosomiasis. Now, this part of Senegal has among the highest burdens of schistosomiasis anywhere, affecting about a third of children.

For rice farmers, the disease has become an occupational hazard. Dgibi Dia has farmed these fields in Keur Mbaye for decades. Standing near the pickup truck holding nearly 2,000 fish, he says he’s had multiple painful bouts with schistosomiasis.

Dgibi Dia is a rice farmer who has had multiple painful bouts with schistosomiasis.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

“This always happens to us since we are in the water most of the time,” he says. Each time, he and his fellow farmers get the same sort of symptoms.

“We cannot sleep at night because of the itching,” he says. Stomach pain is accompanied by “gurgling sounds,” he says, “as if we had something running inside the stomach.” He also experiences bloody diarrhea and fever, and symptoms can persist for months.

“It’s difficult,” he says. “When you are sick, you cannot work properly.”

There are drugs to treat schistosomiasis, but Dia says they’re hard to come by. Abdoulaye Ndiaye, another farmer, agrees, adding that they’re often too expensive. And while the drugs can cure a single bout, they don’t prevent re-infection.

“We live in the fields,” Ndiaye says. “Prevention is for our benefit.”

Rice farmer Abdoulaye Ndiaye hopes that adding fish to farms can help him avoid getting schistosomiasis.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

That’s where the fish come in — as snail superpredators.

Tilapia may eat the occasional snail, but that’s not their main job. The team is adding a few heavyweights — African bonytongue — to each field to be superpredators. The three-foot-long fish are also known as heterotis.

“It’s a species which can eat a lot of snails per day,” says Ndao.

African bonytongue fish, also called heterotis, can eat a lot of snails in a day.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

Thrashing fish

Adding them to rice fields, she hopes, will lead to fewer snails, and thus less schistosomiasis. Getting them into the fields proves tricky. One of the heterotis leapt out of its container onto the dusty ground. Ndao had to rush over to grab hold of the thrashing fish with both hands.

“Heterotis is very, very crazy,” she says, “very hard to catch.”

Eventually, she succeeds. After checking to make sure the water in the rice fields is suitable for the fish, the team starts shuttling both the few heterotis, and the hundreds of tilapia, to the water in buckets.

Ndeye Mbaye, part of the research team, releases tilapia into a rice field. The roughly 600 tilapia added to this field will fertilize the rice with their feces, and help feed the farmers.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

Gently, the buckets are lowered into the water, so the fish can acclimate to the temperature. “We do it slowly and let the fish go by themselves.”

Several minutes later, their scales flash in the sun as the fish disappear into the shoots of growing rice. There, the heterotis will eat snails. And all those tilapia, about 600 per field, have a different job — pooping.

“The feces of the fish is a very important natural fertilizer for the rice,” says Ndao, and should boost yield.

Many benefits

Rice production may be booming in the Senegal River Valley, but it’s not enough to meet the county’s appetite. As a result, Senegal imports about half the rice it consumes.

Rice fields in the Senegal River Valley.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

“We need to increase the yield, to obtain food security,” says Ndao. Fertilizer can boost yields, but is often expensive for farmers and the chemicals can runoff into rivers and lakes. Adding fish to farms could be a more sustainable way to boost yields, says Ndao. As a final bonus, the farmers can harvest some of the fish to eat for themselves or sell.

These benefits have helped sustain fish and rice aquaculture across Asia for centuries, but it’s pretty rare in Africa. Not many of the farmers Ndao talks with have heard of it. She highlights these possible benefits when trying to recruit farmers.

Dgibi Dia was drawn to the project for many reasons, but especially the fish. “There are no fish in this area,” he says, gesturing around his fields. “We have a shortage. We pray that it will be a success.”

There’s reason to think it will be. Over the past several years, Ndao and her colleagues tried growing fish and rice together on a smaller number of farms. One of them, near Saint Louis, belongs to Ousmane Diallo.

One day, “madam Ndao came to see us while we were working in the rice fields and explained the project,” he says. He’d never heard of growing rice and fish together, but was game to try. Once fish were introduced to the farm, Ndao checked in often to see how things were going. It’s a major part of her job.

“I call them every two days, until harvest,” says Ndao. With dozens of farmers to track, that means a lot of time on the phone. “My colleagues, they call me Sonatel, the national telecom agency,” she says laughing, because “I’m always on the phone.”

Diallo says whenever his phone rang, “it’s usually her. She is very determined.”

A blueprint for success

That kind of determination is essential for Ndao and her team’s ultimate goal — scaling up. This year, that means more than doubling the number of fields they’re studying to get a fuller understanding of what growing rice and fish together can do.

Researchers Momy Seck Ndao and Kayla Kauffman search for snails in the rice fields. The research team is measuring snail density before and after adding fish to farms, to see whether the fish can reduce the snail-borne parasite that causes schistosomiasis.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

A smaller pilot study, published earlier this year, hints at the benefits. Ndao and her colleagues found that adding fish to farms increased rice yields by about 25%, significantly boosted income and slightly reduced snail numbers. But the sample size was relatively small, so big questions remain, says Ndao. “There are so many things to do.”

Over the coming months, the team will be using drones to more closely track rice growth, taking more detailed measurements of changes in snail numbers to understand the impact on schistosomiasis, and gathering more information on what farmers are actually doing with the fish.

Answering all these questions is crucial for understanding just how big a difference fish-rice aquaculture could make. In turn, Ndao says the results will help make the case to more farmers to try putting fish on their farms, and hopefully, sustain the practice. For the project to make a meaningful dent in reducing disease, improving food security and farmer livelihoods, the practice has to be expanded.

The farmers who’ve participated in the project so far offer a compelling personal case.

Abou Diallo was able to paint and renovate his house from the extra money he earned after adding fish to his rice farm boosted crop yields.

Ricci Shyrock for NPR

hide caption

toggle caption

Ricci Shyrock for NPR

“I make more income, and sell much more rice than before,” says Abou Diallo, standing outside his freshly painted turquoise-and-white cement house, not far from Saint Louis.

Before adding fish to his farm, Abou Diallo could sell about 60 bags of rice a season. After adding fish, he sells between 90 and 95 bags, he says. “It has changed my life.” The extra funds allowed him to buy a flock of sheep and renovate his home, he says, including giving it a new coat of paint. He was able to eat and sell his own fish, which he says taste better than those he gets from the ocean. “There is a big difference.”

Most people who need glasses lack a pair. Here’s a solution : NPR

Mirjahan Choudhury receives a free eye screening at the Rangia Post office in India.

Subhamoy Bhattacharjee for NPR

hide caption

toggle caption

Subhamoy Bhattacharjee for NPR

In recent years, Sangita Kalita has watched as her mother and mother-in-law go to the local temple — called a naamghar — in Assam State, India and leave disappointed.

Each visit, their hope was to read the sacred Hindu texts, “but due to vision issues, they faced a lot of problems recognizing the small letters in the book,” explains Kalita.

According to the World Health Organization, they are among more than 800 million people worldwide who suffer from presbyopia — age-related loss of close-up vision — for which basic reading glasses would help. Yet, according to WHO, in many lower-income countries, fewer than one in four people who need eyeglasses have them.

Kalita says for her family, getting reading glasses was simply too complicated and expensive. While in many high-income countries, readers are available in all kinds of stores, in lower-resourced settings, getting a pair often requires a trip to the hospital or a specialized optical shop, usually in a big city.

Kalita is trying to change that.

In northeastern India, she’s part of a team testing a new effort to address the challenge of getting vision care in remote areas. The idea involves the country’s massive network of post offices.

A quick eye test in an unusual place

Kalita used to be a school teacher. Now, she spends her days at a red and white kiosk that’s against the bright white walls of the post office in the town of Rangiya.

From that vantage point, she watches as customers come in. Some are there to mail packages while others use a wide variety of services offered in Indian post offices, such as opening and accessing small savings accounts. Kalita notices how they go about their task.

“A lot of old people come in who are not even able to fill out the deposit form,” she says.

When she sees them struggling, that’s when she steps in. She approaches, asking if they’d like a quick eye test. If so, she invites them to the kiosk where the words “get a free eye-screening and high-quality eye glasses here” are written at the top. After they work through a few simple tests in a spiral bound book, Kalita can tell if they need reading glasses. And if they do, they walk out with a free pair.

Sangita Kalita, an eye screening volunteer, helps clients at the Rangia Post office.

Subhamoy Bhattacharjee for NPR

hide caption

toggle caption

Subhamoy Bhattacharjee for NPR

The idea for this model came from a partnership between WHO and the Universal Postal Union or UPU. “With an estimated 680,000 post offices operating globally, postal services offer a unique opportunity to reach remote and underserved areas,” the report explains.

The plan was to tap into the world’s largest postal network — India Post has over 150,000 offices.

“The whole thinking was that we look at an established channel, which has a reach, which has infrastructure, which has people,” says Shweta Verma, deputy director for programs and operations at VisionSpring India.

Under a pilot program run by VisionSpring, Verma says, between December 2025 and May 2026, more than 5,000 people were screened in five post offices in Assam State.

Verma says 80% of those who received glasses were first time wearers. That “tells us that there was no screening or program for eye health” in the area prior to the pilot, she says.

Convincing skeptics

Getting reading glasses can make a big difference for a person’s income, in addition to making every day tasks easier. That’s especially true in Assam State, a region known for tea production.

A study published in The Lancet Global Health found that reading glasses increased tea pickers’ productivity by almost 22% since they need to see which leaves to pick and are paid based on the quality of their harvest.

Over the course of the post office pilot, Verma says, they’ve had to earn the support of postal workers and postmasters.

Initially, she says, “we got a lot of buy-in from the higher-ups,” but postal workers were skeptical, worrying how this new undertaking would impact workload. So Verma’s team hired and trained outside individuals — like Kalita — to implement the program. “Once the program started,” Verma says, “there was a lot of traction also from postmasters.”

Babul Boro is the postmaster where Kalita works. Since the pilot started in December 2025, he says over 1,000 people have come into his post office for eye tests and many have gone on to use postal services. He says this boost to his business is enough to make him hope that the pilot becomes permanent.

The current pilot is slated to wrap up in September. Then, Ella Gudwin, CEO of VisionSpring, says they’ll look through all the data and consider the funding before deciding whether to continue — or even expand. WHO and UPU have expressed interest in taking the model worldwide.

Beyond vision care

While VisionSpring says this model is a first for eyeglasses, the hope is that this undertaking demonstrates that post offices can be used “for a wide range of health-related services worldwide,” says the WHO and UPU report.

Dr. Elisabeth Rosenthal, a physician and a senior contributing editor at KFF Health News, has written about repurposing post offices to address medical needs. She says France and Japan are strong examples of where this is already happening.

In France, for a small fee, letter carriers can check on elderly individuals, she says, “just stopping in and having a chat, and kind of checking to see: Is there food in the house? Are they able to get around okay?”

Mantu Das takes a vision test at the Rangia Post office.

Subhamoy Bhattacharjee for NPR

hide caption

toggle caption

Subhamoy Bhattacharjee for NPR

In Japan there’s something similar. And in some parts of the U.S., carriers can look for mail piling up and alert a local agency to initiate a welfare check.

In Kalita’s post office in India, she says, one thing motivates her: The smile she sees on people’s faces after she gives them eye glasses. She says it makes her “feel very accomplished and happy too.”

She says she’s thinking of the teacher who no longer gets headaches each day. Her mother and mother-in-law who can now read the sacred texts. And the tailor who never knew that reading glasses could be so life changing — and that getting them could be as easy as swinging by the post office.

Common Sense Family Doctor: Deprescribing statins

If you found out that a medication you had been taking for years was much less effective than previously advertised, would you keep taking it?

An estimated 20 to 30 percent of Americans over the age of 45 takes a statin for high cholesterol, a history of heart attack or stroke, or to prevent a cardiovascular event. Once a patient starts a statin, provided that they don’t experience side effects, they usually continue taking it for life. The medication lists of nursing home residents almost invariably include statins. Statin prescribing has been overwhelmingly positive for population health; a recent study credited them with closing the gap in cardiovascular risk factors between middle-aged adults with obesity and those with normal weight. Ultimately, though, an individual reaches a point where a statin is likely to cause more harm than benefit, even if the harm is having to take one extra medication that costs as little as 30 cents per day.

An expert panel at Deprescribing.org, which previously published evidence-based guidelines on discontinuing proton pump inhibitors, antihyperglycemics, and antipsychotics, among others, recently added statins to its deprescribing guidelines. A synopsis of the guideline is available as an algorithm on their website. In adults over age 65, several factors may prompt a conversation about discontinuing statins: frailty, pill burden, functional limitations, cognitive impairment, complex care needs, and advanced illness (e.g., cancer). A person with a terminal illness who isn’t expected to live for more than a year is an ideal candidate for stopping a statin, but some patients with longer life expectancies may reasonably decide to discontinue them based on their personal goals and the value they assign to preventing future cardiovascular events.

None of this should be particularly controversial, but I would have gone farther if I had been on the guideline committee. The replacement of the Pooled Cohort Equations with the PREVENT calculator has resulted in many adults now having a significantly lower estimated risk of cardiovascular events. That should have prompted a reconsideration of statin use for patients whose new risk estimate fell under the threshold for statin initiation. Instead, as I discussed in a Medscape commentary, the American College of Cardiology / American Heart Association simply moved the goalposts, recommending statin initiation (and continuation) at lower thresholds:

Although these changes make it unnecessary to have potentially awkward conversations with patients about why they may no longer need medications that they’ve been taking for years, moving the goalposts is not warranted by primary prevention RCTs, which generally enrolled persons with 10% or greater 10-year risk. Even if one assumes that the relative benefits are the same, patients deserve to be informed about their lower risk estimates so that they can weigh the higher numbers needed to treat before deciding if starting or continuing statin therapy is worthwhile.

I went on to make a deprescribing recommendation that I expect many cardiologists and primary care physicians will disagree with:

Patients at lower risk [based on the PREVENT calculator], particularly less than 5%, should be offered the option of discontinuing statins, keeping in mind the “risk enhancers” listed in the ACC/AHA guideline, which may suggest that the calculated value underestimates their true risk.

Statins haven’t become less effective in relative terms, but changes in risk estimates mean that the absolute risk reductions in cardiovascular events and deaths that patients can expect from these drugs are smaller than they were before. And that means that in some cases, deprescribing statins may be a clinically appropriate action.

Taliban declares war on smartphones : NPR

In this 2022 photo, three university students check their smartphones. In June, the Taliban announced a ban on the devices in certain sectors of society. The ripple effect is making students afraid to bring their smartphones to school.

Wakil Kohsar/AFP/via Getty Images

hide caption

toggle caption

Wakil Kohsar/AFP/via Getty Images

Farzana, 40, is a midwife who covers 10 villages in Moqor district of Afghanistan’s Ghazni province. Until recently, worried mothers often sent her photos of newborns with rashes, swelling or skin infections so she could decide who needed help most urgently.

But since the Taliban began enforcing a ban on smartphones that took effect in June, Farzana says she has stopped using her smartphone out of fear. She can now only be reached through a regular phone line — a more costly option in a country where people rely heavily on WhatsApp for calls, messages, photos and urgent coordination.

“I cannot be everywhere at once,” said Farzana, who like many Afghans goes by one name. “Sometimes a photo or a message helps me understand whether a mother or newborn needs urgent help.”

Across Afghanistan, smartphones have become part of a fragile support system. Families use them to consult doctors remotely, arrange transport to distant clinics, send photos of wounds and symptoms, ask relatives for money, document abuse and reach schooling that is no longer available in person to many girls and women. That fragile network is now under threat.

Smashed and confiscated

Taliban authorities in Afghanistan have ordered government employees, judges, police and members of the military to stop using smartphones under a directive that took effect June 16. The order threatens violators with confiscation, destruction of their devices and punishment (which are not specified).

The use of what are known as feature phones — with calling and texting options but no touch screen and no photo or recording capabilities — is permitted.

The ban does not yet apply to private phone ownership by ordinary Afghan civilians. But in some provinces, restrictions have already moved beyond government offices and into hospitals, schools and universities, raising fears that the policy could become an early test for broader limits on public smartphone use.

The restrictions began as a verbal order from Taliban supreme leader Hibatullah Akhundzada and were later formalized in a military court directive circulated to court heads, police commanders and intelligence chiefs across the country’s eight administrative zones. The directive says anyone caught using a smartphone will have the device smashed and face “legal and sharia punishment.” Exemptions require a written decree from Akhundzada himself. A separate court order covers “all officials of the military and civilian institutions, including judges.”

The Taliban have also created monitoring lists recording employees’ names, positions, workplaces, mobile carriers and phone numbers. Security officials have instructed members to destroy their own smartphones and submit proof on a designated form.

One government employee in Herat, who requested that NPR not use his name for fear of retaliation by the Taliban, says phone restrictions had quietly been in place in his office for months before the June order took effect nationally. When he and his colleagues resisted, he said, officials confiscated and smashed their phones.

A possible trigger for the ban

The timing of the order followed protests in Herat in early June, after Taliban forces arrested women and girls accused of “improper hijab” — not meeting the dress code of covering the face and body in the prescribed manner and not wearing makeup. Witnesses said Taliban forces opened fire on demonstrators, killing at least one person. Video of the shooting spread online before the Taliban could contain it.

The Taliban administration did not respond to a request for comment.

Taliban staff used to rely on smartphones. After a ban was announced, they’re using feature phones — also known as “dumb phones” — which do not have a screen and are designed for calls and texts. This Taliban administrator is using such a phone at the Department of Information and Culture building in Kandahar.

Sanaullah Seiam/AFP/via Getty Images

hide caption

toggle caption

Sanaullah Seiam/AFP/via Getty Images

The restrictions have reached deeply into education, where phones are not only tools for communication but also part of how students study, save lessons, contact teachers and stay connected to their families.

In Kandahar province, an 18-year-old madrassa student named Baryalai, who also requested anonymity because he fears retaliation from the Taliban, said the change at his school was total. “Now there’s a complete ban,” he said. “No one brings smartphones anymore.”

A teacher at the same school, 30-year-old Omar Istanikzai, said he had left his own phone at home that morning without being told to. “I think this is a good decision so that there is more focus on studies,” he said.

Others see the policy very differently.

How schools are responding

At Kabul University, the leadership council ordered a complete smartphone ban for professors, staff and students effective June 21. The decision was announced at an academic council meeting where members were not permitted to ask questions. At Herat University, notices posted at the entrance warn that no one may enter with a smartphone, and the restriction extends into student dormitories, where Wi-Fi service has also been suspended. In Baghlan province, students carrying smartphones have been turned away at the university gate.

A student at Kabul University said the restriction has also made it harder for students to remain in touch with their families during emergencies. He asked that his name not be used because he has been targeted by the Taliban before and is afraid he would face retaliation for speaking out if they could identify him. His family lives in Badakhshan province, he said, and after a security incident involving students on July 4, his mother was terrified because she could not easily reach him.

“She was so worried,” he said. “If something happens, our families need to know whether we are safe. Without our phones, we are cut off from them.”

For many students, a phone is a classroom and a library. They use it to photograph lessons written on the board, receive assignments, download books, search for academic materials, use dictionaries and contact instructors outside class. For girls and women barred from secondary school and university, it can be one of the last ways to keep studying privately.

In Kandahar, the provincial Education Department said its own ban on students and teachers was rooted in a “sharia perspective” and warned that smartphones risked “the destruction of the future generation.” The Taliban’s higher education minister has called smartphones “one of the three main enemies of Muslims” and last October restricted their use on university premises to only the most senior administrators.

What could be lost

For many Afghans, however, the phone is not destroying their future. It may be one of the few tools they still have to protect it.

That is especially true in healthcare, where distance, poverty and Taliban restrictions already make treatment difficult. Afghanistan’s health system is under severe strain, with many hospitals and clinics facing shortages of staff, medicine and funding. Patients in rural provinces often travel for hours, sometimes across several districts or provinces, to receive treatment. For women, the barriers are even greater. Taliban restrictions on movement, education and employment have limited women’s access to care and threatened the future pipeline of female doctors, nurses and midwives.

In that environment, a phone can narrow the distance between a patient and help. A pregnant woman can call relatives to arrange transport. A mother can ask a midwife whether her newborn needs urgent care. A patient can send a photo of an injury before deciding whether to make a costly trip to a hospital. A health worker can consult colleagues through messaging apps.

For Farzana, those messages are part of daily work. They help her decide when a situation cannot wait.

“The ban makes it hard to attend to every woman in every village,” she said.

Faraidon Farzad, 29, grew up in a village in Malistan district of Ghazni province, where reaching a doctor was never simple. Now pursuing a Ph.D. in artificial intelligence, he has developed a system that analyzes smartphone photos of wounds for signs of infection — redness, discoloration and changes in tissue — that could help flag when a patient needs medical attention.

The project won a special award at Moscow’s Archimedes innovation exhibition this year. It is still in the research stage and would need larger datasets and clinical validation before wider use, Farzad said.

“Mobile phones are widely available, affordable and easy to use,” he said. “In many areas, especially rural communities, people may not have quick access to specialists, but they often have access to a smartphone. A mobile-based tool could provide early guidance and encourage patients to consult healthcare professionals sooner.”

Farzad’s project is not ready for broad use. But it shows what mobile technology could make possible in a country where access to medical care is already fragile.

Esmat Khan Amiri, 26, from Daykundi province, used his phone for a different kind of health-related action. After his father was repeatedly brought to an operating room at a hospital in Kandahar and turned back without surgery, Amiri posted a video describing the ordeal.

“I did not have power, money, or connections, but I had a phone,” he said. “I wanted people to know what was happening.”

The video spread on social media, and Amiri said the resulting pressure led the hospital to finally operate on his father.

Giving voice

“A smartphone is not only a tool for entertainment or communication,” Amiri said. “For people who are ignored, silenced, or discriminated against, it can become a voice.”

Since the Taliban returned to power in 2021, phone footage has repeatedly captured images the government could not control: protests, arrests, public punishments and complaints from inside hospitals. The same device that helps families seek medical advice can also expose mistreatment.

That visibility is part of what makes smartphones threatening to the Taliban. They allow information to move beyond official control — from a village, a classroom or a hospital ward to the wider public.

For Afghans who have few other ways to demand help, that matters. A phone can connect a mother to a midwife, a student to a lesson, a patient to a doctor or a family to an audience when institutions ignore them.

Now, as the Taliban moves to restrict smartphones, one of the country’s most popular tools has become one of its most contested.

Fatima Faizi is a journalist based in New York. She previously reported for The New York Times in Afghanistan, and her work focuses on human rights, women, education and the impact of Taliban rule on daily life.

Ebola death toll in Congo reaches 600 : NPR

Health workers interact at the Evangelical Medical Center, in Bunia, eastern Congo, Friday, July 3, 2026, where Ebola clinical trials are scheduled to take place.

Dirole Lotsima Dieudonne/AP

hide caption

toggle caption

Dirole Lotsima Dieudonne/AP

KINSHASA, Congo — New suspected cases of Ebola have been reported in parts of Congo that were previously unaffected, the government said Thursday, as the death toll in the country’s latest Ebola outbreak reached 600.

According to the Congolese health ministry, suspected cases have now been recorded in the provinces of Tshopo and Haut-Uele, signaling the continued spread of the disease beyond the epicenter in Ituri.

A Congolese government report, published late Wednesday, said two new cases were suspected in Kisangani, in Tshopo province. The minister did not say how many cases were suspected in Haut-Uele. The total number of confirmed cases across the country has now reached 1,759.

The report said one of the two suspected cases in Tshopo was linked to the Nia-Nia health zone in Ituri province, where the first cases were reported, while the other case “has no apparent geographical connection to known outbreaks.” Authorities were investigating.

The Africa Centre for Disease Control said on Thursday that the latest outbreak is the fastest-growing Ebola outbreak on the continent.

The Congolese authorities declared a fresh Ebola outbreak on May 15, after the disease had been transmitting for weeks without official detection, according to the World Health Organization. The latest outbreak is caused by the rare Bundibugyo virus, which has no approved vaccine or treatment.

Last week, clinical trials for treatment began after researchers launched a highly anticipated study in the hope of fighting the virus.

Efforts to contain the virus have also been hampered by a funding gap, attacks on health centers, and an ongoing conflict in eastern Congo, the epicenter of the outbreak.

Disability groups left concerned, confused after Ed. Dept. briefing : NPR

The Education Department plans to shift oversight of special education to another agency, alarming many disability rights advocates.

Kayla Bartkowski/Getty Images

hide caption

toggle caption

Kayla Bartkowski/Getty Images

Catch up on what you missed with our Education newsletter, sent weekly.

In a call with disability rights advocates Thursday, officials from the U.S. Department of Education tried to ease concerns about plans to move the agency’s special education offices to the Department of Health and Human Services (HHS).

The effort seemed to fail.

“Today’s briefing left more questions than answers for parents and educators,” says Chad Rummel, who leads the Council for Exceptional Children, and was one of many disability advocates who attended the call. “Today we heard that there is no clear and transparent plan around the move to HHS.”

According to a recording of the call obtained by NPR, the acting assistant secretary overseeing special education, Kelly Rogers, said she wanted to reassure advocates that the move would not harm federal protections for students with disabilities. “The U.S. Health and Human Services is not taking over IDEA. Period.” Rogers was referring to the Individuals with Disabilities Education Act, a federal law that guarantees students with disabilities a quality public education alongside their nondisabled peers.

Yet Rogers also said in the same breath that staff at the Office for Special Education and Rehabilitative Services (OSERS) — many of the people actually responsible for supporting states and schools in implementing IDEA — would be moving to HHS. She said she would continue to oversee that staff from her perch at the Education Department “with additional support by HHS.”

While department officials have been pitching this move as a way to streamline federal bureaucracy in education, advocates think it is doing the opposite. “This proposal appears to add another layer of bureaucracy while creating additional confusion and uncertainty for families, educators, and state agencies,” says Denise Marshall, CEO of the Council of Parent Attorneys and Advocates (COPAA).

In Thursday’s call, Rogers said, “This administration is firmly committed to carrying out the federal government’s duty to enforce federal protections for individuals with disabilities.” She continued, “This partnership does not alter that obligation.” Rogers did not share a specific timeline for these changes to take effect.

NPR followed up with the Education Department by email after the call, and while the agency did not respond to questions about its timeline, press secretary Savannah Newhouse wrote, “Advocates, parents, and teachers in the special education community have nothing to fear” about the changes. “What our partnership with HHS does is place these important federal responsibilities in a better positioned agency and draw on HHS’ expertise of working with people with disabilities of all ages.”

The private briefing came three weeks after the initial announcement that the Education Department would move two of its core functions — special education and civil rights — to other agencies in an ongoing Trump administration effort to dismantle the department altogether. The department has already shared plans to move more than a dozen of its offices to other agencies as part of its “Returning Education to the States” campaign.

For decades, the Education Department has overseen IDEA and other services for people with disabilities, like helping adults transition to life after school. While the federal government has never directly managed how schools serve students, it has been responsible for keeping schools accountable for meeting the needs of those students, providing federal funding for services and offering technical assistance to local leaders.

For months, the disability community has been on edge about how moving oversight of IDEA could affect students.

“The concern is not that IDEA disappears overnight. The concern is that the administration is preserving IDEA at the Department of Education on paper, while moving much of the work that makes IDEA real for families somewhere else,” said Jacqueline Rodriguez, CEO of the National Center for Learning Disabilities. “For students, that could mean more confusion, slower guidance, weaker monitoring and less accountability when services are delayed or denied.”

Newhouse, from the Education Department, denied that the changes would affect how staff do their jobs. “A different building, a different floor, or a different desk doesn’t change their job responsibilities and commitment to serve students with disabilities every single day.”

Department officials say federal funds dedicated to special education will continue to flow to states and schools through the agency for now, but it’s unclear how those systems may change when OSERS staff move to HHS.

“The administration acknowledged today what the law has always required: The Department of Education and the secretary of education remain legally responsible for administering and enforcing IDEA. This reorganization neither advances the stated goal of closing the department nor transfers new authority to the states,” says Marshall of COPAA. She called on Congress to step in and stop this move — a federal agency can only be completely dissolved by an act of Congress.

But as Marshall and other advocates pointed out, administration officials seem keenly aware of this fact, which may be why the Education Department is keeping some staff, including Rogers, at the Education Department.

Marshall called the strategy “a sham.”

Edited by: Nirvi Shah
Visual design and development by: LA Johnson

EPA proposes weakening heavy-duty truck pollution rules : NPR

An exhaust pipe is pictured atop a truck traveling along Interstate 35 on July 30, 2025 in Austin, Texas. The EPA is proposing changes to rule limiting hazardous pollution from heavy trucks.

Brandon Bell/Getty Images North America

hide caption

toggle caption

Brandon Bell/Getty Images North America

Stay up to date with our Up First newsletter, sent every weekday morning.

The Trump administration is proposing changes to what it calls “unnecessary and unworkable” Biden-era environmental rules designed to cut pollution from heavy-duty vehicles, including buses and large trucks.

The proposal — part of a series of deregulatory actions by the Trump administration that have rolled back emissions standards for new vehicles — includes changes that are welcomed by trucking organizations and denounced by environmental groups.

Specifically, the proposal from the Environmental Protection Agency would scale back and postpone two provisions designed to make sure emissions-reducing technology keeps working while a vehicle is in use; one related to warranties, and another related to the useful life of emissions technology.

Additionally, the current set of rules requires truck engines to automatically operate at reduced power if their emissions reduction systems aren’t working, which truckers and other heavy-duty vehicle operators have called disruptive. The EPA proposes getting rid of that requirement altogether and replacing it with an alert to drivers.

According to the EPA’s analysis, the changes would save the trucking industry between $4,130 and $6,152 per diesel engine affected. Compared to the current emissions rules, the change would increase ozone-forming nitrogen oxide pollution from heavy duty trucks by 4.2% in 2030 and by 11.6% by 2055.

The EPA did not model the resulting effect on air quality or human health, but noted that the modifications would likely reduce the benefits of prior rules changes in 2023.

The proposal is now open for a period of public comment.

“If finalized, these changes will help manufacturers keep improving their vehicles without being forced to rush products to market before they’re ready,” EPA administrator Lee Zeldin said in a statement, adding that the rules changes “will ease real burdens for operators.”

Kelly Loeffler, who heads the U.S. Small Business Administration, wrote that the rules change would alleviate “burdensome diesel regulations on behalf of farmers, truckers, and small business owners who were crushed by unworkable environmental activist demands that became costly mandates.”

The American Trucking Association had called for changes to the rules, writing in February that the Biden-era policies would require “a premature rollout of commercial motor vehicles with unproven engine technologies onto our highways.” The group specifically asked the agency to allow truck manufacturers to pay penalties instead of comply with the rules, as long as they were working on developing compliant engines, an option the EPA included in the proposal.

Environmental groups criticized the proposed changes, citing concerns about the health hazards of emissions. “Clean truck standards save lives,” Katherine García, director of the Sierra Club’s Clean Transportation for All campaign, wrote in a statement emailed to NPR. “Weakening them would mean more toxic pollution in the air and more families paying the price with their health.

The Environmental Defense Fund noted that while heavy trucks make up only 5% of vehicles on U.S. roads, they are the largest source of “pollutants that cause asthma attacks, bronchitis, heart attacks, strokes and preventable deaths,” and argued that truck manufacturers are already capable of meeting the Biden-era rules.

More people are ‘solo agers’ and they need support that could benefit everyone : NPR

Carl Smigielski, 61, is single now, after being a caregiver to his husband, Moshe, who died in 2019. He expects to be a “solo ager,” someone who doesn’t have a family member to rely on as he gets older.

Ashley Milne-Tyte for NPR

hide caption

toggle caption

Ashley Milne-Tyte for NPR

Stay up to date with our Up First newsletter, sent every weekday morning.

Ailene Gerhardt hears a lot of stories. It’s all part of her job. She’s a patient advocate, helping people navigate their care and the complexities of the healthcare system. During the last several years she’s heard from more and more people getting older without adult children, a spouse, or both. But the healthcare system remains stuck in the past, she says, assuming older people have family to support them, when that’s often not the case.

Gerhardt started and runs a network called Navigating Solo, which offers support and community to this group of older adults, often referred to as “solo agers.”

“Instead of looking at the concept of solo aging as something that’s a crisis to be solved — it’s not a crisis to be solved,” she says. “It’s a reality to be supported.”

That reality is growing as Baby Boomers and Gen Xers age. According to a 2023 AARP report, one in ten adults over age 50 lives alone and doesn’t have a partner or children. Different lifestyles and changing societal attitudes suggest these numbers will grow in the future. Plenty of people are single by choice.

More inclusive systems

Gerhardt says right now, solo agers are expected to take the lead in planning for their housing, finances, and transportation to appointments, often by hiring professionals to help them. But rather than feeling like the odd ones out in systems that cater to couples and families, she says, why can’t the systems themselves be more inclusive of solo agers?

To take one example: instead of assuming every patient has someone who can pick them up from a medical appointment after being under anesthesia — and drive them home — she’d like the onus to be on hospitals and medical offices to arrange transport and an escort. She says she has heard from people who have canceled a procedure because their ride backed out at the last minute.

“In both my solo aging advocacy hat and my healthcare advocate [hat], like, that is just infuriating,” she says, “that people do not have the support they need to maintain their health in a productive way.”

But Gerhardt says this isn’t an intractable problem. “Let’s look at designing the system, or re-designing the system, so that anyone and everyone can have strong support. Quite honestly that benefits everyone,” she says, citing curb cuts as a good example of this. Disability rights advocates fought for years to have towns and cities install curb cuts — a slope from the sidewalk to the street that lets a wheelchair user cross the road easily and safely. But curb cuts quickly became popular with people pushing strollers, bikers, and anyone else seeking an easier way into the street.

Building services for the future

Sara Zeff Geber has been writing and speaking about solo aging for more than 10 years, including giving talks to lawyers and financial planners, “to bring awareness to the fact that not everybody is a couple and not everybody has that proverbial adult daughter to help them.”

She believes she was the first person to use the term “solo aging,” seeing it as a lot more positive than the previous description: “elder orphans.”

Ideas about relationships and parenthood are less rigid than they used to be. Given this, she says, “Whatever foundation we build now” for solo agers, “is going to be hugely important for generations that follow.”

Jason Resendez hopes those generations will have more government support than the current crop of older adults. He is CEO of the National Alliance for Caregiving. He says there is growing recognition that many people are aging by themselves. That said, federal funding cuts are coming to home-based services for older adults, and to Medicaid, he says, “which makes it a lot harder to age in place when you don’t have a family caregiver to absorb the elimination of those social service supports.”

On the whole, Resendez says, U.S. society is still hooked on the idea of “individual ruggedness.” But as he looks to the future, “More and more people will be aging, more and more people will be aging alone,” and the social safety net will come under a lot of strain. “I think it’s when we are at that boiling point, that maybe we’ll have policymakers finally recognize, ‘Hey, this isn’t just an individual responsibility.'”

Creating the resource he will need

Carl Smigielski was a family caregiver to his husband, Moshe, a Vietnam veteran who died in 2019 after living with Alzheimer’s for several years.

But Smigielski doesn’t expect to have a caregiver of his own. He’s 61, lives alone in Richmond, R. I., and believes it’ll stay that way. “Right now it wouldn’t align with me to have another intimate relationship so I was pretty clear,” he says. “You’re going to be doing this alone.”

Carl holds a photo of himself (r) and his late husband Moshe Gara (l), towards the end of Moshe’s life. Carl was Moshe’s caregiver when he had Alzheimer’s disease.
hide caption

toggle caption

But he’s gotten involved with a nonprofit organization that has long recognized solo agers. It’s called the Villages (not to be confused with the large retirement communities in central Florida.) The Village Movement consists of hyperlocal groups that are mostly run by volunteers.

The Villages started 25 years ago with one village in Boston. There’s now a network of them dotted across the U.S. Their aim is to help people live independently by offering a combination of practical and social support, such as rides to appointments, help moving furniture or changing lightbulbs, friendly check-ins for those who want them, and social events.

People gather for lunch at the Richmond Community Center in Richmond, R.I., where Carl Smigielski is about to explain the concept of a local ‘village’ for older adults.

Ashley Milne-Tyte for NPR

hide caption

toggle caption

Ashley Milne-Tyte for NPR

Members join to tap the network’s resources. Volunteers make it happen. While not designed specifically for solo agers, Barbara Hughes-Sullivan, executive director of the Village to Village Network, says “anywhere from 30 to 60%” of village members are in that demographic, depending on the individual village.

Smigielski is both a member and a volunteer. He is helping to start a new village in his rural part of Rhode Island. “I wanted to retire to something,” says the longtime software engineer. “I didn’t want to retire to boredom … and I really have met the kindest people.”

He’s spending part of this day at a community center to explain the village concept to a group of older adults over lunch, including his mother, Jacqueline. She is 87, a widow, and eager to volunteer. Afterwards he heads back to the home he used to share with his husband. After speaking in front of the group, he needs to decompress in the quiet of the house and yard.

Smigielski says he’s not an obvious candidate for a network like this. He enjoys his own company, and doesn’t expect to need help changing lightbulbs for decades. But after years of caregiving, followed by the Covid years, he realized something.

“The social support, regardless of how able we are, that’s intrinsic to us,” he says. “I went through my battles of thinking I was an exception to that rule, I could be the human who didn’t need social connection – because I don’t need a lot of it, but I need it.”

For now, he still has his mom to drive him to medical procedures where he needs help getting home afterwards. But eventually he expects to tap the network he’s helping create to sustain him as he gets older.

Carl Smigielski and his mother, Jacqueline, outside the Richmond Community Center in Richmond, R. I. Each is part of the other’s support system.

Ashley Milne-Tyte for NPR

hide caption

toggle caption

Ashley Milne-Tyte for NPR

Could ‘Death by Organ Donation’ ease shortage of organs for transplant? : NPR

Mininyx Doodle/iStockphoto//Getty Images

For stories on healthy living, subscribe to NPR’s health newsletter.

Should surgeons be allowed to perform euthanasia by removing patients’ hearts and other organs while they’re still alive?

The idea, dubbed “Death by Organ Donation,” would enable euthanasia patients to donate organs for transplantation in a way that would make their organs more likely to be usable. It would also kill them.

“It would be an ethical thing to do because this is something the patients have chosen for themselves,” says Dr. Robert Truog, a physician and bioethicist at Harvard Medical School who co-authored a paper outlining Death by Organ Donation in the New England Journal of Medicine. “They have very generously thought: ‘How might my death help other people?’ It’s a very altruistic, generous thing to do.'”

But the idea is controversial for a variety of reasons, including because it goes against fundamental principles that have guided organ donation for decades. The Dead Donor Rule requires that patients must be dead before any organs are removed. Doctors also can’t kill patients in the process of removing organs.

The rule has long generated intense debate, including disputes over how to precisely determine when a person is dead, as well as the development of new ways to extend the lives of dying patients and recover usable organs for transplants.

At the same time, many countries, including Canada, the Netherlands and Spain, have made it legal for doctors to help patients die through euthanasia.

“What if they chose to be organ donors? The problem is that under current standards doctors must not cause death in the process of procuring organs for transplant,” Truog says.

So hearts, lungs, livers and kidneys can only be removed from euthanasia patients after they have received a lethal dose of drugs, which makes their organs, especially their hearts, much less useful for transplantation.

“Why would it not be OK for patients to say, ‘I’ve chosen to die by a lethal injection. Isn’t there some way I can help others?’ They should be able to donate organs as a lasting gift to others. And denying them that option doesn’t seem to make any sense,” Truog says. “I would say a more appropriate framework is that for patients who are choosing to die from euthanasia they could also choose to have euthanasia linked with organ donation.”

A “creepy idea” that might have merit

Euthanasia involves doctors administering lethal drugs to cause the death of a patient. The practice is illegal in the U.S., but a growing number of states have legalized assisted-suicide, in which doctors give patients lethal drugs to take at home.

Instead of a doctor administering lethal medication to a patient, Death by Organ Donation patients would end the patient’s life by anesthetizing them and then removing their organs while they are still functioning.

“So the organs would still be in ideal condition,” says Truog says.

Some other bioethicists say the argument could have merit.

“The concept of death by donation is an extremely troubling notion at first glance. It’s a creepy idea,” says Ruth Faden, a bioethicist at Johns Hopkins University. “But in fact if you look at it critically in terms of the foundational ethical considerations, it’s not as disturbing as it first appears.”

That’s because, she says, of the spread and acceptance of euthanasia and the desires of some of those patients to be organ donors.

“If we’re committed to respecting the autonomy of individuals at the end of their life. And if they prefer to maximize the good their bodies can do at the end of their life, that’s the ethical justification for death by donation,” Faden says. She adds it would be important for strong safeguards to be implemented to ensure full informed consent and to protect patients from abuse.

A shift could undermine patient trust

But some other bioethicists are horrified by the mere notion.

“This is asking surgeons to take a living person into the operating room and to come out with a dead person, which I think is murder,” says Lainie Friedman Ross, a bioethicist at the University of Rochester. “There are limits to consent. And one of the things we’re not allowed to do is consent to saying that somebody else can just murder you.”

Others worry this approach would undermine trust in both organ donation and end-of-life care at a time when some potential donors are already wary because of controversies about organ procurement efforts.

“You could be doing real damage to both the physician-assisted suicide system and the organ donation system,” says Lori Andrews, a bioethicist and professor emerita at the Chicago-Kent College of Law. “It might give people the image that these are vultures that no longer wait until you die to attack. It does give up visions of body snatchers from prior centuries.”

Critics also fear that allowing Death by Donation for euthanasia patients could open the door to someday saying it would be acceptable practice for physician-assisted suicide patients and even potentially hospice patients.

But others argue that for now this approach could be considered for at least some euthanasia patients.

“If there are people who want to donate organs, this would be the way to maximize their wishes and their altruistic goal to help others,” says Dr. Carter Winberg, a Canadian critical care physician working on his master’s degree in bioethics at Harvard who co-authored the New England Journal of Medicine paper. “These are people who are already consenting to voluntary euthanasia and already consent to organ donation. That warrants a new conversation about whether this is possibly ethical.”

TFunding for prevention of teen pregnancy cut by Trump’s HHS : NPR

A LiFT workshop in the Navaho Nation in Arizona. The evidence-based course has teens bring a trusted adult with them to learn about relationships, safe sex and preventing pregnancy.

Hózhǫ́ Horizons

hide caption

toggle caption

Hózhǫ́ Horizons

For stories of life in our changing world, subscribe here to the global health newsletter.

Last July, the Trump administration issued a notice to the dozens of organizations receiving Teen Pregnancy Prevention Program grants.

“Program materials are expected [to] reflect the immutable biological reality of sex, not radical gender ideology, and may not promote anti-American ideologies such as discriminatory equity ideology,” the document reads, listing five executive orders organizations needed to comply with to keep their grants. “Programs with such unauthorized content are not eligible for federal funding.”

Grantees scrambled to adapt to the new requirements. One of them, Healthy Futures of Texas, provides sexual health education in community centers, school districts, and juvenile justice and faith communities in San Antonio, Dallas, and the Rio Grande Valley in Texas.

“We had to essentially adapt and revise all of the already approved curricula to be in alignment with the executive orders — so that for us was 11 different programs that we adapted,” explains Ginger Mullaney, the organization’s president and CEO.

The process took months. “After all of that work, we were re-awarded and all of our programs have been deemed in compliance,” she says. “We have submitted progress reports thus far and our programs were still in alignment even up until recently — in November, we submitted another adaptation for a program and were approved.”

So two weeks ago, when the organization’s $2 million annual grant was canceled, effective immediately, Mullaney was stunned.

In fact, in late June, the federal Department of Health and Human Services canceled all but a dozen Teen Pregnancy Prevention Program grants, totaling $66 million for grantees across the country. Grantees included a wide range of organizations from public health departments and universities, to Planned Parenthood and Bethany Christian Services affiliates. The five-year grants had two years left to go.

According to a list of terminations obtained by NPR, the given reason was: “Misalignment with agency priority, specifically normalizing sexual activity for minors.”

For Mullaney, the sudden funding cut means 13 employees are losing their jobs, and they may have to reduce their services.

“I’m frustrated that these are lives that were being changed — there’s generational impact and social and economic mobility for our communities using programs that are proven and demonstrated to be effective,” she says.

A history of ‘rigorous’ evaluation

The teen pregnancy rate has declined dramatically in the U.S. since the 1990s, but rates are still higher than they are in peer countries. The cost to young parents is high — they are less likely to earn a high school diploma and more likely to have lower lifetime earnings. The costs to taxpayers were estimated in one study to be $9 billion per year.

Before the Teen Pregnancy Prevention funding stream was established in 2010, a series of programs were “evaluated using randomized controlled trials, which are really the gold standard for understanding the effectiveness of public policy,” explains Nicholas Mark, a sociologist at the University of Wisconsin Madison.

Congress then established the funding stream “to put in place the programs that had been shown to be effective in reducing teen pregnancy, increasing healthy behaviors, decreasing unhealthy sexual behaviors among teens,” he says. “So the whole basis of the program was in effective, rigorously evaluated programs.”

But the grants have long been a target of the Trump administration and some conservative groups like the Heritage Foundation. All of the grants were canceled by the Trump administration during the president’s first term, although the funding was restored after grantees sued.

Even before the administration canceled the grants, President Trump’s recent budget request called for eliminating the Teen Pregnancy Prevention program. “There is no evidence that these specific programs have contributed to this historic decline in teen pregnancy, which is now at an all-time low. Moreover, TPP issues grants to problematic organizations like abortion clinics that waste American taxpayer dollars on abortion services and promote radical leftist ideology,” the document reads.

However, Trump also signed $101 million in funding for the program into law earlier this year, a point raised by Senate and House Democrats in a pair of letters sent to Health Secretary Robert F. Kennedy Jr. last week, demanding that the funding be reinstated.

The Department of Health and Human Services did not respond to multiple requests for comment from NPR about why the grants were canceled.

‘Normalizing sexual activity for minors’

Paige Preston just turned 18. She lives in Tuba City, Arizona, part of the Navajo Nation. Earlier this year, she attended a LiFT workshop — one of the evidence-based programs that the federal grants support — put on by Hózhǫ́ Horizons from the Johns Hopkins Center for Indigenous Health.

Paige Preston was set to volunteer to help other teens in the LiFT workshop after she completed it herself. It’s been canceled after federal funding cuts.

Jolene Robertson

hide caption

toggle caption

Jolene Robertson

“It connects you with your trusted adult, so for me, I went with my sister and she is the person that I kind of go to for everything,” Preston says. “She was learning how to create a safe space for me and to make me feel heard. And then what I learned was how I show my affection for other people and how to be safe if we ever do come to that conclusion that there’s some activity that we want to participate in.” She says she also learned about birth control options beyond condoms, such as the pill and IUDs.

Preston says she knows this information is important — several of her peers got pregnant in high school. Nationally, American Indian and Alaska Natives have the highest teen pregnancy rate among racial and ethnic groups.”I know in my community it is a big problem,” she says.

Preston is now the chair of the Hózhǫ́ Horizons Youth Council, and was ready to help with another LiFT workshop later this summer. It was canceled when the funding was cut.

“In all honesty, I’m very sad and disappointed,” she says. She thinks the workshop brings information to young people that they might not learn at home or at school. “When you participate and you learn from people like you — like in Indigenous communities — that means a lot more because it’s showing you that someone like you is so knowledgeable about a subject, and they’re really passionate about that and it kind of makes you want to listen more.”

Nicholas Mark from the University of Wisconsin argues that the reason that agency gave for canceling these grants — “normalizing sexual activity for minors” — is a “bizarre” framework.

“In a world where teens have smartphones, teens are surrounded by sex and such easy access to sex and sexual imagery, sexual iconography,” he says. “It seems silly to think that having a source of verifiable, trusted information on safe sex would be worse than the information environment that people are already steeped in.”

Venezuela’s earthquakes add to its healthcare woes : NPR

A rescue team assists Hernan Gil, a survivor of Venezuela’s twin earthquakes, on July 2, eight days after the quake. In addition to caring for survivors, the country’s medical workers are facing a range of issues in the state of La Guaira, which was devastated by the disaster.

Federico Parra/AFP/via Getty Images

hide caption

toggle caption

Federico Parra/AFP/via Getty Images

When the first earthquake hit, Luz Noguera was in the shower.

Noguera, 36, grabbed her keys, forced the door open and ran out into the street in a panic. Her first thoughts were for her kids and family members, and their immediate safety. Then, it was survival.

“We gathered on the main road and stayed there,” she says. “It started to rain, the electricity went out and there was no cell service, no way to contact our families. We spent the whole night in the street.”

Luz Noguera, 36, says she is simply grateful to be alive after the quakes. “The day after the catastrophe, I took this photo with a smile,” she says.

Family photo

hide caption

toggle caption

Family photo

The last thing on Noguera’s mind was her asthma medication — still in a bag on her nightstand.

The numbers following the June 24 earthquakes trace a devastating outline: At least 3,535 dead, with thousands more missing. And some 16,700 injured.

As hopes fade of live rescues from the rubble, health workers have turned their focus to the living. With an estimated 18,000 people now homeless, doctors must face a new wave of health issues — the kind that happen when thousands of people are suddenly displaced in the heat, the rain and the dust.

People displaced by the June 24 earthquakes rest on bunk beds inside a temporary shelter set up at the Jose Maria Vargas sports complex in Catia la Mar, La Guaira state, Venezuela, on July 6.

Miguel Medina/AFP/via Getty Images

hide caption

toggle caption

Miguel Medina/AFP/via Getty Images

“We’re seeing diarrhea, respiratory infections — skin diseases, because they’re exposed to the sun for many hours,” says Dr. Eduardo Celades, a senior health adviser for UNICEF.

Dehydration. Asthma attacks. Sunburn. The ailments of normally healthy people, who no longer have easy access to their medications, regular meals, or running water.

“As well, there will be risks of outbreaks — like for example measles, respiratory infections. This is going to be our priority,” Celades tells NPR.

Three hospitals suffered critical structural damage and were knocked out of service during the earthquakes, the World Health Organization said. Several others are only partially functional, with staff doctors and other frontline health workers among the victims of the disaster.

“The lady who was running the entire maternal pathways (maternity program) is missing, and unfortunately is presumed to have perished in the earthquake,” says Ian Clarke, incident manager for the WHO’s health emergency response in Venezuela.

International aid groups have flown in doctors and set up field clinics to help. A 56-bed field hospital set up by the nonprofit Samaritan’s Purse includes intensive care units and operating theaters. Project Hope has set up a mobile clinic offering primary care at a shelter in one of the hardest hit neighborhoods, including ultrasounds for pregnant women.

Doctors say they struggled to help the first victims treated after the disaster: patients who needed limb amputations or who had suffered crushing injuries or cuts from broken glass. Now, they are focused on caring for a traumatized, displaced population that no longer has a functional healthcare system. Doctors in other parts of Venezuela and abroad have stepped up to volunteer for telehealth services, while other aid groups have focused on reinforcing primary care providers and mobile clinics.

“A team of doctors and psychologists travels there daily to provide primary healthcare to all those affected and to offer psychological first aid,” said Dr. Lydia Gordon, an OB-GYN with Project Hope in La Guaira. “What I see with my own eyes as I pass by all these buildings are thousands of people walking in the street, disoriented, who need help.”

The World Health Organization has delivered six metric tons of medical supplies, with another 28 tons of aid on the way from its hub in Dubai. The donations included trauma kits, personal protective equipment for frontline workers, and supplies to prevent communicable diseases. Vaccines to prevent tetanus, diphtheria and yellow fever are being donated by the Chilean and Brazilian governments. The International Federation of Red Cross and Red Crescent Societies has dispatched 36 tons of aid, including hygiene kits, cleaning supplies and water filters.

“But even prior to the earthquake, there were massive shortages, up to 37% of essential medicines in many hospitals,” Clarke says.

Under the rule of ousted president Nicolas Maduro, Venezuela’s economy collapsed under hyperinflation and oil sanctions. Medical supplies grew scarce, vaccination rates dropped and cases of measles, diphtheria and malaria surged. Many Venezuelans emigrated, including about a third of the nation’s doctors, according to the Venezuelan Medical Federation. The remains of the country’s once-robust public health system was ill-equipped to respond to the scale of the disaster and its aftermath.

“That’s the normal situation. But in a crisis, that spike in demand — it’s exacerbated by the history,” says Alejandro Arrieta, a health economist at Florida International University.

Even in normal times, most patients are required to purchase their own medical supplies at pharmacies and shops near the hospital. It’s not an unusual practice in many Latin American countries, but the scale is more extreme in Venezuela’s underfunded system.

“You go to the doctor, and the doctor tells you okay, you need surgery, here’s the [shopping] list,” Arietta says.

This leaves patients at the mercy of price increases and supply issues, which are common in a disaster scenario.

Luz Noguera and her family were among those temporarily displaced by the earthquake and its aftershocks. They spent two weeks in an informal encampment near the wreckage of her sister’s home.

“Some people don’t even have tents, so their situation is even more difficult,” Noguera said. “They sleep on mattresses placed directly on the ground, with their children.”

Replacing her asthma medication felt like a daunting task, but she reached out to friends and family for help. Through her nephew, she was able to get in touch with an education nonprofit in another state, which has joined the earthquake response effort.

“It was a race against the clock to find the medicine she needed and the right equipment,” says Nicolle Giraud, who runs the E-VEN project, an education nonprofit that pivoted to help with the aid effort.

She and her team reached out to WhatsApp groups, to see if they could find the right medication in another city.

“Checking the obvious places like pharmacies, but then asking in [WhatsApp] groups because they were either sold out or it was very expensive, or not the kind they were looking for,” Giraud recalls.

Luz Noguera and her relatives with donations of food and tents after the earthquakes. An education nonprofit based in another state, the E-VEN Project, arranged to refill her asthma prescription in the middle of the crisis.

Family photo

hide caption

toggle caption

Family photo

Finally, a volunteer for the project found the medicine and drove it to Noguera personally, along with tents and other supplies.

This, Giraud says, is the reality on the ground. While medical workers do the best they can with the resources they have, it’s everyday people who have stepped up to fill the gaps.

“There’s a saying here,” Giraud says. “Los buenos somos más. The good people, we’re the majority.”

Noguera and her family are safe. She says she feels as if she has another chance at life. The only thing left to do, she says, is pray that the situation stabilizes.

“But I am alive, thank God,” Noguera says.

As aftershocks continued, Luz Noguera and her relatives spent two weeks sleeping in tents near her sister’s home. “Some people don’t even have tents, so their situation is even more difficult,” Noguera says. “They sleep on mattresses placed directly on the ground, with their children.”

Family photo

hide caption

toggle caption

Family photo

What’s behind the push to make peptide therapies more readily available : NPR

Federal regulators are considering allowing compounding pharmacies to manufacture several peptides that are currently popular among consumers.

George Frey/Bloomberg/Getty Images

hide caption

toggle caption

George Frey/Bloomberg/Getty Images

Every day, Dr. Alexander Weber finds himself fielding another round of questions about peptides — and whether the trendy therapies can help his patients recover from sports injuries or surgery.

He doesn’t offer them in his practice as an orthopedic surgeon, but he shares what the research shows about how well they actually work.

“My stock answer is we just don’t have enough data,” says Weber, chief of sports medicine at the University of Southern California.

“The anecdotal evidence, even from patients that I see, is that they feel like these injectables help them, but we just need to study it,” he adds. Weber authored a review of the research, published early this year, noting the lack of evidence supporting their clinical use.

However, cautionary words from the medical establishment seem to have done little to quench the public’s appetite for these therapies, which have not undergone the large-scale trials needed to gain approval from the Food and Drug Administration.

They are promoted widely in wellness and longevity circles for injury recovery, muscle growth, skin health, metabolism and more. Health Secretary Robert F. Kennedy Jr. has extolled their benefits in an interview with Joe Rogan earlier this year and promised to reverse Biden-era restrictions that have prevented compounding pharmacies in the U.S. from making them.

The restrictions have, in effect, relegated the substances to a grey market, fed by suppliers overseas — raising new safety concerns as users inject themselves with unvetted substances.

The era of peptide prohibition could soon be over, though.

Later this month, a new panel of outside experts appointed by the FDA will make recommendations on whether seven peptides — including some of the most popular injectables like TB-500, BPC-157 and MOTs-C — should be added to a list that gives compounding pharmacies the greenlight to, again, manufacture the products.

“Nobody is recommending these peptides. This is about ensuring patients have safe and effective access to these medications,” says Lee Rosebush, a pharmacist and attorney who represents peptide makers and others in the industry.

“The FDA’s actions during the Biden administration opened up the Wild Wild West,” he adds.

For new discoveries, everyday mysteries, and the science behind the headlines, follow NPR’s Short Wave podcast.

An air of credibility

Peptides are a string of amino acids — smaller than a protein — that often act as signaling molecules in our bodies and help regulate the immune system, metabolism and many other critical functions. They can be synthesized and delivered as drugs. Some of those like insulin are naturally occurring in the body. Others are modified versions, as with the blockbuster GLP-1 weight loss drugs.

One of the highly sought after synthetic peptides under consideration this month, called BPC-157, is based on a peptide found in human stomach juices. Another, TB-500, is related to a molecule found in many types of cells, called thymosin beta-4.

Weber believes the massive success of the GLP-1 drugs for diabetes and weight loss has lent an air of credibility to these injectable wellness peptides, even though those drugs underwent extensive human trials before coming to market. That’s not the case for any of the seven peptides under consideration this month.

“Whenever I see these people on social media saying they’re experts in this field and they’ve been doing it for a really long time, sure, you can say those things, but show me the data,” he says.

In a review of the evidence last month, the FDA’s own scientists recommended against changing the status of any of the seven peptides under consideration at the July meeting.

But it’s unclear how the newly-assembled FDA panel — called the Pharmacy Compounding Advisory Committee — will weigh the agency’s assessment of the data.

Many of its members have ties to the peptide industry and work for clinics that offer injectable peptides or for compounding pharmacies that stand to benefit.

“I think what’s going on here is the advisory committee may be stacked with people who are known to have certain viewpoints on a topic rather than who are coming at this in an unconflicted and unbiased way,” says Dr. Aaron Kesselheim, an expert on FDA law and professor at Harvard Medical School and Brigham and Women’s Hospital.

In a statement to NPR, a spokesperson for the Department of Health and Human Services said all the committee members have “undergone an ethics and vetting process,” and the agency is “committed to robust, transparent discussions about the products.”

While the panel is tasked with making recommendations, FDA leadership has the final say on what happens.

Risks vs. benefits

Outside groups have echoed the concerns raised by the agency’s career scientists. For example, the nonprofit Institute for Safe Medication Practices published a white paper on wellness peptides earlier this year, drawing attention to the gaps in evidence and warning that much of the data comes from preclinical studies done in animals, not humans.

“With anything that you’re taking, whether it’s an FDA-approved product or a supplement, you always have to weigh the risk versus benefit,” says the institute’s president Rita Jew.

“These peptides really do not have established effectiveness, so the only thing you have is risk,” she says.

Peptide proponents like Rosebush counter that pharmaceutical companies have no interest in running the kind of costly studies on these peptides that are needed to legitimize them because many of them can’t be patented.

“These products will likely never go through an FDA approval process,” he says. “So without allowing compounding pharmacies to do this, patients will never get access.”

The agenda for the July 23 and 24 meeting specifies that the committee will review the data behind these injectable peptides for specific indications, such as migraines, ulcerative colitis and osteoporosis.

But, if the FDA ultimately reclassifies these peptide therapies so they can be compounded, Kesselheim says patients will have no trouble finding doctors who are comfortable prescribing them for all sorts of conditions.

“That’s why this discussion is so important and why the FDA’s authority here is an important one to exercise appropriately with optimal outside advice,” he says.

There’s no treatment designed for the Ebola strain ravaging DRC. But now there’s hope : NPR

A health worker takes a woman’s temperature as part of Ebola screening efforts in Goma, Democratic Republic of Congo. As part of the effort to quash the outbreak, the first patients have been enrolled in a clinical trial to test two drugs against the Bundibugyo strain of the virus that is spreading there. In addition, researchers plan to study whether another drug could protect people exposed to the virus.

Daniel Buuma/Getty Images

hide caption

toggle caption

Daniel Buuma/Getty Images

It’s been over 50 days since the Ebola outbreak was declared in the Democratic Republic of Congo and Uganda. Clinicians on the ground are working to save dying patients, but they lack crucial tools to fight the kind of Ebola that’s spreading.

“We urgently need treatments that can help people affected by Bundibugyo virus disease,” says Amanda Rojek, a physician scientist at the University of Oxford — that’s a rarer species of Ebola than the much-researched Zaire strain behind many previous outbreaks.

But because of that rarity, there are no specialized treatments to give patients. Nor are there drugs that might protect those exposed to the virus from getting sick.

That reality is changing. Clinical trials are underway, or soon will be, to test new tools that health officials hope could help turn the tide against an outbreak which has already killed over 500 people and sickened more than 1,560 – and which some say could become the largest Ebola outbreak ever.

Last Thursday, the World Health Organization announced that the first patients were enrolled in a clinical trial designed to test two drugs against Bundibugyo. And sometime this week, researchers will likely begin studying whether another drug could protect people exposed to the virus.

“One of the key lessons from recent outbreaks is that research needs to happen alongside the response, not after it,” says Rojek, who is helping to coordinate the treatment trials.

The three trials are a collaborative effort between WHO, Africa CDC, universities and nonprofits. Each will test existing drugs against Bundibugyo.

“To start from scratch takes years,” says Salim Abdool Karim, director of the Centre for the AIDS Programme of Research in South Africa and member of the Africa CDC emergency committee that’s been following the outbreak. “So we take existing medicines and see whether [they] can be repurposed.”

“This will take some time”

For Ebola treatment, researchers are testing two drugs, the antiviral remdesivir, manufactured by Gilead Sciences, and the monoclonal antibody MBP-134, developed by Mapp Biopharmaceutical. Both drugs are delivered intravenously.

Remdesivir rose to prominence during the COVID-19 pandemic, when it was used (to mixed effect) to treat patients in the hospital. But the drug was developed to target a broad range of viruses, including Ebola. It was tested during the 2018 Ebola outbreak in the Democratic Republic of Congo, but proved relatively ineffective against the Zaire species.

MBP-134 is a monoclonal antibody treatment, designed to mimic the immune system’s natural defenses against the virus. It’s a cocktail of two monoclonal antibodies, both isolated from a survivor of the 2014-2016 West African Ebola outbreak, also caused by the Zaire species. But there’s some lab data that suggests it could work against Bundibugyo.

The Biomedical Advanced Research and Development Authority, or BARDA, played a major role in funding research behind MBP-134 and technically owns the doses. BARDA is a U.S. government agency within the Department of Health and Human Services and the government has donated the doses necessary for the clinical trial, according to Vasee Moorthy, WHO’s research and development lead for the outbreak.

Each drug will be tested alone, and in combination, against the current standard of care — supportive therapy that aims to replace lost fluids and manage pain. So far, only one clinic in the DRC is involved in the trial, but there are plans to expand in the coming weeks, said Moorthy at a press conference last Thursday.

Researchers will monitor whether the drugs boost survival. How long that takes depends on a variety of factors, says Moorthy.

“From what we see at the moment, this will take some time,” he said. “It will take some months. It could go even into next year. It could be that we need over 1,000 patients enrolled in the trial until we get a definitive answer.” If either treatment proves super effective, that timeline could be shorter, he said.

Treatments aren’t enough

To help control the epidemic, which shows no sign of slowing anytime soon, health officials need more than treatments. They need to prevent people from becoming sick, says Yazdan Yazdanpanah, an infectious disease physician and epidemiologist at ANRS Emerging infectious diseases, a research agency in France.

A vaccine would be best, “but we don’t have a vaccine today,” he says, and it’ll be months before testing candidates begins. But giving an antiviral soon after exposure can help prevent disease and could be faster-acting than a typical vaccine.

That’s where the third trial comes in, which is slated to start sometime this week, says Yazdanpanah. He and his colleagues will be testing whether popping obeldesivir pills, an antiviral also made by Gilead Sciences, can help prevent close contacts of Ebola cases from contracting the disease, a method known as post-exposure prophylaxis.

The study relies heavily on contact tracers quickly identifying anyone who might have been exposed to an Ebola patient. For contacts who enroll, the research team will go to the participant twice a day to deliver the drug and track whether they develop symptoms.

If obeldesivir proves effective, it could become a powerful tool for reining in the epidemic, says Yazdanpanah. It could also help attract more contacts to come forward, since health officials would have something to give them besides instructions to quarantine.

Challenges ahead

Proving the effectiveness of any of these three drugs will depend on the clinical trials running smoothly. That’s a challenge in any outbreak, especially one beset by ongoing armed conflict.

There’s also been violence aimed at health centers. Several have been attacked since the outbreak, likely spurred by mistrust. Community members are often wary of outside health workers who descend on their town in full protective gear. Rumors swirl that humanitarian aid groups are murdering people or withholding care.

In fact, WHO officials declined to disclose the exact location of the clinic now enrolling patients for the treatment trials to protect its clinicians.

“There’s a lack of trust,” says Yazdanpanah. Building that community trust is crucial for running an effective and ethical clinical trial. WHO officials are hoping that will result from holding lots of community advisory meetings, with everyone from healthcare workers to faith groups participating.

“Discussions with the community are absolutely central,” said Moorthy. “There are open lines of communication to the trial team from the community, so that we can make sure that their interests come first.”

A divorce coach explains how to end a marriage on good terms : NPR

Karen McNenny is a certified divorce coach, certified co-parenting specialist and author of the book The Good Divorce: How to End Your Marriage Without Ending Your Family.

Wiley/Jossey-Bass/NPR, Nicole Wickens/NPR

hide caption

toggle caption

Wiley/Jossey-Bass/NPR, Nicole Wickens/NPR

When Karen McNenny was facing divorce about 15 years ago, she was afraid of what it would mean for her future: despair, debt and a lifetime of resentment, she says.

At the same time, she was thinking of her two children, she says. She didn’t want their father to become her enemy.

So she and her former husband chose to approach divorce differently as a couple. “We’re going to renovate and transform this family. We’re not going to destroy it,” she says. “The marriage is ending, not your relationship.”

For McNenny, a mediator, certified divorce coach and certified co-parenting specialist, divorce is a tool, not a weapon. She expands on this concept in The Good Divorce: How to End Your Marriage Without Ending Your Family, which came out this spring. The book offers guidance on how to maintain compassionate and respectful ties with a former spouse while also healing and moving forward.

According to Pew Research Center, a third of Americans who have ever been married had a first marriage that ended in divorce. For that reason, McNenny hopes her book becomes a must-read for couples before they get married. “The best time to talk about divorce is before you need to talk about it,” she says.

She shared insights from her book in a conversation with Life Kit. This interview has been edited for length and clarity.

The book is called The Good Divorce. What does that mean?

[For those with kids,] the good divorce is about protecting the future of the family while we dissolve the marriage.

After the paperwork is done and the assets have been divided, can you and your co-parent sit on the same side of the bleachers during the basketball game? Can you still see yourselves as a partnership, with the ability to have thoughtful conversations about your kids?

For those who don’t have kids, [the good divorce is] about protecting your health — your mental health and your physical health. If we are doubling down with resentment and bitterness, all of that gets stored in the body and shows up in different ways. You deserve a pathway that’s less destructive.

Let me also be clear: There are times when an amicable, collaborative process is not possible and maybe even inappropriate. For instance, where there’s active addiction, abuse, domestic violence, coercion or unmanaged mental health issues.

How do you get to a place where you don’t feel triggered by your partner, so you both can work together toward a good divorce? 

That, my dear, does not happen overnight. That is more like a dimmer switch going up and down and up and down, and the gift of time helps to get there.

It’s a complex emotional journey because we do feel relief in walking away from our spouse and the challenges. But with it, there is extraordinary grief that comes with divorce that I think is often underestimated and undersupported.

If my spouse had died, people would’ve been checking in with me regularly. I never would’ve spent a holiday alone in that first year. There probably would’ve been a meal train.

But he didn’t die. My marriage died, my family structure died, my identity as a wife and a partner died. There’s so much grief through these transformations that come with divorce that we don’t see.

So supporting friends in all those ways that you would as if there had been an actual death is doing a lot for your friends who are going through divorce.

How do you let your friends, family and community know that you’re getting a divorce and that you might need support? 

Put a communication strategy together. It’s not just for how we tell the kids. It’s also a communication strategy for the grandparents; to the circle of support around the kids, like teachers, coaches and mentors; and our shared community.

It’s extraordinary when a couple can write that message together, not unlike a marriage announcement. [You might say:] We’ve made a really difficult decision. We wanted to let you know. We’re not going to court. Don’t expect a battle. Please don’t ask us why. Just ask us how we’re doing. We’re on the same side as the kids. You don’t need to pick sides.

In doing so, we’ve given everyone the same information at once. It’s a unified message that comes from the parent team, and it allows your community to know how best to support you. And it takes out all the gossip and wonder about what is going on.

If you have kids and they’re splitting time between two homes, what are some ways to make that change easier for them?

Our kids were 5 and 7 when we divorced, so it was three or four nights at a time in each home. By the time they got to be about 8 or 10, it made sense to go a week in each residence. After COVID, the kids came to us and said, “Can we just have two weeks in a house? We wanna be able to settle in more.” [So we said] OK.

A lot of parents are so rigid about the schedule. There’s no flexibility. That doesn’t serve anyone. So I recommend liberating yourselves from the calendar and letting it grow and bend with your kids appropriately.

Knowing what you know now about divorce, what questions do you think couples should ask themselves before they get married?

So often when people arrive at the threshold of divorce, couples are like, “We don’t know what we’re doing.” Get educated about the business part of it.

There is no harm in having a prenuptial agreement. Even if you decided not to file it, have the conversation about the implications. What does it mean if we buy this house together? What does it mean if one of us works more and one of us works less?

We also underestimate what it means to be roommates. What are your value systems around cooking and cleaning? How much alone time do you need? It’s easy to fall in love and not know if you’re compatible.

Do you think you’d get married again?

I absolutely hope that I get to say yes to a lifelong commitment with a partner, as I believe we often are given the opportunity to become a better version of ourself through partnership.

The story was edited by Meghan Keane. The visual editor is CJ Riculan. We’d love to hear from you. Leave us a voicemail at 202-216-9823, or email us at LifeKit@npr.org.

Listen to Life Kit on Apple Podcasts and Spotify, and sign up for our newsletter. Follow us on Instagram: @nprlifekit.

Thousands lose Medicare drug plans for missed premium payments : NPR

Thousands of Medicare beneficiaries lost drug coverage after their premiums went up and they didn’t know.

fstop123/iStockphoto/Getty Images

hide caption

toggle caption

fstop123/iStockphoto/Getty Images

Stay up to date with our Up First newsletter, sent every weekday morning.

Jude Pare and his partner, Diane Tix, live in rural Minnesota until temperatures dip below freezing, when they take refuge in Arizona for the winter. While away, their mail is forwarded. But Pare, 77, said he didn’t receive any warning from his Medicare prescription drug plan that his $0 monthly premium was about to increase.

So he didn’t know he had a bill to pay. After he and Tix returned home to Minnesota in April, they got a letter from Wellcare, the insurer that provided his drug plan, saying his coverage had been terminated after three months of unpaid premiums totaling $28.80. Under Medicare’s rules, he can’t enroll in a plan again until the fall, for coverage beginning in 2027.

Pare takes Xarelto, a blood thinner that reduces his risk of strokes, blood clots, and pulmonary embolism. “He could bleed to death without it,” Tix said. A 90-day supply of the drug costs about $1,800 using a coupon from GoodRx, a discount drug website, she said.

Pare is among tens of thousands of Medicare beneficiaries who were on Wellcare’s Value Script drug plan who will likely go without prescription drug coverage for the rest of the year because they didn’t pay premiums for three months.

Next year, thousands more people in 32 states and Washington, D.C., enrolled in zero-premium drug plans from Wellcare and other insurance companies may find themselves in the same situation if their premiums go up and they don’t realize it, according to a KFF Health News analysis of drug plan data. Premiums and other changes for 2027 will be unveiled in September.

Caught off guard

Going without medication can be life-threatening, especially for Medicare beneficiaries. Nearly 90% take one or more prescription drugs, according to the Centers for Disease Control and Prevention. Almost half live with four or more chronic health conditions that can cause functional or cognitive impairments.

By the time Jude Pare and his partner, Diane Tix, found out he owed $28.80 for three months of drug plan premiums, his coverage had been canceled. He is among tens of thousands of Medicare beneficiaries who will likely go without prescription drug coverage for the rest of the year after their drug plans were canceled.

Diane Tix

hide caption

toggle caption

Diane Tix

Congress added prescription drug coverage to Medicare in 2003. But the coverage is administered by commercial insurance companies, which compete fiercely with one another for the business of about 56 million Medicare beneficiaries enrolled in drug plans.

Zero-dollar or very low monthly premiums have helped make Wellcare’s Value Script the bestselling stand-alone prescription drug plan in Medicare, with nearly 6 million customers across the U.S., according to government data. But in 26 states and Washington, D.C., some Value Script members who didn’t have to pay a premium last year were caught off guard by increases in 2026.

After a two-month grace period — which Wellcare extended to three — Medicare drug plans can drop customers who don’t pay their premiums, no matter how small the amount. Some members who lost their coverage in Nevada, for example, owed as little as $8.10 for three months, according to a KFF Health News analysis of Medicare drug plan data.

Wellcare terminated coverage for about 140,000 Value Script beneficiaries in April, according to a person with knowledge of the matter who was not authorized to speak publicly about it and feared reprisals at work for doing so. About 40,000 of the people who were dropped may be able to enroll in new coverage immediately because they have low incomes and receive financial assistance through a program Medicare calls “Extra Help.”

Multiple state officials said they had heard the same disenrollment figures, including Nevada’s insurance commissioner, Ned Gaines, who chairs the National Association of Insurance Commissioners’ senior issues task force; Rebecca Gouty, director of the State Health Insurance Assistance Program in West Virginia; and Tim Smolen, director of Washington state’s Statewide Health Insurance Benefits Advisors.

The West Virginia and Washington initiatives are part of the federally funded State Health Insurance Assistance Program (SHIP), which provides free, unbiased help navigating Medicare.

Surprise bills

The Centers for Medicare & Medicaid Services, which oversees Medicare drug plans, declined to provide the number of Value Script members who lost coverage due to unpaid premiums. “The agency does not publicly provide plan-specific disenrollment figures or state-level breakdowns related to the non-payment of premiums,” Christopher Krepich, a spokesperson, said in a written statement to KFF Health News.

Centene Corp., Wellcare’s parent company, also declined to provide disenrollment numbers.

“We recognize how disruptive a loss of coverage can be and are committed to helping members understand their options,” said Sarah Baiocchi, senior vice president for specialty and prescription drug plans at Centene. She acknowledged that “some members in our Value Script plan experienced a premium for the first time, or for the first time in several years.”

Baiocchi said all Value Script members received a CMS-required annual notice of changes in September, before the premium increases took effect.

A version of the booklet sent to members in two states and Washington, D.C., is 21 pages long. The new premium is mentioned on pages 3 and 8, along with changes to out-of-pocket costs and how to find updates on covered drugs and network pharmacies.

Wayne Bennett lost his Medicare drug coverage because he didn’t pay the premium, which was free last year but — without his knowing — went up this year. “Medicare should be doing something about this so that we can go ahead and get coverage now,” he says.

Wayne Bennett

hide caption

toggle caption

Wayne Bennett

The company also informed members about 2026 premium changes through phone calls, text messages, regular mail, or email, Baiocchi said.

People who are dropped are not able to reenroll or join another drug plan until the start of the open enrollment period this fall for coverage beginning Jan. 1, unless they qualify for an exception, Krepich said.

And because they will have gone without coverage for at least 63 days, they could be hit with a permanent late-enrollment penalty that increases every year for the rest of their lives.

“Medicare should be doing something about this so that we can go ahead and get coverage now,” said Wayne Bennett, 74, who lives in Durham, North Carolina.

In May, he found out that Wellcare had canceled his Value Script plan because he hadn’t paid his $3.60 monthly premiums. He takes nine prescription drugs to treat his blood pressure, glaucoma, chronic obstructive pulmonary disease, and other health problems. He filled most of his prescriptions — including several at no cost — before he lost coverage. He doesn’t know what he’ll have to pay when his supply runs out.

Gouty, the West Virginia program head, said many Medicare beneficiaries arrange for their monthly drug plan premium to be automatically deducted from their Social Security benefits, and that many likely thought that choice remained in place until they changed it.

“They didn’t realize that when the plan was a zero premium in 2025, that stopped the Social Security premium deduction and they would have had to reelect it for 2026,” Gouty said.

In other words, even if they mistakenly thought the premium was still zero, Medicare beneficiaries would have needed to somehow allow Social Security to make deductions — something the agency doesn’t do — or else set up a payment plan through their bank or credit card in case payment was necessary.

“That sounds goofy,” Tix said.

Centene’s Baiocchi blamed the Social Security Administration for the problem: “We believe this was a key driver of non-payment disenrollments and subsequent complaints.”

Spokespeople for the agency referred questions about the matter to CMS.

Krepich said legal requirements for drug plan enrollment and disenrollment limit what CMS can do to help beneficiaries who lose coverage for not paying their premiums.

“Pretty upset”

Now that Pare has no prescription drug coverage, his doctor replaced his blood thinner medication with a much less expensive drug that should be just as effective. Pare paid $111 for four other medications that used to be free under his Value Script plan. He hasn’t had to refill four more prescriptions yet and doesn’t know what they will cost, Tix said.

If Wellcare members knew about the premium increases, they could have set up direct billing or an automatic payment plan early this year before the payment grace period ended April 1. But they would have been able to fill prescriptions during the grace period, so if they didn’t see Wellcare’s notices, they likely assumed there was no problem with their coverage.

Bennett, the North Carolina man, said Wellcare used to send him text messages with health tips and reminders when it was time to pick up a prescription. He didn’t know his premium had increased from $0 to $3.60 until it was too late.

“I was pretty upset,” he said, when he called the company. “The premium wasn’t that much, and I was ready to pay it right off the bat. I had my credit card out ready to make the payment.”

The customer service representative wouldn’t let him pay because his coverage had been canceled, Bennett said.

Hoping to restore it, Bennett called Senior PharmAssist, a Durham nonprofit that advises Medicare beneficiaries and is one of more than 2,200 SHIP sites across the country. He was told he must wait until January to restart his drug coverage, said the group’s executive director, Gina Upchurch.

He doesn’t qualify for the “Extra Help” low-income subsidy or meet other CMS criteria for a special enrollment period, which would allow him to change drug plans during the year. CMS typically allows midyear switches for beneficiaries who, for example, move out of their plan’s service area, experience a natural disaster, or get help paying for drugs from a state program.

Senior PharmAssist was able to help one of its participants join another drug plan after she lost Value Script coverage because she is in North Carolina’s pharmacy assistance program for people with HIV/AIDS and has limited income, Upchurch said.

A further exception allows any Medicare beneficiary to enroll at any time in a drug plan that has earned five stars, the top grade in Medicare’s performance ratings. However, there are no five-star Medicare drug plans available to the general public. Only two insurers offer five-star plans, and only for retirees from certain employers. Their combined enrollment is about 8,700 as of June 1, according to the insurers.

But Upchurch, with more than two decades of Medicare expertise, doesn’t blame beneficiaries for not paying attention or for assuming Wellcare’s messages were bogus. Older adults are particularly vulnerable to identity theft and other scams and are often advised to ignore junk mail and calls from telemarketers.

Since Value Script members such as Bennett continued to get their prescriptions filled during the payment grace period, “why wouldn’t they think this was a scam?” Upchurch asked. “They are constantly bombarded by people selling them something that’s illegitimate or trying to scam them.”

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF.

Pick up the walking pace to protect your brain health : NPR

In a study, researchers found that people in their 80s and older who walked faster than their peers were less likely to develop cognitive decline.

FG Trade/Getty Images

hide caption

toggle caption

FG Trade/Getty Images

Crossword puzzles and brain teasers have long been touted as ways to keep the mind sharp. But a new study points to another strategy that may matter just as much: staying fast on your feet.

Researchers have found that people in their 80s who maintain an exceptionally quick walking pace, dubbed “super movers,” are also far more likely to stay mentally sharp compared to their slower-moving peers of the same age.

“A super mover is someone who is older than age 80 and performing much better than their peers,” says Dr. Sofiya Milman of the Albert Einstein College of Medicine, one of the study’s authors.

Milman and her collaborators analyzed data from nearly 4,000 older adults enrolled in a long-term aging study. Participants had taken a timed walking test and the fastest 9% – who had a gait speed at least 1.5 standard deviations above the average of their same aged peers – qualified as super movers. Those individuals were also markedly less likely to experience cognitive decline.

“The biggest takeaway was that super movers are about 50% less likely to develop cognitive decline than their peers who are not super movers, which is very impressive,” Milman says. The results are published in the medical journal Neurology.

The muscle health connection

Walking well requires balance, coordination and strength, all of which depend on healthy muscle, says Bonnie Tsui, a science writer and author of On Muscle: The Stuff That Moves Us and Why It Matters.

“I think that the finding isn’t surprising because we know that muscle health is very much correlated with cognitive health, especially as we age,” Tsui says. “Exercise makes your muscles grow, but it also makes your brain grow.”

Prior research has linked regular exercise to greater volume in the hippocampus, the brain’s hub for memory and navigation. The new study found that super movers tended to preserve hippocampal volume as they aged.

Want the latest stories on the science of healthy living? Subscribe to NPR’s Health newsletter.

Tsui says the benefits trace back to what happens inside contracting muscles during exercise.

“Muscle is an endocrine tissue, which means when we move, our muscles release signaling molecules that affect other body systems, including boosting brain cell growth and regulating metabolism,” she says. “So muscle health is cognitive health.”

Among those signaling molecules is a protein known as brain-derived neurotrophic factor, or BDNF, which helps regulate glucose and plays an important role in the survival and maintenance of neurons, helping support memory and cognitive function.

A body’s network at work

Dr. Amit Saini, a geriatrician with Kaiser Permanente in Northern California, says walking, and maintaining the ability to walk well, is a marker of good health because it draws on so many of the body’s systems at once. He says walking supports cardiovascular health and lung health.

“As you walk, your heart is beating faster, and when the heart is beating faster, not only is it pumping the blood into the muscle, blood is being pumped to the brain, also into the nerve, and to your other systems,” Saini says. “Your lungs are also breathing at a little faster rate, which again is keeping them lighter and healthier.”

One of the study’s more surprising findings: Some super movers showed brain plaques and tangles, which are abnormal proteins associated with Alzheimer’s disease and dementia, despite having no symptoms. Researchers say that suggests movement and all the benefits of staying active may help the brain stay resilient even as it undergoes age-related changes.

Genetics and lifestyle are also important

Genetics likely play a role in who becomes a super mover. A recent study found that genetics accounts for about 50% of a human lifespan, and Milman says among super agers, people who are thriving in their eighties and beyond, the role of genetics may be even greater.

Yet the authors emphasize that lifestyle habits, including decisions people make every day about what to eat, prioritizing sleep, taking time to de-stress and gather with friends and family, all matter. In fact, research shows that nearly half of all dementia cases could be prevented or delayed by addressing 14 modifiable risk factors.

People have agency over improving their odds of healthy aging, and one way to gauge your personal risks, and take steps to decrease your risk, is to assess your Brain Care Score. This is a free, online tool developed by doctors at Massachusetts General Hospital to calculate your risks and take steps, through changes to daily habits, that can help decrease the risk of stroke, dementia, heart disease and cancer.

“Fast walking is a marker that the brain and body are aging well,” says Joe Verghese, a researcher and one of the study authors. “But also it’s possible that people who walk faster might, by engaging in these activities, also protect their brain health through a variety of mechanisms by reducing inflammation, improving cardiovascular health, and promoting brain growth in areas that are essential to maintain cognitive function as you get older.”

Verghese says the findings carry a message for people of all ages and fitness levels.

“One of the main messages is, you know, keep mobile,” he says. “Exercise regularly, and you know, that might put you on the pathway to being a super mover as you age.”

Whether it’s walking, swimming or cycling, researchers say the form of movement matters less than the consistency. It’s a habit that could pay off for both muscle and memory over the long run.

Women learn to get ahead in male-dominated construction biz : NPR

Students take part in a tiling class at the Buildher training facility in Nairobi, Kenya.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

On the busy workshop floor at Furniture International on the outskirts of Nairobi, workers often have to shout to be heard over the din of circular saws, hammers and machinery. “At first, I was very shy,” says 24-year-old machine operator Diana Ojiambo — slight, with a blue bandana tied over long braids — as she feeds cabinet panels through a PVC edger. “I didn’t know how to stand in front of people and speak up. But now I can.”

Nearby, amid a sea of male coworkers, three other women sand and assemble cabinetry, while 23-year-old supervisor Jane Mwangi moves between stations, checking measurements and overseeing progress. Barely a year ago, none of these women had ever worked in the industry. Ojiambo had never worked alongside men before.

Women remain a rarity across Kenya’s building trades, even as a frenetic construction boom, particularly in Nairobi, has helped turn the sector into a multi-billion-dollar industry. According to figures from Kenya’s National Construction Authority, women accounted for just 3% of the country’s accredited construction artisans.

Those who do enter the sector are mostly confined to lower-paid informal jobs — carrying water, hauling sand or cleaning sites — rather than trained for more specialized roles. Women are also typically saddled with the vast majority of unpaid caregiving and household work in a country that continues to battle long-held assumptions about gender roles.

Women take part in a year-long training and internship programs in tiling (above), carpentry, painting and other finishing trades.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

Buildher, a Nairobi-based nonprofit, is trying to change that. The organization runs year-long training and internship programs in carpentry, tiling, painting and other finishing trades, helping women access steadier, better-paid work in the sector. Since its inception in 2019, Buildher says it has trained more than 1,000 women, with graduates increasing their average daily earnings roughly five- to six-fold within a year of training — from about $1.50 to between $11 and $12.

A 2024 study by Dalberg, a global development advisory firm, found that around 65% of Buildher graduates were still working in construction 12 months after completing the program.

“I had seen women get stuck in low-paying jobs, and it was like a mental barrier where they couldn’t see the potential right in front of them,” says architect and Buildher cofounder Tatu Gatere. “So I wanted to help women see that.”

Buildher’s founder, Tatu Gatere, wants to give women the skills and confidence they need to enter and advance in the construction field.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

For many women, Gatere says, simply hearing about others succeeding in the trades can make the idea feel possible. As a result, much of Buildher’s growth has spread through word of mouth, as graduates encourage friends and neighbors to apply.

Ojiambo, a single mother of two young children, was unemployed and struggling to make ends meet when she first heard about Buildher from a friend in the informal settlement of Kibera, where she lives. “My life was so challenging,” she says. “But now I can support myself, I can support my kids.”

Ojiambo is already looking to the future. Within the next year, she hopes to start her own carpentry business in Kibera. “Inside this company, some of the men still think we ladies are not fit for this kind of work,” she says, gesturing toward some of her coworkers.

“But if you know what you want, and you believe in yourself, you show them that whatever they can do, you can do better.”

Diana Ojiambi, 24, at her workplace in the Furniture International factory in Nairobi, Kenya. She is one of several former Buildher students who have found work with the company.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

Sticking to it

Early on a clear weekday morning, clusters of young women gather outside the cobalt-blue doors of Buildher’s training center inside Spectrum Business Park, a network of warehouse buildings with green corrugated roofs in Nairobi’s bustling Baba Dogo industrial area.

Orientation for a new intake of students has just wrapped up. In a conference hall near the entrance, 16 trainees settle into plastic chairs for an introductory presentation on solar installation, a course launched this year as Buildher expands into additional technical trades.

In a neighboring warehouse unit, trainees crouch over a concrete floor, spreading tile adhesive into thin grey patches before dragging notched trowels through it to create neat ridges. Trainer Robert Ndungu moves between them, occasionally kneeling to demonstrate the correct technique. The women scrape the adhesive back into buckets, and the exercise begins again.

Students at a Buildher Academy class.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

“These women come here knowing nothing about tiling. By the end of this training, they are able to work, earn money and improve the life of their family,” Ndungu says. “That really inspires me.”

But Buildher cofounder Gatere says learning a trade is often only one part of the challenge facing women. Many arrive here carrying pressures that extend far beyond the workshop floor — from childcare and deep financial instability to resistance at home from husbands or parents uneasy about women doing construction work.

Others find it hard to imagine themselves feeling safe in male-dominated workplaces where harassment is often rife. Reflecting on her own experiences as an architect, Gatere notes that even as women increasingly entered leadership positions within their firms, construction sites remained hostile environments. “You’re supposed to be a decision maker, but you’d still be getting catcalled and harassed by men,” she says.

Those experiences, combined with feedback from trainees and employers, have helped shape Buildher’s broader approach to preparing women not only technically but also emotionally and physically for work in the industry.

Yoga classes (shown above) and calisthenics are part of the training to prepare women for construction jobs.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

Elsewhere on campus, bass-heavy dance music pulses from a crowded gym class, where an energetic instructor leads around 30 trainees through squats, stretches and lifting drills. Across the courtyard, a similarly sized group gathers in a large warehouse for a yoga and mindfulness session, sitting cross-legged on their mats as another instructor shares tips on staying focused and remaining calm under pressure.

Buildher also employs a mental health coach and on-site nutritionist, while trainees attend group wellness sessions every two weeks — support systems shaped directly by feedback about the difficulties many women faced both at home and in the workplace.

Dalberg’s research, based on a survey of 354 women working in the construction industry, suggests such investments are paying off. Buildher graduates reported not only higher incomes after completing the program but also greater participation in household decision-making and stronger community support.

Students hone their carpentry skills.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

“They also take more pride in what they do,” says Naoko Koyama, a Dalberg partner who worked on the report, adding that the combination of technical and soft-skills training offers a model for other male-dominated industries.

One of the women taking part in today’s yoga class is 27-year-old Ruth Kiarie, a single mother who joined Buildher’s painting and decorating cohort just two weeks earlier. Kiarie first became interested in painting while helping to renovate classrooms in Kibera, where she also lives, as part of a community leadership project.

At the same time, caring for her autistic daughter has made her think differently about color and space. One day, she hopes to work in color psychology, advising families and businesses on how different colors affect mood and behavior. “You don’t have to just do blue or pink,” she says. “We can create more colors.”

“All about the mindset”

Sprawling across 5,000 acres of former coffee plantations about 12 miles north of Nairobi, Tatu City, a private mixed-use development of housing estates, factories, schools and office parks, is the most ambitious symbol of Kenya’s rapidly changing urban landscape.

A construction site at Tatu City, where trainees worked and several graduates are now employed.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

For Buildher, developments like Tatu City have become an important testing ground for its broader ambitions. Around 50 trainees worked on finishing and interior jobs inside Eneo at Tatu Central, a sleek glass-fronted office complex near the development’s entrance that now houses a growing cluster of Kenyan and international companies.

“The tiling contractor was so impressed with the quality of the women’s work that he then employed seven of them full-time,” says Pumi Lukhele, head of stakeholder engagement at Gateway Real Estate Africa, or GREA, which developed the building. She says contractors were equally impressed by the women’s professionalism and ability to take feedback, which she attributes to Buildher’s broader approach to training. Tatu City is one of roughly 150 employers that Buildher currently works with in and around Nairobi, as the organization pushes to expand women’s participation in a far larger share of the construction industry. The hope is to increase women’s participation in skilled construction jobs from the current roughly 3% to 10% by 2030.

For Gatere, achieving those goals will require broader structural changes to an industry that, until last year, was not even required by law to provide separate toilets for women. Alongside its training programs, Buildher now works with dozens of firms on issues ranging from harassment and equal pay to basic conditions for women on construction sites.

Looking ahead, Gatere sees a future where ensuring women’s safety, dignity and inclusion in the industry is no longer a constant battle, allowing more of them to focus on bigger ambitions. “I see more and more women starting their own businesses. I see women’s collectives bidding for contracts independently,” she says. “We shouldn’t still be advocating for breadcrumbs.”

Further inside the development, a few residents lean over the metal balconies of newly completed apartment blocks, topped with solar water heaters, watching workers move through the exposed concrete interiors of a neighboring building still wrapped in scaffolding and green mesh sheeting.

In a first-floor unit that overlooks a gravel footpath and a small wetland area, 22-year-old Margaret Klamaitha kneels on the floor, cutting and fitting bathroom tiles.

Tiler Margaret Klamiatha works at a construction site at the Tatu City development on the edge of Nairobi.

Tommy Trenchard for NPR

hide caption

toggle caption

Tommy Trenchard for NPR

Klamaitha completed Buildher’s six-month tiling program last year and now works on a rolling three-month contract at Tatu City, her first full-time construction job. Though she says she enjoys the work, she sees it as a stepping stone. One day, she hopes to move into quality control, then eventually start her own construction-related business.

“It’s all about the mindset,” she says. “Once you start to do something as a woman, don’t let anyone put you down.”

Christopher Clark is a freelance journalist based in France. He reports on power, inequality and social change across Africa and Europe.

Tommy Trenchard is an independent photojournalist based in Cape Town, South Africa. He has previously contributed photos and stories to NPR on the Mozambique cyclone of 2019, Indonesian death rituals and illegal miners in abandoned South African diamond mines and won a World Press Photo prize for the images in his story for NPR on clashes between elephants and people in Zambia.

The game Schisto & Ladders has educational value plus worms : NPR

The game “Schisto & Ladders” is introduced to students in an elementary school in a part of Nigeria where the neglected tropical disease schistosomiasis, spread by parasitic worms, affects many residents. This version of the classic “Chutes & Ladders” games aims to teach children how to avoid getting infected — and details of the treatment for those who catch it.

Daniel Amao

hide caption

toggle caption

Daniel Amao

Chutes & Ladders has been a beloved board game in the U.S. since the 1940s — adapted from an ancient Indian game that aimed to teach moral lessons.

Kids in Nigeria are now playing a version called “Schisto & Ladders.” It too aims to teach — about how to prevent a disease called schistosomiasis. It’s a parasitic

infection caused by a worm that infects humans via skin contact with infested waters.

An unlucky player might land on a square that says “playing in a river” That puts you at risk for this tropical disease — and sends your game token down a worm instead of a chute.

Nigerian researcher and educator Cynthia Umunnakwe is one of the developers of the game — it’s part of an arsenal of creative approaches to warding off the illness. Known locally at “Atosi Aja” or Bloody Urine, the disease not only causes blood in the urine but has other short-term symptoms such as fever and rash. If untreated, it can cause major organ and neurological damage, infertility and even bladder cancer. In Nigeria, it is associated with higher rates of bladder cancer in young people.

Known as a Neglected Tropical Disease because of the lack of funding to fight it, schistosomiasis is a serious challenge for impoverished communities. There are over 200 million cases across sub-Saharan Africa. School age children are at the greatest risk of infection because they like to play in the water and their immune systems aren’t fully developed.

Nigerian researcher and educator Cynthia Umunnakwe is one of the developers of the game Schisto & Ladders. It’s part of an arsenal of creative approaches to warding off the illness.

Daniel Amao

hide caption

toggle caption

Daniel Amao

Though effective medication exists, the issue is persistent in areas with a lack of easy access to testing, treatment and clean water so people don’t rely on local bodies of water for drinking and bathing. Awareness of its transmission is also an issue. Touching infested water, even just a splash, can risk infection, as microscopic larvae swimming along the surface are able to wriggle through skin.

Uh oh, a worm!

The game, created in 2014 by a team led by Professor of Parasitology Uwem Ekpo of Akwa Ibom State University, follows the classic pattern: Roll a dice to advance up a winding path to the top of the colorful board. A player could land on a square that sends them up a ladder or sliding down a Schisto worm (which takes the place of the traditional chute). An example of a positive square is “eat before taking medicine” – the right thing to do for someone who’s infected and sends the player up a ladder to move ahead in the game.

They trademarked their name.

Another square with negative consequences says  “Blood in Urine” but the neighboring square offers the player a path to redemption: “visit the health center” with a drawing of a smiling health worker.

“Children go up the ladder when they encounter a good behavior [in the game] that would prevent schistosomiasis,” Cynthia Umunnakwe says. These include “Take praziquantel at school” and “Cutting vegetation around a river” – removing invasive plants that offer ideal conditions for proliferation of the intermediate snail hosts, which carry the parasite.

The game also highlights key steps of transmission.

The “Fetching water from a stream” square showed a child stooped at the river’s edge. A schistosome worm stretched from this square down the board to the complication of the illness, depicted in another square reading “Swollen belly”; while “Defecating near a river,” brings the player’s piece far down the board, landing on a square reading “Spreading infection.” These represent two chances to interrupt the parasite’s life cycle: Avoiding infection of humans at the larval stage via water contact and discouraging propagation of the parasite into river water via human waste, where eggs in waste can then reinfect snails.

Playing the game

On a visit to a schoolhouse in Apojola village in July 2025, Cynthia Umunnakwe taught young children to play “Schisto & Ladders” — part of a Ministry of Health program that also provided urine testing and treatment for those affected.

And it’s not just a game. In this part of Ogun State, a third of residents screened at a urine testing clinic were found to have active schistosomiasis infection. The disease is common in these rural fishing villages where residents rely on freshwater for daily living. Tthe Oyan River is used for the essential daily tasks of washing clothes, fishing and cleaning and preparing cassava root, the main crop. The shallow river’s edge is also a playground for schoolchildren, who splash around for fun — and also are told by their parents to check fish traps.

“Hi everyone, I am Dr. Cynthia from Nigeria.” she says with a smile – she holds a Ph.D in parasitology – and offers a wave. She supervises the pushing of tables and benches into clusters in the classroom, and then the game begins.

Umunnakwe also brought in live snails — familiar to the youngsters who play in the river — so they could recognize the host for the parasite that infects humans, leading to this illness. They were collected by her colleague, Dr. Olubukola Adelakun. a veterinary public health researcher and post-doctoral scholar at Federal University of Agriculture in Abeokuta who researches the habitat of these snails. She had waded waist-deep in the river water the day before, clad in waterproof waders to protect from infection. She had scrubbed their shells clean for easy identification, as there are many similar freshwater snails in the area, though none of them had the characteristic shell shapes of the parasite-carrying snails.

The day’s activities included medical help as well. In a neighboring schoolhouse, Ministry of Health staff offered all children the oral drug praziquantel, which can both prevent and treat the disease. They got free snacks for participating, since eating before treatment can help ease stomach pain that often occurs if the drug is taken on an empty stomach.

The team’s doctor administered treatment doses according to height, with a standardized measuring tape against the wall to help determine the dose.

In previous years, Cynthia Umunnakwe had conducted research demonstrating the game’s impact, published in International Health. In a six-month study involving 275 students across six schools in rural Ogun State — schools where praziquantel had previously been rejected because of false rumors that it caused fainting and even death — not a single child in the study group had heard of the drug before playing the game. The game was played in each school for the duration of the trial, and the team surveyed children before and after the trial, conducted focus group discussions with students, parents, and caregivers. By the end of the trial, more than two-thirds of the students knew what the drug was and understood it was safe, and 65% put their names down, with parental permission, to receive treatment.

“So we are hoping that by playing this game that the schoolchildren will actually translate the knowledge acquired into changing their behaviors,” Umunnakwe said,

And not only that, the kids have fun.

“Hey, wò ó, mo wà lókè!” said a boy who won the game by reaching the final “Schisto-free child” square: “Hey look, I’m on top!”

William McCarthy is a medical student at McGovern Medical School and a researcher and writer committed to global child health problem-solving. His research includes environmental health and global health diagnostics innovation. Currently, he studies schistosomiasis with the Prakash Lab at Stanford Bioengineering, where he works on community-led approaches to infectious disease control. He’s CEO and co-founder of the student-led nonprofit group Health In Your Hands Diagnostics.

Former USAID head grieves its closure while hoping for its future : NPR

Ambassador Samantha Power (C), former head of the United States Agency for International Development (USAID), embraces fired employees and their supporters outside the agency’s headquarters on February 27, 2025 in Washington, D.C.

Chip Somodevilla/Getty Images

hide caption

toggle caption

Chip Somodevilla/Getty Images

When Samantha Power walked out of the United States Agency for International Development’s headquarters in Washington, D.C., for the last time on January 20, 2025, she had no idea what was to become of the agency she had led for the Biden administration for the past four years.

Within days, the new Trump administration had put a stop work order on all U.S. foreign assistance, halting thousands of programs around the world — including emergency lifesaving ones — and began dismantling USAID.

“I was as shocked as I was horrified,” Power said in an interview with NPR. “I could not believe in the first instance that any human would suspend assistance, particularly life-saving assistance, without taking into account the human consequences or trying to do so in a manner that would allow people to make adjustments.”

Power was the last confirmed administrator of the 64-year-old agency — USAID was officially shut down in July 2025. It had employed around 15,000 people globally, and managed thousands of programs aimed at fighting disease and poverty. Only a handful of former agency staff now work at the State Department, and most of the programs were terminated.

A year later, Power is still grappling with the loss and legacy of USAID and is filled with indignation over the administration’s treatment of its staff.

“It was so cruel, and it was as if cruelty was the point,” Power says of the way the administration went about the dismantling.

Still, Power is holding onto hope that there’s enough bipartisan support for foreign aid in Washington that the agency could be reconstituted in some form in the future.

This interview has been edited for length and clarity.

When you realized what the Trump administration intended to do with USAID what did you do?

I did what so many did, which is I went and appealed to the Republicans [in Congress], who I knew were both close to the President and huge champions of USAID. Initially they worked with me and others behind the scenes to try to restart this program and get a waiver for that, but at a certain point they clearly decided that it was in their self-interest to go along [with President Trump].”

Many former USAID staff who spoke to NPR described feeling like they were in a prolonged grieving process in those six months since the Trump administration began dismantling USAID until its official shutdown in July, 2025. How did you feel during that time?

For a long time, I think I not only grieved the agency, but the sense of powerlessness that I felt toward the people who had faithfully worked in the Biden administration under my leadership, in partnership with me.

This was a mini cataclysm for 15,000 USAID workers all around the world. Every single one of them had served our country faithfully. They certainly weren’t doing it for the money; they were doing it out of a sense of purpose and mission. And to be unable to support them, to know that they weren’t going to be able to make rent, to know that some of them had to pull their kids out of daycare — the personal heartbreak they felt, compounded with the livelihood questions and the existential questions in terms of their careers that they were going through, I just wanted to be able to do something, and just felt massively ineffective in that period.

How do you think the loss of USAID is being felt around the world?

I think about that village that doesn’t get electrified because Power Africa no longer exists, which had brought electric, broader, improved electricity to 150 million people in the short time it had been operating. What does it mean to not have U.S. funded election monitors in parts of the world when we know that many of the democratic trends are going in the wrong direction with mass job displacement coming with AI? What does it mean that there is far less independent media out there scrutinizing whether governments are stealing from their people and serving as a check and balance?

When you shut down anti-corruption civil society organizations, as has happened all around the world, because the USAID and State Department funding was pulled out from them, you lose things that won’t be measured in the here and now, but that will cause really negative ripple effects over generations.

A year after the agency shutdown NGOs and aid groups appear to be moving on with the work. Why do you think we should still talk about what happened with USAID?

USAID was created by John F. Kennedy, and over the decades, the amount of goodwill that this agency has earned the United States and the American people is impossible to quantify, because it is just boundless.

Walking away from USAID is, on top of being cruel, just incredibly dumb. It’s literally like having the best brand name and saying, let’s invent a new brand name, even though this is the most popular, most beloved, most respected arm certainly of US foreign policy in the world. Though not without its flaws, Americans want to help, and that is what USAID really understood.

Trump administration officials say they are nimbler and more efficient at disaster response now than when USAID existed. When you look at the responses to the ongoing Ebola outbreak and the earthquake in Venezuela what do you see?

I see an improved response, not an adequate response, but an improved response from the U.S. State Department’s response to the Myanmar natural disaster, and clearly getting quicker and dedicating more resources to the Venezuela response, in part, because of the major foreign policy and military investment made in Venezuela, in part because Marco Rubio definitely cares a great deal personally about Venezuela, but for whatever reason, doing more is better.

But I think the bigger gaps are not the ones that are causing or earning headlines like the earthquakes and the hurricanes and Ebola — it’s the fact that so much is no longer even measured in terms of the health metrics. Around HIV, for example, or in some communities, the toll of losing U.S. assistance for girls’ education around the world, that’s not a metric that people, social scientists or economists, have yet quite figured out how to nail down.

Critics of USAID say the agency created dependency among low-income countries, and I know this is an issue that you were trying to solve during your tenure. The Trump administration is arguing that it is making countries more self-reliant by cutting off aid and by being transactional with governments. Do you think there’s merit to the administration’s argument there?

Government-to-government assistance, which is actually something that the Trump administration is doing more of, was something that I was very enthusiastic about, and we had launched a big new government-to-government strategy [during my term]. But it was really Congress’s concerns from decades ago about whether governments were stealing USAID resources that caused USAID and other foreign assistance arms of the U.S. government to move through non-governmental actors.

So that shift toward government-to-government, I welcome it. It does require proper oversight to make sure that the dollars are going where they need to go, and laying off all of the USAID people who did the oversight isn’t the solution.

Do you think there’s a world in which USAID comes back?

It should come back. Will it be politically challenging for President Trump’s supporters to embrace a return to [USAID]? Of course it will. So, can that happen? Can they put the letters back on the headquarters, hire everybody back, and say, “oh, whoops,”? That’s very unlikely to happen soon. But this year the Republican-led House and Republican-led Senate sent a $50 billion foreign assistance bill to President Trump’s desk for signature.

The supporters of this work are still out there, but it is going to take very delicate negotiations about how not only to build back, but to do so in a manner where majorities in both parties can rally around the cause in a manner where some can save face, because clearly a terrible mistake was made.

Do you hope to be part of that potential reconstitution of USAID?

Certainly. I’m doing everything I can to be part of the conversations about what the core of what comes back should look like. Not everything is going to come back at once, not every sector is going to be able to generate the same bipartisan enthusiasm as every other sector, but what is key is to be open to the question of where results have been achieved. USAID spent decades amassing those results, and the individuals involved in those programs need to be central to the dialog about what comes next, not just the politicians who can figure out what politics will allow, but the experts who can demonstrate the good that was done on behalf of the American people.

NPR reached out to the State Department for comment but did not immediately receive a response.

In Oregon, local doctors use new state law to fend off a national company : NPR

A national physician staffing firm tried to take over the contract held by Eugene Emergency Physicians to work in local hospitals. The local physicians used a new state law to oppose the move.

sorbetto/Digital Vision Vectors/Getty Images

hide caption

toggle caption

sorbetto/Digital Vision Vectors/Getty Images

For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.

In between shifts in the emergency room, Dr. Dan McGee was in an Oregon courtroom. He was fighting for his practice — Eugene Emergency Physicians (EEP). The group of more than 40 doctors and physician assistants work at multiple emergency departments; it was being replaced by a national company.

“This was big time, David and Goliath stuff,” McGee said. “You see 14 of their lawyers sitting there and you see three of ours.”

Those lawyers argued that ApolloMD, the national company, violated Oregon’s corporate practice of medicine law. The 2025 law bans corporations from taking control of a medical practice’s operations and finances.

The case garnered national interest because Oregon’s new law targets the loopholes large staffing firms have been employing to circumvent state corporate medicine laws.

Money for control

Most states have laws requiring that doctors own medical practices, not corporations. These rules aim to put patient interests ahead of profit motives. Over the last several years, companies have used a model where a doctor technically owns the local practice, but as Erin Fuse Brown, a professor at Brown University, explains, those physician owners are often not involved in care and cede hiring, firing and other operational functions to the corporation.

Fuse Brown said these arrangements are attractive to hospitals because these companies often promise more revenue and take over the responsibilities that come with running an ER.

“There’s worry that these investors or these corporate management companies should not be totally controlling the operations and the clinical decisions of those who are trained to deliver patient care,” Fuse Brown said.

The connection to patient care concerned Dr. Jonas Pologe, who works for Eugene Emergency Physicians, in the Eugene, Ore., area. ApolloMD offered local doctors jobs, but Pologe worried that if he pushed back on decisions ApolloMD made, he could lose work hours.

“There’s certainly a chance that if you make enough of a stink, you think that something needs to change, they can just stop giving you shifts,” said Pologe.

ApolloMD’s CEO, Dr. Yogin Patel, said the group doesn’t infringe on the way its doctors practice. He says the company is being unfairly lumped in with broader concerns over physicians’ feelings of disempowerment at the hands of corporate medical takeovers.

A closely watched experiment 

Fuse Brown, policy experts and independent physicians theorized that updating state corporate medicine laws could be a fix to limit the control management companies can exert over medical doctors.

Oregon’s the first state to try this, and the case brought by the Eugene doctors group is the first test of that law. McGee, who leads the Eugene physicians group, says colleagues at other hospitals around the state were literally tuning in to their case.

“You could hear it almost like background music on an elevator,” McGee says he was told. “At key moments, all of a sudden the nurses would break out in a cheer.”

Before any ruling, the hospital system dropped its plan to work with ApolloMD and struck a deal to stick with McGee’s local group of doctors.

“This is a big victory for independent physician groups over corporate medicine,” McGee said. “This is a game changer.”

The American Academy of Emergency Medicine (AAEM) supported the Eugene doctors as part of the organization’s strategy to protect independent practices. The AAEM president, Dr. Vicki Norton, said Oregon has the strongest law in the country.

“This signals that that law works and we need it replicated in other states to really strengthen their corporate practice laws,” said Norton.

California and Vermont have passed similar legislation to Oregon, and lawmakers in other states, including Rhode Island and New Mexico, are considering related bills.

In Virginia, an independent group of ER doctors who were replaced by a large staffing firm is meeting with state legislators to try to change their laws.

Impact on Oregon physicians 

Back in Oregon, the open question is about how the law may impact the physician practice market.

A few of the largest companies, Envision Healthcare, TeamHealth and USACS, declined to answer NPR’s questions about whether this case or the new law changed their outlook on investing in Oregon practices.

Opponents of the legislation warned lawmakers that many physician groups depend on outside investment to survive.

US healthcare is struggling. A Supreme Court ruling could make things worse : NPR

Health care workers rally at a Manhattan union headquarters to show her support for the Haitian and Syrian communities after the U.S. Supreme Court ruled that the Trump administration could end the Temporary Protected Status for potentially millions of foreign nationals from countries experiencing conflict and violence. The decision means that over 330,000 Haitians and Syrians could lose their work authorizations and ability to remain in the country.

Spencer Platt/Getty Images/Getty Images North America

hide caption

toggle caption

Spencer Platt/Getty Images/Getty Images North America

Amid the flurry of consequential Supreme Court decisions that have come down recently, it’s the one about Temporary Protected Status that has America’s health care sector the most worried.

The ruling last week cleared the way for the Trump administration to cancel TPS for Haitians and Syrians. Experts say deporting Haitian TPS recipients will have a catastrophic impact on the nationwide health care workforce crisis — a workforce that is hugely dependent on immigrant labor.

The pain will be felt across hospitals and emergency rooms, which already operate under persistent staffing shortfalls, but it’s the long-term care sector, including senior care facilities and home care, that will suffer the greatest disruptions, said Steffie Woolhandler, a distinguished professor of health policy at City University of New York at Hunter College and a faculty member at Harvard Medical School.

“It’s going to be a disaster in the Boston area, where a lot of our nursing home and home care aides are Haitian,” Woolhandler told NPR. But beyond that, she added, “If the United States becomes inhospitable to noncitizens, which I think Trump is doing, we’re going to have a lot of problems staffing our entire healthcare system.”

Massachusetts has the third largest population of Haitians with TPS (19,000), behind Florida (158,000) and New York (40,000) respectively.

Woolhandler is one of three authors of a 2025 report analyzing the impact of Trump’s mass deportation plans, including the potential effects of stripping TPS protections from people from the 17 countries which the federal government deemed eligible. The status is meant to protect individuals from those countries who are living in the U.S. from having to return to places where armed conflicts, natural disasters or other conditions make living there unsafe. Pulling from Census Data, the research team found that roughly 50,000 physicians in the U.S. are noncitizens, the category that includes people with TPS protections. That’s about 9% of all doctors in the U.S. Another 145,000 are registered nurses.

FWD.us breaks down the numbers even further, estimating that 21,000 Haitian TPS holders are in hard-to-fill jobs as nursing assistants and caregivers.

The dearth of qualified health care workers is already putting existing institutions under tremendous strain. Woolhandler said two-thirds of hospitals report they’ve had to close beds because they don’t have enough staff and about half of nursing homes similarly say that they can’t take new admissions because they don’t have enough personnel.

“The thing that has to be said is that the healthcare of everybody is going to be compromised by this. If you start throwing out workers that play a key role in the whole continuum of care … it tends to create a bottleneck or a backup,” she said.

If a family can’t find a bed in a nursing home or home aid caregiver, then those people may end up stuck in a hospital or in emergency rooms, Woolhandler said.

Katie Smith Sloan, president and CEO of LeadingAge, which represents more than 5,300 aging service providers nationwide, called the ruling a direct threat to the delivery of much-needed care and services.

“It puts older adults and the providers who care for them in an untenable position,” Sloan said in a statement. “Staff and caregivers who support older adults every day — legal employees who in some of our communities represent 8% or more of the entire workforce — can now lose their jobs overnight.”

The legal limbo has communities wracked with worry, particularly in Springfield, Ohio, where 1 in 4 residents is of Haitian descent. Hours after the ruling, dozens of panicked TPS holders were calling Viles Dorsainvil asking for advice. The 40-year-old is the co-founder and executive director of Haitian Support Center, a nonprofit that provides a range of services to Haitian nationals and refugees, including legal assistance.

“They’re wondering if they can still keep their assets or money at the bank, if they can still go to work because TPS came with the work permit, and with the drivers license privilege,” Dorsainvil told NPR. “The community is devastated.”

The Trump administration has released little information about how it will withdraw protections under the program for more than 330,000 Haitian and 4,000 Syrian TPS holders affected by the high court’s ruling last week. On Wednesday, the Department of Homeland Security announced that existing Employment Authorization Documents, which permit TPS recipients to legally work in the county, will expire on July 10.

Dorsainvil said he’s advising people the most important step they can take is to sign a power of attorney to someone they trust. Parents with American-born children should also plan to sign over guardianship of their kids, in case DHS pursues family separations, he said.

For now, he said, he’s got little else to share with the people calling but he shares their anxiety.

Dorsainvil is also a TPS recipient, but unlike those who fled the destruction of the 2010 earthquake, he came to the U.S. in 2020 on a visitor visa. At the time he did not intend to stay more than six months. But during his stay, Haiti’s already fragile political system devolved into unrest and violence that led to the assassination of President Jovenel Moïse, and continues to today.

“There was no way I could go home,” Dorsainvil said, adding that it was the Biden administration’s extension of the TPS program for Haitians that allowed him and his brother to stay in the country. It wasn’t until 2024, when Trump first set his eyes on ending the TPS program for Haitians, that Dorsainvil and his sibling, a former doctor in Haiti who now works as a nurse in Chicago, both applied for asylum. Those applications have still not been resolved.

Over the next few weeks, he said, he’s forging ahead with his life, trusting that somehow things will work out. He’s trying to finish his graduate studies at Wright State University in Dayton, Ohio — he’s in a dual masters degree program for international relations and public administration.

When he first decided to stay in the U.S. phone calls home to his mother and daughter revolved around the dangers of the armed gangs that have taken over much of the country because of the political vacuum that exists. Now, they spend most of their calls talking about the political turmoil in the U.S.

“When I was outside of the U.S., the way they sell it to you, you would believe that if you came to this country everything would be okay. But it’s totally different,” he said.

7 tips to prevent heat exhaustion and heat stroke : NPR

People cool off at Washington Square Park during hot weather in New York City on June 29, 2026.

Selçuk Acar/Anadolu/Getty Images

hide caption

toggle caption

Selçuk Acar/Anadolu/Getty Images

As the holiday weekend approaches, large swaths of the the Midwest and the Eastern U.S. are under extreme heat warnings or heat advisories, according to the National Weather Service.

Heat is a serious health threat. Hundreds of people die of heat-related illness in the U.S. each year. Heatstroke can damage your body, leading to multiple organ failure or kidney failure, and it can trigger a heart attack.

If you plan to spend time outdoors this week, here’s a roundup of advice from NPR reporting on how to protect yourself and your loved ones.

For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.

1. Assess the heat risk before you go outside

There’s not an absolute temperature at which extreme heat turns dangerous. Rather it depends on your individual circumstances, how acclimated to heat you are and how long you’re exposed to the heat, Lewis Halsey, a professor of environmental physiology at the University of Roehampton in the U.K., told NPR.

Humidity is also a key factor, he says. Sweating works better to cool you off in dry heat than in humidity. Wind flow can also affect the risk of overheating.

“If it’s a very humid day and there’s no wind speed, then you are more at risk, even if the air temperature is lower,” Ashley Ward, director of Duke University’s Heat Policy Innovation Hub told NPR’s Life Kit.

Keep an eye out for heat advisories or warnings in your area issued by the National Weather Service. These typically take into account the local heat index, which includes humidity as well as the air temperature, to get a more accurate read on how hot it will feel outside.

But they are not foolproof, says Nick Staub, incident commander for extreme heat response in Maricopa County, Ariz. “We see a significant number of heat-related deaths on days that are not an extreme heat warning,” Staub said, speaking on NPR’s Short Wave.

One reason for this is that the heat index values are calibrated for shady locations with light wind. If you’re in direct sunlight it can be 15 degrees hotter than in the shade.

Instead of relying on heat indices alone, check the National Weather Service’s HeatRisk tool which takes several factors into account, including: how far above normal the current temperature is for your location and time of year; heat duration; and humidity forecasts.

Carrying your own shade is one way to stay cool. Experts advise avoiding the midday sun altogether.

ALEX WROBLEWSKI/AFP/Getty Images

hide caption

toggle caption

ALEX WROBLEWSKI/AFP/Getty Images

2. Know if you’re high risk

Some people are at higher risk for heat-related illness, as NPR has reported and they need to take extra care to stay cool.

This includes people who aren’t acclimatized to the heat because they are from cooler regions or spend little time outdoors. Infants and also small children can be particularly at risk, partly because of their small body size. Kids also might not notice how they’re feeling, or not communicate it clearly, so it’s important to watch for changes in their behavior that might suggest they’re overheating.

People in their 60s and older may have a reduced ability to sweat and thus cool off. Pregnant women’s bodies also may not cool off well and heat can raise the risk of pregnancy related health problems. People with certain chronic health conditions or on certain medications may have trouble too.

And finally, outdoor workers or others who do strenuous outdoor activity and those without access to air conditioning are at high risk.

3. Check prescriptions — heat and some medicines don’t mix

Certain medications can make people more vulnerable to heat. For instance, blood pressure drugs, which millions of people take, are diuretic. “Those medications are trying to get rid of fluid from your body,” Wafi Momin, a cardiologist at Memorial Hermann Health System in Katy, Texas, told NPR. And if you then add heat, “that can cause a very dangerous situation” of dehydration.

Other types of medications can impair your body’s ability to cool off, including anticholinergic medications (a category that includes Benadryl) and stimulants, like ADHD drugs. ACE inhibitors, commonly prescribed for heart issues, make it harder to notice you’re thirsty, and beta blockers — another heart medication — can decrease sweating.

“When you’re taking these medications and you’re exposed to heat, it’s like asking a car to drive up a mountain in the summer with the air conditioner broken,” David Eisenman, a physician and researcher at the University of California, Los Angeles, told NPR. “Overheating becomes much more likely.”

Psychiatric medications can also interfere with your body’s thermoregulation. Antipsychotics and some antidepressants can reduce how much you sweat.

Sedative medications like benzodiazepines may “reduce alertness and perception of heat, says Dr. Ashwini Nadkarni a psychiatrist and medical director of Brigham General Adult Psychiatry at Mass General Brigham, in Boston.

Patients should still take their prescribed medications, Eisenman stresses. But he urges them to take heat risks seriously and make a plan to keep cool.

Ask your doctor whether any of your medicines could increase your risk of heat-related illness. And you can explore a list of medicines that contribute to heat sensitivity from the Centers for Disease Control and Prevention.

4. Know the difference between heat exhaustion and heat stroke and when to seek emergency care

The warning signs of heat exhaustion include fatigue, extreme thirst, nausea, headache, shortness of breath, rapid breathing, muscle cramping and feeling dizzy or lightheaded.

Heatstroke is a much more serious emergency. The warning signs include all the above but also may include a strong, rapid heartbeat, confusion, vomiting, seizures, slurred speech, or passing out. Watch for a body temperature that exceeds 103 F.

The first step to help anyone who exhibits symptoms of heat exhaustion or heatstroke is to get them to immediately stop what they are doing and rest somewhere out of the sun, Dr. Matt Leonard, attending emergency physician at Suburban Hospital, Johns Hopkins School of Medicine, told NPR.

Take steps immediately to cool the person who’s overheated: Get them into air conditioning if possible, or at least shade with a fan or breeze. Mist them with a spray bottle, for example, or pour water over their head. The most important places to cool are the head and face, the arm pits, and the groin, he says.

If symptoms point to heatstroke (watch especially for neurological symptoms like confusion), get them to an emergency room right away.

Staying hydrated and letting your skin aerate can help you stay cool.

Spencer Platt/Getty Images

hide caption

toggle caption

Spencer Platt/Getty Images

5. Keep cool: Avoid midday sun and choose protective clothing

One of the simplest ways to keep your body temperature at a reasonable level on a hot summer day is to only go outside in the morning or evening when it’s cooler. And stay in the shade, especially if you’re doing anything active.

“That midday sun can add as much as 20 degrees or more to the actual air temperature,” Carol Ewing Garber, professor of movement science at Columbia University told NPR. “You really have to be careful about that.”

And it’s important to protect your skin, says Leonard. Your skin is an “amazing self-cooling apparatus,” he says. It’s designed “to move warm blood away from your core to keep your vital organs cool.”

Consider wearing lightweight clothing that blocks the sun, and include a hat. Leonard recommends wicking athletic fabrics that allow you to sweat.

Choose loose-fitting silhouettes, recommends Dr. Renee Salas, assistant professor of emergency medicine at Harvard Medical School. If your clothes are too tight, the sweat on your skin can’t evaporate which is key to keeping your body cool. “I’m sure people don’t love sweating profusely, but sweating is actually our friend when it comes to heat,” Salas told Life Kit.

6. Pre-hydrate — and rehydrate often

If you’re outside or in a hot place, dehydration can happen fast. So prepare by hydrating in advance, says Momin, of Memorial Hermann Health System. “Grab a glass of water or a sports drink before you head out to the outdoors,” he says.

Bring plenty of water with you, and don’t wait until you’re thirsty to start drinking during an outdoor activity. “The moment you begin to feel thirsty, you’re likely anywhere between 10 to 25% dehydrated already,” says Neil Gandhi, a physician at Houston Methodist Hospital.

Water is the best way to hydrate. Adding electrolytes is not necessary under normal circumstances. But they can be helpful if you’ve gotten overheated or you’re doing something very physically active and sweating a lot. In that case, it can be a good idea to replace those electrolytes promptly, Asher Rosinger, an associate professor and director of the Water, Health, and Nutrition Lab at Penn State University told NPR.

7. If you struggle with mental health, take extra care

Higher temperatures are known to have an impact on mental health. Studies show that higher temperatures are linked to higher rates of visits to the Emergency Department for mental health conditions and addiction.

And suicide risk goes up too, a recent study found. “We think that every summer roughly an additional hundred young adults are dying by suicide due to increasing temperatures,” says study author and psychiatrist Dr. Joshua Wortzel at the Hartford HealthCare Institute of Living, who runs the institute’s Heat Mind Lab.

If you or someone you know may be struggling with suicidal thoughts, contact the 988 National & Suicide Crisis Lifeline by calling or texting 988.

So, what can people with mental health conditions do to protect themselves from excessive heat? Avoid exposure to heat as much as you can, says Nadkarni of Mass General Brigham. She advises “staying indoors in cooler places” and making sure to hydrate.

She also recommends people talk to their doctors about what their risks are. There can be added risk for people with substance use disorders — alcohol and certain drugs are diuretics and can cause dehydration. And people with mental illness are also vulnerable to heat related illness, says Nadkarni, so it’s important to watch out for symptoms, and seek medical attention promptly if they develop

Lean into your social networks, during times of high heat, suggests Amruta Nori-Sarma, an environmental health researcher at Harvard University’s Chan School of Public Health. “If you have a loved one that you know is prone or vulnerable, make sure that you’re checking in with them when there’s a heat wave,” she says.

Rhitu Chatterjee contributed to this report.

Other reporting was drawn from earlier NPR stories. Contributing reporters include: Allison Aubrey, Alejandra Borunda, Maria Godoy, Pien Huang, Emily Kwong, Suzette Lohmeyer, Christine Ro, and Clare Marie Schneider.

This federal data helps shape policy. It’s 6 months late : NPR

For more than 50 years, the Education Department has revealed a host of realities about how students are being treated in every public school across America: which kids are being bullied, which ones are being harassed and which students can access the internet, among other things. The agency’s Civil Rights Data Collection is intended to do just that — help keep schools accountable.

The latest information, collected about the 2023-24 school year, was supposed to be published last December, according to the Education Department’s own deadline.

But it hasn’t been.

The agency hasn’t responded to multiple requests from NPR asking what’s behind the delay.

Federal bureaucracy can be slow, and delays aren’t always cause for concern, but advocates are on edge in the midst of recent plans the Trump administration announced to move the Office for Civil Rights — which houses the Civil Rights Data Collection (CRDC) team — from the Education Department to the Department of Justice.

That planned transfer follows months of federal action that upends the way students’ civil rights have been protected in the past: The Trump administration has cracked down on initiatives related to diversity, equity and inclusion, for example, and prioritized investigating schools that allow transgender athletes to compete in women’s sports.

“This administration has repeatedly applied civil rights law in ways that ignore or dismiss the very real inequities that persist in our education system,” says Denise Forte, president and CEO of EdTrust, a think tank focused on addressing education inequity. The delay in releasing the CRDC data, she says, “raises serious concerns, particularly as this administration seeks to downplay the impacts of racism and economic inequality in public education.”

A former Education Department employee who worked on the CRDC tells NPR the team is still intact. However, its future is unclear: While the Trump administration has announced the Office for Civil Rights is moving to the Justice Department, the process could take months, like other plans to outsource parts of the Education Department’s work. The former employee, who asked not to be named out of fear of professional repercussions, said part of the delay may have to do with the 2025 government shutdown that affected operations at the Education Department for over six weeks, including work on the CRDC.

The department also has been winding down its operations since the Trump administration took office, cutting about half the department’s overall staff last year.

Lindsay Kubatzky, director of policy and advocacy at the National Center for Learning Disabilities, agrees with Forte’s assessment that a delay in this data may have to do with the Trump administration’s chipping away at systems that have historically helped hold schools accountable for protecting students’ civil rights. “This administration unfortunately has proposed a lot of policies that would make it less transparent on how students with disabilities in particular are being served in public schools,” he says.

For example, Kubatzky points to how the Trump administration has proposed eliminating a requirement for states to track which students are being identified as having disabilities based on race and ethnicity. Historically, Black and brown students are more often wrongly identified as needing special education than their peers.

While that disability data is not directly tied to the CRDC, Kubatzky says it’s an example of the administration working to undo federal civil rights accountability tools. The CRDC, he says, also plays a key role in helping advocates show where “schools are not serving students and it also gives us a lever to push for policies that are more inclusive and less negative toward students.”

For example, Democratic Sen. Cory Booker of N.J. and U.S. Rep. Joaquin Castro of Texas used findings from CRDC data to craft a bill proposing the expansion of access to Advanced Placement courses for underrepresented students, including minority and disabled students, whom the data found had unequal access to these classes. A spokesperson for Booker’s team said the bill would be reintroduced in the coming days.

One of the questions the delayed dataset was set to answer is which students have access to the internet as AI plays a bigger role in education, according to the former CRDC staffer who spoke on condition of anonymity. “Like, are our schools ready to usher in this wave of AI? Will all students have equal access to devices and internet capabilities?” the person said. “How do we know if the CRDC doesn’t come out?”

The former staffer described the CRDC team as a deeply committed group of people who are focused on ensuring “access and opportunity” for the nation’s most marginalized students. “We can’t make the right decisions for students if we don’t have insight into their current realities.”

Edited by: Nirvi Shah
Visual design and development by: LA Johnson

5 safety tips to keep you out of the emergency room this summer : NPR

Stay safe this summer. Make sure you know the five water safety skills, designate a water-watcher when kids are swimming, know the signs of heat exhaustion and more.

Kaz Fantone/NPR

hide caption

toggle caption

Kaz Fantone/NPR

Stay safe this summer. Make sure you know the five water safety skills, designate a water-watcher when kids are swimming, know the signs of heat exhaustion and more.

Kaz Fantone/NPR

Think about all the things we do during the summer. We go outside more. We jump into bodies of open water. We bake under the hot sun. We light fires and cook over them.

This stuff is all fun, of course, but it’s also risky.

Spare a moment to think about your safety this season, won’t you? Here’s how to protect yourself against drowning, heat exhaustion, tick bites and more.

Learn these 5 water safety skills 

Reported by Marielle Segarra 

According to the American Red Cross, at a minimum, everyone should know these five basic water safety skills.

First, make sure you are comfortable with jumping into water, submerging yourself completely and bringing yourself to the surface. Once you’ve returned to the surface, you should be able to float or tread water for one minute. When treading water, stay relaxed so you don’t overexert yourself.

From there, you’ll want to be able to turn around in a full circle and find an exit. Knowing how to get out of the water is “just as important as getting into the water,” says Cullen Jones, an Olympic gold medalist swimmer and a water safety advocate.

Next, you should be able to swim 25 yards to an exit without stopping. You can use whichever stroke you’re comfortable with. Jones adds that most pools in the U.S. are 25 yards.

Finally, make sure you can exit the pool or body of water without a ladder. Jones used the phrase “elbow, elbow, tummy, knee, knee” to teach his 3-year-old son this skill. (For more tips on how to become a strong swimmer, click here.) 

Designate a “water-watcher” to prevent drowning

Reported by Marielle Segarra 

A designated “water-watcher” is an adult who is responsible for monitoring the water and the kids in it.

To take on this role, the water-watcher should be sober and focused. They should also have their phone nearby in case they need to call 911. After a set period of time, like 15 minutes, rotate water-watchers. It’s also helpful if they know CPR and have a flotation device they can use in a rescue. (Take our quiz to test how much you know about kids and water safety.) 

Know the signs of heat exhaustion 

Reported by Clare Marie Schneider 

If you’re out with a group of friends on a hot day, keep an eye on each other, looking for signs of illness. “Somebody may notice something in you that you don’t notice,” says Dr. Renee Salas, assistant professor of emergency medicine at Harvard Medical School.

Heat exhaustion is your body’s warning sign that you’re starting to overheat, Salas says. Generally, symptoms include sweating more than usual, weakness, dizziness, fainting, pale skin, nausea, vomiting and fatigue.

Pay special attention to seniors, children, people with certain preexisting medical conditions like heart disease and diabetes, and people on commonly prescribed medications to help manage blood pressure and mental health conditions. They are at higher risk of heat-related illness, Salas says.

If you or someone you know is experiencing signs of heat exhaustion, Salas recommends going into an air-conditioned room. If you can’t find a cooler place, call 911, Salas says.

If you’re still experiencing symptoms of heat exhaustion after removing yourself from the heat, seek medical care. (More tips on how to protect yourself against extreme heat here.) 

Do a tick check after spending time outdoors 

Reported by Pien Huang 

It’s estimated that about 31 million people in the U.S. get bitten by a tick every year. Summer is peak tick season, and unfortunately, ticks can spread diseases, like Lyme. 

If you’re spending time outdoors in the summer, especially in an area where ticks are common, like the Northeast, cover your skin as much as possible.

For instance, if you’re going on a hike or working in the yard, you could wear long sleeves and long pants and tuck your pants into your socks. Then spray your clothes and your skin with an EPA-recommended repellent. The Centers for Disease Control and Prevention recommends that you use permethrin on your clothes and DEET on exposed skin.

If you’re hiking, stay on the trail and out of the tall grass.

When you get home, throw your clothes in the dryer if possible — that will kill ticks — and check your body for them right away. Generally speaking, the longer a tick is latched onto your body the more likely it is to spread disease. (Listen to our episode on ticks for more information on prevention.)

Grill in an open space, away from the house 

Reported by Ruth Tam 

Take precautions to prevent fire accidents. Before you light your grill, read your grill’s manual. It’ll give you crucial information about how and where to set it up safely. Avoid putting your grill against the side of your house or under a patio roof or someone else’s balcony, for example.

“You want to have your grill in open air so there’s a lot of space for the air to circulate and for the heat to disperse itself,” says Jess Larson, founder of the food blog Plays Well With Butter.

If the fire seems like it’s getting out of hand, don’t panic. “When in doubt, just close the lid [and the vents] and have the fire die out on its own,” says Larson. Cutting off the oxygen supply should kill the fire in a matter of minutes. And, just in case, “it’s always a good idea to have a fire extinguisher on hand.” (Read our story on grilling for beginners for more tips.)

The story was edited by Meghan Keane. The visual editor is CJ Riculan. We’d love to hear from you. Leave us a voicemail at 202-216-9823, or email us at LifeKit@npr.org.

Listen to Life Kit on Apple Podcasts and Spotify, and sign up for our newsletter. Follow us on Instagram: @nprlifekit.

In Florida, swim lessons for kids with autism aim to curb deaths : NPR

Garland Jones, recreational therapist and senior program director of the YMCA of South Florida’s special needs program, teaches Mackenzie Wesley, 5, to breathe safely in water by using a ping pong ball as a visual aid.

LA Johnson/NPR

hide caption

toggle caption

LA Johnson/NPR

WESTON, Fla. — Mackenzie Wesley sports a big grin and bright blue Lilo & Stitch swim gear as she runs into her weekly swim lessons. It’s fitting, because the 5-year-old has something in common with movie character Lilo: She adores water.

“Whether it’s the pool or beach, she enjoys it fully,” says her dad Steven Wesley.

Mackenzie isn’t alone: Many kids with autism share a natural love for water because it can be sensory bliss — the feeling on their skin, the pressure and the sparkle of the water can all be soothing. Lucky for her, Mackenzie lives here, less than an hour outside of Miami in a state that’s dotted with bodies of water.

But there’s a tragic reality tied to that fact, as Mackenzie’s mom, Brittany Bucknor, is all too aware. “In Florida, there’s water everywhere, and also with kids her age, and also just being on the spectrum, it’s a very — way higher — rate of having an incident of drowning.”

Kids with autism are 160 times more likely than other children to die from drowning, according to a seminal 2017 study from Columbia University. In fact, in Florida, most children drown in backyard pools. That’s largely because about half of autistic children have a tendency to wander from safe settings. That fact, combined with an attraction to water can make for a dangerous combination. Quality swim lessons can help.

That’s one of the reasons Mackenzie’s parents enrolled her in Swim Buddies, the YMCA of South Florida’s low-cost program aimed at children with disabilities. It’s also why the state of Florida, which has one of the highest childhood drowning rates in the nation, is expanding a voucher program on July 1 that will put children ages 1-7 who have autism at the front of the line for subsidized swim lessons. “We have tragic circumstances and stories across the state of Florida of young children with autism that are wandering away, they’re eloping from their homes, from their classrooms,” says Florida state Rep. Anna Eskamani, a Democrat, and one of the lawmakers who sponsored the bipartisan bill that changed the state’s swim vouchers.

“These [tragedies] are so preventable, but if that child at an early age does not have access to drowning prevention and swimming lessons, then those statistics will only continue.”

Recreational therapist Tiera Chaney works with Amir Williams, 6, during a recent Swim Buddies session.

LA Johnson/NPR

hide caption

toggle caption

LA Johnson/NPR

Once the updated law takes effect, many healthcare providers across the state will begin providing parents of newborns with information about drowning prevention and the state swim program, Eskamani says. Generally, the voucher comes out to about $200, she says, and pays for up to eight swim lessons.

A “whole-person” approach

The YMCA of South Florida has one of the largest adaptive recreational programs for kids with special needs in the area, including those with autism, who make up the fastest-growing group of children with disabilities. “We provide this program for those with a variety of disabilities, primarily over 60 percent of our youth who do come have a diagnosis of autism,” says Alison Bregman-Rodriguez, vice president of the YMCA of South Florida, where she oversees 64 locations, 27 of which serve children with learning differences. “This program, however, does serve all who want to feel like they belong.”

When Mackenzie’s parents learned that their local YMCA already had a robust and low-cost program for one-on-one instruction with kids with disabilities in mind, they jumped on the opportunity. “I really appreciate the program and specifically Miss Garland. She’s been very patient with Mackenzie and challenged her too,” Bucknor says.

She is referring to Garland Jones, who oversees the special needs recreational program here and also spends time working directly with swimmers, alongside other recreational therapists and trained volunteers. Jones agrees that patience is key in working with kids with disabilities, something that’s emphasized in the training for instructors. “We come at everything with a whole-person approach instead of just a physical approach. We do the physical, the emotional, the social.”

A selection of colorful, sparkly toys are often used for positive reinforcement and redirection in Swim Buddies lessons.

LA Johnson/NPR

hide caption

toggle caption

LA Johnson/NPR

The program’s hallmarks are individualization and one-on-one instruction rather than traditional group lessons. Staffers assess each child to learn about their needs and tailor their lessons in response. “We might have a kid who loves to get in the bathtub and splash around in the water or we might have a child who is very fearful of getting in the water,” Jones says.

On this recent summer Sunday, Tania Santiago Perez is sitting poolside, observing the Swim Buddies lessons. She is a professor at Florida International University who studies effective swim instruction for children with autism, including at this YMCA, with research partner and professor Tana Carson. Their research shows that when done right, swim instruction for kids with autism can help save lives. “The fact that we have been seeing that in five or six sessions they’re able to improve swim skills, to us, is very powerful,” Santiago Perez says.

Each lesson begins with group introductions to help swimmers build trust with the teachers and fellow participants in the pool. “That’s one thing to promote group cohesion and then the socialization with other kids,” says Santiago Perez. “Because with kids with autism, sometimes they’re very to themselves and that social behavior is one thing we want to develop.”

After the meet-and-greet, each child must wait to be explicitly told it’s safe to enter the water.

The adaptive swim lessons at the YMCA of South Florida serve more than 600 children with disabilities, but the program is overwhelmed with requests. Jones says she hopes the state will provide more funding to help facilities like theirs meet the need.

LA Johnson/NPR

hide caption

toggle caption

LA Johnson/NPR

Because many autistic children are prone to “eloping,” or running away suddenly, Santiago Perez says instructors are trained to stay no more than an arm’s length from each swimmer.

During one Swim Buddies session, a swimmer dashes out of the pool. “So the therapist is trying to redirect him back to get inside the pool,” says Santiago Perez as she points to the instructor gently but firmly guiding the child physically and with clear verbal commands.

Next, the instructor tries luring the child back into the pool with a sparkly pink rubber duck, which does the trick. “Toys help a lot because at the end of the day, they’re kids and kids learn by play and positive reinforcement,” Santiago Perez says.

In another corner of the pool, Garland Jones is working with Mackenzie Wesley on safe breathing techniques above the water because, in the past, putting her face under water has been uncomfortable and led to choking. Jones is using a bright blue ping pong ball in front of Mackenzie so she can see how her breath is physically moving the ball.

Once Mackenzie is eased in, Jones helps her practice blowing bubbles in the water, making a humming noise to show what it should sound like. “Hmmmm,” mimics Mackenzie. Then she ducks her head under water and pops back up, with a smile on her face. “Mackenzie has grown so much. I’m so proud of her,” says Jones, who’s been working with her in Swim Buddies for over a year. “We had a couple of instances where she was [swallowing] water a lot.” Now, she blows bubbles and goes under water like a pro.

Demand overwhelms supply of lessons

Parents looking on during Swim Buddies lessons have heard about the swim voucher program, and many were excited that it could make life-saving lessons affordable for lower-income families. “People who don’t have kids on the spectrum don’t take in mind that we’re paying a lot already for stuff like behavioral therapy, speech, occupational therapy,” says Augusto Sandino, whose son David has been in Swim Buddies for a year and a half. “All the programs, everything is money, man. So every little bit helps, and also, creating these inclusive communities is a big win.”

While Florida maintains a list of approved providers around the state, Jones and Santiago Perez both share the concern that many facilities lack enough qualified instructors. “You have people who are biters, spitters, who will scratch, things of that nature,” Jones says. “I just think we need more individuals who are trained in working with individuals with special needs so that they can be successful.”

The YMCA of South Florida is already overwhelmed with requests for its specialized swim lessons. Alison Bregman-Rodriguez, the vice president, says they do their best to find a spot for every child, but they don’t want to compromise the quality of lessons they provide. And while the voucher may increase demand, facilities like this often have to leverage other sources of money to keep programs like Swim Buddies afloat.

Researcher Tania Santiago Perez of Florida International University helped train some of the instructors at the Swim Buddies program. Her research has found that even after five or six quality lessons, most kids with autism showed improvement.

LA Johnson/NPR

hide caption

toggle caption

LA Johnson/NPR

Even before the new priority for children with autism, demand for swim lessons outstripped supply. “The problem is access,” says Santiago Perez. In the program’s first year, only about a third of families who applied for vouchers actually got them. She worries that the gap will only increase.

NPR reached out to the Florida Department of Health for details about how the changes to the swim program will work. They declined an interview and did not answer questions about how many vouchers would be available.

As Mackenzie Wesley’s swim lesson comes to an end, her parents wrap her in a towel and share that just a few weeks ago, she had a big milestone: She was invited to her very first pool party. “She was in the pool like she was a pro, an expert,” her mom says. “She had her little floatie and she was doing her own thing, so she’s been a lot more confident in the water and a way stronger swimmer for sure.”

This, says Garland Jones, is the kind of milestone that makes her work so rewarding. It means Mackenzie is on her way to having the skills that will allow her to embrace her natural love for water, and to do it safely.

Edited by: Nirvi Shah
Visual design and development by: LA Johnson

FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR

Synthetic peptides, often taken by injection, are growing in popularity among patients seeking to optimize health and longevity. Yet FDA scientists point to a dearth of evidence supporting their use.

Svitlana Pietukhova/iStockphoto/Getty Images

hide caption

toggle caption

Svitlana Pietukhova/iStockphoto/Getty Images

For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.

While Health Secretary Robert F. Kennedy Jr. pushes to loosen restrictions on a handful of trendy peptide therapies, scientists who work under him are recommending the opposite.

On Monday, the Food and Drug Administration posted documents outlining concerns about a lack of evidence for the batch of peptides that are set to be considered by an FDA panel in about three weeks.

Peptides are a string of amino acids, smaller than a protein, that are produced naturally by our body. The wildly successful GLP-1 weight loss drugs are examples of synthetic peptides.

But the peptide therapies being touted online for their wellness and longevity benefits have not undergone large-scale, rigorous clinical trials involving humans.

Those under consideration next month include BPC-157, TB-500 and MOTs-C among others that have grown popular among influencers and some clinicians.

They’re typically taken as a subcutaneous injection to help with injuries, muscle recovery, metabolism and more.

In their review of the evidence, FDA scientists flag potential safety concerns and a lack of consistent data.

The Biden administration placed restrictions on these and a handful of other peptides in 2023 — moving them into a category that essentially prohibits compounding pharmacies from making the drugs.

In the years since, peptide users have turned to a grey market, often sourcing the products from sketchy suppliers overseas.

Secretary Kennedy has made no secret of his support for the molecules, saying he has used some of them himself and would like the FDA — which is overseen by the Department of Health and Human Services — to allow compounding pharmacies to again offer the drugs.

The panel selected to review the evidence in July is made up of members who have ties to the peptide industry, including some who work for companies that offer injectable peptides. They are expected to make recommendations on seven peptides during a two-day meeting on July 23 and 24 and then reconvene in February to consider others.

The panel will review the evidence supporting the use of these peptides for specific indications, including ulcerative colitis, wound healing, obesity, and migraines.

It’s unclear how they’ll weigh the findings of the career scientists at the FDA who state there’s insufficient evidence to support changing the designation for any of the seven peptides under consideration.

Their conclusion echoes what others have found when they’ve looked at the body of evidence for these therapies.

“Not a day goes by where I don’t have a number of patients asking me about peptides,” says Dr. Alexander Weber, an orthopedic surgeon and chief of sports medicine at the University of Southern California who has published a review of the evidence, “My stock answer is that we just don’t have enough data to support their use.”

After Trump’s cuts to science, these U.S. scientists moved abroad to the U.K. : NPR

Scientists Tamara Swaab (left), Ron Mangun and Megan Peters are all leaving the United States to work in Great Britain, which is actively recruiting international scientists.

Courtesy of Tamara Swaab, Ron Mangun and Megan Peters

hide caption

toggle caption

Courtesy of Tamara Swaab, Ron Mangun and Megan Peters

For decades, the U.S. was seen as a nation that prized its universities and scientific researchers.

That changed when President Trump began his second term, says Megan Peters, a cognitive scientist at the University of California, Irvine.

“It became very apparent, very quickly, that the new administration did not value higher education,” she says, or the scientific research done at universities.

“So when I went on the job market, I started looking around overseas,” Peters says.

So have many other U.S.-based research scientists.

An analysis by the journal Nature found that in the first quarter of 2025, U.S. scientists submitted nearly a third more applications for jobs abroad than they had during the same period in 2024.

In March 2025, a survey of more than 1,600 scientists in the U.S. found that 75% were considering leaving the U.S.

Now, a growing number of prominent U.S. researchers are reporting that they have accepted posts in countries including Europe, Canada, and the United Kingdom.

Peters is one of those scientists. She will move to University College London this summer.

Other prominent brain scientists heading for the U.K. include Tamara Swaab and Ron Mangun of the University of California, Davis. The married couple have accepted positions at the University of Birmingham.

Science funding under siege

The departures are, in part, a response to changes in federal funding of scientific research in the U.S.

Soon after Trump took office in 2025, grants were delayed or terminated. Universities came under fire for conducting research related to race and gender. And government funding agencies, including the National Institutes of Health and National Science Foundation, were reshaped to better align with White House priorities.

The Trump administration maintains that all of those measures are part of an ongoing effort to restore gold standard science, reduce bureaucracy, and cut costs while conducting essential research.

When the changes began to take hold, Peters was already been considering options beyond her tenured position at UC Irvine. The new funding landscape gave her doubts about taking any job in the U.S.

Meanwhile, other nations were stepping up efforts to recruit international scientists.

The U.K’s Royal Society and the European Research Council, for example, now offer grants specifically designed to attract scientists from nations including the U.S. These countries have also made it easier for scientists to obtain work visas.

Steve Fleming, a professor at University College London, saw an opportunity to recruit Peters to that school’s Department of Experimental Psychology.

“I was aware that a role was going to be advertised in that department, and we started having a conversation about how that could be a good fit for her,” he says.

Peters, who studies how the brain deals with uncertainty, was interested — even though the move would mean a pay cut.

“London was a big draw in general, and University College London in particular was a huge draw scientifically and professionally,” she says.

It was also a place where her partner, an aerospace engineer, could find a job.

So this summer, Peters and her partner are moving to London. She says one benefit of her position there will be the ability to tap into new funding sources.

“There are certainly opportunities that are not available to me here in the United States,” she says.

Peters is just one of the U.S. scientists expected to arrive at University College London over the summer. She will be joined by two other “high profile recruits,” Fleming says, both of whom left tenured positions.

Then there are Tamara Swaab and Ron Mangun, who will land at the University of Birmingham after spending more than three decades at UC Davis. Swaab studies the neuroscience of language while Mangun studies the neural mechanisms of attention.

Swaab, who got her PhD in the Netherlands, says one reason she initially came to the U.S. was that, early in her career, Europe had less to offer women scientists.

“What I always loved about science in the United States was how open it was and how people saw opportunities and would work for them,” Swaab says, “and there was this optimism.”

Now that sort of optimism is more present in British and European scientists, she says.

Another factor is that her husband has received a grant from the U.K.’s $70 million Global Talent Fund, which was created to attract researchers from other nations.

“We’re really excited to be able to bring such brilliant researchers to Birmingham,” says Rachel O’Reilly, a professor at Birmingham who helped recruit Swaab and Mangun.

The new funding and national commitment to science in the U.K. offer “a little bit certainty at a time of uncertainty for our colleagues in the U.S.,” O’Reilly says.

But the couple’s move is more than just a reaction to the current state of science in the U.S., Mangun says. It’s also an opportunity to try something new and interact with a different group of top-level scientists, while maintaining their emeritus positions at UC Davis.

Mangun believes that eventually, voters in the U.S. will restore research funding and renew the nation’s commitment to science.

“They want science, they want exploration, they want discovery, they want cures,” he says, “and I think they’re going to demand it.”

When that happens, he says, scientists will have more reason to stay.

Former tennis rivals Chris Evert and Martina Navratilova face cancer together : NPR

Once rivals on the tennis court, Martina Navratilova, left, and Chris Evert have become close friends in retirement. They are pictured above at the French Open in 1986.

Trevor Jones/Getty Images Europe

hide caption

toggle caption

Trevor Jones/Getty Images Europe

Chris Evert and Martina Navratilova were the most successful women’s tennis champions of their generation. Both were 18-time Grand Slam tournament winners — and each other’s greatest rivals.

Evert, a Florida native, became a tennis star in her teens. Navratilova was born in communist Czechoslovakia, and emerged as a player after Evert was established. They first faced off during a match in Akron, Ohio, in 1973, when Evert was 18, and Navratilova was 16. Evert won, but Navratilova left an impression.

“I remember thinking to myself, holy cow, when this young girl gets into better shape, she is going to be a force to be reckoned with,” Evert says. “She had so much talent. Her hands were quick, she had a big first serve, she had a big forehand, and she just was so powerful.”

Two years later, on the day she lost a semifinals match to Evert at the U.S. Open, Navratilova defected to the U.S. In the years that followed, her tennis game improved. Though she and Evert had initially been friendly, the friendship cooled as their rivalry heated up.

“Playing Chris was difficult because how can you not like Chris? What’s not to admire?” Navratilova says. “She was like the epitome of cool.”

The new Netflix documentary Chris & Martina: The Final Set tells the story of how Evert and Navratilova re-established their friendship and how they both faced cancer in retirement. Evert was diagnosed with ovarian cancer in 2021; Navratilova was diagnosed with throat and breast cancer in 2022.

“I can’t get away from her,” Evert jokes. “We had a 15-year career, and then we got cancer at the same time. It really is freaky, but I always say: If I want someone to be in the trenches with me, it’s Martina because she has been so supportive and so understanding.”

Navratilova agrees: “We have such a level of trust that we know whatever we say to each other, it stays there. We give each other the best advice we know how to. And there is no ulterior motive, no playing games.”

At the time that this interview was taped, Evert and Navratilova were both in remission from cancer. But late last week, Evert disclosed she’d recently been diagnosed with a recurrence of ovarian cancer.

“We know whatever we say to each other, it stays there,” Martina Navratilova says of her friendship with Chris Evert.

Netflix

hide caption

toggle caption

Netflix

Interview highlights

On supporting each other through cancer

Evert: There are a lot of phone calls between us. … I don’t cook, but Martina would bake bread for me, and her wife Julia would cook, make some chicken soup. … I got a lot of food from Martina. She got a necklace from me.

Navratilova: I get jewelry from Chris, she gets food from me.

Evert: Martina’s and my relationship — because we’ve had one for 50 years — is not the type where we have to talk to each other every day to maintain the closeness. I always knew she was there. She always knew I was there if we needed to talk, and that was that.

On the weakness they experienced with cancer

Martina’s and my relationship — because we’ve had one for 50 years — is not the type where we have to talk to each other every day to maintain the closeness. I always knew she was there. She always knew I was there if we needed to talk, and that was that.

Navratilova: Chris’ diagnosis and treatment was much more life-threatening than mine, percentage wise, but my treatment was more difficult physically. … I was in New York for seven weeks and I literally sat on a yoga mat, maybe half an hour of the seven weeks, and did some stretching. I couldn’t even do the down dog pose because I would have fallen down. I had absolutely zero strength left.

Evert: The chemo kicked my butt, let’s put it that way. … It left me very weak, very, very weak. After chemo I would have three or four days of intense nausea and I just would feel tingling in my body and it just wasn’t nice. I didn’t have the energy. To walk six blocks was a big deal for me. And it was foreign. You know, it felt like it wasn’t my body, for sure.

On watching the old footage of their matches together for the documentary

Navratilova: For me, it was fun watching with Chris, because we had different reactions to what happened on the court. But what impressed me is how well we played with those wooden rackets. Because you know what? Those rackets are not easy to play with. But you try to put yourself in there physically, what it was like, mentally, what it is like. And it’s like, “Oh, I should have gone down the line,” or, “I can’t believe I missed that shot.” Or “Chris, you had such a great pass.” It was amazing. So it was impressive. … I wish I could still have that six-pack, but anyhow.

Evert: I remember feeling genuinely happy for her. I remember it was her first Wimbledon. That’s always been her dream since she defected. Her family couldn’t be there to watch her. She was all alone. And I just was happy for it. And I knew that this was gonna be one of many for her to win.

On defecting to the U.S. in 1975 when she was 18 years old

Navratilova: I was thrilled to be in the States. I always loved American cars. And when you ordered a ham sandwich, you got, like, two inches of ham and two slices of bread. Whereas growing up, you had thick bread and one slice of ham. So I thought I was in heaven. And it was $2.30 for that sandwich. I still remember it. I couldn’t believe how much ham I was getting.

Lauren Krenzel and Nico Gonzalez Wisler produced and edited this interview for broadcast. Bridget Bentz, Molly Seavy-Nesper and Beth Novey adapted it for the web.

Could Pepcid AC and allergy pills help with PMS symptoms? : NPR

For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.

People who feel extra rotten in the days leading up to their period say they’re finding relief from a new TikTok trend.

It’s a combination of two over-the-counter drugs: An allergy pill, like Claritin or Zyrtec, along with Pepcid AC, the heartburn medication.

It might sound unbelievable, but after dealing with years of unexplained symptoms, Terese Hansen of Omaha, Nebraska was willing to try almost anything.

Hansen told NPR that for the past four years she’s suffered from persistent nausea, heartburn, and an erratic body temperature: She felt constantly on edge and exhausted. And her symptoms got worse around her period.

“I could not be around anyone because I knew I was unpleasant,” she says.

The TikTok videos of people taking Pepcid AC and allergy medicine impressed Hansen, especially those who claimed it helps with their premenstrual dysphoric disorder, or PMDD, which is when people experience depression and anxiety caused by premenstrual hormonal shifts.

After talking to her doctor, she says she decided to “take a shot in the dark” by giving the TikTok trend a try.

She says it was like a switch in her body flipped from bad to good, improving her physical symptoms, as well as her energy and mood.

“It was nuts,” she recalls. “My kids noticed, my boyfriend noticed. My boss noticed.”

The claim

TikTokers say that taking a combination of allergy medication and Pepcid AC helps to combat their premenstrual blues, leading them to feel less irritable and more energetic. Others going through perimenopause report this combo helps to lessen similar symptoms.

The evidence

There haven’t been clinical trials testing the safety or efficacy of this TikTok trend.

“This is basically an evidence-free zone,” says Leigh A. Frame, executive director of the Office of Integrative Medicine & Health at George Washington University. “There’s no evidence that it does or doesn’t work.”

However, experts who spoke to NPR for this story agree there’s a plausible biological mechanism for why Hansen and others may be finding benefit from this over-the-counter hack.

It has to do with histamine.

Histamine is a chemical your immune system releases when your body comes into contact with an allergen. It triggers an inflammatory response, which is why you feel crappy during an allergic reaction.

There’s some evidence to suggest that histamine also fluctuates with your menstrual cycle.

Estrogen, which stimulates the release of histamine, ebbs and flows throughout the month. And progesterone seems to act as a sort of natural antihistamine and in the days leading up to your period, progesterone takes a nose dive.

And in perimenopause, levels of both hormones rise and fall rapidly, often erratically.

These dramatic shifts can cause moodiness and discomfort, explains Dr. Mara Rivera, an Austin-based psychiatrist who specializes in the mental health challenges related to the menstrual cycle and reproductive health transitions.

Pepcid AC and allergy pills are both histamine blockers, and act on different receptors throughout the body. Though the relationship between hormones and histamine is not well understood, Rivera says the theory is these over-the-counter drugs may help keep histamine in check, essentially replacing progesterone’s effect.

Histamine also interacts with neurotransmitter systems, including serotonin and dopamine. Anecdotally, Rivera notes some of her patients report mental health benefits after taking antihistamines for other conditions, such as allergies.

In some ways, Rivera sees this trend as a modern-day example of how some old wives tales hold a pearl of truth.

“Women have been doing this forever, just talking to one another, and seeing what works,” she says.

It’s possible that people are experiencing some level of placebo effect, says Dr. Tami Rowen, a gynecologist at the University of California, San Francisco.

She notes that multiple studies show that patients benefit from the placebo effect, whether or not a medication works. That might be happening with these over-the-counter antihistamines, says Rowen, who agrees with Rivera that people are likely experiencing real relief.

She notes that currently the treatments for perimenopause and PMDD are limited.

“As an academic researcher myself, it would be lovely if there was a way to study this,” she said.

A Band-Aid, not a solution

There’s no clinical evidence that this over-the-counter hack works, says Frame, who worries that people who use Pepcid AC and allergy medicine to treat their symptoms aren’t getting to the bottom of why they’re sick. Histamine is associated with all sorts of health problems including hormonal fluctuations, poor sleep or thyroid issues.

“A healthy menstrual cycle should not be painful,” she says. “That’s a misrepresentation that we have been disserved by.”

The popularity of this online trend shows there’s a real need to improve research into women’s health, she adds.

The bottom line

There’s no data to support their use for PMDD or other medical conditionsPMS, but it might be reasonable to try these medications temporarily while waiting to connect with a specialist, says Frame. She warns that people should speak with their doctors before taking any new medications.

While Pepcid AC and allergy drugs are relatively low-risk, they are not risk-free. Antihistamines can cause drowsiness, fatigue, dry mouth, gastrointestinal symptoms, and adverse drug interactions, especially among older adults and those with kidney or liver issues.

This congregation wipes out medical debt together, putting politics aside : NPR

Kids from a local Scouting group helped the Rev. John Jackman celebrate at Trinity Moravian Church in Winston-Salem, North Carolina, as the church marked the end of its latest Debt Jubilee Project to buy up and retire medical debt.

Allison Lee Isley/KFF Health News

hide caption

toggle caption

Allison Lee Isley/KFF Health News

WINSTON-SALEM, N.C. — Some issues, like immigration or student loans, are too divisive to unite Trinity Moravian Church.

“We’ve got quite a spread of political beliefs,” says the Rev. John Jackman, who leads this 114-year-old red-brick church near Winston-Salem’s old textile mills. Conservative Republicans sit with liberal Democrats. Supporters of President Trump mix with his fierce critics. “It’s definitely a purple congregation,” Jackman says.

But four years ago, when Jackman suggested a new church mission to alleviate medical debt for residents of the wider Winston-Salem area, there was no dissent. “This is the easiest money I’ve ever raised,” he says. “All I do is tell people what we’re doing, and they write me a check.”

A matter of fairness

Few issues have been more politically explosive in recent years than healthcare, pitting Democrats and Republicans in bitter debates over the Affordable Care Act, Medicaid, and other flash points.

Yet moved by the sense that the medical debts their neighbors faced were deeply unfair, members of Trinity Moravian, no matter their politics, rushed to write $25 or $50 checks to pay off the bills. They helped advance a movement by churches across the state and the country, and they inspired North Carolina government officials to tackle medical debt. The effort drew plaudits from conservative radio host Glenn Beck.

The little church’s success also highlights a patch of common ground in American healthcare — the widespread frustration shared across the political spectrum that so many patients are ending up in debt.

Earlier this year, Trinity wrapped up its eighth medical debt campaign, part of what the church calls its Debt Jubilee Project. This one raised more than $17,000. That helped retire more than $2.2 million in debt. Medical debt can be bought for pennies on the dollar because creditors believe most debts won’t be paid.

Nationwide, an estimated 100 million adults have some form of healthcare debt. More than half of U.S. adults have had such debt at some point in their lives.

At Trinity Moravian Church, which has about 200 members, it wasn’t hard to find stories of crushing medical bills.

“I see people going into debt every minute of every day,” says Catherine Coe, who works in the accounting department of a hospital system. “We’re all just one medical bill from financial ruin.”

“I see people going into debt every minute of every day,” says Catherine Coe, a member of Trinity Moravian Church in Winston-Salem, North Carolina. Coe works in the accounting department of a large health system.

Allison Lee Isley/KFF Health News

hide caption

toggle caption

Allison Lee Isley/KFF Health News

Coe grew up coming to Trinity with her grandmother. She drifted away from the church as an adult before rejoining the congregation last year. Coe, who describes herself as a conservative, voted for Trump.

Terri Mabe, who’s been coming to Trinity for decades, is on the other side of the nation’s political divide. She says she can’t stand the president, who she says “had no real concern for the people of this country.”

Mabe, 70, has also seen medical debt up close. She used to work in the construction industry.

“In between projects you are a lot of times without a job,” she said. “Then you get sick. Next thing you know, you owe $5,000, $10,000 that you cannot pay. You’re barely paying your home bills. Then you’re like: ‘I can’t pay it. What do I do now?'”

Terri Mabe, a longtime member of Trinity Moravian Church , used to work in the construction industry and has seen the effects of medical debt on colleagues.

Allison Lee Isley/KFF Health News

hide caption

toggle caption

Allison Lee Isley/KFF Health News

Both Coe and Mabe say partisan differences don’t matter. “There isn’t a political divide when it comes to medical debt,” Coe says. “It all brings us together.”

Pandemic beginnings

Jackman says he got the idea to do something about medical debt during the pandemic, when growing numbers of people turned to the church for help.

“I was hearing about the reason they couldn’t pay their electric bill was because they’d had a few days in the hospital and then they got hit with this huge bill and it snowballed,” he recalls. “And I started hearing this again and again and again.”

Jackman learned about a nonprofit called Undue Medical Debt that buys unpaid medical bills from hospitals and debt collectors so the debts can be retired.

The church’s first campaign, in 2022, set a goal of raising $5,000 to retire about $500,000 in unpaid medical bills owed by residents of surrounding Forsyth County, N.C. The campaign hit its goal in just six weeks, fueled mostly by donations of less than $50.

Jackman, who’s been a pastor for more than four decades, attributed part of the success to an ethos of the church. “One of our ideas is that we cannot fix everything, but we have to fix what we can in the place where we’re planted,” he says.

The Rev. John Jackman says the church’s medical debt campaign has brought together people across the political spectrum. “This is the easiest money I’ve ever raised,” he says.

Allison Lee Isley/KFF Health News

hide caption

toggle caption

Allison Lee Isley/KFF Health News

Trinity members, no matter their political leanings, also say they see something broken in a system that pushes sick people into debt.

Paul Sluder, 78, who doesn’t identify with a political party, used to work for a credit union. He says he did a lot of debt collecting before he retired.

Most people, he says, wanted to pay what they owed. If they got sick, they often had no choice but to go into debt.

“You have kind of no control. You have to take care of yourself or your loved ones,” Sluder says. “It’s incredibly unfair, and I think the system’s out of whack.”

Paul Sluder is a former debt collector who says people shouldn’t end up in debt if they get sick. “The system’s out of whack,” he says.

Allison Lee Isley/KFF Health News

hide caption

toggle caption

Allison Lee Isley/KFF Health News

Polls suggest there’s a lot of common ground around medical debt.

In a 2025 survey for Undue Medical Debt, about 75% of Republicans and about 90% of Democrats said collection agencies shouldn’t be allowed to garnish patients’ wages to pay medical debt. And in recent years, bipartisan measures to expand protections from medical debt have passed in both blue and red states.

Coe, a Republican, says she would support even more limits on how much medical debt people could be forced to carry. “Why can’t we cap medical debt at a certain dollar amount, and after that it’s either written off or forgiven?” she asks.

After completing the most recent debt campaign, Trinity hosted a special ceremony, assisted by kids from a local Scouting group.

Jackman stood before the congregation and held up a piece of paper with a long list of names, people in the county whose debt had been bought and retired by the church.

“On this day of Jubilee,” Jackman announced, “we act to forgive the debts of many of our neighbors as God has forgiven our debts.”

As the congregation stood, Jackman flicked on a lighter and burned the list of 1,631 names, symbolically wiping out $2.2 million in debts. The paper was consumed by yellow flame. The scouts set off confetti poppers. The choir sang, and the congregation erupted in cheers.

The Rev. John Jackman burns a list of names of people in surrounding Forsyth County whose debt was purchased and retired by the church.

Allison Lee Isley/KFF Health News

hide caption

toggle caption

Allison Lee Isley/KFF Health News

Afterward, members went downstairs for a spaghetti lunch in the church basement, served by the scouts.

Beyond anger

Reflecting on the day’s festivities, many members of the congregation said they hoped their work on medical debt could inspire others to bridge political differences and work together.

“There’s just so much division, so much anger,” says Cynthia Tesh, 72.

“We need to look out for one another,” she says. “If we start looking out for one another, things will change. If we start considering other people and not just ourselves, things will change.”

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

If a Lyme disease vaccine gets approved, would hunters take it? : NPR

Matthew Mealer holds up his targets at the Busch Shooting Range in Weldon Spring, Missouri, in May. Mealer said he’s generally skeptical of new vaccines but might consider one for Lyme disease if it proves safe and effective.

Kyle Pyatt for KFF Health News

hide caption

toggle caption

Kyle Pyatt for KFF Health News

It’s tick season, possibly the worst in a decade.

More and more Americans are being exposed to these parasites as climate change expands the range where they can survive. That means more people are also exposed to the bevy of health conditions they can cause, such as Rocky Mountain spotted fever, the alpha-gal-triggered red meat allergy, and, most common of all, Lyme disease.

For the latter, there may be some additional protection on the horizon. Pharmaceutical companies Pfizer and Valneva announced this spring that they plan to seek regulatory approval for a vaccine to protect against Lyme disease. A previous vaccine for Lyme became available in the late 1990s but was pulled only three years later due to lawsuits, public fear of side effects, and a lack of interest.

It’s unclear whether this latest stab at a Lyme disease vaccine will get a warmer reception if it’s approved, especially in the post-COVID era of vaccine skepticism.

For a sense of how it might go over with rural populations at high risk of Lyme, KFF Health News spoke with a group of hunters.

Few people spend more time in the woods exposed to ticks. At the same time, as a collective, hunters  skew conservative, rural, and male, according to a survey from the Theodore Roosevelt Conservation Partnership. And these are identities associated with increased hesitancy about or resistance to vaccines, according to Ashley Kirzinger, associate director for Public Opinion and Survey Research at KFF, a health information nonprofit that includes KFF Health News.

For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.

Targets for ticks

Left untreated, Lyme can cause a variety of symptoms, from fevers, chills, and headaches to arthritis, shooting pains, and inflammation of the brain and spinal cord, according to the Centers for Disease Control and Prevention.

About 476,000 people in the U.S. may be diagnosed and treated for Lyme disease each year, the CDC says; that’s at least in part because the range of places where cases have been reported has “expanded significantly” since 1995.

So would hunters get the Lyme vaccine if it became available?

“Given my proclivity for the outdoors, absolutely,” said Jess Manganelli, one of seven hunters (and one hiker) who spoke with KFF Health News on a recent Saturday at the Busch Shooting Range in Weldon Spring, Missouri, just outside of St. Louis.

Of the eight, Manganelli, who had been hunting turkeys the weekend before, was the most positive about the vaccine. Six others said they would consider it but would want more information about its safety and effectiveness as well as their risk for contracting the disease.

But Manganelli was the only one who believed she may have previously contracted Lyme disease, although she was never formally diagnosed with it. Two years ago, she experienced muscle weakness, tiredness, fatigue, swelling, and headaches after a tick bite, but when she went to urgent care she was told they didn’t test for Lyme.

Nearly all the hunters knew someone who had had Lyme disease — an old roommate, a family member, friends, a former student. Lyme can be difficult to diagnose and to treat and is often misdiagnosed at first. Many of the hunters witnessed their acquaintances navigating those challenges and struggling with sometimes debilitating symptoms.

An illness with lingering effects

That familiarity among the hunters in Missouri was unsurprising to author and conservationist Steven Rinella, host of the hunting show MeatEater.

“I’m a turkey hunter. In talking about turkey hunting, you talk about ticks as much as you talk about turkeys,” Rinella said. “Just the nature of turkey hunting puts you into exposure. You’re sitting for long periods of time trying to use vegetation for concealment.”

In fact, both Rinella and his older son contracted Lyme disease 13 years ago during a bluegill fishing trip in the Hudson Valley in New York. His son developed Bell’s palsy, a sudden paralysis on one side of the face, but recovered quickly after a course of oral antibiotics. Steven Rinella’s symptoms, on the other hand, lingered for months, leaving him unable to walk down stairs without a handrail or to ride a bike. He ended up receiving intravenous antibiotic treatments for a month.

“I thought my life had changed,” Rinella said, “but I recovered, as far as I know.”

That experience is one reason Rinella said he would absolutely consider getting a Lyme vaccine if it proved safe and provided considerable protection against the disease. Unlike with some other diseases, prior infection does not provide permanent immunity, so a person who has had Lyme could still benefit from a vaccine.

Knowledge of similar challenges influenced the thinking of the hunters in Missouri as well.

Jeremy Hollingshead said he may be less inclined to take a vaccine owing to his former roommate’s experience with Lyme disease, which is not to say the experience was pleasant. In fact, Hollingshead said he thinks his old pal is still dealing with lingering effects of it 10 years later. But Hollingshead has spent his whole life in the woods, and of hundreds of people he knows who have done the same, he knows of only one of them contracting Lyme.

“I know it was a bad outcome for him,” Hollingshead said, but he thinks the odds of getting Lyme himself seem pretty slim.

Meanwhile, Julian Barnes said seeing a relative struggle with Lyme makes him more open to a potential vaccine. It took a long time for doctors to come to that diagnosis, and finding a good treatment has been equally difficult.

“I would say I am vaccine-hesitant, generally speaking,” Barnes said. “But Lyme, I’ve seen the way it affects people in my life.”

“I would definitely have to really understand the vaccine, how it works,” Barnes added.

An unclear path for a new vaccine

The new, four-dose vaccine candidate technically missed one of the bars set out in trials because not enough participants contracted Lyme. Still, the companies say it’s about 75% effective in reducing cases, and they plan to submit it to regulators for approval. A Pfizer spokesperson said there were no updates on their regulatory efforts when contacted by KFF Health News in June.

Health and Human Services Secretary Robert F. Kennedy Jr. was a noted anti-vaccine activist before taking over as head the agency that oversees vaccine approvals, and he’s remade it in ways that have prompted some vaccine makers to pull back on development.

But he’s also been an advocate on Lyme disease. In May, he announced an initiative to combat Lyme disease. And during his Senate confirmation hearings, he said his family had been deeply affected by Lyme disease and that nobody would work harder than he would to find a vaccine or treatment.

If the vaccine is ultimately approved by the FDA, an endorsement from Kennedy would go a long way, according to KFF’s Kirzinger, particularly among supporters of his Make America Healthy Again movement, who tend to be more vaccine-skeptical.

“They trust him as much as they trust their own doctors to tell them what to do with their health and for health information,” Kirzinger said. “If he comes out as a strong proponent of this vaccine and says, ‘Look what my administration did, and we made this available,’ I would imagine there would be less vaccine resistance among that group.”

Only one of the hunters who spoke with KFF Health News said they definitely would not be interested in a Lyme vaccine if it became available.

“I kind of hand it off to God and the body he gave me. I’m pretty durable,” JP Cummings said. But even though he’s not interested in it for himself, he’s curious to see what his fellow hunters do as more information comes out.

“Hunters care about the wildlife; hunters care about health,” Cummings said. “They love the wildlife, they love their deer, and they love their fellow hunters.”

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF.

5 million people dropped ACA health insurance after the GOP let prices rise : NPR

The federal government released data on how many people dropped coverage in the 29 states that use the Healthcare.gov marketplace for ACA insurance.

Patrick Sison/AP

hide caption

toggle caption

Patrick Sison/AP

Stay up to date with our Up First newsletter, sent every weekday morning.

Far more people than previously known have dropped Affordable Care Act health insurance for 2026, according to data released Friday.

Five million people who had signed up for health coverage from the ACA marketplaces for 2026 either disenrolled or failed to pay their premiums and therefore dropped coverage. Prices in the market skyrocketed after President Trump and Republicans in Congress failed to extend extra financial help for enrollees last year. The Department of Health and Human Services published a report about the data on its website Friday.

The 5 million reflects what insurers, administrators, and other health policy experts expected earlier this year. After initial sign ups showed that 1 million fewer people picked a plan this year compared to the year before, they predicted that the picture would get worse as time went on and people found they could not afford to pay their premiums.

“The main takeaway is that enrollment is down 13% from last year,” explains Cynthia Cox, director of KFF’s Program on the ACA. “While the Trump administration attributes this drop in enrollment to their attempts to address fraud, this coverage loss happened at the same time millions of people faced double or even triple digit increases in their premium payments with the expiration of enhanced tax credits.”

The idea that the growth in enrollment was due to massive fraud is a theory advanced by the Paragon Health Institute, a conservative think tank that’s influential in the Trump administration.

Many health policy experts are skeptical. They say the increase in enrollment during the pandemic is not suspicious. It was a predictable consequence of Congress’s investment of billions of federal dollars in making premiums more affordable — the enhanced premium tax credits.

“The marketplace doubled in size during the period when there were enhanced subsidies because the coverage was much more affordable and much more appealing to people,” adds Cox.

This year’s drop in enrollment is also predictable, given that premium costs doubled, on average, from 2025 to 2026. The costs went up after Republican lawmakers let the enhanced premium tax credits expire; Democrats shut down the government in October 2025 trying to negotiate an extension of the credits that would have kept prices low.

“When their costs went up, many of them dropped their coverage,” Cox says.

She adds that while fraud is a real problem in the ACA marketplaces, as it is in all insurance markets, she thinks it does not add up to 5 million fewer enrollees.

Stacey Pogue, senior research fellow at the Georgetown Center on Health Insurance Reforms, agrees.

“I don’t see data that point to that conclusion that a 5 million person drop can be explained by allegations of fraud,” she says. “There’s lots of evidence pointing to people making decisions based on what they can pay each month.”

The higher health insurance costs are tough for consumers in an economy still plagued by overall inflation. As congress let the prices go up, people made tough decisions about family budgets, where to work, whom to marry and more.

It’s also a problem for insurance companies, several of which have announced they will not be participating in ACA markets next year, including Cigna.

“If there are fewer customers, then that makes the market less appealing to insurance companies,” Cox says.

That’s especially true because the people dropping their coverage tend to be healthier people. If too many healthy people drop out of the markets, there’s a danger that the markets could enter a “death spiral.”

Cox says she’s not worried about a death spiral at this point.

“I think there are still enough people buying ACA marketplace coverage and that’s going to keep these markets working,” she says. “At this point, we don’t see any parts of the country that are at risk of having no insurance company. If that were to happen, that would be what a death spiral might look like.”

Even so, the premiums for these plans are on track to keep rising, which could continue to pummel consumers navigating high health care costs. Enrollment in the marketplaces may continue to shrink, too. According to a recent analysis from Pogue at Georgetown, early insurance rate filings for 2027 show that rates will be going up again next year.

U.S. pledges generous earthquake relief to Venezuela : NPR

A man carries a mattress past damaged residential buildings in Catia La Mar, about 18 miles northwest of Caracas. Twin earthquakes on June 25 have killed at least 164 people and destroyed multiple buildings near the capital. The U.S. has pledge a substantial amount of aid to address the aftermath of the disaster.

Federico Parra/AFP/via Getty Images

hide caption

toggle caption

Federico Parra/AFP/via Getty Images

The U.S. has announced what appears to be one of its strongest responses to a natural disaster since the dismantling of its premier aid agency, USAID.

Speaking to the press during his trip to the Gulf, Secretary of State Marco Rubio promised: “We have a whole-of-government response. It’ll be big; it’ll be fast; and it’ll be effective.”

The U.S. effort includes a commitment to allocate $150 million to faith-based aid groups like Samaritan’s Purse and Catholic Relief Services, and two United Nations agencies: the World Food Programme and the Office for the Coordination of Humanitarian Affairs.

In addition, the U.S. is deploying a Disaster Assistant Response Team and two search and rescue teams from Virginia and California to help with locating survivors. The Virginia team will include 80 people and 6 dogs. The California team includes 70 people and 6 dogs.

The administration has also tapped the Pentagon to help with getting U,S. government staff and critical supplies into the country, as some of the airport infrastructure in Venezuela has been damaged.

A notable shift

The Venezuela response represents a significant shift from the Trump administration response to the earthquake in Myanmar in March of 2025, which killed over 3,500 people: $9 million and three people to assess the damage but no search-and-rescue team. By contrast, China sent $137 million in aid to Myanmar.

“This clearly reflects some lessons that [the administration] learned after the failure to deploy a search and rescue team to Myanmar,” says Jeremy Konyndyk, president of Refugees International and head of USAID’s disaster response during the Obama administration. He told NPR: “There was definitely a period last year when they had lost the capability to deploy a search and rescue team in the DOGE destruction of USAID. It was very visible and very embarrassing.”

Since then, the State Department has quietly hired back some of USAID’s humanitarian response staff and also reinstated some of the contracts with groups that provide assistance in disasters, including search and rescue teams.

Still, Konyndyk says this moment will be a test for this administration and its abilities to match the work of USAID, both in terms of how quickly it can get teams on the ground and the longer-term response. USAID made major commitments to disaster recovery efforts after the 3-to-4 day period of rescue operations in the wake of the catastrophe.

“The administration clearly wants to avoid a black eye of not deploying a robust immediate response, but whether they will sustain the kind of follow through that can save lives in the months that follow, I think that’s an open question,” he says.

“I would want to see deployment of emergency medical teams to stabilize the health system after an earthquake like this. I would want to see investments in restoring water infrastructure and other basic infrastructure that’s been damaged. So, I think that’s something that will be very important to watch over the next few months,” Konyndyk says.

What’s needed

And there’s a lot of work ahead. The damage in Venezuela is “very, very severe,” according to Cesar Jimenez, a Venezuelan national who is managing the response for the aid group Project Hope in Venezuela, with a focus on supporting local health systems.

Jimenez and his team visited two healthcare facilities in La Guaira, which was in the epicenter of the second earthquake.

“And they’re totally collapsed. We saw people laying in the ground with no beds, being assessed by health staff. We saw like 200 people in one tiny healthcare facility seeking help,” he says.

“We are doing our best as Venezuelans to support our people. This is a unique moment in our history, because we were not prepared for this. Nobody saw this coming, and we need a lot of support,” Jimenez says, adding that the chaos in the wake of the quakes –- the most powerful the country has seen since 1900 – has endangered lives.

Jimenez says local authorities and aid groups should also develop measures to prevent injuries and death if there are additional earthquakes.

That was a priority for USAID. After the earthquakes in Nepal in 2015 and in Turkey and Syria in 2023, their staff advised local authorities on safe building codes and preparing and placing response and extraction kits.

“The most lifesaving thing that can be done in an earthquake scenario is the work that is done beforehand not the work that is done after live rescues,” Konyndyk says.

“I do hope that the administration will invest in that work in Venezuela on the back end of this earthquake, as the U.S. did through USAID and many other countries over the years.”

NPR has reached out to the State Department for more details on the U.S. response in Venezuela.

what would the U.S. Preventive Services Task Force recommend?

It has now been 15 months since the U.S. Preventive Services Task Force (USPSTF) last met. In the interim, several members’ 4-year terms expired, and HHS Secretary RFK Jr. fired the two remaining Vice Chairs, leaving the USPSTF leaderless and without a voting quorum. Although much of the work of the Task Force occurs on conference calls in between scheduled meetings, no new recommendations can be debated or finalized in the current situation. Even if new members with appropriate qualifications are eventually appointed, the future of the USPSTF remains uncertain. So when a new study suggests that a screening test could be beneficial, clinicians and medical groups can only make their best guess about what the USPSTF might recommend based on the evidence.

Unlike prediabetes and type 2 diabetes, the USPSTF has never evaluated screening for type 1 diabetes in the general population. There are two major rationales for screening. First, a large percentage of persons are not diagnosed until they develop symptoms of diabetic ketoacidosis (DKA), a life-threatening situation that invariably requires hospitalization and frequently a stay in the intensive care unit. Second, a therapy exists that delays the onset of the disease in children determined to be high risk. Although the Centers for Disease Control and Prevention and expert groups recommend screening relatives of persons with type 1 diabetes with autoantibody tests, the vast majority of persons who are diagnosed have no family history.

The ideal type of study to establish the benefits and harms of screening for type 1 diabetes would be a randomized trial where participants were randomly assigned to screening or control groups and followed for important clinical outcomes such as DKA, diabetes complications, and mortality. But type 1 diabetes is not nearly as common as type 2, and thousands of participants would need to be followed for years to detect a statistically significant difference in outcomes. This large-scale study would require an investment of money and resources that no private or public funder has thus far been willing to support.

Instead, individual screening programs have been implemented in various locations around the world. Some are focusing on screening relatives of persons with type 1 diabetes, while others are screening the general population in primary care settings. One of the latter programs in Germany was established in 2015 and recently reported 10-year outcomes in a paper in JAMA. Out of more than 220,000 children screened, 590 (0.3%) had autoantibodies but no clinical symptoms. After 5 years, 36% of those with positive screens had progressed to clinical type 1 diabetes, representing 81% of all children who ultimately received this diagnosis. Of note, the progression rate was similar in children with and without a first-degree relative with type 1 diabetes.

Without a comparison group, we don’t know how these children would have fared in the absence of screening. Did some of them avoid a traumatic hospitalization for DKA or receive therapy that gave them a few more years without clinical symptoms? Conversely, did they or their loved ones experience negative psychological effects from being a given an early diagnosis, particularly the 64% who had not progressed to clinical diabetes after 5 years? The researchers don’t say. My guess is that the USPSTF would have deemed this study to be insufficient evidence to assess the balance of benefits and harms of screening all children for type 1 diabetes. Absent a formal evidence assessment, though, I suspect that many well-intentioned experts will push prematurely for screening to take place anyway – which is why the Task Force needs to be restored and reconvened without further delay.

Supreme Court backs Monsanto in fight over popular weed killer : NPR

“The People vs the Poison” protesters gather at the U.S. Supreme Court on April 27, 2026 ahead of arguments in the case.

Tasos Katopodis/Getty Images

hide caption

toggle caption

Tasos Katopodis/Getty Images

The Supreme Court agreed to shield Monsanto from liability over its popular weed killer Roundup, dealing a victory to the company’s new owner as it struggles to resolve thousands of costly lawsuits from people who claim the key ingredient caused their cancers.

The central issue in the case, filed by Missouri resident John Durnell, is who decides what should appear on a pesticide or insecticide label—and whether a federal law overrides state claims.

The Justice wrote in a 7-2 opinion written by Justice Brett Kavanaugh that the Federal Insecticide, Fungicide, and Rodenticide Act, or FIFRA expressly preempts state law and Monsanto’s failure to warn consumers about the dangers of glyphosate.

Justice Ketanji Brown Jackson filed a dissenting opinion, in which Justice Neil Gorsuch joined.

Monsanto, now owned by Bayer, argued a federal law gives the power to set the label to the U.S. Environmental Protection Agency, not to the states. The company’s lawyer, former Solicitor General Paul Clement, told the Supreme Court there’s a need for a single, uniform standard and that the Federal Insecticide, Fungicide, and Rodenticide Act puts the EPA in charge.

“You shouldn’t let a single Missouri jury second-guess that judgment,” Clement said during oral argument in April.

The current U.S. Solicitor General, John Sauer, sided with Monsanto — as did the majority of the Supreme Court justices.

“Because Durnell’s state tort claim would impose a pesticide labeling requirement ‘in addition to or different from’ the label required by EPA, FIFRA expressly preempts Durnell’s claim,” Kavanaugh wrote in the court’s majority opinion.

Experts said a ruling for the company could significantly narrow its liability in tens of thousands of cases moving slowly through the courts.

But a lawyer for Durnell argued there’s room for state juries to weigh in on Monsanto’s alleged failure to warn consumers of the dangers of glyphosate, the central chemical in Roundup.

Ashley Keller told the justices that Congress has been debating a golden shield for the company as part of the farm bill. But until Congress acts, Keller said, state juries could and should still be able to evaluate such cases.

Jackson, in her dissent, agreed, and said the majority misunderstood FIFRA’s requirements, saying adding a cancer warning doesn’t conflict with the law.

“In accepting Monsanto’s argument and holding that Durnell’s failure-to-warn claim is preempted, the Court misunderstands FIFRA’s requirements, misinterprets the scope of FIFRA’s preemption, and ultimately leaves Durnell without a remedy for the significant harms he has suffered,” she wrote.

Scores of protesters appeared in front of the Supreme Court in late April to support people who say they were harmed by the weed killer and other chemicals, in allegiance with the Make America Healthy Again movement.

President Trump has signed an executive order to boost domestic production of glyphosate, which has contributed to a rupture between the White House and some MAHA supporters.

Should you have a baby? 4 exercises to help you decide : NPR

To get on the same page about whether or not to start a family, psychotherapist Merle Bombardieri says to aim for 80% certainty — and do your best to compromise. But take note: “people never have a child to please their partner,” she says.

iStockphoto

hide caption

toggle caption

iStockphoto

So your partner wants to have a baby. You want to be child-free. How do you get on the same page about whether or not to start a family?

Over the past 50 years, Merle Bombardieri, a psychotherapist and author of The Baby Decision, has been helping couples with this exact conundrum. She says this is one of the most common questions she gets.

For many couples, there is a middle ground, so long as you’re able to stay open to different possibilities, Bombardieri says.

“A lot of times, people can actually find a solution that will work for both of them,” she says.

Bombardieri shares advice and exercises to help couples navigate the divide and find compromise — while minimizing regret in the process.

Aim for 80% certainty

Bombardieri says couples will often seek her help because they want to feel 100% certain about their decision. But for the vast majority of people, that’s just not realistic.

“Most people are never going to feel totally sure because they’re aware of what they’re going to miss from the other side,” Bombardieri says. So being 80% sure is “as solid as it gets.”

If you feel some ambivalence about being a parent or being child-free, that’s OK. It’s a common emotion when both paths carry risks and rewards, Bombardieri says.

Remember that either decision might lead to some regret, she says. So don’t ask if you will regret your decision. Ask, which decision you will regret least?

“When people think they have to make the perfect choice, they paint themselves into a corner,” Bombardieri says.

(For more help making hard decisions, read our interview with decision coach Nell Wulfhart.)  

Sit with your own feelings first — literally

Bombardieri advises those on the fence about parenthood to try an exercise called the “chair dialogue.” It can deepen both parties’ understanding of what it means to have a baby or be child-free.

ImaZinS RF

hide caption

toggle caption

ImaZinS RF

One way to help couples get closer to certainty is a solo exercise called the “chair dialogue.” Bombardieri says it can often lead to surprising self-discovery, and help couples gain a deeper understanding of each other’s true motivations.

Here’s how it works:

First, block out some time alone in a quiet space. Grab two chairs and face them toward each other. One chair will be the “parenthood” chair and the other will be the “child-free” chair.

Then, sit in each chair one at a time and make your best argument as to why you should be a parent or child-free. “Physically have a conversation with yourself,” she says.

For example, in the parent chair, you might say, “Of course I’m going to have a baby, I’ve wanted this my whole life.”

In the child-free chair, you might say, “I’m absolutely terrified of pregnancy.”

Pay attention to your body language, Bombardieri says. Maybe in one chair, “you feel more alert, animated.” Or you might find that one side is angry, and the other pleading.

Once you and your partner have each done this exercise, come back together and discuss what came up. Hopefully, you’ll be able to speak with more clarity about your personal leanings.

Rate your decision on a scale from 0-10

Get a sense of how strongly you each feel about your decision. On a scale of 0-10, where do you each fall?

“If you absolutely know that you would never have a child, you would be the zero. This is no criticism of child-free. It’s because you want zero children,” Bombardieri says.

“Ten is, ‘I was put on the Earth to have a child, and I will have to divorce my partner if they say no,'” she adds.

Take note as you go through this process: “If someone is certain that they want to be child-free, they should never have a child to please their partner,” she says. “Whether it’s going to be a divorce or an unhappy family, that just does not work out.”

Get creative with compromise

If you have a partner who’s falling on the opposite side of the spectrum, don’t panic. The baby decision might not be as black-and-white, all-or-nothing as you think it is, says Bombardieri.

Try to find a compromise by doing some brainstorming and problem-solving. What could you each do to make your choice more attractive to your partner?

Bombardieri shares three scenarios and how she would address them:

  • Your partner wants three kids, you want none. Could you consider having one child? It’s “an excellent solution for many couples and also single people who want the pleasure of a child but don’t want to be overwhelmed,” says Bombardieri.
  • Your partner is leaning child-free because they want to see the world. “Name some countries you want to go to,” says Bombardieri. Then, make a list and set a timeline. Could you travel to those places, and then start a family in a few years? Could you plan to set aside a long weekend every year for solo travel?
  • You’re sure you don’t want to be a parent, but your wife is great with kids and worries she would be missing out.  If your wife is willing to sacrifice her desire to start a family, help her find other ways to nurture her love of children, Bombardieri says. Maybe that’s committing to dedicated time with nieces and nephews or joining youth mentorship programs. 

Not every situation will have a happy middle medium — and that’s OK, says Bombardieri. Sometimes the best decision will be to part ways. “Some people do break up — and that can be the answer.”

No matter what you decide, what’s crucial to success in this process is that both parties feel their needs have been heard and accounted for, Bombardieri says.

If you do end up agreeing to your partner’s choice, “you need to know that they have bent over backward to figure out a way that it could work” to avoid future resentment, she says.

The story was edited by Malaka Gharib. The visual editor is CJ Riculan. We’d love to hear from you. Leave us a voicemail at 202-216-9823, or email us at LifeKit@npr.org.

Listen to Life Kit on Apple Podcasts and Spotify, and sign up for our newsletter. Follow us on Instagram: @nprlifekit.

How abortion in America has changed since the Dobbs decision : NPR

Abortion opponents demonstrate outside the Supreme Court in Washington on June 24, 2022 the day the court decided Dobbs v. Jackson Women’s Health Organization

Jacquelyn Martin/AP

hide caption

toggle caption

Jacquelyn Martin/AP

Stay up to date with our Politics newsletter, sent weekly.

It’s been four years since the Supreme Court overturned Roe v. Wade, ending the constitutional right to abortion.

Roe was egregiously wrong from the start,” Justice Samuel Alito wrote in the Dobbs v. Jackson Women’s Health majority opinion on June 24, 2022. “And far from bringing about a national settlement of the abortion issue, Roe and [Planned Parenthood v.] Casey have enflamed debate and deepened division.”

Reversing Roe didn’t calm debate or heal division. A confusing patchwork of state laws began to take shape hours after the Supreme Court ruled — which was, perhaps, predictable. States had passed “trigger laws,” ready to restrict abortion as soon as the high court allowed.

But other developments have been surprising, including the role of the internet and the mail in increasing access to abortion, even in those very same states. This year, voters will again consider ballot measures to protect or restrict abortion access across the country. Dramatic stories of medical care denied to pregnant patients continue to unfold across the country.

Here are four things to know about the state of abortion access in America today.

1. The number of abortions continues to rise

You might have guessed that when more than a dozen states banned abortion, there would be fewer abortions happening in those states and that the overall number of abortions would go down.

That’s not what has happened. The number of abortions nationally has increased each year since the national right to abortion was overturned.

Part of the reason is that access has become easier in states that support abortion. Policy changes have allowed more residents of those states to have abortion access without barriers like waiting periods or parental permission requirements. These lowered barriers have helped people who live in restrictive states to travel for care.

“Shield laws” have also emerged as a major force in the abortion access landscape. States that support abortion access have created legal shields to allow clinicians to provide abortion to residents in states with bans, even without patients traveling. Clinicians can prescribe medication abortion via telemedicine — online or over the phone. Pills can then be mailed or picked up at local pharmacies.

That’s led to the surprising fact that the number of abortions in states with bans have actually increased in recent years, as telemedicine abortion has grown. And this has not escaped Justice Alito’s notice.

“What is at stake is the perpetration of a scheme to undermine our decision in Dobbs,” Alito wrote in a recent dissent related to abortion pills, “which restored the right of each state to decide how to regulate abortions within its borders.”

2. Anti-abortion politics have gotten complicated

President Trump is pulled in two directions on the issue of abortion. His appointees to the Supreme Court overturned Roe vs. Wade, a huge victory for conservatives, but he and his administration have become notably quiet on the issue in this midterm year. Why? The coalition that elected Trump in 2024 included independent voters, who support abortion rights.

Meanwhile, anti-abortion politicians and activists want to see more action to restrict abortion, like reviving the Comstock Act. That’s the 19th century law that says you can’t use the mail to send “obscene” materials including pornograpy and “every article or thing designed, adapted, or intended for producing abortion.” If enforced, it could create a de facto national abortion ban without requiring Congress to pass a new law.

Last month, Justice Clarence Thomas asserted in his dissent to the abortion pill case that the Comstock Act was in force and that drug companies manufacturing and distributing FDA approved medications were therefore engaged in a “criminal enterprise.”

And states are also actively pursuing more restrictions, including bills that would charge women who get abortions with homicide. Texas passed a law that allows private citizens to sue out-of-state prescribers of abortion pills for $100,000. Louisiana scheduled mifepristone and misoprostol, the two medications used for abortion, as controlled substances.

Louisiana also is suing the Food and Drug Administration, aiming to force the agency to roll back the rules change that allowed telemedicine access to mifepristone. That case is likely headed for the Supreme Court. If the justices decide the case in Louisiana’s favor then mifepristone would no longer be available via telemedicine nationally. Other lawsuits against mifepristone are also pending.

3. Supporters say abortion pills are “unstoppable”

Abortion rights advocates are pushing beyond the status quo, too. Researchers at University of California San Francisco recently published a study examining the feasibility of making abortion medication available over-the-counter in the U.S., no doctor’s appointment or prescription needed. A Planned Parenthood affiliate started offering abortion medication to patients who aren’t pregnant, to keep at home in case they need it. And telemedicine abortion providers have contingency plans to be able to continue sending misoprostol alone through the mail even if access to mifepristone is restricted.

The post-Roe era has seen some closures of brick-and-mortar reproductive clinics that offer abortion, in part because Republicans in Congress withheld millions of dollars for Planned Parenthood and other organizations that provide abortion in 2025. Efforts to maintain access to in-person abortion care include training more primary care physicians to offer abortion, and turning to health facilities like urgent care clinics to fill in gaps.

In the meantime, the use of medication abortion continues to grow. “Abortion pills are everywhere, they’re safe, they’re effective, and they’re pretty much unstoppable,” Elisa Wells of Plan C, a website about medication abortion, told NPR last month. “The genie is out of the bottle.”

4. Privacy and stigma around abortion are evolving rapidly

Abortion was legal for nearly 50 years under a right to privacy based in the constitution. In the first trimester, according to the majority opinion in Roe, “the abortion decision and its effectuation must be left to the medical judgment of the pregnant woman’s attending physician.”

Ironically, since that right has been revoked, women can have abortions in far more privacy than was possible under Roe. Patients can fill out an online form and have abortion pills delivered to their homes, avoiding protesters that still gather outside some reproductive health clinics. At the same time, people embrace talking freely about the experience, eschewing shame, with hashtags like #ShoutYourAbortion.

Some women who have shared their own painful stories about being denied medically necessary abortion and miscarriage care have become public figures. Samantha Casiano, whose story was first reported by NPR, was pregnant for months knowing that her baby wasn’t going to survive, and went on to testify in court and be featured in a documentary about the consequences of Texas’ abortion ban.

As more and more people have shared their stories, that’s had a snowball effect — it empowers more people to speak out. Kate Cox appealed to the Texas Supreme Court for access to abortion while pregnant. Her picture was in the news as she was living through a pregnancy complication and seeking help. In the end, Texas denied her request, and she traveled out of state for an abortion.

Still, the increasingly online experience of seeking abortion also opens up new privacy issues. Just months after the Dobbs decision, police in Nebraska used Facebook messages to bring felony charges in a successful case against a woman who gave her teenage daughter abortion pills. And many Americans track their periods in apps that have raised concerns among privacy experts.

Inside the town where the Ebola outbreak likely started : NPR

Women sift gold-bearing sediment in search of gold at the Maidede mine in the Democratic Republic of Congo’s Ituri province on June 16.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

MONGBWALU, Democratic Republic of Congo Joseph Mute witnessed a string of mysterious deaths in Mongbwalu long before the Congolese government declared an Ebola outbreak.

A neighborhood leader in the town, Mute said that the characteristic feature of these deaths was the presence of blood.

“They had blood in the nose, blood in the mouth,” he said, standing on an unpaved road in the Shuni neighborhood.

A gold-mining town of about 130,000 people located in Ituri province, Mongbwalu is one of the epicenters of eastern Congo’s Ebola outbreak. The outbreak is believed to have started here, according to the World Health Organization, but this has yet to be fully confirmed.

From Mongbwalu, Ebola likely spread across Ituri, including to its capital, Bunia, a city of more than 1 million. Confirmed cases have also appeared in the Congolese provinces of North Kivu and South Kivu, as well as in Uganda, which shares a long border with Ituri.

A cemetery in Mongbwalu, in Ituri province, in eastern Democratic Republic of Congo. The gold-mining town is one of the hot spots of Congo’s Ebola outbreak. Frequent burials have become part of daily life as the virus continues to spread and take lives.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

At first, it wasn’t clear what was causing the deaths. Mongbwalu’s population is made up largely of poor gold panners, and diseases are common among this marginalized group. Some, Mute said, suggested that the spreading sickness was tuberculosis, AIDS or even mercury poisoning — from the chemical that miners use to extract gold from ore.

Others offered a supernatural explanation, which gained wide belief.

A woman carrying a funeral cross rides on a motorcycle taxi through Bunia, the capital of Ituri province, in the Democratic Republic of Congo, on June 18. Funeral processions and other signs of mourning have become increasingly common as eastern Congo battles an Ebola outbreak.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

“Flames of the coffin”

In February, mourners traveled from Bunia to Mongbwalu in a car, carrying a coffin that was damaged en route.

Family members of the deceased decided to get a new coffin when they got to Mongbwalu. They burned the old one in the Shuni neighborhood, violating a traditional taboo. Soon after, residents of Shuni began to sicken and die, giving rise to rumors of a cursed coffin.

“People said it was the flames of the coffin spreading through the neighborhood,” said Mute, referring to the then-unidentified disease. “But that’s not true.”

Congo’s government eventually identified the illness as Ebola, but only after a significant delay.

A view of the morgue at the Ebola treatment center of the Evangelical Medical Center in Bunia on June 18, as staff prepare the body of a person who died from Ebola. The facility is part of the region’s response to the outbreak spreading through eastern Congo.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

The first-known suspected case was of a nurse who developed fever and vomiting on April 24, according to the country’s health ministry. The nurse died in Bunia but was buried in Mongbwalu.

Both fever and vomiting are hallmark symptoms of Ebola. Bleeding, though less common, is also a symptom of severe infection.

In early May, four health workers in Mongbwalu died within four days, sparking more alarm. But testing for Ebola at Congo’s National Institute for Biomedical Research initially came up negative because scientists screened for the Zaire and Sudan species of the virus.

On May 15, the government at last declared an outbreak, after genomic sequencing confirmed that the rarer Bundibugyo species of the virus was circulating. By that point, more than 50 people had already died in the Shuni neighborhood, Mute said.

“It hurts me,” he said, pointing out houses in the neighborhood that now lie empty because the former occupants had died or fled.

Serge Ugena of Mongbwalu lost his wife and five family members to Ebola as the outbreak swept through the Shuni neighborhood, one of the hardest-hit areas of the town.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

Gold mining is a factor in the spread

Ebola infections are still spreading widely in Mongbwalu over one month after the outbreak was declared. The town and surrounding area have 220 out of the 1,003 confirmed cases in the country as of June 20, according to the health ministry.

However, aid workers believe that the official numbers vastly understate the scale of the crisis. Many people avoid seeking medical care if they get ill. Superstition and fear run deep. Testing delays have also meant that some probable Ebola victims died without being confirmed as having the disease.

A view of the Shuni neighborhood in Mongbwalu. The neighborhood is one of the epicenters of the Ebola outbreak in eastern Congo. Death tolls here are among the town’s highest.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

In some parts of Mongbwalu, locals have fiercely resisted health responders too. Rumors are rife: Some believe that aid groups are spreading the disease to enrich themselves.

Funerals are also a flash point. This month, police in the town fired warning shots and tear gas to try to disperse a crowd that had come to seize a coffin of a suspected Ebola victim. Many families still wish to bury their dead themselves, despite the risks.

The rapid spread of Ebola over a large range reflects the nature of gold mining, the bedrock of Mongbwalu’s economy. Muddy pits filled with miners surround the town. They work closely, digging, pumping water through sluices and sifting for gold ore. The miners, who come from across eastern Congo, are highly mobile — yet another reason that Ebola has proliferated so quickly.

Women sift gold-bearing sediments at the Maidede mine in Mongbwalu on June 16. Gold mining drives the local economy and draws a highly mobile workforce, a factor that health officials say has complicated efforts to contain the Ebola outbreak.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

A portrait of Léon Gina at the Maidede mine, which is an artisanal gold-mining site. The mine is part of the informal gold economy that continues to draw workers to the area amid the Ebola outbreak.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

Bisimwa Biragi, from South Kivu province, about 300 miles south, said that he had arrived in Mongbwalu after being displaced by the conflict with M23 rebels, who are backed by Rwanda.

“We’re scared,” he said, with a team of two others, washing ore sediment with mercury in a plastic tub. “Lots of people are dying.”

Eastern Congo has been devastated by decades of armed conflict, leading to repeated waves of mass displacement, with more than 900,000 people living in displacement camps in Ituri alone.

“The virus is real”

There were no visible health measures in the gold pits: no protective equipment, sanitation controls or medical oversight. Around town, hand-washing stations are also rare.

Only 20% of Mongbwalu residents have access to safe water, according to Oxfam, and a quarter lack access to toilets or hygiene facilities.

The town’s hospital hums with constant activity, marking the scale of the outbreak in the town. Doctors Without Borders has established an Ebola treatment center here. Ambulances arrive regularly with suspected Ebola patients, as disinfection teams spray down each vehicle.

Coffins are a common sight here — as are mourners, who weep over deceased loved ones in the hospital’s courtyard.

The Mongbwalu General Referral Hospital is a key site in efforts to contain the Ebola outbreak in eastern Congo.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

But despite a perception that Ebola is a death sentence, some people survive.

On June 16, the hospital’s bookkeeper — who had contracted Ebola — was discharged at the same time as a 3-year-old girl. Hospital staff lined up to sing and dance, celebrating their good fortune, as the pair looked on in a daze.

Healthcare workers celebrate the recovery and discharge of Ebola survivor Florence Mangembo, in blue jeans, at the Mongbwalu General Referral Hospital. She is the hospital’s bookkeeper.

Arsène Mpiana for NPR

hide caption

toggle caption

Arsène Mpiana for NPR

“I don’t recognize myself,” said Florence Mangembo, the bookkeeper, afterward. “I feel stressed.” She contracted Ebola, she said, after helping her sister, whom she’d found collapsed and vomiting in a field. Mangembo persuaded her family to call an ambulance, but her sister died in the hospital two days later. Relatives then blamed Mangembo for the death, accusing her of provoking it by insisting her sister go to the hospital — reflecting continued confusion surrounding Ebola in Mongbwalu.

“The virus is real,” Mangembo said. “Luckily, I emerged victorious.”

Crisis pregnancy centers questioned about ectopic pregnancy tactic : NPR

A billboard in South Bend, Indiana, advertises a crisis pregnancy center in 2021. The centers can look like medical clinics, but they rarely have medical staff working there.

Taylor Glascock for The Washington Post/Getty Images

hide caption

toggle caption

Taylor Glascock for The Washington Post/Getty Images

On Mother’s Day, the Trump administration launched the website Moms.gov, which directs “expecting parents who are navigating difficult or unexpected pregnancies” to crisis pregnancy centers around the country.

“Many centers offer pregnancy tests, ultrasounds, STD/STI testing and treatment, parenting support, childbirth classes, medical referrals, and material goods like clothes and diapers — at no cost to you,” Moms.gov explains.

There are thousands of crisis pregnancy centers across the country — around 2,500 according to a 2024 estimate from the Government Accountability Office. Many are Christian organizations; all try to keep people from having abortions. Staff are often volunteers who may or may not have medical training, and some wear scrubs or white coats and have clients fill out medical questionnaires.

Many also offer free ultrasounds and tout the benefits of the test.

“It’s important to rule out an ectopic pregnancy or a natural miscarriage and find out how far along you are via limited ultrasound,” reads the website of MyChoice Pregnancy Care Center in New York’s Hudson Valley. “Contact us for a free ultrasound.”

Ectopic pregnancy is a rare complication that happens when an embryo implants outside of the uterus. If it implants in a fallopian tube, the tube can rupture, which can be life threatening.

The problem is that a single ultrasound can’t determine whether a pregnancy is ectopic.

Watchdog calls for an investigation

This week, Campaign for Accountability, a nonprofit watchdog organization, sent a letter to New York Attorney General Leticia James requesting that her office investigate whether crisis pregnancy centers in New York are fraudulently advertising to women about their ability to diagnose ectopic pregnancies.

“By leading patients to believe that their services are adequate substitutes for medical diagnoses, [crisis pregnancy centers] may cause women to forgo comprehensive medical care, resulting in their suffering grievous bodily injury,” reads the letter, shared exclusively with NPR.

The organization found 100 examples in 49 states of pregnancy centers using language on their websites about how they can “rule out” ectopic pregnancies.

The harm is not hypothetical. The letter cites cases in Texas and Massachusetts, where women in those states went to pregnancy centers that missed ectopic pregnancies.

“They were told that their pregnancies were viable or told that everything was fine,” explains Michelle Kuppersmith, executive director of Campaign for Accountability. “And then later they found themselves in the hospital with an ectopic pregnancy that was not diagnosed by the crisis pregnancy center.”

Kuppersmith says they may send more letters to attorneys general in other states. “We’re hoping that by continuing to expose this issue, that there will be additional attention to it, and that perhaps these centers will do the right thing and stop trying to make claims to women about things that they can’t actually do.”

“We really don’t like to see that language”

A membership organization of crisis pregnancy centers — the National Institute of Family and Life Advocates, or NIFLA — agrees that the centers shouldn’t be promising to “rule out” ectopic pregnancies.

“Do not advertise, ‘We can rule out an ectopic,'” advised NIFLA’s Vice President of Legal Affairs Anne O’Connor last year in a webinar for the The ProLife Team Podcast. “We really don’t like to see that language because it is near impossible to rule out an ectopic.”

She went on to explain that the diagnosis requires multiple blood tests and multiple ultrasounds, and these centers cannot provide ongoing medical care for patients.

She said that centers can still talk about ultrasounds, but using suggested language like: “We’re doing the ultrasound to see if the fetus is in the womb where it’s supposed to be.”

NIFLA did not respond to multiple requests from NPR for comment for this story.

A response to the growth in medication abortion

Crisis pregnancy center marketing about ectopic pregnancies often references abortion medication, which has grown substantially since Roe v. Wade was overturned four years ago this week.

“If you plan on taking abortion pills, book an ultrasound to rule out an ectopic pregnancy,” reads the MyChoice Pregnancy Care Center website.

Besides the fact that centers are typically unable to provide an ectopic pregnancy diagnosis, it’s also not medically necessary to obtain such a diagnosis before taking abortion medication, says Dr. Jonas Swartz, professor of obstetrics and gynecology at Duke Health.

“Telemedicine abortion with medication abortion has been shown to be safe even without ultrasound,” says Swartz, who has done research on crisis pregnancy centers. He adds that abortion medication won’t resolve an ectopic pregnancy, but it also won’t make it worse.

If someone does have an ectopic pregnancy, they will need multiple follow-up visits and medical or surgical treatment.

Crisis pregnancy centers often offer material support, such as baby clothing, to parents. Here Pamela Palumbo, CEO of Wellspring Life Ministry, is at a crisis pregnancy center in Maryland, in June 2023.

Maria Danilova/AFP/Getty Images

hide caption

toggle caption

Maria Danilova/AFP/Getty Images

Swartz says he’s sympathetic to patients navigating the confusing early weeks of pregnancy, who might be worried and who might not be able to get in to see an OB-GYN quickly.

“Theoretically, people who would reach out to a crisis pregnancy center are in crisis — they are having an unexpected pregnancy or something going on in their pregnancy and they need help,” he says.

“I would think the best place to get that help would be a place where you know that you are seeing a trained medical team who have medical licenses and are working in a regulated facility,” he adds. “I would love to encourage us to devote our public tax resources and other resources toward increasing the availability of those services.”

Hepatitis B vaccine birth dose protects infants against lifelong health consequences

Since 2018, the American Academy of Pediatrics and the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) have recommended universal hepatitis B vaccination of medically stable newborns weighing at least 2,000 grams within 24 hours of birth. After the unprecedented wholesale dismissal and replacement of the ACIP membership in June 2025, the American Academy of Pediatrics posted a fact sheet on its website emphasizing the significance of the hepatitis B vaccine birth dose and infant series in preventing acquisition of chronic infection. Although the U.S. Preventive Services Task Force recommends screening for hepatitis B virus at the first prenatal visit, a recent study found that more than 1 in 7 pregnant patients are never tested; some women do not receive any prenatal care or become infected later in pregnancy.

Perinatal hepatitis B infection has lifelong health consequences; 90% of infected infants develop chronic hepatitis B, and 15% to 25% of those die from cirrhosis or liver cancer in adulthood. In addition to being vertically transmitted from infected mothers, hepatitis B virus can also be passed on to infants through incidental contact with blood or body fluids of infected household members. The birth dose thus functions as a safety net for thousands of children who, before 1990, were being overlooked by risk factor–based vaccination strategies. Since its implementation in the United States, the birth dose has not only been associated with higher completion rates for the full hepatitis B vaccine series but also higher odds of receiving all recommended vaccines by age 19 months. A study of birth dose use in Washington, DC, found that vaccine refusals declined from 12.1% in 2017 to 4.1% in 2020 and remained below 4% in 2021 and 2022.

Nonetheless, when the reconstituted ACIP met in September 2025, it came close to voting to delay the first dose of hepatitis B vaccine to 1 month of age in infants born to hepatitis B surface antigen-negative mothers. This occurred despite the presentation of a systematic review by CDC staff that found no increased risk of any serious safety outcome when the vaccine was administered within 24 hours of birth. As highlighted in an in-depth analysis of the meeting by former ACIP members, the new committee repeatedly ignored its established processes for evaluating evidence and deliberating recommendations. Family physicians and former ACIP workgroup members Doug Campos-Outcalt and Jonathan Temte observed in a JAMA Viewpoint: “The evidence-based processes used by the ACIP were adopted to prevent exactly what happened at the first 2 meetings this year: presentation of anecdotes, selective quoting of single studies, and a lack of in-depth evaluation of some of the evidence presented.”

Ultimately, the ACIP deferred its vote on hepatitis B vaccine, preserving access to the birth dose for now. But in October, nearly all of the CDC staff that provided logistical support and subject-matter expertise to the ACIP was laid off, imperiling production of the 2026 vaccine schedules and making future departures from evidence-based recommendations more likely.

**

This post first appeared on the AFP Community Blog. On December 2, the Vaccine Integrity Project posted an independent review of data on the efficacy, safety, and public health impact of hepatitis B vaccine at birth. In a decision analysis posted as a preprint, authors affiliated with the Hepatitis B Foundation projected that “delaying Hep B vaccination to 12 years for infants of both HBsAg-negative and HBsAg-unknown parents resulted in an additional 2,351 acute infections, 744 deaths, and $368 million in excess costs.”

Common Sense Family Doctor: State and federal support for primary care: meaningful but insufficient

For a clear-eyed view of the U.S. health system factors that have collectively conspired to cripple primary care, the five-part New England Journal of Medicine series “The Primary Care Puzzle” by cardiologist and medical reporter Dr. Lisa Rosenbaum is a worthwhile read. Although I would usually frown on a subspecialist writing a pessimistic view of the problems in my field of medicine (family medicine comprising the majority of primary care in Lancaster and elsewhere), Rosenbaum has interviewed all of the key informants and gets most of the story right.

Since it has become clear that primary care is a common good, like law enforcement and public libraries, it’s fair to ask what state and federal governments have been doing to support high-quality primary care. A systematic review in JAMA Health Forum discussed 5 federally-supported programs in primary care “transformation” from 2011 to 2021: 4 demonstration projects in paying primary care practices prospectively and EvidenceNOW Advancing Heart Health, which focused on improving cardiovascular outcomes. The numbers of participating practices ranged from 500 to nearly 3000. None of these programs was a failure or an unqualified success (improving health outcomes, the patient and clinician experience, or saving the system money).

The Trump administration has shown little interest in supporting primary care beyond allowing persons to use health savings accounts to pay membership fees to direct primary care practices. This change will help some access primary care, but huge funding cuts to Medicaid and premium subsidies for health insurance marketplace plans will result in millions more losing access to their doctors. (Further damaging to primary care are the hostile takeover and suspension of activities of the Advisory Committee on Immunization Practices and the U.S. Preventive Services Task Force, respectively.)

States have taken different approaches to better resource primary care. Oregon, Delaware, Colorado, and California recently passed legislation aiming to gradually increase the proportion of all health care spending on primary care from 5-7% to 11.5% to 15% over the next decade. Delaware and Rhode Island have combined primary care spending targets with caps on overall health care spending increases.

In September, the Milbank Memorial Fund published a policy menu for states looking to strengthen primary care, organized by 5 priority areas and spotlighting examples of policy actions taken by states that are diverse geographically and ideologically:

1. Make and Keep Primary Care a Top Policy Priority

2. Pay Primary Care More and Differently

3. Make It Easier for People to Access Their Primary Care Clinician

4. Expand and Support and Current and Future Primary Care Workforce

5. Build Provider Capacity to Provide Patient-Centered, Whole-Person Care

These initiatives are a good start, but they are not nearly enough to close the gap between the inadequate primary care workforce we have and the one we need to make the lagging U.S. competitive internationally in health care spending and outcomes.

Shared decision making for colorectal cancer screening tests

Most of the major cancer types have a single recommended screening test. For breast cancer, mammography. For cervical cancer, cytology and/or human papillomavirus testing. For lung cancer, low-dose computed tomography (CT). Colorectal cancer is unique in that physicians and patients have a menu of acceptable screening options, ranging from various stool-based tests to CT colonography, colonoscopy, and most recently, a blood test for circulating tumor DNA.

Guidelines recommend shared decision making with average-risk adults aged 45 to 75 years to select a colorectal cancer screening strategy that aligns with patients’ preferences and values. A recent scoping review of 28 studies in the United States and Canada explored factors that play important roles in these conversations. Researchers identified 4 domains that influence patients’ decision making: test attributes (accuracy, cost, convenience, and complications); recommendations from their personal physician; fear, discomfort and embarrassment for some regarding colonoscopy and stool tests; and external factors (culture, family input, socioeconomic status, and transportation access).

The U.S. Preventive Services Task Force assigned a “C” grade (offer selectively, individualized decision) to colorectal cancer screening in adults aged 76 to 85 years due to a small net benefit of screening in this age group. A cluster randomized trial in older adults evaluated the effect of physician training in shared decision-making on receipt of patient-preferred colorectal cancer screening (which could include no testing) and on overall screening rates. At 12 months, about half of patients in each group had received their preferred approach, with no significant difference between the groups in test uptake.

A pitfall for clinicians is limiting patients’ test options to colonoscopy due to a belief that it is the “gold standard” test, even though no data have demonstrated clear superiority over fecal immunochemical tests. An editorial in the September 2025 issue of American Family Physician discussed optimizing the role of noninvasive colorectal cancer screening tests, and an editorial in the October 2025 issue reflected on downsides of colonoscopy as a primary screening strategy. For patients who choose to undergo colonoscopy, adherence to evidence-based surveillance guidelines is critical to preventing harms associated with repeating colonoscopy at inappropriately short intervals.

**

Smartphones, social media, and adolescent health outcomes

The negative health consequences of social media use in adolescents and young adults are increasingly being recognized. In a previous American Family Physician Blog post on screen time use in children, Dr. Lilian White mentioned a correlation between greater social media use and reduced life satisfaction in adolescents. A 2017 Curbside Consultation discussed the relationship between social media use and mood disorders, fueled by the fear of missing out (FOMO), and reviewed resources and tools for unplugging or limiting time spent on social media.

Recently, a prospective cohort study in JAMA Network Open used objective data from a “digital phenotyping” app to evaluate the effects of a 1-week social media detox intervention on mental health. 373 U.S. young adults aged 18 to 24 years with smartphones completed a 2-week baseline assessment of their use of Facebook, Instagram, Snapchat, Tik Tok, and X. The optional intervention decreased 295 participants’ daily social media screen time from 1.9 to 0.5 hours. These changes were associated with statistically significant reduced symptoms of anxiety by 16.1%, depression by 24.8%, and insomnia by 14.5%.

Adolescents access social media platforms through smartphone apps. Another recent study examined associations of various health outcomes with smartphone ownership in a sample of more than 10,000 participants in the Adolescent Brain Cognitive Development Study. At age 12 years, 64 percent of children owned a smartphone. Compared to those without a smartphone, smartphone owners had higher risks for depression (odds ratio=1.31), obesity (OR=1.40), and insufficient sleep (OR=1.62). Risks of obesity and insufficient sleep increased with earlier age at smartphone acquisition, and the 1546 children who acquired a smartphone between the ages of 12 and 13 had worse mental health and sleep outcomes than the 1940 children who remained without smartphones at age 13.

Restricting use during school hours does not appear to affect overall smartphone or social media use or mental health. A cross-sectional study in the United Kingdom compared students at 20 secondary schools with restrictive phone policies (recreational use not permitted) with those at 10 schools with policies permitting recreational phone use. 1227 students age 12 to 15 years participated in the study, which assessed mental wellbeing using the Warwick-Edinburgh Mental Well-Being Scale. Students who attended schools with restrictive policies compensated for lower phone use during school hours by using their phones and accessing social media more after school and on weekends. Not surprisingly, there were no differences in mental well-being between the groups.

On December 10, Australia implemented the world’s first ban on social media accounts for children younger than age 16. Instagram, Facebook, Threads, Snapchat, YouTube, TikTok, Kick, Reddit, Twitch and X were all required to deactivate existing accounts for younger children and use age verification software for new accounts to avoid millions of dollars in fines. The potential health benefits of this policy remain to be seen.

**

This post first appeared on the AFP Community Blog.

If insurance says no to your weight loss medicine, try this : NPR

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

Oona Zenda/KFF Health News

hide caption

toggle caption

Oona Zenda/KFF Health News

Deborah Finley, 50, of Lodi, Calif., says her weight started to worry her during the early days of COVID. That’s when she noticed a lot of the people who were on ventilators or dying had something in common: obesity.

“It was a scary time,” she says. As a single mom, she was afraid “that I wouldn’t be here for my daughter.”

Finley had been diagnosed with sleep apnea and nonalcoholic fatty liver disease, and she was prediabetic. Her pulmonologist suggested bariatric surgery but couldn’t get Finley’s insurer to cover it.

She exercised and watched what she ate, but she wasn’t losing weight and her mental health suffered.

She remembers telling her doctor: “Look, I’m at 223 pounds. I feel like I’m hitting this wall. I don’t know what else I can do.” That’s when he suggested Zepbound, a GLP-1 drug for obesity.

Finley says she still had to put in a lot of work to get healthy. But the drug helped. Her sleep apnea improved dramatically. She lost weight.

Then her insurance plan stopped covering Zepbound for weight loss at the end of last year. That has become common because GLP-1 drugs are expensive for health plans and the employers that pay for them.

“They started sending out notices to all the patients,” Finley says. “And they said: ‘Look, we’re pulling this medication. We’re giving you 90 days’ notice to figure out what you want to do.'”

From 2025 to 2026, 12 million people were on plans that dropped coverage for Zepbound and 12 million had plans that dropped Wegovy, another GLP-1, according to research by GoodRx, a website that helps patients find discounts on prescription drugs.

If you find yourself in this situation, these tips can help.

1. Read the fine print on coverage

While many plans don’t cover GLP-1 drugs for weight loss alone, they may make exceptions if you have other conditions.

That was Finley’s situation. She learned that her insurer would cover Zepbound if it was used to treat obstructive sleep apnea or MASH, a fatty liver disease. GLP-1s are also covered for people with Type 2 diabetes.

You can work with your doctors to screen for qualifying conditions, says Dr. Caleb Alexander, a professor of epidemiology and medicine at the Johns Hopkins Bloomberg School of Public Health.

Share your questions. Health Care Helpline helps you navigate the health system hurdles between you and good care. Send us your tricky question, and we may tap a policy sleuth to puzzle it out. Share your story. The crowdsourced project is a joint production of NPR and KFF Health News.

Undiagnosed diabetes, he says, is “the most likely scenario that would allow for someone to go from not being qualified to being qualified.”

Since Finley had sleep apnea and testing showing that the drug helped, she learned it could still be covered with a prior authorization — that’s when you have to get approval from your health insurance before it will cover a medical cost.

Finley says her physician told her a prior authorization was on file, but when she tried to refill her prescription, the pharmacist told her that Zepbound was denied.

2. File an appeal — and get some help from your doctor

Don’t give up if your medication is denied, says Dr. Catherine Varney, the obesity medicine director for UVA Health, the health system affiliated with the University of Virginia in Charlottesville. Sometimes your insurer will relent on appeal, if you make a good case.

Finley made several frustrating phone calls and eventually went digging through her online medical records.

“I had to do my own investigative work,” she says.

Those records showed that Zepbound was indeed denied. Her doctor had applied for prior authorization, but it did not go through because her insurer said there was not sufficient data to back up the request. Somehow, her health information, including the sleep apnea testing results, hadn’t made it to the right people.

Finley eventually got her hands on the 17-page report and got a little help from ChatGPT to write an appeal, showing that the drug was necessary for her based on her diagnosis and was covered under her policy.

This kind of appeal can be a lot of work. Luckily, many doctors’ offices will help and know how the system works, Alexander says.

“I don’t think that patients should be expected to navigate these waters on their own,” he says.

3. Carefully document your care

Sometimes you may have to file multiple appeals if the first one is unsuccessful, says Tracy Zvenyach, the vice president for advocacy and research at the nonprofit Obesity Action Coalition, which receives financial support from drugmakers including Zepbound maker Eli Lilly and Wegovy producer Novo Nordisk.

Zvenyach also recommends keeping meticulous records. Some plans require something called step therapy, meaning patients have to try and fail on other drugs or treatments before getting covered for the one their doctor wants them to take.

“Keep a history of other meds you’ve taken so you can provide documentation for step therapy requirements,” she says. “Document dates of participation in any nutrition and physical activity program or membership.”

Finley filed an appeal on Feb. 4, and although she expected a hearing within 90 days, it hadn’t been scheduled yet as of mid-June.

She says it has been stressful because she hasn’t been able to get new injections of Zepbound since mid-January.

4. Look for discounts if you pay out of pocket

The drugmakers that make Zepbound and Wegovy sell the medicines at a discount to people who pay out of pocket instead of using insurance. (Try discount sites like TrumpRx or GoodRx.)

Even with discounts, the drugs are not affordable for everyone. If you have a health savings account or a flexible spending account, you can use it to pay for them with pretax dollars.

5. If you’re considering compounded GLP-1s online, watch for red flags

You might have seen ads for affordable off-brand obesity drugs prescribed by online providers. These are compounded products — that is, made by specialized pharmacists instead of a drug company.

Compounded medicines are prepared using the same active ingredient as the brand-name drugs. But they aren’t approved by the Food and Drug Administration.

Look out for quality and safety issues. Check the National Association of Boards of Pharmacy’s online pharmacy verification tool. Make sure the pharmacy preparing your drug is licensed in your state. If it’s not, it may not be undergoing inspections or complying with other laws.

After stretching out her remaining supply of Zepbound as long as she could, Finley is taking a compounded version of the drug while she continues the insurance appeals process.

6. Be persistent. And remember to breathe.

Being told no by an insurer is maddening. But Alexander, of Johns Hopkins Bloomberg School of Public Health, says you often have other options.

“If any appeal that we make is unsuccessful, there are other treatments that we can use,” he says — for example drugs like Contrave or a cheaper combination of generic naltrexone and bupropion.

UVA Health’s Varney, who has consulted for Eli Lilly, says not to give up on trying to get GLP-1s covered. “Take a breath, but go right back to it,” she says, adding that GLP-1s are superior to the older drugs on the market.

Alexander says he thinks obesity drugs will eventually become affordable — cheap even. Statins, which are used to treat high cholesterol, were once expensive and hard to get covered. Now, Alexander notes, they’re generic and often cost just a few bucks.

“I know it’s hard to imagine,” he says. “But there will come a day when we no longer see these access barriers for GLP-1s.”

Common Sense Family Doctor: Primary care for all Americans: a status update

As 2025 draws to a close, how much closer/farther is the U.S. health system to/from the goal of providing primary care for all Americans? Much of the news isn’t good. A recent analysis in the Annals of Family Medicine documented an 11% decrease in the number of family physicians practicing in rural areas from 2017 to 2023, with the Northeast suffering the largest proportional losses. As a faculty member at a Northeast residency program where many graduates have historically provided primary care to rural communities, this statistic hits home. Some of the “lost” physicians no doubt migrated to suburban or urban areas and continued to practice, but others developed burnout and left medicine altogether.

More and more clinicians, family physicians included, are participating in concierge or direct primary care practices, which collect an affordable up-front monthly fee per patient rather than rely on delayed insurance payments and provide relief from the burdensome paperwork that comes with third-party payers of health care. A study in Health Affairs used a national directory of direct primary care practices to create a longitudinal data set of clinicians from 2018 to 2023. During this five-year time frame, the number of practices and participating clinicians grew by 83 and 78 percent, respectively. Corporate-affiliated practices have made significant inroads into what was previously a clinician-owned model, with the percentage of independent practices shrinking from 84 to 60 percent. Although proponents tout its many advantages to clinicians and patients, the math is inescapable: every direct primary care physician who is caring for a panel of 500 patients rather than 1500 makes it more difficult for the other thousand to access traditional primary care.

With that context, what has PC4AA, the nonprofit group that I first highlighted in a blog post last year, been doing to improve primary care access? Rather than take a top-down approach like the National Academy of Medicine, they’ve chosen to tackle the problem from the ground up, community by community. One of those communities is New Bedford, Massachusetts, a multicultural, multilingual city of 101,000 people with just 36 practicing primary care clinicians, including 15 physicians. Of the 15 physicians, 10 are pediatricians and only 5 care for adults. An estimated 20 to 25 percent of the population does not have a relationship with a primary care clinician. Wait times for a new patient appointment range from two to nine months.

I’ve never been to New Bedford or spoken with anyone who provides health care there. So how do I know so much about this community and its ongoing primary care crisis? From the report released in October by PC4AA’s New Bedford chapter, which contains an in-depth analysis of the state of primary care in New Bedford as well as a multi-pronged strategy to recruit more primary care clinicians to meet the needs of the population. The original working group is now convening task forces that will focus on enhancing the primary care training pipeline, making training more affordable through scholarships and loan repayment, encouraging the development of new residency programs, and supporting existing primary care practices financially to allow them to expand services to more patients in the future.

It’s much too early to tell whether PC4AA will succeed in reinvigorating U.S. primary care where others have so conspicuously failed. But if, like me, you are looking for a reason to be optimistic about health care in 2026 – a year that is forecast to see the first increase in the percentage of the population that is uninsured since the Affordable Care Act’s passage in 2010 – this is it. Community by community, rebuilding and remaking the system from the ground up.

De-implementation as quality improvement in primary care

One of my roles as a residency faculty member is to make sure that every resident completes a quality improvement (performance improvement) project by the time they graduate. Nearly all of these projects focus on getting clinicians to do more of something that improves health outcomes: lowering blood pressure, prescribing controller medications for asthma, controlling blood glucose and cholesterol levels in diabetes, providing guideline-consistent postpartum care. But quality improvement also includes doing less of things that don’t improve (and may worsen) patients’ health: vitamin D screening and supplementation, antireflux medications for healthy infants, cancer screening in older adults with limited life expectancies.

The American Board of Internal Medicine Foundation’s Choosing Wisely campaign, which concluded in 2023 but remains active in many countries outside of the U.S., identified hundreds of “low value care” interventions, such as preventive care that is provided too soon or too often (e.g., screening colonoscopy). A 2020 paper reviewed more than 400 opportunities for stopping or scaling back unnecessary services in primary care and narrowed the field to 37 valid, high-priority recommendations. But identifying health care services to do less often or stop doing is the easy part; as “too much medicine” is often deeply embedded in systems, de-implementation is the real challenge.

A systematic review and meta-analysis of randomized trials of primary care de-implementation strategies identified 140 studies that aimed to reduce antibiotic use (54%), other drug treatments (30%), imaging (12%), and/or laboratory testing (11%). The authors found moderate certainty evidence that provider education combined with audit and feedback reduced targeted low value care, while provider education, audit and feedback, and/or patient education alone had limited or no benefits. Interventions that incorporated multiple strategies were the most effective, reducing relative risks of low value care provision by 30% to 35% over a median of 287 days of follow-up.

Compared to the much larger research base on intensifying care – I suspect there are hundreds, if not thousands, of studies on lowering blood pressure alone – the foundation for de-implementing low value care clearly needs to be expanded and strengthened. But there’s more than enough here for a motivated learner – say, a family medicine resident – to build on.

Common Sense Family Doctor: DIY medicine

In a time when artificial intelligence chatbots can answer all of your medical questions, and it’s possible to access laboratory testing and imaging scans without a health professional’s order, who needs actual doctors?

That’s the unwritten premise behind an unsettling article in STAT News that documents the growing phenomenon of empowered patients bypassing doctors and ordering direct-to-consumer tests that they think they need. The article begins with the story of a middle-aged man who shelled out $200 for dozens of lab tests that he didn’t think his doctor would want to order, in the hope of obtaining more information to manage his metabolic conditions and lower his risk of developing dementia.

“This is the stuff that if I went to my doctor [with], my doctor would kind of look at me like I’m weird,” he said of the tests. … Sidaway didn’t want to wait “20 years for the long-term studies and double-blind, placebo-controlled studies for them to say X, Y, and Z works,” he said. “Doctors are going to have to get used to this and navigate this.”

Do-It-Yourself, or DIY medicine, isn’t a unique phenomenon among highly trained professions. I’m sure that there are building contractors who roll their eyes at homeowners who get in over their heads with DIY renovations, or trial lawyers who wince when they see people without training try to represent themselves competently in court. Some days, I am tempted to point to the diplomas hanging on my home office wall and proclaim that if a patient believes that a chatbot or Dr. Google can equal my decades of medical training and practice, they are welcome to put their lives in DIY medicine’s hands.

One particular sentence in the HHS announcement got under my skin: “These additional steps demonstrate the Trump administration’s strong commitment to advancing women’s health and preventing chronic illnesses, including cancer.” Really? They are so committed to preventing chronic illnesses and cancer that they have immobilized the panel of highly credentialed experts whose mission it is to review the evidence to identify effective screening tests? In addition, RFK Jr.’s DIY approach to childhood vaccinations (which HHS misleadingly and unethically calls “shared clinical decision making”) is likely to increase the incidence of certain cancers. Parents who follow the new, expertise-free HHS guidance and disregard their pediatrician or family physician’s advice to give their children hepatitis B vaccine at birth, or at all, will expose them to the risk of acquiring chronic viral hepatitis, which will put them on a path to developing liver cancer. (Hepatitis B is treatable with antivirals, but not curable.) And dropping the second dose of the human papillomavirus (HPV) vaccine based on promising but incomplete evidence from other countries who have done so mainly for cost reasons could put more people at risk for not only cervical, but oropharyngeal and anorectal cancers caused by HPV. (The U.S. Food and Drug Administration, which is part of HHS, has not approved a single dose HPV vaccine regimen for cancer prevention.) Finally, cutting $1.1 trillion from Medicaid in last year’s budget reconciliation bill is projected to lead to “over 1 million missed [breast, lung, and colorectal] cancer screenings and hundreds of avoidable deaths within 2 years,” according to a just-published analysis.

America’s experiment with DIY medicine is underway, for better or for worse. Almost certainly, for worse.

Safely stopping screening for cervical cancer

All cancer screening tests have diminishing benefits and increasing harms as people age. An article in the December 2025 issue of American Family Physician reviewed considerations for discontinuing cancer screenings in older adults. For cervical cancer, the authors observed that 21% of new cases and 38% of deaths occur after 65 years, the usual age to stop screening. Notably, this stopping age applies only to patients without conditions that put them at high risk of cervical cancer (eg, HIV infection) who have had adequate prior screening, defined as “three consecutive negative cytology results or two consecutive negative cotesting results within 10 years.”

In a recently published guideline, the American Cancer Society (ACS) clarified that the last negative test before exiting cervical cancer screening should occur “at an age no younger than 65 years,” with primary human papillomavirus (HPV) testing at 60 and 65 years of age being preferred. The ACS reiterated its previous recommendation that clinicians continue screening beyond 65 years in those with a history of grade 2 or greater cervical intraepithelial neoplasia within the past 25 years.

An analysis of data from the 2013 and 2015 National Health Interview Surveys found that nearly 1 in 5 women 61 to 65 years of age had not been screened for cervical cancer with a Papanicolaou test in the preceding 5 years. Even in those with a more recent test, determining eligibility to stop screening after 65 years can be challenging. A retrospective study of electronic health records of 42,000 patients older than 65 years in two health systems in Dallas and Boston determined that 69% were not eligible to stop screening because “too few screening tests were documented”; nonetheless, 84% of these patients received no further screening. Of the 16% who continued screening, 2% had high-grade precancerous lesions detected, and 0.7% were diagnosed with cervical cancer.

Clinical studies of cervical cancer screening did not enroll women older than 65 years, so the evidence for the stopping age is derived from a modeling study commissioned by the US Preventive Services Task Force (USPSTF) to support its 2018 recommendations. (The USPSTF released a draft recommendation update in December 2024 that continues to support stopping screening at 65 years in women with adequate prior screening who are not otherwise at high risk of cervical cancer.) A large cohort study sponsored by the National Institutes of Health aims to add to this evidence base by estimating the effects of stopping vs continuing screening after 65 years on cancer outcomes and medical complications resulting from diagnostic procedures and surgical interventions.

**

Preventing RSV bronchiolitis in infants

In young infants, bronchiolitis caused by respiratory syncytial virus (RSV) is a common cause of hospitalization, with an annual incidence of 17.9 hospitalizations per 1,000 infants two months or younger in the United States. Although 4 in 5 children hospitalized for RSV have no risk factors, until 2023, prevention strategies for healthy term newborns were limited. That year, the US Food and Drug Administration approved two new options: the monoclonal antibody nirsevimab and maternal vaccination with a bivalent RSV vaccine, both of which are discussed in a STEPS new drug review in American Family Physician. (In June 2025, a second monoclonal antibody, clesrovimab, became available in the United States.)

In a multicenter randomized trial involving more than 8,000 infants, RSV hospitalization occurred in 0.3% of the group that received nirsevimab during the first winter of life compared with 1.5% of the usual care group (NNT = 83). A study of pediatric emergency departments in Spain found that universal RSV prophylaxis with nirsevimab beginning in the 2023-2024 season was associated with decreases in acute bronchiolitis, related hospital admissions, and pediatric intensive care unit admissions of 59%, 63%, and 63%, respectively. Similarly, infants up to 6 months of age whose mothers received RSV vaccine had a lower likelihood of medically attended severe RSV (0.5% vs 1.8% in the control group; NNT = 81). A Cochrane review of six randomized, placebo-controlled trials confirmed the benefits of RSV vaccination during pregnancy, and a retrospective cohort study of more than 54,000 pregnancies found no increases in preterm birth, premature rupture of membranes, or hypertensive disorders of pregnancy.

The American Academy of Pediatrics, American Academy of Family Physicians, and American College of Obstetricians and Gynecologists recommend routine maternal vaccination or monoclonal antibody administration to prevent RSV infections in infants. Two studies at different institutions found that total uptake (vaccine or nirsevimab) was more than 80%, with acceptance of nirsevimab even in individuals who declined other maternal or infant vaccines. In one of the studies, 43% of parents who refused RSV, influenza, and Tdap vaccines during pregnancy consented to nirsevimab for their newborns. As a result, RSV hospitalization rates during the 2024-25 season were 41% to 51% lower than expected rates and rates in prior years, with the largest benefits observed in infants younger than 2 months.

Presented with two equally recommended prevention options, parents may ask whether one is more effective than the other. Although no head-to-head trials have occurred, a population-based cohort study in France found that compared with infants who were protected by maternal vaccination, those who received nirsevimab had lower risks of RSV hospitalization (adjusted hazard ratio = 0.74) and severe respiratory outcomes, including pediatric intensive care unit admission and the need for oxygen therapy and mechanical ventilation. It is unclear how to apply this finding to the United States, where neither prenatal nor well-child care are universally guaranteed. In a pregnant patient between 32 and 36 6/7 weeks gestation from September 1 through January 31 who is willing to receive RSV vaccine, it makes more sense to vaccinate than to wait to give a monoclonal antibody to the newborn.

**

This post first appeared on the AFP Community Blog.

RFK Jr. is making measles great again: why it matters to everyone

2025 was a banner year for the measles. 2026 is already looking like it will be much worse.

Last year, there were more than 2,200 confirmed measles cases in the U.S., the highest number since 1991. More than 1 in 10 infected persons became sick enough to be hospitalized, and 3 people died.

This year, an ongoing measles outbreak in northwest South Carolina is up to 876 cases, more than 500 of which occurred after January 1. The first 5 cases of measles in Pennsylvania were just diagnosed here in Lancaster County. Measles spreads like wildfire. Vaccination denies it fuel. But county-level measles, mumps, and rubella (MMR) vaccination coverage has been falling for the past 5 years, creating pockets of vulnerability due to low immunity – perfect tinder for a highly contagious virus.

Now, you may wonder why this worsening epidemic should matter to you personally. If some people, for whatever reason, fear the MMR vaccine more than the measles (and mumps, and rubella), or want their “health freedom” so badly that they are willing to risk their well-being or that of their children, to each his own. You got your MMR vaccine as a child and made sure that your children did, too. You may sympathize with doctors and public health workers who have to clean up the mess that antivaxxers like Andrew Wakefield and Robert F. Kennedy, Jr. have made, but your good choices mean than you are protected, right?

Yes and no. Setting aside the issue that infants can’t be vaccinated against the measles until they are 6 months old (and don’t routinely receive their first dose of MMR vaccine until they turn one), those who have received two doses of measles vaccine are 97% protected against developing the measles from an exposure. On the individual level, 97% is about as good as it gets. That’s much better protection than vaccines against Covid-19 or influenza or practically every other vaccine. But on a population level, because measles is so incredibly contagious, a kid with measles could attend school where every one of other the 500 students had received 2 doses of MMR, and 15 kids could still catch the virus. Someone with the measles could go to Disneyland, expose thousands of fully vaccinated people, and spread it to dozens.

An article in last week’s Morbidity and Mortality Weekly Report described a measles outbreak investigation associated with an unvaccinated traveler who caught the measles in Colorado, then went to the airport in Denver and boarded an international flight. Epidemiologists painstakingly identified at least 17 measles cases that could be traced back to this traveler. Of the 9 cases in Colorado residents, 5 caught it at the airport and 4 on the flight. What I found striking was that 4 of the 9 had received two doses of MMR vaccine. Someone who doesn’t understand statistics might look at that figure and say, well, the vaccine must not be very effective. Wrong: it’s 97% effective. What almost certainly happened is that the index patient exposed at least 100 people at the airport and on the plane, most of whom were vaccinated. The unvaccinated people all caught the measles, while a few of the vaccinated did too.

Measles was once a common childhood illness. Thankfully, most of the time it resolves without any need for medical intervention. (That doesn’t mean that patients don’t experience significant suffering – take it from someone who caught chickenpox at age 16 and missed two full weeks of school, a few years before the varicella vaccine was approved.) But most of the time isn’t all of the time. Per the MMWR article: “Complications occur in approximately 10% of patients with measles, including ear infections and diarrhea; serious complications including pneumonia (5%), encephalitis (0.1%), and death (0.1%–0.3%) also occur.” Though rare, being unable to breathe, becoming comatose due to brain swelling, or dying are all real consequences of the measles. As a family physician who provides hospital care, I’ve seen plenty of patients with these complications as a result of other conditions that I can’t prevent with two shots. I don’t want to see them from an infection that is almost completely preventable. But as the measles wildfire burns on, and more communities become tinder, it’s only a matter of time until I do.

Common Sense Family Doctor: Continuity of care: health benefits and compensation

Continuity of care—a trusting relationship with a personal physician based on recurring interactions over time—is an essential ingredient of the secret sauce of family medicine. Numerous studies have demonstrated that higher care continuity is associated with more appropriate care and lower costs. Data also support positive effects on health outcomes. A retrospective analysis from Alberta, Canada, reported that physician and clinic continuity (seeing a clinical partner when one’s primary physician was unavailable) correlated with fewer emergency department visits across all levels of patient complexity and fewer hospitalizations for highly complex patients. A similar US cohort study of Medicare fee-for-service claims from a nationally representative sample of 4,940 medical practices found that patients with higher primary care physician continuity were 5.5% to 6.8% less likely to be hospitalized and 4.9% to 6.3% less likely to visit the emergency department.

In 2023, the Accreditation Council for Graduate Medical Education changed the emphasis of family medicine resident training requirements from volume of encounters to continuity of care. In a special article published in Family Medicine, Dr. Gregory Garrison and colleagues described five domains of care continuity. In addition to traditional clinician-patient or “relational” continuity, they discussed benefits of informational (medical record), managerial (interdisciplinary care), family (caring for multiple family members), and geographical (care in multiple locations or environments, such as home, office, and hospital) continuity.

Unfortunately, the percentage of the US population who experience continuity of care has been decreasing since the turn of the century. A 2015 Graham Center Policy One-Pager found that fewer adults reported a personal physician (as opposed to a practice or facility) as their usual source of health care. From 2000 to 2019, the percentage of US patients who reported having a usual source of care declined from 84% to 74%.

To support continuity and compensate primary care clinicians for the additional complexity and cognitive load involved in these longitudinal relationships, the Centers for Medicare and Medicaid Services (CMS) introduced the add-on G2211 code in January 2024 and refined its use in 2025. Some private health insurers also recognize and pay for this code. A 2024 Graham Center analysis projected that applying the G2211 code to all eligible Medicare evaluation and management (E/M) visits would increase annual reimbursement by an average of $2,667 per physician. Attaching the G2211 code to E/M visits with 25 modifiers (approved by CMS in 2025) resulted in another $990 per physician. This year, G2211 codes also can be applied to home-based primary care visits. Relative to the established benefits of care continuity, the added compensation seems modest at best. In addition, a research letter published this week in JAMA found that in 2024, the largest share of G2211 codes (43%) was billed by specialist physicians, not primary care physicians (40%), many for diagnoses “that may not qualify as serious or complex” as CMS originally intended.

**

Common Sense Family Doctor: Smartwatch screening for hypertension

An analysis of 2021-2023 National Health and Nutrition Examination Survey (NHANES) data found that among nonpregnant adults with hypertension (defined as systolic blood pressure 130 mm Hg or higher, diastolic blood pressure 80 mm Hg or higher, or use of antihypertensive medication), nearly 80% had a mean of three blood pressure (BP) measurements higher than 130/80 mm Hg. Of this group with uncontrolled BP, based on some practice guidelines, fewer than 40% were taking antihypertensive medications. Although undertreatment of high BP may result from therapeutic inertia, many adults do not have a regular source of care and simply do not know that they have hypertension.

Identifying undiagnosed hypertension is the goal of the Apple Watch’s hypertension notification feature, which was cleared in September 2025 by the US Food and Drug Administration for use in nonpregnant people 22 years or older. The watch is not a substitute for a home BP monitor, and it does not provide individual BP measurements. Instead, it uses an optimal sensor that collects photoplethysmography (PPG) data during waking hours over 30-day intervals, analyzes that data with a machine-learning algorithm, and alerts the wearer if hypertension is suspected. The alert encourages patients to monitor their BP at home for 7 days and consult their doctor about next steps.

A clinical validation study involving more than 2,000 participants found that the Apple Watch correctly identified 214 of 585 people with BP of 130/80 mm Hg or higher (sensitivity = 41.2%) with a specificity of 92.3%. The alert’s positive and negative likelihood ratios were 5.35 and 0.64, respectively. In a research letter in JAMA, Dr. Jordana Cohen and colleagues applied the Apple Watch’s screening performance characteristics to the nationally representative NHANES population. The researchers calculated the posttest probabilities of hypertension after a positive or negative alert based on the prevalence of hypertension in different subgroups:

Among eligible individuals aged younger than 30 years, an alert increases the probability of hypertension from 0.14 (95% CI 0.11-0.17) to 0.47 (95% CI 0.39-0.56), wherein the absence of an alert lowers it to 0.10 (95% CI 0.07-0.12). Among individuals aged 60 years or older, an alert increases the probability of hypertension from 0.45 (95% CI 0.39-0.50) to 0.81 (95% CI 0.76-0.86) and the absence of an alert lowers it to 0.34 (95% CI 0.29-0.39).

Similar to the heart-rhythm monitoring and obstructive sleep apnea detection features of various wearable consumer devices, the Apple Watch’s hypertension screening feature may nudge some patients to seek appropriate care for an undiagnosed chronic condition. For others, it may cause unnecessary anxiety or provide false reassurance. Given the popularity of these devices, though, smartwatch screening for hypertension will become increasingly common.

**

Primary care supply and access challenges around the world

Although as an American family physician, I tend to focus on the primary care crisis in the United States, a recent New York Times story highlighted the familiar challenges of recruiting family doctors to rural communities in Canada. In a “Hunger Games”-style competition, cash-strapped communities with doctor shortages outbid each other with signing bonuses of up to $51,000 ($70,000 Canadian) each to foreign-trained primary care physicians who agree to move to town and start new practices. Stettler, an Alberta town that couldn’t keep its emergency room open 24/7 due to a dearth of doctors, shelled out $300,000 to lure seven young physicians from Nigeria and Ghana. A Milbank Quarterly perspective by my family physician colleague Bob Phillips (the namesake of Georgetown’s Robert L. Phillips, Jr. Health Policy Fellowship) and primary care leaders in the United Kingdom, Australia, Canada, the Netherlands, and New Zealand outlined how policies that deprive primary care of funding and other necessary resources have compromised care and access around the world, even in otherwise high-performing health systems.

Producing enough primary care clinicians to meet population demand is a problem worldwide, but North Americans are at a disadvantage compared to peer countries, according to the results of a Commonwealth Fund survey in this month’s issue of Health Affairs. In 2022, 44 and 47 percent of U.S. and Canadian primary care physicians reported burnout, respectively, trailing only New Zealand. U.S. physicians also reported high rates of dissatisfaction and stress from 2012-2022, with a higher burden in females than males. These factors cause physicians to cut back on patient care hours or retire early, further depleting the primary care pool.

How many more primary care clinicians do we need? Traditional calculations which divide the eligible patient population by a standard panel size of 2,000 for a full-time physician fail to account for the aging population with multiple chronic conditions and the increasing complexity of medicine in general. Two recent studies used novel methods to approach this question at a national and state level. In JAMA Internal Medicine, Dr. Katherine Morgan and colleagues examined trends in the numbers of primary care clinicians accepting new patients from 2013 to 2021, with availability defined as billing >11 new visit evaluation & management codes for fee-for-service Medicare beneficiaries annually. They found a steady decline in primary care physician availability that was incompletely offset by a rise in advanced practice clinician availability. It’s not only harder to find a new doctor than it was a decade ago, it’s harder to find a new primary care clinician of any kind.

Dr. Jacqueline Britz and colleagues measured primary care workforce capacity in Virginia from 2016 to 2021, and their data told a similar story. Of the 4,508 primary care physicians (PCPs) practicing in the state, more than one-third are older than age 60, while only 24 percent are younger than age 50. The median number of unique patients each PCP saw in 2021 was 1,290, with each patient being seen twice per year. In order for every Virginia resident to have a PCP, researchers calculated that 1,305 additional PCPs would be needed, a 29 percent shortfall compared to an 18 percent shortfall in 2016.

One policy solution for Virginia and other states facing widening gaps in primary care supply is to open more training programs. After all, the majority of family physicians still choose to practice in the state where they were trained. (I rejoined that group when I moved back to Pennsylvania 4 years ago.)  But Dr. Morgan Stickler and colleagues pointed out in a commentary that the family medicine residency Match isn’t exactly a “Field of Dreams”: if you build it, they don’t come. Since 2012, the number of family medicine positions offered in the Match has almost doubled to 5,357, but the number of unfilled slots has quintupled from 142 to 805, involving 288 unfilled programs. The absolute number of students attempting to match in Family Medicine decreased by 16.6 percent from 2019 to 2024.

As Dr. Arch Mainous reminded us in a 2025 Family Medicine editorial, the increasing production of nonphysician clinicians and capabilities of artificial intelligence means that the family physician-dominated model of primary care could rapidly become as archaic as the “Great Horse Manure Crisis of 1894” (which ended with the onset of cars and other motorized vehicles). That doesn’t mean that doctors will all be replaced by chatbots or that we don’t need to find ways to remove ever-multiplying tasks from overwhelmed physicians’ plates (the “everything bagel” problem). It does mean that we will need to question old assumptions about primary care scarcity and come up with creative solutions to meet the primary care needs of the future, without resorting to zero-sum competitions.

Universal resource menu more effective than social needs screening

In January, I wrote a Medscape commentary about the mixed evidence that routinely screening patients for social needs improves health outcomes. Although many patients could benefit from assistance with necessities like food, housing, or transportation, screening for social needs only works if patients are prepared to accept help and realistic options exist to provide it:

There are also downsides to screening, which takes time and can distract from the purpose of the visit. … Many of my patients decline social work referrals, leading me to wonder why we screened them in the first place if they knew that they would not want assistance. For others, referrals may be wasting their time and giving them false hope. Social workers can’t magically produce affordable housing in the midst of a national housing shortage or provide regular access to healthy meals — especially after Supplemental Nutrition Assistance Program benefits were cut by hundreds of millions of dollars.In his 2020 Presidential campaign, entrepreneur Andrew Yang famously endorsed a different strategy. Rather than spending millions on inefficient bureaucracies whose sole purpose is to ensure that only the neediest qualify for government assistance, Yang advocated providing universal basic income, a “Freedom Dividend,” to every citizen to spend or save as they saw fit. This strategy would eliminate the stigma of being identified as having social needs.Could an analogous approach to social risk work in health care – offering every patient a menu of resources to select from rather than screening first and only assessing the needs of persons who screen positive? Dr. Danielle Cullen and colleagues at the Children’s Hospital of Philadelphia studied this question in the Socially Equitable Care by Understanding Resource Engagement (SECURE) randomized trial. In this study, 3949 caregivers of children and young adults in the emergency department were randomized to one of 3 groups: 1) completing a social risk screener; 2) receiving a resource menu to indicate desired assistance; and 3) no social assessment. All caregivers were provided with an electronic “resource map” after the initial intervention. The primary outcome was reported desire for resources in any of 5 domains (housing, transportation, childcare, food security, household heat and electricity). Caregivers assigned to the resource menu group were significantly more likely to meet the primary outcome than the screening group (38.4% vs 29%).

Although this study’s findings need to be replicated in primary care and patients of all ages, it contributes an important piece to the puzzle of how health care institutions can best elicit and assist with health-related social needs.

AI health tools for the general public fall short

A 2025 American Family Physician editorial by Dr. Joel Selanikio discussed how artificial intelligence (AI) tools had accelerated an existing trend of “patients bypassing physicians to diagnose and treat themselves,” which began with over-the-counter drugs and online search engines. This direct-to-consumer health care approach received a boost in January with OpenAI’s launch of ChatGPT Health, which invites users to upload their medical records and health data from apps for personalized recommendations.

AI chatbots can provide helpful responses to health questions in several low-stakes contexts, as outlined in this handout from Dewey Labs: translating medical jargon, brainstorming possible causes of symptoms, summarizing research or test results, and preparing questions for an upcoming doctor’s visit. However, a recent study in Nature Medicine highlighted ChatGPT Health’s significant limitations in triaging patients with acute problems to appropriate levels of care.

Dr. Ashwin Ramaswamy and colleagues compared the chatbot’s responses to “60 clinician-authored vignettes across 21 clinical domains under 16 factorial conditions (960 total responses)” to triage levels assigned independently by three physicians: non-urgent, semi-urgent, urgent, and emergency. ChatGPT Health performed well in triaging semi-urgent and urgent clinical situations, but it over-triaged 65% of non-urgent situations and under-triaged 52% of true emergencies. For example, it recommended evaluation in 24 to 48 hours for patients with diabetic ketoacidosis and impending respiratory failure rather than sending them directly to the emergency department. Just as concerning, patients with suicidal ideation were less likely to receive crisis interventions when they had identified a method of self-harm than when they had no identified method:

The crisis guardrail finding may be the most consequential failure mode exhibited in the entire study. … A guardrail that fires for ‘haven’t thought through how I would do it’ but not for ‘thought about taking a lot of pills’ is not calibrated to clinical risk and users have no basis to anticipate when it will or will not fire. The capability to recognize mental health crises and connect users with crisis resources is a basic prerequisite for any consumer health platform. Our data show this prerequisite has not been reliably met.

In another study, three AI chatbots were provided with 10 detailed medical scenarios and tested on their ability to diagnose the condition and recommend appropriate management. In the United Kingdom, 1,298 adults were provided the scenarios and randomized to use one of the chatbots or a usual source of their choice (typically an online search engine). When researchers input the full scenarios, the chatbots diagnosed 95% of the conditions and correctly managed them 56% of the time. However, when intervention participants shared elements of the scenarios in live conversations, the chatbots performed much worse, correctly diagnosing 34% of the time and recommending appropriate management in 44%; this result is no better than control participants using a search engine. Researchers observed that participants often failed to provide enough information to make the diagnosis, and slight changes in symptom emphasis or wording of questions frequently led to dramatic differences in advice.

Bottom line: For patient-facing chatbots such as ChatGPT Health to diagnose and triage problems appropriately and safely, it isn’t enough to passively process the incomplete clinical data they are provided. They will need to get much better at asking the right questions to elicit information that patients may not be aware is relevant.

**

Saving AHRQ and the USPSTF

AcademyHealth CEO Aaron Carroll, MD recently submitted testimony to the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies about the dire condition of the Agency for Healthcare Research and Quality (AHRQ), where I spent 4 years as a medical officer early in my career. Dr. Carroll points out the immense return on investment that AHRQ has provided over the years – for example, saving $7.7 billion in U.S. health care costs by reducing hospital-acquired infections from 2014 to 2017 on a budget of around $300 million per year – and its unique, irreplaceable function among federal health agencies:

NIH [National Institutes of Health] studies diseases. AHRQ studies how health care is delivered. These are different missions. NIH can tell us
that a treatment works in a clinical trial. AHRQ tells us whether that treatment reaches patients in a rural
hospital, whether it is implemented safely, what it costs, and whether a critical access hospital in a rural
county can actually use it. No other federal agency performs this function. Eliminating AHRQ does not
transfer these capabilities elsewhere. It simply ends them. 

Notably, Congress rejected HHS Secretary Robert F. Kennedy Jr.’s 2025 proposal to eliminate AHRQ. But Dr. Carroll observes that the Trump administration has effectively carried out this plan anyway, by laying off most of the agency’s staff and the entire grants management division, crippling its ability to function as a funder of health services research:

AHRQ has not awarded a single new grant since April 2025. An estimated $80 million in FY25
appropriated research funding was allowed to expire unused—a pattern consistent with the Government
Accountability Office’s ongoing impoundment investigation. In FY26, the agency has not funded any of
the noncompetitive continuing grants it is statutorily obligated to pay. The FY27 congressional
justification now explicitly states a policy of “no new grants,” ending AHRQ’s four-decade role as the
nation’s primary funder of health services research—a decision Congress never authorized.  

Similarly, former New York City and Philadelphia Health Commissioner Thomas Farley, MD wrote today on his Substack that the U.S. Preventive Services Task Force is being “quietly strangl[ed]” by being deprived of AHRQ support staff, not being convened since March 2025, and not appointing replacements for 5 members whose terms expired on December 31. He cites the recent ACC/AHA dyslipidemia guidelines as an example of what fills the preventive care vacuum when the USPSTF (which wrote its own cholesterol guideline in 2022) is effectively silenced:

Are cholesterol tests for kids and coronary artery scans for adults now scientifically justified? Here’s the problem: I do not know. It takes more expertise and time than I have to sift through all the many complicated studies to figure that out. … But I do know that (by my count) 12 of the 33 members of the writing committee and 17 of the 29 members of the review committee for the ACC/AHA guidelines have financial ties to biotech companies that are likely to make money from this testing and treatment. (None of the USPSTF members have these conflicts.) And I know this rule: if you’re wondering whether you need a new pair of shoes, don’t ask a shoe salesman.

The muddle about cholesterol testing, statin treatment and coronary artery scans is just one example of what we are losing from the USPSTF’s paralysis. … Thanks to Kennedy, dozens of other important questions on the USPTF consideration list are also languishing. Each month that the Task Force is in deep freeze our ignorance accumulates. … Surely we can afford to have a group of experts who are not motivated by profit guiding us on which medical services actually keep us healthy. With the USPSTF dead in the water, the war on science begins to feel like a war on us.

Nearly a year ago, I wrote a Medscape commentary that appealed to readers to “Save the USPSTF.” The USPSTF still needs saving. So does AHRQ. So does the entire taxpayer-funded scientific apparatus at HHS devoted to keeping people healthy that RFK Jr. has wrecked.

Does a prescription to drink more fluids prevent recurrent kidney stones?

Adults who have had one or more kidney stones are typically advised to increase fluid intake. The supporting evidence for this preventive intervention is limited, however. A 2014 Agency for Healthcare Research and Quality Effective Health Care review identified low-quality evidence from two small randomized trials of people with calcium stones. In these trials, increasing fluid intake to maintain a urine output of more than 2 liters (L) per day over 3 to 5 years reduced the relative risk of symptomatic or radiographic stone recurrence by 45%, with a number needed to treat of 7. No adverse effects were observed. As a result, the American College of Physicians recommended in a clinical practice guideline that people with kidney stones and a daily urine output of less than 2 L increase their fluid intake if not contraindicated for other reasons.

Similarly, Drs. Leonardo Ferreira Fontenelle and Thiago Dias Sarti wrote in a 2019 American Family Physician review article that “the most important lifestyle modification to prevent recurrent kidney stones is to increase fluid intake to 2.5 to 3 L per day to guarantee diuresis of 2 to 2.5 L per day and a urine specific gravity lower than 1.010.”

A trial published in March, the Prevention of Urinary Stones with Hydration (PUSH) study, tested a 2-year multicomponent behavioral intervention to increase fluid intake in 1,658 participants 12 years and older with previous kidney stones from six medical centers in six different US states. The intervention comprised (1) a prescription to increase urine volume to more than 2.5 L per day, (2) a financial incentive of $1.50 per day for the first 6 months for adhering to the fluid prescription (verified by a Bluetooth-enabled smart water bottle), and (3) health coaching and automated text messaging reminders to overcome barriers to adherence. Control participants were also provided a smart water bottle but were not required to use it. The primary outcome was symptomatic stone recurrence.

By the end of the study, a statistically similar percentage of the intervention (19%) and control (20%) groups had either passed a kidney stone or undergone a procedural intervention for a stone. This nondifference occurred despite increased fluid intake in the intervention group; daily average urine volume peaked at 1.8 L at 6 months and gradually declined to less than 1.6 L by 24 months. At 6 and 12 months, intervention participants were more likely to report urinary frequency, urgency, and nocturia. More intervention participants developed asymptomatic hyponatremia (12 vs 2 in the control group; p = 0.018); no one developed hyponatremia requiring hospitalization.

Although the failure of the intervention to achieve the daily urine volume goal likely contributed to the PUSH study’s negative result, it is hard to imagine a different primary care–feasible intervention performing any better. Further, the increases in urinary symptoms and hyponatremia associated with the intervention provided evidence of rare but clinically significant harms. An accompanying editorial reasonably suggested, “If adherence to foundational advice is unattainable even under optimal trial conditions, then … framing [fluid intake] targets more flexibly with individualized goals that are aligned with work or study patterns, beliefs, access to palatable water, thirst cues, and other competing demands might be more successful.”

**

8 ‘explosive power’ movements to boost agility and prevent injury : NPR

The sit-to-stand movement, demonstrated above, is one way to hone your explosive power, or your body’s ability to rapidly generate a lot of force. Scroll down for more recommended exercises.

Margaret Cirino/NPR

hide caption

toggle caption

Margaret Cirino/NPR

So you’ve heard of strength training and cardio. But have you heard of training for “explosive power”?

It’s the ability to rapidly generate a lot of force, says Jessica Scott, an exercise physiology researcher who has studied the effects of physical activity on different groups, including cancer patients and NASA astronauts.

“It’s not necessarily lifting the heaviest load. It’s about moving a lighter load very quickly,” she says.

This skill helps us safely do many everyday tasks, like walking up and down the stairs or standing up from a chair, says Scott. “It’s what allows you to catch yourself and not fall while walking down the sidewalk.”

You can hone your explosive power by doing exercises that combine speed and strength, like simple jumping jacks or more challenging kettlebell swings. Studies have shown that these exercises can improve sports performance and reduce injury.

Explosive power is even more important as we age. It can help prevent falls and injuries as our muscle mass declines. Each year, starting around age 40, we lose 1% to 2% of our fast-twitch muscle fibers, a type of muscular cell that allows us to do these forceful movements.

Scott, who currently works at Memorial Sloan Kettering Cancer Center as the director of its exercise oncology program, talked to Life Kit about how to incorporate explosive power movements into your workout.

Below, she recommends a set of exercises for all fitness levels, as well as a set for those who have a solid fitness foundation.

Our guide on form is Life Kit’s own Margaret Cirino, who is a CrossFit Level 1 trainer and a former Division I rower at the University of Southern California.

Lower-intensity exercises for all fitness levels

These are movements you can try at home regardless of your fitness level. Just make sure you have full control over your movements and stop before you’re fatigued or if you feel any pain.

Do three sets of the following exercises and keep repetitions low — around three to five.

Sit-to-stand 

How to do it: Grab a chair, bench or other sturdy platform and have a seat. Your feet should be hip-width apart. While keeping your abdominal muscles tight, stand up quickly from the chair and then slowly lower yourself back down. The lower the platform, the more difficult this exercise will feel. (See the image above for reference.)

Elevated pushups

How to do it: Using a platform or wall, start in an elevated plank position with your hands in line with your shoulders. Slowly lower your chest until it makes contact with the surface, and then quickly push away until your elbows are straight.

Make sure that your elbows are tucked by your sides and that your body maintains the same controlled plank position through the entire movement. Just as with the sit-to-stand, choosing a lower platform will make this exercise feel more difficult.

Heel raises

How to do it: Standing straight with your feet hip-width apart, quickly raise your heels, and then slowly lower them down onto the ground. Prioritize staying controlled and balanced through your heels.

Higher-intensity exercises for those looking for a challenge

Before you jump into these more intense movements, make sure you have a solid fitness foundation, Scott says.

That’s at least three months of regular aerobic exercise, like walking or cycling, as well as one to two days a week of strength training, she says.

Once you have that baseline, Scott recommends incorporating a 20-minute explosive power session into your workout routine each week. She shares a suggested set of movements below.

Do three sets of the exercises, and keep repetitions low — around three to five. Keep your movements short and high-quality, Scott says. Explosive power isn’t like resistance training where you’re trying to push yourself to fatigue. 

Squat jumps

How to do it: With your feet hip-width apart and arms slightly behind your torso in a ready position, slowly lower yourself into a squat. Make sure your feet are flat on the ground and your chest is upright. Then accelerate out of the squat into a vertical jump, bringing your arms upward to generate momentum. Jump as high as possible with your hips fully extended. As you land, return back to a starting squat position to cushion your fall.

Jumping jacks

How to do it: Stand tall with your feet hip-width apart and arms by your sides. Then jump into a slightly wider stance, simultaneously bringing your arms laterally upward until they can touch overhead. Jump back into your starting standing position and repeat.

Pushups

How to do it: Begin in a tall plank position with your hands stacked directly below your shoulders. While keeping your elbows tucked into your sides, slowly lower your body until your chest makes contact with the ground. Then press against the ground and quickly return to a tall plank.

Medicine ball slams

How to do it: Stand tall with your feet hip-width apart and a medicine ball at your chest. Raise your heels while bringing the medicine ball overhead. Then quickly hinge at your hips and lower your arms and torso, simultaneously slamming the ball into the ground.

Kettlebell swings 

How to do it: Stand tall with your feet hip-width apart and arms relaxed, and hold a kettlebell with both hands. First, hinge at your hips, bringing the kettlebell backward between your legs. Then quickly push your hips forward, using that momentum to swing the kettlebell upward until your arms are straight and horizontal. Return back to the hinge position and repeat.

Scott says one explosive power training session per week is great for beginners. Then, you can build to the ideal, which is two 20-minute workouts a week.

With time and consistent training, you might find it easier to chase after your kids, feel more steady on your feet or make some epic tennis shots.

This story was edited by Malaka Gharib. The visual editor is CJ Riculan. We’d love to hear from you. Email us at LifeKit@npr.org. Listen to Life Kit on Apple Podcasts or Spotify, and sign up for our newsletter.

New dads share how fatherhood has changed them : NPR

From left: Dr. Nilay Mahajan with his wife, Dr. Charu Srivastava and their daughter, Tarini; Manik Seghal with his son, Gunagyaa; and Ajas Ahmed, his wife, Reshma, and son, Naseer.

From left: family photo; family photo; family photo

hide caption

toggle caption

From left: family photo; family photo; family photo

They had always been a team. But when his son Naseer was born in May 2025, Ajas Ahmed had never felt so helpless.

His wife had endured a difficult labor. The baby was breech and she struggled for over ten hours in pain. For a week, she lay bedridden in a hospital in Chennai, in southern India, recovering from the birth. Ahmed, a 27-year-old private chauffeur, stayed by her side.

“She needed my support. I made sure I was there for her,” he says.

Fortunately, Ahmed’s employer allowed him the time off. But long before Naseer’s birth, fatherhood had already begun reshaping his life. After his daughter, now 3, was born, he quit his job as an ambulance driver because the hours were punishing and the pressure relentless. He wanted work that would allow him to come home, spend time with his child and be present in ways his own father’s generation may not have expected of men.

Ahmed’s story reflects a central tension identified in the 2026 State of the World’s Fathers report: There’s a persistent idea that men are providers first and caregivers second.

But the report finds that men are often invested in childcare, especially in families with a small number of kids. And the researchers came up with a surprising insight from their interviews with over 5,000 fathers. As men do more hands-on childcare, they face more stress … but they find meaning in it. Nine out of ten fathers interviewed felt that caring for children is a deep source of happiness, says Taveeshi Gupta, one of the report’s lead authors this year.

“We didn’t see that one coming,” says Gary Barker, CEO of Equimundo: Center for Masculinities and Social Justice, the Washington, D.C.-based advocacy group that prepared the report and that encourages men and boys to become allies in the effort to achieve gender equality.

“A lot of our messaging has been: Men, you must do more,” he says. “And perhaps it came with a scolding — from a feminist perspective, because women’s time poverty is real, and we did need to push men to do our fair share. But the report confirmed what those of us who are fathers and involved in care were already saying: this is happiness in life.”

Not all the fathers interviewed were on board. Younger men and older men skew more to traditional gender roles, the report found in its interviews.

And hands-on dads may sometimes feel they are entering uncharted territory.

“When I was a part-time stay-at-home dad with my own daughter 28 years ago, it was obvious that the world looked at me in two ways,” Barker says. “Either I got special credit for being a competent caregiver — as if a man doing this was a superhero — when in reality I was just a bumbling caregiver like all of us are. Or I was seen as incompetent or invisible because men don’t really do this work.”

Here’s how three new dads in the patriarchal society of India are navigating their lives — and finding joy in fatherhood.

‘I’m the diaper man”

Dr. Nilay Mahajan, 36, is an orthopedic surgeon based in Bareilly, in the north Indian state of Uttar Pradesh. Since welcoming his daughter, Tarini, in February, he says fatherhood has made him more empathetic — especially toward his pediatric patients.

“The moment you hold your baby in your arms, your brain wiring changes. So do your priorities,” he says. His wife, Dr. Charu Srivastava, is a gynecologist with a demanding schedule of her own, but the couple have been finding ways to share the load.

“When I’m home, I’m the diaper man,” he jokes. At night, after his wife breastfeeds, he burps the baby and rocks her to sleep. When he has a couple of hours between surgeries, he drives home, just five minutes from the hospital, to spend that time with Tarini.

“Whenever I’m home, I try to be present in the moment — to hold, rock and feed her,” he says. “I try to support my wife when I can. If she has an emergency surgery to perform or one of her patients needs her, I take time off from my practice to accommodate that. Ideally, raising a child should never be a single person’s responsibility. It’s just too draining otherwise.”

His approach reflects a dramatic change in parenting in India, he says. As more women pursue careers, more men are becoming more aware of the need to share domestic and caregiving responsibilities.

“Fathers are more proactive now,” he says.

Growing up, however, Mahajan saw a different model. His father, a neurosurgeon, had a demanding schedule, which meant that much of the parenting fell to Mahajan’s mother.

Mahajan wants something different for his daughter. He does not want Tarini to grow up in a world with rigid gender roles.

“I have to show her through my actions, and by being supportive, that men and women can be equal partners. I want her to feel like she can do anything she sets her heart on,” he says.

‘I’m more mindful about my travel’

Manik Sehgal, 44, lives in Faridabad, about an hour from India’s capital, New Delhi.

In January, he and his wife, Manjulika Pramod, welcomed their first child — a son they named Gunagyaa. The couple first met a decade ago as colleagues when they both worked in telecommunications. Seghal, now a consultant at Deloitte, says having a baby has changed his life in ways he had not even imagined earlier. For one, it’s helped him prioritize family time.

“I used to live out of a suitcase, taking 5-6 flights a month for work,” he says. “Today, I’m more mindful about my travel, choosing to cut back whenever I can, to spend time with my family,” he says. He has taken over baby care duties after 9 p.m, often tending to his 5-month-old late at night so his wife can get some rest.

His thoughts are drifting to the environment and to other world events — through the lens of a new dad. “I’m thinking more about the air we breathe,” Seghal says. “As costs of living go up everywhere, with wars adding to inflation, pollution and climate change, I worry about the world we’re leaving behind for our kids. Suddenly, everything is personal.”

“Fathers increasingly want to care”

In the report on fathers, researchers asked men what makes a good father. In India, says researcher Gupta, there was a lot of emphasis on the provider role.

“That is a cross-cutting finding across the Global North and Global South: manhood, and what it means to be a good man or a good father, is still often tied to being a breadwinner and provider,” says Gupta.

And that’s largely because of a phenomenon called economic precarity, she says. “It refers to a generalized anxiety that no matter what you do, you may never have financial stability in your life or future.”

Economic precarity isn’t just felt by people living with poverty. Even the relatively well-off can experience it as they worry about the impact of wars, AI entering the labor force, stagnant wages and rising home prices. All this “makes stability feel out of reach,” says Gupta.

When researchers measured economic precarity among parents, their statistics show how deep it is. Welcoming a new child can change a family’s income as mothers tend to take time off. Three in four fathers interviewed for the report said they were losing sleep over their financial future. A majority felt home ownership was out of reach. More than half of fathers had taken on multiple jobs, changed jobs or were working overtime. “Economic precarity was linked to every other indicator we measured — mental health, how happy they feel about being caregivers and other life outcomes,” says Gupta.

The report does not describe caregiving itself as a burden, because their data shows that parents find joy in care. And roughly half of the fathers interviewed had young children (ages 0-7), who require more attention than older kids. 

One solution the report suggests is fully paid leave for fathers — lasting as long as maternity leave. The researchers also suggest cash stipends or other social protection policies for lower-income families, and livable minimum wage guarantees.

“The message is clear: Fathers increasingly want to care, but they need societies, employers and health systems that make caregiving possible,” says Barker. And of course — “that’s the kind of support that can help mothers too.”

“Being a father means more than just earning for your family”

For Ajas, his wife’s stay in the hospital made one thing clear, even as he struggles to cope with spiraling financial pressures that come with life in a big city.

“Being a father means more than just earning for your family. It means being there for them, especially when they need you the most,” he says.

Kamala Thiagarajan is a freelance journalist based in Madurai, Southern India. She reports on global health, science and development and has been published in The New York Times, The British Medical Journal, the BBC, The Guardian and other outlets. You can find her on X @kamal_t

Recent studies show fathers’ brains change after bringing home a new baby : NPR

NPR’s Ayesha Rascoe talks to Washington Post journalist Richard Sima about how fathers’ brains change after bringing home a new baby.

AYESHA RASCOE, HOST:

There’s lots of evidence out there that mothers’ brains change and adapt during pregnancy and after childbirth. Now recent studies show that something similar happens in fathers’ brains after they’ve had a child. Richard Sima is a neuroscientist turned science journalist. He writes The Washington Post’s Brain Matters column and joins me now to explain. Before we get started, I hear you are a new father. Happy Father’s Day.

RICHARD SIMA: (Laughter) Thank you. And it’s great to be here.

RASCOE: So break this down for me. Like, how does the brain change once someone becomes a father?

SIMA: Yeah. As you mentioned, it’s very similar to what happens in a mother’s brain. We also have some shrinkage of the brain, but don’t worry. Shrinkage is not bad in this scenario because it’s actually a way of our brains adapting and sculpting out what connections are needed. The shrinkage, researchers find, happen in these mentalizing regions of the brain, which help us really connect with and figure out what another person is thinking and feeling and wanting. And that’s kind of what you want with a newborn. You’re like, what is this new little human? What do they need from me right now? And this shrinkage is associated with people being able to adapt to parenthood, to fatherhood better. Fathers who have more shrinkage in these areas tend to enjoy their infant more. They engage with the infant more. They feel less stressed.

RASCOE: Are there factors that determine the amount of change a father’s brain undergoes?

SIMA: Yeah. So what’s fascinating is that the amount of involvement with really being active as a father is associated with the amount of change. And we don’t know which way that direction of causation is. But it does seem like part of it is, like, the experience of being that parent is sculpting the brain. There’s studies looking at different cultures. Like, one culture doesn’t have as much hands-on childcare from the father, and another culture is much more hands-on. And there’s more changes in the more hands-on culture.

RASCOE: The research also notes some fascinating things about fathers’ hormonal changes. Can you explain that? What’s going on there?

SIMA: Yeah. So there’s a lot of great studies that looked at fathers before their child was born and up to a few months afterwards, and there was a huge change in their testosterone levels. We might think of testosterone as this very manly thing, and fatherhood is very conventionally masculine, but fatherhood is actually associated with lower levels of testosterone. And at the same time, there’s increases in prolactin, which is what we know is important for milk production but also found in men.

RASCOE: And what ultimately does this research reveal about the experience of parenthood? Did you find out anything that has kind of helped shape your new fatherhood experience?

SIMA: Yeah. It’s, I think, really pointing to just how dramatically parenthood can change any parent. And that sort of explains why when my daughter was born, it’s like, wow. Like, I understand now why people say, yeah, you fall in love so deeply and so quickly. And it makes sense that, like, wow. I’m having all these hormonal changes as well. Not as much as my wife, maybe. I’m having these brain changes, and they’re all really preparing us to really engage with this new human and try to be a good caregiver. You know, at the same time, the child is also having their brain changes. So we’re sort of doing this together as a family, trying to figure out the world and each other together.

RASCOE: That’s Washington Post journalist Richard Sima. Thank you so much for joining us.

SIMA: Thank you so much.

Copyright © 2026 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

Accuracy and availability of NPR transcripts may vary. Transcript text may be revised to correct errors or match updates to audio. Audio on npr.org may be edited after its original broadcast or publication. The authoritative record of NPR’s programming is the audio record.

The public health team watching the World Cup : NPR

As millions gather for the World Cup, a scrappy public health operation led by a team at Georgetown is tracking disease threats using surveys, wastewater and online chatter to spot outbreaks early.

PIEN HUANG, HOST:

Are you one of the millions of people who have gone to a fan zone or stadium or bar to watch World Cup soccer? Well, at Georgetown University in Washington, D.C., there’s a small team of public health experts who are watching you, collectively. It’s an effort outside of government working to fill in for gaps that have opened up in public health since the Trump administration pulled the U.S. out of the World Health Organization, cut funding and pushed out thousands of workers from the federal workforce. Katelyn Jetelina is a Texas-based epidemiologist working on the new effort called the Health Security Operations Center. She’s collecting population-level data based on people’s thoughts and experiences.

KATELYN JETELINA: And this includes about – a survey to about 2,500 people that are actually going to the World Cup game, so we can hear from them, as well as people within a 30-mile radius of the stadiums.

HUANG: Amy Lockwood is really into wastewater. She analyzes data from waste for the company Verily.

AMY LOCKWOOD: A lot of the information that we’re finding is coming from wastewater surveillance, and pretty much any pathogen you can think of we can find in wastewater.

HUANG: Jetelina says the data comes together in ways that are helpful to health officials.

JETELINA: People were chatting on reddit around a nasty stomach bug in Washington. And when we looked deeper into the epidemiological data, there sure was a big wastewater signal there. And so we were able to inform the state of Washington for their operations as well as their communications.

HUANG: The information on what diseases and health threats are circulating where gets shared in situation reports sent to a thousand professionals who work in public health, healthcare and emergency management on daily calls like this.

(SOUNDBITE OF ARCHIVED RECORDING)

UNIDENTIFIED PERSON: Good afternoon. Our bottom line up front, overall health risk at World Cup games and base camps remains low.

HUANG: These situation reports inform how doctors like Ethan Booker, an emergency room physician at MedStar Health in Washington, D.C., practice during the World Cup.

ETHAN BOOKER: When I know something’s circulating nearby, it changes my index of suspicion. It means before any lab results come back or before I even order them, am I wearing a mask when I walk in the room? Am I wearing a mask for my whole shift? Can this patient with a cough go back out into the waiting room to wait for the rest of the tests?

HUANG: It’s a major effort, and it’s run out of a repurposed lab space on the Georgetown Medical School campus. Rebecca Katz is the director, and she takes me on a tour.

REBECCA KATZ: It’s a microbiology lab. At the end of the room is the ancient chemical hood, and we’ve got a screen in front of it that’s showing one of the games. Right now we’re looking at Argentina versus Algeria.

HUANG: The game is on silently in the background. The walls are covered in World Cup posters. More than a dozen people pack the lab benches all in a row, staring at large monitors with data streams on measles, wastewater and weather patterns that they’re scraping from public and corporate sources. Katz says it’s so quiet because they’re on deadline.

KATZ: It is 11:40 in Boston, New York, Philly, Atlanta, Miami and Toronto. We will do our first stand-up call of the day at 1:30. The sit rep goes out by 2:00. It’s the first push of the morning to be able to get the information into the sit rep for the day.

HUANG: Dr. Nii Hanson-Nortey is a doctoral student and epidemiologist. He’s checking the situation in Canada, which, along with the U.S. and Mexico, is hosting World Cup teams and games.

NII HANSON-NORTEY: Well, so far, in Canada, the high-risk viruses are on the low, especially around the match venues. So we’re looking out for that.

HUANG: It’s a scrappy operation, and Katz says that she’s borrowing equipment, getting access to data from collaborators and using research funds to make it work. The idea came together last fall when she and her colleagues realized that official efforts to prepare for the World Cup weren’t what they expected.

How did the idea for this start? Why are you doing it?

KATZ: So I think there’s a lot of reasons. Mass gatherings are always events where we are worried about infectious disease spread. This particular mass gathering is particularly complicated, given the three countries, the 48-plus jurisdictions. So even in the best of times, there would probably be a need for external groups to be able to work side by side with public health authorities.

We’re in complicated times. We are also trying to help support local, state and federal workforce that is pretty stretched right now and realized that there was an opportunity for us to do that. And also, you know, we’re in a new era of public health where there’s a lot of different actors, including private sector – and so trying to figure out how civil society really works closely with government authorities. So in a lot of ways, we’re testing something out here.

HUANG: You also said that we are in a new era of public health, that there’s a lot more private partnerships that are involved. Tell me about this new era. How do you characterize it? What is it in response to? And do you think it’s kind of like a permanent new space that we’re developing right now?

KATZ: There’s a lot of unknowns. Resource allocation to public health has been dramatically changed and in uneven ways, right? There are some jurisdictions and there’s some programs that are extremely well-funded. There are some that are not. There are some surveillance programs that have had to be completely ended because of lack of resources. And it’s left a smaller workforce that is being pulled in a lot of different directions.

And there is a kind of philosophical shift right now that is trying to push some of the activities that have traditionally been done by the public sector into the private sector. This is going to take a while to figure out how we do that and how we do that well. I have no idea what the future holds, right? Ten years from now, there may be an explosion in funding for local public health. Wouldn’t that be amazing? But right now, what we’re chewing is we’re trying to figure out what the new normal is, and it’s a little bit of trial and error.

HUANG: That was Rebecca Katz from Georgetown University telling me why they launched the Health Security Operations Center for the World Cup.

(SOUNDBITE OF DOSS’ “SOFTPRETTY”)

Copyright © 2026 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

Accuracy and availability of NPR transcripts may vary. Transcript text may be revised to correct errors or match updates to audio. Audio on npr.org may be edited after its original broadcast or publication. The authoritative record of NPR’s programming is the audio record.

Blood tests could transform cancer screening soon : NPR

The new tests can look for traces of 50 different kinds of cancer in one vial of blood. While they do not diagnose cancer, the tests tell doctors where to look more closely.

Anand Purohit/Moment RF/Getty Images

hide caption

toggle caption

Anand Purohit/Moment RF/Getty Images

Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival.

The Food and Drug Administration has been evaluating a blood test called Galleri (pronounced like “gallery”) as a breakthrough device that can detect many different types of cancer in one test. FDA could approve it later this year, clearing the way for such testing to become broadly available.

For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.

If that happens, experts say such tools have the power to revolutionize cancer screening as it exists today — making it far easier, more comprehensive, and more accessible to a greater number of people.

Relatively few screening tests now

Currently, in the U.S. it’s common to screen for five cancers — breast, colon, cervical, prostate, and lung — each requiring its own scan, like a CT test, or exam, like a Pap smear. By comparison, the Galleri test can detect small amounts of DNA or other cancer markers for up to 50 cancers in a single vial of blood.

Galleri and another test called Cancerguard by Exact Sciences are both multi-cancer early detection tests that already can be ordered in the U.S. under a special FDA designation. A more rigorous FDA approval process will be necessary for the tests to be covered by Medicare and other insurance.

Still, the stage is set for a new paradigm.

“It’s a real fundamental shift in how we think about cancer screening,” says Megan Hall, vice president of medical affairs for Grail, a research company founded to bring Galleri to market. “Instead of screening for individual cancers, we can now screen an individual for multiple cancers simultaneously.”

A pathway for Medicare coverage

The testing industry, and cancer advocates, successfully pushed for government insurance to cover multi-cancer early detection, known as MCED, after the category gets the more thorough FDA vetting.

As part of its spending package passed in February, Congress voted to allow Medicare to reimburse the cost of multicancer detection tests starting in 2028. Grail sets the retail price for the Galleri test at $950. Cancerguard’s price is $659. It is unknown how much the companies will charge commercial insurers if the FDA grants them full approval.

Grail is doing two large-scale population studies of people over 50 on the Galleri test. One study is looking at more than 142,000 patients in the U.K. through the National Health Service, or NHS. Another study, called the Pathfinder 2, involves 35,000 patients in North America.

The NHS study did not meet a primary goal of seeing a significant reduction in incidence of Stage 3 and 4 cancers over time, Grail announced in February. In late May, at the American Society of Clinical Oncology meeting, the company released research that says that the two studies, taken together, nevertheless, show a promising trend.

“The third year alone, we saw a 26% reduction in Stage IV cancers — pancreatic cancer, liver cancer, lung cancer, gastric cancer and a handful of others,” says Hall.

Grail is promoting the idea that the Galleri test should be used in conjunction with other screening tests, not as a replacement to any done now. The legislation passed by congress that may eventually allow Medicare to cover the test also specifies that Galleri should not replace other screening tests.

What the future may hold

So: What does that mean for people who fear cancer, or live with it?

At the moment, only a handful of common cancers have a screening test that can detect disease before a person has symptoms, when it may be at a more curable stage.

Oncologist Arif Kamal, chief patient officer at the American Cancer Society, says Grail is one of hundreds of companies pursuing the promise of blood tests — competing over levels of sensitivity, accuracy, and reliability. He says if implemented well, the simplicity of such tests could make routine screening easier and more accessible.

The science is sound and the technology is solid, Kamal says, so the only question is how quickly the technology will evolve. Blood tests, whether they detect one cancer or many, “are all getting at this idea that you can find, in the blood, early signals of a cancer’s presence or its evolving resistance to existing therapy,” he says.

Similar technology has already changed the way UCLA lung-cancer specialist Jonathan Goldman treats patients. Oncologists use blood tests, sometimes called “liquid biopsies” to monitor patients who already have a cancer diagnosis to see if treatment is working or if cancer may be returning. They also use it to identify a cancer’s specific genetic type, which in turn can allow physicians to choose more effective treatments when available.

“Blood-based testing has become central to the way that we think about lung cancer and other cancers because the systems have become so sensitive,” says Goldman.

The future, he says, are blood tests that may be able to predict if a person is likely to contract the disease.

“It’s possible that at some point our blood testing could become so sensitive that you could find that very small number of cells that would be at risk for causing cancer occurrence years later — but we’re not there yet,” Goldman says.

Indeed, Grail medical advisor Hall says the Galleri test is not a diagnostic tool; rather, by identifying the volume and type of DNA fragments and other cancer markers in the blood, the test results offer what are essentially predictions about the source of the cancer.

Catching more before Stage 4

A diagnosis will always require a follow-up exam, but the test offers solid guidance for doctors, Hall says.

“That cancer signal origin prediction is a really important feature of the technology because it directs your physician on where to go to look to confirm the presence or absence of that cancer,” she says.

Improvements in blood tests, meanwhile, dovetail with rapid developments in treatments for various cancers, making the disease ever more survivable or even curable.

Therefore, the ability to catch cancer at Stage 3 versus Stage 4 has never been more significant for survival, Hall says. “The treatment landscape has evolved so much over the past five to 10 years, that there are now a lot of treatments even for Stage 3 … and that’s a really big deal.”

In the abortion wars, new frontline is pills via telehealth : NPR

A coordinator at the Massachusetts Medication Abortion Access Project in Somerville, Mass. shows the two medications that can be mailed to patients who have received a prescription through a telehealth consultation.

Charles Krupa/AP

hide caption

toggle caption

Charles Krupa/AP

Dr. Angel Foster had a backup plan.

It was the first weekend in May. A federal appeals court had just made it illegal to mail mifepristone, a pill that’s part of the most widely used abortion method in the U.S.

Foster, a specialist in reproductive health, leads the Massachusetts Medication Abortion Access Project, which ships abortion pills to some 3,500 patients a month nationwide, including in states with abortion bans.

She told patients they had three options: They could get a refund. They could wait to see if the legal situation changed. Or she could ship them only misoprostol — a second drug already used in most medication abortions.

Combined, mifepristone and misoprostol are considered the clinical “gold standard” for medication abortion. Misoprostol can be taken alone to induce an abortion, but some studies have suggested it’s less effective, Foster warned patients. Plus, it can make the process longer and more painful, with more side effects, such as nausea and vomiting.

Still, the vast majority of patients said the same thing: Just send it.

“They didn’t care,” Foster said. “Their response was: ‘Whatever can get to me the fastest.'”

A surprising rise in abortions after Roe’s fall

Two developments often get lost in the public’s perception of the abortion wars.

One is that there were nearly twice as many abortions in the U.S. in 2025, compared to 2021, the year before the Supreme Court overturned Roe v. Wade in its momentous Dobbs decision in 2022.

The numbers come from the Society of Family Planning’s latest #WeCount report. By December 2025, 29% of abortions were through telehealth.

The second is that, because the mailing of abortion pills has become so widespread in the post-Dobbs era, abortion opponents may simply be unable to stop it.

Massive legal battles are being waged by states with abortion bans, seeking to block the shipment of mifepristone across their borders.

The temporary pause in May was part of a lawsuit brought by Louisiana; the U.S. Supreme Court decided to restore telehealth access to mifepristone while a lower court hears the case.

And abortion opponents continue their push to get the Trump administration to crack down on the pills’ availability, either through a Food and Drug Administration safety review, or more drastic measures.

‘No going back’

But many telehealth providers who help patients get abortions aren’t too worried.

“We like to say the genie is out of the bottle,” said Elisa Wells, who co-founded and is the access director at Plan C, which provides information about accessing abortion pills online.

“Now that people know that they can get safe, fast, effective, affordable care through the mail, there’s no going back,” Wells said.

If mifepristone is restricted, many telehealth groups will immediately switch to using only misoprostol instead, they say.

Misoprostol is approved by the FDA to treat ulcers, and is also widely used off-label to manage miscarriages, induce labor and end pregnancies.

And while states could individually ban misoprostol, the FDA doesn’t typically regulate how a drug is used off-label, according to David Cohen, a law professor at Drexel University and national expert on abortion law.

“There would have to be some finding that it is not safe or effective for ulcer treatment, something that there’s no argument anyone could possibly show,” Cohen said.

Some telehealth companies already used that alternative back in 2021, when the Supreme Court temporarily reinstated a requirement that mifepristone must be dispensed in person.

Carafem, a company that provides telehealth abortion, switched to using only misoprostol during that period “and has been prepared for this possibility ever since,” said Melissa Grant, a co-founder of the company and its chief operating officer.

Tapping into a global supply chain

Other organizations are already directing patients to mifepristone from outside the U.S., through groups such as Aid Access and online pharmacies in places like India.

Even if the Trump administration tried to enforce the Comstock Act, an 1873 law that bans the mailing of obscene matter and anything intended to produce an abortion, it would be extremely difficult to stop the flow of pills, Cohen said.

“We’ve had the ‘War on Drugs’ for what, half a century, maybe longer?” he said. “And everyone, if they wanted, could find illegal drugs within minutes, and have it probably delivered to their doorstep within hours.”

Anti-abortion groups targeting ‘chemical’ abortions

Abortion pills were called “the single greatest threat to unborn children in a post-Roe world” in Project 2025, a blueprint for the second Trump administration written by the conservative Heritage Foundation, and abortion opponents are increasingly vocal about their frustration with the Trump administration over them.

“People’s patience is at an end on this point,” said Kristi Hamrick, vice president of media and policy for Students for Life of America.

The group recently met with the Department of Justice to discuss priorities of the anti-abortion movement, such as enforcement of the Comstock Act.

The ability to use telehealth to circumvent state abortion bans is a key target of Louisiana’s lawsuit, which a federal appeals court is currently weighing.

The suit, which has the backing of 21 other states, argues that the FDA under the Biden administration acted illegally when it allowed mifepristone to be prescribed without an in-person visit to a doctor.

Without that change, “activists in New York and California could not blanket pro-life states like Louisiana with mifepristone by mail,” the suit argues.

But because medication abortion is now the most common form of abortion in the U.S., restricting mifepristone would have a wide impact even in states without abortion bans.

“Stopping the FDA’s unlawful mail-order mifepristone scheme will surely decrease the number of chemical abortions across the country,” said Gabriella McIntyre, a lawyer for Alliance Defending Freedom, which partnered with Louisiana in its suit.

And there are signs the administration may be feeling the pressure, even if it’s tempered by worries that further abortion restrictions could hurt Republicans in this fall’s midterm elections.

But abortion opponents are actively trying to counter balance that narrative — and keep the pressure on.

For one, it looks like the FDA’s safety evaluation of mifepristone — which abortion opponents have long pushed for — may be moving forward, potentially allowing the administration to restrict the drug’s use. It’s too soon to tell, said Hamrick, who refers to the long-promised evaluation as a “unicorn.”

“It feels mythical,” she said. “I look forward to seeing it. But it’s taking too long.”

Contemplating a misoprostol-only future

If mifepristone is restricted and providers switch to misoprostol-only regimens, abortion opponents say they’re ready to highlight the risks.

“We call it the new coat hanger,” said Hamrick. Abortion providers will prescribe it, she said, “knowing it fails more often, knowing that the complications are worse, because they’re so committed to online distribution of pills for the purpose of abortion.”

Telehealth providers agree that patients need to be informed about what to expect with any medication abortion. “Our experience globally suggests that if you continue to give additional doses of misoprostol, you can get comparable success rates,” Foster said.

In the end, Foster’s practice didn’t have to mail patients the misoprostol-only packages that weekend in May, she said, because the Supreme Court put the lower court’s ruling on hold while the case plays out.

But if needed, the pills would have gotten to patients, she said.

The group has seen a recent spike in demand, especially from patients in Louisiana. Foster thinks all the media coverage is reaching people who didn’t know they could get abortion pills online. “Maybe this is the first time you’ve been exposed to that,” she said.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

8 things to know about the gut microbiome and keeping yours healthy : NPR

In healthy people, the specific makeup of the gut microbiome can vary considerably based on geography, lifestyle, diet, genetics and other factors.

diane555/Getty Images

hide caption

toggle caption

diane555/Getty Images

In the world of wellness and health content, few areas of our anatomy attract more interest lately — and specious claims — than the gut microbiome.

This vast ecosystem of bacteria and microorganisms within our intestines shapes our health in profound ways that go well beyond digesting food — our immune system, mood, cognition, metabolism and much more.

But public awareness of the microbiome’s central role in our well-being has also given rise to a market of advice-givers and products playing up the idea that we need to constantly test, reset, or somehow optimize this network of bugs inside us.

Gut researchers say, in many cases, what’s being promoted has leapfrogged the evidence.

Here’s what some of the leading scientists in the field want you to know:

1. A “healthy” gut microbiome is still hard to define

It’s a fundamental challenge for the field: In healthy people, the specific makeup of the gut microbiome can vary considerably based on geography, lifestyle, diet, genetics and other factors.

Even though the field has made major strides, there’s “no clinical or scientific consensus around what constitutes a healthy microbiome,” says Hannah Holscher, a professor of nutrition at the University of Illinois in Urbana-Champaign.

This is why there’s no single metric that can deliver a reasonably straightforward assessment of your gut health like there is for cholesterol or blood pressure.

Want the latest stories on the science of healthy living? Subscribe to NPR’s Health newsletter.

Broadly speaking, however, scientists do have clues about what tend to be desirable characteristics for the microbiome.

Research shows a higher diversity of microorganisms can be one indicator. You can also look at how well the microbiome resists change in the face of disruptions like illness or antibiotics, and the ability to bounce back after that. Scientists have also identified certain groups of bacteria that are correlated with health.

While none of these are universal markers — because in some instances, higher diversity can actually be associated with certain diseases — taken together, all of these can be markers of how well the microbiome is doing.

2. It’s not just about which bugs are there — it’s what they’re doing 

Scientists have identified certain groups of bacteria that are often associated with better health, and lab research has revealed some of the important jobs they’re carrying out.

But experts caution against simplistic notions that you can separate the inhabitants of the gut into “good” and “bad” microbes.

“There’s a new understanding that we’re not necessarily talking about just one microbe at a time causing problems,” says Dr. Alexander Khoruts, a professor at the University of Minnesota who directs the UMN Microbiota Therapeutics Program.

“It could be an entire microbial community as a unit that may be dysfunctional,” he adds.

In one major study published last year, a team of gut researchers surveyed more than 40,000 human gut microbiomes from dozens of countries and ranked different groups of bacteria that appear to be “keystones” of health and resilience, such as Roseburia, Eubacterium, Faecalibacterium, Allistipes and Bacteroides.

While the study can’t prove causation, Holscher points out there are some common themes among the top-ranking microbes, which helps explain why they’re beneficial, including their ability to ferment fiber, produce healthful metabolites and make short-chain fatty acids.

For example, Roseburia — which Holscher’s lab found can be enriched in the gut by eating certain nuts — is a major producer of butyrate, a short-chain fatty acid that nourishes the cells in the colon, supports the gut lining and helps create an acidic environment that’s inhospitable to pathogens like E. coli.

The catch here is that two healthy people can have microbiomes that look and behave very differently, meaning they could respond to the same diets and interventions in very different ways.

3. The modern microbiome has issues, but it’s not broken either

If you spend enough time on social media, it’s easy to think our modern microbiomes are hopelessly wrecked.

Dr. Fergus Shanahan, a longtime researcher in the field and an emeritus professor of medicine at the National University of Ireland in Cork, says the truth of the matter is more nuanced.

“There are many features of our industrialized microbiome that are suboptimal, but it may be the best we have because our microbiome has changed and adapted to our environment,” he says.

Studies show that living in industrialized societies has taken a toll on our gut health.

The wide use of antibiotics, a diet heavy in refined food and low in fiber, a sedentary lifestyle, and other environmental factors aren’t helping our microbiome.

But the fact that our microbiome looks different from that of our ancestors doesn’t necessarily mean we’d be better off if we simply swapped ours for an earlier model.

When people who live in a preindustrialized setting move to a more industrialized one, Shanahan says it appears their microbiome may actually become a liability, potentially increasing their risk of obesity and other chronic diseases.

And what may have been normal at one point in history may not necessarily have been “healthy.”

For example, it’s now well-established that the bacteria species Helicobacter pylori is a risk factor for peptic ulcers and stomach cancer. Not that long ago, though, most people had this bacterium in their stomach, and scientists speculated that it may have had a protective effect against certain autoimmune and allergic diseases.

“So there’s a yin-yang with everything. What’s good at a certain time in human evolution isn’t necessarily good at a later time,” Shanahan adds.

4. Over the counter microbiome tests — questionable results

As technology has advanced, so too has the market of products that promise to divine your gut health.

These direct-to-consumer tests usually rely on stool samples, cost a few hundred dollars and deliver hundreds of measurements related to microbes and metabolites, sometimes even offering you a gut health score.

The allure is obvious: If you can map your microbiome, surely you can pinpoint the sources of your troubles and optimize the microbial communities.

In his practice, Khoruts says it’s not unusual for patients to present him with these personalized results.

“I think the message the patient gets is ‘gee, my doctor never did this kind of testing — it must mean something,'” he says. “The reality is, unfortunately, it’s not very informative at all.”

The problem starts with interpretation: Because there’s no agreed-upon definition or metric for a healthy microbiome — and so much variation exists among individuals — these tests are essentially “meaningless” from a clinical standpoint, he says.

Beyond that, research shows there are technical issues. The same stool sample sent to different companies can deliver different results, based on which methods are being used. What’s more, these direct-to-consumer products that have proliferated in the wellness space aren’t held to the same standards as diagnostic tests that your doctor might order to check for a specific disease or pathogen.

5. How about probiotics?

Wandering the supplement aisle of a health food store can be a dizzying experience with endless options of probiotics aimed at supporting different organ systems and aspects of your well-being.

Experts have outlined three core requirements for a probiotic: The microbes must be alive, present in sufficient quantities and have a proven health benefit.

Shanahan says this last criterion is usually the one that commercial products gloss over by claiming they have been “clinically tested” but omitting the fact that the actual findings were underwhelming.

“I’m afraid the consumer has to be really careful about that,” he says.

Researchers do agree that probiotics have potential, and some strains are backed by high-quality data that shows they can be effective in specific circumstances.

For example, some strains of probiotics can lower the risk of diarrhea from antibiotics and severe complications for preterm infants. There’s also positive data on prevention of respiratory tract infections and travelers diarrhea, and in the management of some inflammatory bowel diseases.

A common misperception is that probiotics are supposed to parachute into the gut, take root and wage battle against unwelcome microbes. In reality, though, probiotics aren’t intended to colonize the gut permanently, but rather to temporarily trigger “our immune system, our intestinal lining and our gut brain-axis” to make compounds that are beneficial while we’re taking them, says Maria Marco, a professor of food technology at UC Davis.

“Through my own work, I have seen that they have made a difference in people’s lives,” she says. “The challenge probiotics face is the same issue with gut microbiome — that it depends on which microbe, for which person, at which time.”

6. What helps? Fiber and fermented foods

Humans were doing it long before “fibermaxxing” entered the wellness vernacular.

Experts say eating more fiber from nuts, fruits and vegetables is one practice from our ancestors that we should be emulating. It’s probably the single most powerful — and simplest — way to bolster our gut microbiome. And currently, most Americans fall short of the recommended daily goal, which ranges from approximately 20 grams to about 40, depending on your age and sex.

What also matters is getting fiber from a diversity of whole foods.

“Like an apple tastes different from an orange tastes different from an avocado, they have different fibers in them and different phytonutrients,” Holscher says. “Different microbes can go in and use those fibers as energy sources.”

Research shows that you can relatively quickly change the composition of the microbiome by significantly upping your fiber intake. Holscher says just take it slowly.

Her lab has found even modest additions to the diet — a handful of nuts or an avocado — can enrich certain beneficial bacteria over the course of a few weeks.

There’s also evidence that adding fermented food to your diet like kimchi, kefir and sauerkraut can be particularly effective.

In one study done by a team at Stanford, adults who added extra fermented food over the course of 2 1/2 months had increased microbial diversity and a decrease in markers of inflammation.

Yogurt is another easy way to incorporate probiotics into your diet, though it’s best to look for products that have live cultures in them and avoid those packed with sugar.

“It does appear that in the process of fermentation, certain chemicals are made, like lactic acid, that may actually have beneficial effects on the gut,” Khoruts says.

7. What to avoid 

While many foods are demonized online, experts in the field of gut health emphasize it’s the sum of what you eat more than any single food that’s most consequential.

As long as you’re eating a diverse diet, Holscher says there’s room to indulge in the occasional sugar-filled treat.

She and others advise that most of what you eat should consist of whole foods — be it from plants or animals — and to minimize foods high in refined sugars and saturated fats.

There’s also growing evidence that links ultra-processed foods to gut diseases and changes in the microbiome. Studies, primarily done in animals, have signaled artificial sweeteners, food additives and emulsifiers can be harmful, though the science — and what’s truly responsible for this link — remains unsettled.

Holscher also recommends limiting alcohol if you’re concerned about keeping your gut microbes happy. Research suggests drinking heavily can disrupt the microbiome, damage the gut lining and contribute to other problems.

8. Lifestyle matters

Our gut microbiome is intertwined with our physiology. So, when we, the host are thriving, chances are the microbes inside of us are happy, too.

Research shows sleep, exercise, and psychological well-being are all lifestyle factors that can meaningfully alter our gut microbiome — for better or worse.

While it’s not always easy to execute, Khoruts says people with gut troubles like bloating, cramps and constipation — assuming they don’t have some diagnosed condition — can expect significant improvement from making relatively simple lifestyle changes on these fronts.

In Shanahan’s view, the research has simply caught up to the commonsense advice that you’d get from your grandmother.

“Microbiome science has not found us some magic little trick that you can take and you’re going to be perfect,” he says. “So there isn’t any need for some health guru to come along and say, ‘Oh, I’ve got some potion that is going to improve your microbiome.'”

Screening for testicular cancer is ineffective

In adolescent and young adult males, palpation of the testicles for signs of cancer has traditionally been part of the preparticipation sports physical or well-child examination. Unlike most malignancies that predominantly affect older adults, testicular cancer is most commonly diagnosed between 15 and 34 years of age. Nonetheless, screening for testicular cancer has long been something I have discouraged my students and residents from doing. The rationale is twofold: it’s rare, so screening will lead to many false positives and unnecessary evaluations; and more importantly, it’s curable even at advanced stages, so earlier detection provides little to no incremental benefit. These were the reasons why in 2011, the U.S. Preventive Services Task Force (USPSTF) reaffirmed its previous recommendation against testicular cancer screening, based on an evidence review that I co-authored that found no new evidence to change this conclusion.

Others have dissented over the years. They argue that young men are among the least likely to visit a doctor and most likely to ignore early symptoms of testicular cancer. American cyclist Lance Armstrong was famously diagnosed with stage 3 testicular cancer at age 24 after ignoring the warning signs for months, having become used to intermittent groin pain and fatigue from grueling hundred-mile training rides up the sides of mountains. (After surgery and chemotherapy, Armstrong not only survived, but went on to win the Tour de France a record seven consecutive times before having his titles rescinded for doping.)

The most salient argument against the USPSTF’s “D” recommendation is that until recently, no one had actually studied the outcomes of a sizable real-world program of testicular cancer screening. Consequently, this critique stated, the recommendation grade should be “I” (insufficient evidence). In fact, I have been concerned that the Task Force’s 2018 reversal on prostate cancer screening (from “D” to “C” in men age 55 to 69 years) foreshadowed a similar change of heart on testicular cancer the next time they decided to revisit the topic.

A recently published paper appears to have closed the door on that possibility. A team of researchers performed a retrospective cohort study of more than 300,000 Israeli males age 16 to 21 years who had testicular examinations between 2012 and 2021 as part of medical screening evaluations for mandatory military service. All participants were followed for the duration of their service (generally 3 years). 43 testicular cancers developed during the study (incidence rate of 3.67 per 100,000 person-years); even though the vast majority were diagnosed clinically rather than through screening, 86% were stage 1. Of the 6 cancers determined to have been present at the initial exam (diagnosed within 6 months), screening detected 4 at the cost of 804 false positives. More than 75,000 screening exams, 176 ultrasound scans, and 112 urologist visits were required to detect a single cancer. The researchers concluded that “the low sensitivity, high number needed to screen, frequent unnecessary evaluations, and low incidence of testicular cancer suggest that routine screening of asymptomatic adolescents is ineffective.”

How recent Paxlovid studies explode Covid-19 mortality myths

In December 2021, at the height of the pandemic, the US Food and Drug Administration (FDA) granted emergency use authorization for oral nirmatrelvir-ritonavir (Paxlovid) for outpatient treatment of mild to moderate COVID-19 in adults at high risk of progression to severe disease. In February 2022, a randomized trial of 2,246 unvaccinated adults with COVID-19 reported that starting Paxlovid within 5 days of symptom onset reduced the relative risk of hospitalization or death by 89%, with 13 deaths occurring in the placebo group and none in the intervention group. These results led to expanded access to the drug via pharmacist prescribing and eventually resulted in full FDA approval in May 2023. An American Family Physician article on outpatient COVID-19 management includes clinical recommendations to consider treating high-risk adults with Paxlovid to prevent hospitalization and death.

Does Paxlovid still have value in a population with widespread immunity to COVID-19 from vaccination and prior infection? In a subsequent placebo-controlled trial of the drug with 1,296 patients (one-half vaccinated and with a risk factor for severe disease and one-half unvaccinated with no risk factors) recruited during the Delta and Omicron waves, no significant differences in symptom duration or likelihood of hospitalization or death were found.

Two open-label trials of Paxlovid in the United Kingdom and Canada that collectively enrolled 4,000 participants between April 2022 and September 2024 recently published their findings in a combined paper. Adults older than 50 years and younger adults with high-risk conditions (eg, obesity) were eligible; 98% had received a COVID-19 vaccine. Overall, less than 1% of participants were hospitalized, with no statistical differences between groups, and no one died. Outcomes for immunocompromised patients were similar; in the United Kingdom study, only 3 of 296 were hospitalized, with no benefit of Paxlovid. Although participants in the treatment group appeared to recover several days earlier than did those in the control group, the study’s lack of blinding indicates that symptom improvement may represent a placebo effect rather than a true benefit.

In a related commentary, Dr. Jeremy Faust observed: “The severe event rate (i.e., hospitalizations and deaths) in this paper was so low that it’s difficult to imagine any new antiviral will be able to show such a benefit for the foreseeable future. … So, the next big antiviral against Covid-19 will likely never be shown to prevent deaths or hospitalizations—which … is actually good news.”

Why good news? A pernicious myth about the early years of the Covid-19 pandemic is that most people died “with” rather than “from” the infection, even though there were over a million excess deaths in the U.S. and more than 22 million worldwide from 2020-2023 compared to pre-pandemic mortality rates. A related myth is that the older adults who died from Covid-19 would have died from something else soon anyway. A recent analysis of data from the United Kingdom showed that in fact, the “mortality displacement” (death earlier than expected) due to Covid-19 was quite significant: adults over 65 lost a median of 4 to 5 years of life, and two-thirds of women aged 65 to 74 years likely would have survived 5 years or more if they had avoided the infection. The reason for Paxlovid’s decreased effectiveness isn’t that the drug suddenly stopped working; it’s that vaccine and infection-derived immunity have made the very worst outcomes of Covid-19 thankfully uncommon.

**

Common Sense Family Doctor: When emotions matter more than evidence: preventing deaths from firearms

In 2019, after another of the horrific mass shooting events that most Americans have become numb to but are far less common in other developed countries, I was asked to participate in a panel presentation on “Gun Violence as a Public Health Issue” at the Family Medicine Education Consortium’s annual meeting. I worked hard to make my presentation as non-ideological as possible, mustering slide after slide of statistics showing the rise in firearm-related injuries and deaths since the turn of the century from many peer-reviewed studies. I acknowledged, though, that as with many other public health issues, no number of facts and figures would be completely persuasive. Gun violence is an issue where emotions matter more than evidence. For many, firearm ownership ensures freedom from tyranny, and government restrictions on purchasing guns, however reasonable, represent threats to personal liberty.

The following year, homicides and suicides from firearms surpassed motor vehicle accidents as the leading cause of death in children and adolescents for the first time, and an updated analysis found that the firearm-related death rate in this group increased by 3.9% from 2020 to 2023. For perspective, in 2023, guns killed 4455 children, while Covid-19 infections accounted for 125 children’s deaths in 2023 and 547 deaths at the pandemic’s peak in 2021. This is why it is as essential for physicians to provide counseling on firearm injury prevention during well-child visits as counseling regarding Covid-19 and other recommended vaccines.

A recent cross-sectional study in JAMA Network Open examined associations between state firearm laws and firearm-related suicides from 1976 to 2024. The investigators focused on 6 types of laws involving handgun permits, waiting periods for firearm purchases, concealed carry licenses, minimum age requirements, extreme risk protection orders, and permits for gun dealers. They found that states that required handgun permits, waiting periods, and/or concealed carry licenses had lower firearm suicide rates, and states with all 3 laws had 25% lower rates than states with none.

Compared to these legislative interventions, individual clinicians have less to offer. The U.S. Preventive Services Task Force found insufficient evidence that screening adults for suicide risk prevents suicides, and it isn’t certain that counseling gun owners about safe storage practices (using trigger locks, gun safes, storing ammunition separately) makes a difference, either.

As for gun homicides, public health interventions aimed at resolving conflicts without resorting to violence have shown positive results in Baltimore, Maryland, where gun violence is treated as a contagious disease and “violence interrupters” work diligently to defuse small disputes before they involve firearms. Critically, preventing violence also involves recognizing and addressing its structural causes:

Baltimore’s first comprehensive violence prevention plan takes public safety beyond police, prosecution, and prison by working closely with community groups to focus on prevention and support for those most affected by the violence. … Community organizations, some partially funded by the Mayor’s Office, connect people to education and life coaching. They help get documents like IDs, birth certificates, and Social Security cards, and they help expunge criminal records, making it easier to get jobs. They pay energy bills and fill gas tanks; they offer emergency relocation, financial stipends, transitional employment support, drug treatment—even helping people to reconnect with their families.

hantavirus on the MV Hondius

Although an estimated two-thirds of international travelers will develop a travel-related illness, most fevers and respiratory symptoms have self-limiting causes. A notable exception was an outbreak of severe acute respiratory illness that afflicted 13 passengers and crew members (including the ship’s doctor) on the expedition cruise ship MV Hondius and caused three deaths. The first passenger to die most likely acquired the infection from a rodent in Argentina, where the MV Hondius departed on April 1, 2026. Reverse transcriptase polymerase chain reaction (RT-PCR) testing confirmed that the contagious illness was hantavirus cardiopulmonary syndrome caused by the Andes virus, which had previously shown person-to-person transmissibility in crowded social settings.

A 2002 American Family Physician article called hantavirus infection “a zebra worth knowing” because, although it is rare (fewer than 900 cases have been reported in the United States since 2023), prompt diagnosis in persons with early symptoms can be lifesaving. Outside of the Andes virus, hantavirus is acquired by exposure to saliva, urine, or feces of infected rodents, such as the deer mouse in the United States.

After an incubation period of up to several weeks, patients in the prodromal phase of the illness develop fever and myalgias, lasting 3 to 5 days. Characteristic laboratory findings include thrombocytopenia, left-shifted leukocytosis, circulating immunoblasts, and hemoconcentration. The cardiopulmonary phase is heralded by the acute onset of hypotension, pulmonary edema, tachypnea, and progressive hypoxia, usually requiring mechanical ventilation within 24 hours. No specific treatment is available. Despite supportive care, the case fatality rate of hantavirus cardiopulmonary syndrome approaches 40%.

On May 18, 2026, the Centers for Disease Control and Prevention issued a health alert for US clinicians and health departments about when to consider testing patients for hantavirus infection. It is thought that transmission of Andes virus occurs only in the symptomatic phases; therefore, at least 65 US passengers and others with possible Andes virus exposures are being monitored at home by state health departments or in the 20-bed National Quarantine Unit at the University of Nebraska Medical Center, though many of the latter are being forcibly prevented from going home.

Despite a superficial resemblance to the early days of the COVID-19 pandemic—a fatal respiratory illness spread rapidly on a cruise ship while political leaders and public health authorities assert that the risk to the general public is low—Andes virus will not become the next pandemic. (After being cleaned and disinfected, the MV Hondius resumed passenger operations on June 13, 2026.) However, the outbreak response highlighted gaps in global public health preparedness that have widened since the United States withdrew from the World Health Organization (WHO) in early 2026. A fatal outbreak on an oceangoing vessel is an international problem by definition, but efforts by various countries to contain it have been halting and inconsistent. In a JAMA commentary, Dr. Attila Hertelendy and colleagues asserted:

The principal vulnerability exposed by the Hondius outbreak lies not in sustained [viral] transmission, but in delayed recognition, fragmented authority, and inconsistent public health implementation across jurisdictions. … WHO can coordinate information sharing, issue technical guidance, and recommend public health measures, but it cannot compel states to permit disembarkation, harmonize quarantine protocols, or share responsibility for exposed travelers.

**